final program - pic1.cmt.com.cnpic1.cmt.com.cn/newspic/files/cit2014_final_program.pdf · cit2014...

Organizer

Co-Sponsors

Chinese Medical Association

National Center for Cardiovascular Diseases of China

Board of Directors, China Interventional Therapeutics

Chinese Society of Cardiology

Cardiovascular Research Foundation

FINAL PROGRAM

CIT 2014 www.citmd.com

003

Organizer

￤ Chinese Medical Association

Co-Sponsors

￤ National Center for Cardiovascular Diseases of China

￤ Board of Directors, China Interventional Therapeutics

￤ Chinese Society of Cardiology

￤ Cardiovascular Research Foundation

Associations and A�liations

￤ EuroPCR

￤ European Association of Percutaneous Cardiovascular Intervention (EAPCI)

￤ Complex Cardiovascular Therapeutics (CCT)

￤ Sociedad Latinoamericana de Cardiología Intervencionista (SOLACI)

￤ Cardiovascular Summit - TCTAP

￤ Cardiovascular Research Technologies (CRT)

￤ Asian Interventional Cardiovascular Therapeutics (AICT)

￤ Society for Cardiovascular Angiography and Interventions (SCAI)

￤ New Cardiovascular Horizons (NCVH)

￤ International Society of Endovascular Specialists (ISES)

￤ Division of Medicine and Health, Chinese Academy of Engineering

￤ Asian-Pacific Society of Interventional Cardiology (APSIC)

￤ Cardiovascular Society of Cross-Straits Medicine Exchange Association

￤ China Cardiovascular Promotive Association, China International Exchange and Promotive Association for Medicine and Health Care

￤ Hong Kong College of Cardiology (HKCC)

￤ Hong Kong Society of Transcatheter Endo-Cardiovascular Therapeutics (HKSTENT)

￤ Chinese Medical Journal

￤ NewYork-Presbyterian Hospital / Columbia University Medical Center, USA

￤ St Thomas' Hospital, London, United Kingdom

￤ Guangdong Provincial Cardiovascular Institute, China

￤ Second Affiliated Hospital of Zhejiang University School of Medicine, China

￤ Affiliated Ruijin Hospital of Shanghai Jiao Tong University School of Medicine, China

￤ Fudan University Zhongshan Hospital, China

￤ Nanjing First Hospital, Nanjing Medical University, China

￤ Affiliated Xijing Hospital of the Fourth Military Medical University, China

￤ Shenyang Northern Hospital, China

￤ Affiliated Chaoyang Hospital of Capital Medical University, China

￤ Peking University People's Hospital, China

￤ Chinese PLA General Hospital, China

￤ Affiliated An Zhen Hospital of Capital Medical University, China

￤ Fu Wai Hospital, Chinese Academy of Medical Sciences, China

主办单位

￤中华医学会

协办单位

￤国家心血管病中心

￤中国介入心脏病学大会理事会

￤中华医学会心血管病学分会

￤美国心血管研究基金会

支持单位

￤ EuroPCR

￤欧洲心血管介入治疗协会（EAPCI）

￤日本复杂心血管治疗学大会（CCT）

￤拉丁美洲介入心脏病学会（SOLACI）

￤韩国Cardiovascular Summit - TCTAP

￤美国心血管研究技术会议（CRT）

￤亚洲心血管介入治疗学会议（AICT）

￤美国心血管造影和介入学会（SCAI）

￤美国心血管新地平线会议（NCVH）

￤国际血管内专科医生学会（ISES）

￤中国工程院医药卫生学部

￤亚太介入心脏病学会（APSIC）

￤海峡两岸医药卫生交流学会心血管专业委员会

￤中国医疗保健国际交流促进会心血管疾病管理委员会

￤香港心脏病学院（HKCC）

￤香港经导管心血管腔内治疗学学会（HKSTENT）

￤中华医学杂志英文版

￤美国纽约长老会医院 / 哥伦比亚大学医学中心

￤英国伦敦圣托马斯医院

￤广东省心血管病研究所

￤浙江大学医学院第二附属医院

￤上海交通大学医学院附属瑞金医院

￤复旦大学附属中山医院

￤南京医科大学附属南京市第一医院

￤第四军医大学附属西京医院

￤沈阳军区总医院

￤首都医科大学附属朝阳医院

￤北京大学人民医院

￤中国人民解放军总医院

￤首都医科大学附属安贞医院

￤阜外心血管病医院


004

SEPTEMBER 13-17 2014 WASHINGTON, DCWalter E. Washington Convention Center

Register today at: WWW.TCTCONFERENCE.COM

NEW STRUCTURE AND NEW SCHEDULE:Live Cases and Late Breakers now begin on Saturday

TCT再次聚首华盛顿


005

SEPTEMBER 13-17 2014 WASHINGTON, DCWalter E. Washington Convention Center

Register today at: WWW.TCTCONFERENCE.COM

NEW STRUCTURE AND NEW SCHEDULE:Live Cases and Late Breakers now begin on Saturday

TCT再次聚首华盛顿 Complex Cardiovascular Therapeutics 2O14

Challenge andInnovation

Call for Cases / AbstractsSubmission Period April 10 Thu. – June 30 Mon., 2014

Kobe International Exhibition HallPortopia Hotel, Kobe, Japan

October 30 thu.-November 1 sat., 2014

CCT Website●http://cct.gr.jp/

Dates

Venues


006

Yasushi AsakuraYasumi IgarashiEtsuo Tsuchikane

Fudan University Zhongshan Hospital, Shanghai转播:复旦大学中山医院


上海跨国采购会展中心二层201会议室上海跨国采购会展中心二层201会议室Room 201, Level 2, SHCECRoom 201, Level 2, SHCEC

Saturday, March 22 8:30-12:30Saturday, March 22 8:30-12:30Date

Venue

3月22日星期六 8:30-12:303月22日星期六 8:30-12:30

Complex Cardiovascular Therapeutics

Live Case from

Operators


001

TABLE OF CONTENTS

Venue and Floor Plan 会场平面图

Welcome Message

Organization

General Information

Program at a Glance

Live Case Sites

Detailed Program

Thursday, March 20, 2014

Friday, March 21, 2014

Saturday, March 22, 2014

Sunday, March 23, 2014

Moderated Poster Program

E-Case Presentations 电子病例

欢迎辞

大会组织结构

会议信息

日程一览表

示教演示中心

会议详细日程

2014年3月20日星期四

2014年3月21日星期五

2014年3月22日星期六

2014年3月23日星期日

CIT Hands-on Center 实习中心

Exhibit Floor Plan 展位图

Exhibitors 参展单位

Acknowledgment 1

Sponsored Services

Acknowledgment 2

Acknowledgment 3

Map 地图

002

007

008

021

024

028

029

029

044

062

086

099

108

110

111

121

124

128

129

129

143

160

182

194

205

207

223

224

225

226

227

Yasushi AsakuraYasumi IgarashiEtsuo Tsuchikane

Fudan University Zhongshan Hospital, Shanghai转播:复旦大学中山医院


上海跨国采购会展中心二层201会议室上海跨国采购会展中心二层201会议室Room 201, Level 2, SHCECRoom 201, Level 2, SHCEC

Saturday, March 22 8:30-12:30Saturday, March 22 8:30-12:30Date

Venue

3月22日星期六 8:30-12:303月22日星期六 8:30-12:30

Complex Cardiovascular Therapeutics

Live Case from

Operators


002

VENUE AND FLOOR PLAN 会场平面图

一层平面布置图1F

Speaker Ready Room试片室

Faculty Lounge主席团休息区

Registration | 注册区Registration注册区

Industrial Exhibition 学术展览区

Exhibitors' Lounge

展商休息区

Moderated Poster Discussion主持壁报交流区

自助注册区Express Registration

CRF/TCTMD

CIT-on-Dem

andInternet Station


003


一夹层平面布置图1MF

Industrial Lounge-MicroPort微创医疗企业休息区


004


二层平面布置图2F

Room 202202会议室








美敦力企业休息区

用餐区

Future Meeting Desk

Industrial Lounge-Medtronic

雅培企业休息区

Industrial Lounge-Abbott Vascular

Future Meeting Desk


005


三层平面布置图3F

电子病例区

Main Arena-Pearl Hall主会场-明珠厅

Room 302A302A会议室

Room 302B302B会议室

Room 308308房间

Room 310310房间

Room 306306房间

Room 303303房间

Room 305A305A会议室

Room 305B305B会议室


Industrial Lounge-Boston Scienti�c波科企业休息区

Electronic Cases


006


三夹层平面布置图3MF Room 3M4

3M4房间Room 3M63M6房间

Room 3M13M1房间

Room 3M53M5会议室

Room 3M33M3房间

Room 3M23M2房间


007

Dear colleagues and friends,

It gives me great honor and privilege to welcome you all to the 12th annual scientific sessions of China Interventional Therapeutics (CIT) 2014 in Partnership with TCT, which will be held on Thursday, March 20th through Sunday, March 23rd, 2014 at Shanghai Convention & Exhibition Center of International Sourcing. CIT2014 is organized by the Chinese Medical Association, sponsored by National Center for Cardiovascular Diseases of China, CIT Board of Directors, Chinese Society of Cardiology, and Cardiovascular Research Foundation (CRF), and supported by 32 international and national societies and well-known heart centers.

As CIT enters its second decade, a new vision and mission has emerged beyond the traditional academic exchanges and technical training. The abbreviation CIT has embraced a new interpretation since last year. The new focus of CIT is C-Cooperation, I-Innovation, and T-Transition. Under the core concept and direction, CIT 2014 will offer more than 1,350 didactic presentations, 700 abstracts, and 50 live cases in its three-and-half-day program. The grand opening and exclusive plenary session will take place in the morning on Friday, March 21st, 2014. Original researches are presented in the forms of oral and poster abstracts, late-breaking clinical trials, topic-oriented symposia, workshops, and concurrent sessions. The basic research, practical interventional techniques, interventional pharmacology, cardiovascular prevention, and cardiovascular imaging are also covered in-depth. CIT will make an effort to minimize gaps between evidence and practice, and to facilitate and accelerate the incorporation into clinical practice of new therapies with proven safety and efficacy in appropriately conducted clinical trials. The transition theme of CIT also highlights the current and future expansion of interventional cardiovascular practice from treatment of obstructive vascular disease to other common cardiovascular problems including structural heart disease, atrial fibrillation and refractory hypertension.

As the largest interventional cardiology meeting in Asia-Pacific region, it is expected that more than 7,500 experts, cardiologists, radiologists, vascular medicine specialists, industrial partners and other health care professionals with a special interest in the field of interventional cardiology will attend the meeting. Participants will have the opportunities to share scientific information and the latest advances, to exchange expertise in interventional cardiology, to renew our friendship, and to increase worldwide collaboration. CIT2014 will also provide a unique opportunity for the industries to exhibit their new products and to contact with the cardiologists more closely.

After 10 years, CIT is again moving to Shanghai, the largest metropolis in China. The city serves as one of the most important cultural, commercial, financial, industrial and communication centers. The Bund located along Huangpu River is one of the symbols of Shanghai, it offers a living exhibition of multi-national architectures, most of which were built before 1930s. On the east side of Huangpu River (Pudong) a forest of skyscrapers has been erected since 1990s, which is one of the achievements of the reform and opening-up policy. In the evening, colorful lights illuminate both sides of the river and create a shimmering deserving of the name Pearl of the Orient.

Once again, welcome to CIT 2014 in Partnership with TCT, and have an enjoyable stay in Shanghai!

Sincerely Yours,

Run-lin Gao, MD, FACC, FESC, FSCAIProfessor of MedicineChairman, China Interventional Therapeutics (CIT)

WELCOME MESSAGE

ORGANIZATION


008

Chairman

Run-Lin Gao, MD

Co-Chairman

Martin B. Leon, MD

Chairman of Scienti�c Committee

Yong Huo, MD

Dayi Hu, MD

Course Co-Directors

Jilin Chen, MD

Jiyan Chen, MD

Shaoliang Chen, MD

Jean Fajadet, MD

Junbo Ge, MD

Yaling Han, MD

Dejia Huang, MD

Guoliang Jia, MD

Shiliang Jiang, MD

Eisho Kyo, MD

Yean-Leng Lim, MD, PhD

Shuzheng Lu, MD

Changsheng Ma, MD

Seung-Jung Park, MD, PhD

Shubin Qiao, MD

Shigeru Saito, MD

Patrick W. Serruys, MD, PhD

Weifeng Shen, MD

Gregg W. Stone, MD

Haichang Wang, MD

Jian’an Wang, MD

Weimin Wang, MD

Yuejin Yang, MD

Shu Zhang, MD

Guoying Zhu, MD

Honorary Co-Chairmen of Organizing Committee

Shengshou Hu, MD

Yanfei Liu, MD

Guoming Qi, MD

Shengli Yang, MD

Secretary General

Bo Xu, MBBS

Advisory Committee

Kejiang Cao, MD

Haozhu Chen, MD

Junzhu Chen, MD

Shulan Chen, MD

Zaijia Chen, MD

Changcong Cui, MD

Yuhuan Du, MD

Luyue Gai, MD

Jingxuan Guo, MD

Congxin Huang, MD

Baoqi Jiang, MD

Yuannan Ke, MD

Huatai Li, MD

Weimin Li, MD

Shuguang Lin, MD

Guoshu Liu, MD

Tangwei Liu, MD

Yili Liu, MD

Jieming Mao, MD

Youfang Ni, MD

Xuewen Qin, MD

Luhua Shen, MD

Fangzheng Wang, MD

Fengzhi Wang, MD

Yinsheng Wu, MD

Dingyin Zeng, MD

Yun Zhang, MD

Bingrang Zhao, MD

Aiqing Zhou, MD

Wenling Zhu, MD

Scienti�c Committee

Yasushi Asakura, MD

Maurice Buchbinder, MD

Jacques Busquet, MD

Fang Chen, MD

Yundai Chen, MD

Chung-Seung Chiang, MD

Antonio Colombo, MD

Costantino R. Costantini, MD, PhD

Bernard De Bruyne, MD, PhD

Zhimin Du, MD

Eric Eeckhout, MD, PhD

Murray D. Esler, MD, PhD

Quan Fang, MD

Weiyi Fang, MD

Guosheng Fu, MD

Xianghua Fu, MD

Wei Gao, MD

Juan F. Granada, MD

Liliana R. Grinfeld, MD

Eberhard Grube, MD

Wenyi Guo, MD

Ben He, MD

David E. Kandzari, MD

Adnan Kastrati, MD

Hyo-Soo Kim, MD, PhD

Spencer B. King III, MD

Ajay J. Kirtane, MD, SM

Alexandra J. Lansky, MD

Jianjun Li, MD

ORGANIZATION


009

Zhanquan Li, MD

Roxana Mehran, MD

Gary S. Mintz, MD

Marie-Claude Morice, MD

Thach Nguyen, MD

Masahiko Ochiai, MD

Horst Sievert, MD

Huay Cheem Tan, MD

Etsuo Tsuchikane, MD, PhD

Renu Virmani, MD

Ron Waksman, MD

Craig M. Walker, MD

Lefeng Wang, MD

Chris Kwok-Yiu Wong, MD

Yawei Xu, MD

Hongbing Yan, MD

Xinchun Yang, MD

Yanzong Yang, MD

Alan C. Yeung, MD

Bo Yu, MD

Ruiyan Zhang, MD

Yujie Zhou, MD

Organizing Committee

Jue Chen, MD

Lei Ge, MD

Wei Guo, MD

Wei Hua, MD

Xiongjing Jiang, MD

Zening Jin, MD

Quanmin Jing, MD

Michael Kang-Yin Lee, MD

Lang Li, MD

Yi Li, MD

Yue Li, MD

Jian Liu, MD

Xuebo Liu, MD

Yuyang Liu, MD

Jianfang Luo, MD

Shaoping Nie, MD

Jie Qian, MD

Juying Qian, MD

Xiantao Song, MD

Ning Tan, MD

Yongjian Wu, MD

Jinqing Yuan, MD

Bin Zhang, MD

Qi Zhang, MD

ORGANIZATION


010

International Faculty

Alexandre Abizaid, MD, PhDBrazil

Stephan Achenbach, MDGermany

Nazir Ahmed, MDBangladesh

Jung-Min Ahn, MDSouth Korea

Tae-Hoon Ahn, MD, PhDSouth Korea

Takashi Akasaka, MDJapan

Fernando Alfonso, MD, PhDSpain

Yaron Almagor, MDIsreal

Yasushi Asakura, MDJapan

Joseph D. Babb, MDUSA

Vinay K. Bahl, MDIndia

Theodore A. Bass, MDUSA

Marc Bedossa, MDFrance

Jacques Berland, MDFrance

Nelson Bernardo, MDUSA

Jacek Bialkowski, MDPoland

Yuval Binur, PhDIsrael

Maurice Buchbinder, MDUSA

Clifford Buckley, MDUSA

Wacin Buddhari, MDThailand

Jacques Busquet, MDFrance

Davide Capodanno, MDItaly

Anil Chagarlamudi, MDUSA

Jack P. Chen, MDUSA

Paul TL Chiam, MBBSSingapore

Kenneth Chin, MBBSMalaysia

Min Young Cho, RNSouth Korea

Gim-Hooi Choo, MDMalaysia

Antonio Colombo, MDItaly

Costantino O. Costantini, MDBrazil

Costantino R. Costantini, MD, PhDBrazil

Paul Cummins, MDNetherlands

Donald E. Cutlip, MDUSA

Ramesh B. Daggubati, MDUSA

Debabrata Dash, MDIndia

Rajesh Dave, MDUSA

Justin E. Davies, MBBS, PhDUnited Kingdom

Keith D. Dawkins, MDUSA

Bernard De Bruyne, MD, PhDBelgium

Tom De Potter, MDBelgium

Anthony DeMaria, MDUSA

Eric Dippel, MDUSA

Timothy Dy, MDPhilippines

W. Britton Eaves, MDUSA

Benit Edouard, MDBelgium

Murray D. Esler, MD, PhDAustralia

Jean Fajadet, MDFrance

William F. Fearon, MDUSA

Ted E. Feldman, MDUSA

Peter J. Fitzgerald, MD, PhDUSA

Philippe Généreux, MDUSA

Ömer Göktekin, MDTurkey

Nina Goodheart, MBAUSA

B. K. Goyal, MDIndia

Juan F. Granada, MDUSA

Liliana R. Grinfeld, MDArgentina

Eberhard Grube, MDGermany

Hyeon-Cheol Gwon, MDSouth Korea

Yuji Hamazaki, MDJapan

Tetsuya Hata, MDJapan

Ziyad M. Hijazi, MDUSA

Yutaka Hikichi, MDJapan

John McB. Hodgson, MDUSA

Myeong-Ki Hong, MD, PhDSouth Korea

Dongming Hou, MD, PhDUSA

Seung-Ho Hur, MD, PhDSouth Korea

Hweung Kon Hwang, MD, PhDSouth Korea

Yasumi Igarashi, MD, PhDJapan

ORGANIZATION


011

Fumiaki Ikeno, MDJapan

Yang-Soo Jang, MD, PhDSouth Korea

Rakesh K. Jaswal, MDIndia

Nigel Jepson, MBBSAustralia

Haizal Haron Kamar, MBBSMalaysia

David E. Kandzari, MDUSA

Soo-Jin Kang, MD, PhDSouth Korea

Saibal Kar, MDUSA

Adnan Kastrati, MDGermany

Hyo-Soo Kim, MD, PhDSouth Korea

Young-Hak Kim, MD, PhDSouth Korea

Spencer B. King III, MDUSA

Ajay J. Kirtane, MD, SMUSA

Tian-Hai Koh, MBBSSingapore

Bon-Kwon Koo, MD, PhDSouth Korea

Jan Kovac, MDUK

Richard C. Kovach, MDUSA

Mitchell W. Krucoff, MDUSA

Eisho Kyo, MDJapan

Alexandra J. Lansky, MDUSA

Nae Hee Lee, MD, PhDSouth Korea

Martin B. Leon, MDUSA

Amir Lerman, MDUSA

Michael Lim, MDSingapore

Richard Lim, MBBS, MDAustralia

Yean-Leng Lim, MD, PhDAustralia

Sidney Tsz Ho Lo, MDAustralia

William L. Lombardi, MDUSA

Chaim S. Lotan, MDIsrael

Josef Ludwig, MDGermany

Ryan D. Madder, MDUSA

Akiko Maehara, MDUSA

Felix Mahfoud, MDGermany

Fazila Tun Nesa Malik, MDBangladesh

Jean Marco, MDFrance

Motomaru Masutani, MD, PhDJapan

Samuel K. Mathew, MDIndia

Roxana Mehran, MDUSA

Nazir Ahmed Memon, MDPakistan

Carlos Mena, MDUSA

Ian T. Meredith, MBBS, PhDAustralia

Gary S. Mintz, MDUSA

Rosli Mohd Ali, MDMalaysia

Marie-Angèle Morel, BScNetherlands

Marie-Claude Morice, MDFrance

Jeffrey W. Moses, MDUSA

Toshiya Muramatsu, MDJapan

Michael A. Mussallem, BScUSA

Christoph K. Naber, MD, PhD Germany

Aravinda Nanjundappa, MDUSA

Richard Ng, MDSingapore

Swee Choon Ng, MBBSMalaysia

Thach Nguyen, MDUSA

Masahiko Ochiai, MDJapan

Masaaki Okutsu, MDJapan

Yoshinobu Onuma, MDNetherlands

Satoru Otsuji, MDJapan

Kenan Ovunc, MDTurkey

Jai-Wun Park, MDGermany

Kyung-Woo Park, MD, PhDSouth Korea

Sang Man Park, RTSouth Korea

Seung-Jung Park, MD, PhDSouth Korea

Roberto Patarca, MD, PhDUSA

Atul Pathak, MD, PhDFrance

Raghotham R. Patlola, MDUSA

Nico H. J. Pijls, MD, PhDNetherlands

Matthew J. Price, MDUSA

Jenny Zhen Qin, MSUSA

ORGANIZATION


012

Sufia Rahman, MDBangladesh

Sudhir Rathore, MDUK

Johan H. C. Reiber, PhDNetherlands

Gianluca Rigatelli, MD, PhDItaly

Alfredo E. Rodriguez, MD, PhDArgentina

Campbell Rogers, MDUSA

Martin T. Rothman, MDUSA

Witold Ruzyllo, MDPoland

Shigeru Saito, MDJapan

Sean Salmon, MBAUSA

Gustavo Samaja, MDArgentina

Teguh Santoso, MD, PhDIndonesia

Bruno Scheller, MDGermany

Wolfgang Schillinger, MDGermany

Patrick W. Serruys, MD, PhDNetherlands

Ashok Seth, MDIndia

Magnus Settergren, MD, PhDSweden

Imad Sheiban, MDItaly

Won-Heum Shim, MD, PhDSouth Korea

Thomas Shimshak, MDUSA

Eak-Kyun Shin, MD, PhDSouth Korea

Horst Sievert, MDGermany

Kui-Hian Sim, MBBSMalaysia

Charles A. Simonton, MDUSA

Pieter C. Smits, MD, PhDNetherlands

Shinjo Sonoda, MD, PhDJapan

Pieter R. Stella, MD, PhDNetherlands

Gregg W. Stone, MDUSA

Neil E. Strickman, MDUSA

Satoru Sumitsuji, MDJapan

Harry Suryapranata, MD, PhDNetherlands

Rurus Suryawan, MDIndonesia

Malgorzata Szkutnik, MDPoland

Seung-Jea Tahk, MD, PhDSouth Korea

Akihiko Takahashi, MD, PhDJapan

Masamichi Takano, MD, PhDJapan

Corrado Tamburino, MDItaly

Huay Cheem Tan, MDSingapore

Etsuo Tsuchikane, MD, PhDJapan

Thomas M. Tu, MDUSA

Wasan Udayachalerm, MDThailand

Mujeeb Ul-Haq, MDPakistan

Pietro Vandoni, MDItaly

Joseph Varon, MDUSA

Rajesh Vijayvergiya, MDIndia

Renu Virmani, MDUSA

Kenji Wagatsuma, MD, PhDJapan

Marco Wainstein, MDBrazil

Ron Waksman, MDUSA

Craig M. Walker, MDUSA

Wan Azman Wan Ahmad, MDMalaysia

Jie Wang, MD, PhDUSA

Kai Wang, MD, PhDUSA

John G. Webb, MDCanada

Shing-Chiu Wong, MDUSA

Marvin L. Woodall, BBAUSA

Yoshito Yamamoto, MDJapan

Masahisa Yamane, MDJapan

Joo-Young Yang, MDSouth Korea

Yi-Ming Yang, MDUSA

Yee Guan Yap, MBBSMalaysia

Alan C. Yeung, MDUSA

Fuminobu Yoshimachi, MD, PhDJapan

Jiangtao Yu, MDGermany

Robaayah Zambahari, MDMalaysia

David X. M. Zhao, MDUSA

ORGANIZATION


013

Chinese Faculty: Hong Kong, Macau and Taiwan

Alan Ka-Chun Chan, MDHong Kong, China

Chi-Kin Chan, MDHong Kong, China

Jason Leung-Kwai Chan, MDHong Kong, China

Kam-Tim Chan, MDHong Kong, China

Kelvin Chan, MDHong Kong, China

Wai-Kwong Chan, MDHong Kong, China

Chung-Seung Chiang, MDHong Kong, China

Tak-Shun Chung, MDHong Kong, China

Xiwei Deng, MDMacau, China

Ching-Chang Fang, MDTaiwan, China

William Kongto Hau, PhDHong Kong, China

Duncan Hung-Kwong Ho, MDHong Kong, China

I-Chang Hsieh, MDTaiwan, China

Chien-Ming Huang, MDTaiwan, China

Paul Hsien-Li Kao, MDTaiwan, China

Patrick Tak-Him Ko, MDHong Kong, China

Vincent On-Hing Kwok, MDHong Kong, China

Simon Cheung-Chi Lam, MDHong Kong, China

U Po Lam, MDMacau, China

Yat-Yin Lam, MDHong Kong, China

Chu-Pak LauHong Kong, China

Michael Kang-Yin Lee, MDHong Kong, China

Stephen Wai-Luen Lee, MDHong Kong, China

Wen-Lieng Lee, MD, PhDTaiwan, China

Changzhao Liao, RNTaiwan, China

Ping-Han Lo, MDTaiwan, China

Ju-Pin Pan, MDTaiwan, China

Li-Wah Tam, MDHong Kong, China

Chuen-Den Tseng, MD, PhDTaiwan, China

Kin-Lam Tsui, MDHong Kong, China

Ping-Tim Tsui, MDHong Kong, China

Shih-Pu Wang, MDTaiwan, China

Chris Kwok-Yiu Wong, MDHong Kong, China

Edmond Wong, MDHong Kong, China

Philip Hung-Chung Wong, MDHong Kong, China

Chiung-Jen Wu, MDTaiwan, China

Wei-Hsian Yin, MDTaiwan, China

Cheuk-Man Yu, MDHong Kong, China

ORGANIZATION


014

Chinese Faculty

An Jian, MD

An Yi, MD

Bai Feng, MD

Bu Jun, MD

Cai Shanglang, MD

Cao Feng, MD

Cao Xuebin, MD

Chang Guangqi, MD

Chang Qian, MD

Chen Buxing, MD

Chen Fang, MD

Chen Hui, MD

Chen Jilin, MD

Chen Jiyan, MD

Chen Jue, MD

Chen Keping, MD

Chen Lianglong, MD

Chen Lin, MD

Chen Mao, MD

Chen Minglong, MD

Chen Shaoliang, MD

Chen Wenqiang, MD

Chen Yuguo, MD

Chen Yundai, MD

Chen Zhi, MD

Chen Zhong, MD

Chen Zhujun, MD

Cheng Biao, MD

Cheng Guanchang, MD

Cheng Shujuan, MD

Cheng Xiaoshu, MD

Cheng Yingzhang, MD

Cong Hongliang, MD

Cui Junyu, MD

Cui Lianqun, MD

Shanxi

Shandong

Gansu

Shanghai

Shandong

Shaanxi

Hebei

Guangdong

Beijing

Beijing

Beijing

Beijing

Beijing

Guangdong

Beijing

Beijing

Fujian

Fujian

Sichuan

Jiangsu

Jiangsu

Shandong

Shandong

Beijing

Hunan

Beijing

Guangdong

Sichuan

Henan

Beijing

Jiangxi

Jiangxi

Tianjin

Beijing

Shandong

Dai Jun, MD

Dang Qun, MD

Ding Shifang, MD

Ding Yansheng, MD

Dong Jianzeng, MD

Dong Pingshuan, MD

Dou Kefei, MD

Du Zhimin, MD

Fan Bing, MD

Fang Pihua, MD

Fang Quan, MD

Fang Weiyi, MD

Feng Yanguang, MD

Feng Yuan, MD

Fu Guosheng, MD

Fu Xianghua, MD

Fu Weiguo, MD

Gan Jihong, MD

Gao Chuanyu, MD

Gao Lianjun, MD

Gao Pingjin, MD

Gao Run-Lin, MD

Gao Wei, MD

Gao Wei, MD

Gao Zhan, MD

Ge Junbo, MD

Ge Lei, MD

Gong Jianbin, MD

Gu Dongfeng, MD

Gu Yongquan, MD

Guan Jun, MD

Guang Xuefeng, MD

Guo Chengjun, MD

Guo Jincheng, MD

Guo Jun, MD

Guo Lijun, MD

Beijing

Tianjin

Hubei

Beijing

Beijing

Henan

Beijing

Guangdong

Shanghai

Beijing

Beijing

Shanghai

Hebei

Sichuan

Zhejiang

Hebei

Shanghai

Xinjiang

Henan

Liaoning

Shanghai

Beijing

Shanghai

Beijing

Beijing

Shanghai

Shanghai

Jiangsu

Beijing

Beijing

Shandong

Yunnan

Beijing

Beijing

Beijing

Beijing

Guo Ning, MD

Guo Tao, MD

Guo Wei, MD

Guo Wenyi, MD

Guo Xiaohua, MD

Han Lixian, MD

Han Yaling, MD

Han Zhanying, MD

Hang Jingyu, MD

Hao Yunxia, RN

He Ben, MD

He Qing, MD

He Zuoxiang, MD

He Yong, MD

He Yuquan, MD

Hong Kui, MD

Hong Lang, MD

Hou Guihua, RN

Hou Jingbo, MD

Hou Yuqing, MD

Hou Zishan, MD

Hu Chengheng, MD

Hu Dayi, MD

Hu Fenghuan, MD

Hu Shengshou, MD

Hua Wei, MD

Hua Yihong, MD

Hua Yimin, MD

Huang Chaolian, MD

Huang Dejia, MD

Huang He, MD

Huang Lan, MD

Huang Lianjun, MD

Huang Rongchong, MD

Huang Shi'an, MD

Huang Weijian, MD

Shaanxi

Yunnan

Beijing

Shaanxi

Neimenggu

Hebei

Liaoning

Henan

Shanghai

Beijing

Shanghai

Beijing

Beijing

Sichuan

Jilin

Jiangxi

Jiangxi

Beijing

Heilongjiang

Guangdong

Shandong

Guangdong

Beijing

Beijing

Beijing

Beijing

Beijing

Sichuan

Beijing

Sichuan

Hubei

Chongqing

Beijing

Liaoning

Guangdong

Zhejiang

ORGANIZATION


015

Shaanxi

Yunnan

Beijing

Shaanxi

Neimenggu

Hebei

Liaoning

Henan

Shanghai

Beijing

Shanghai

Beijing

Beijing

Sichuan

Jilin

Jiangxi

Jiangxi

Beijing

Heilongjiang

Guangdong

Shandong

Guangdong

Beijing

Beijing

Beijing

Beijing

Beijing

Sichuan

Beijing

Sichuan

Hubei

Chongqing

Beijing

Liaoning

Guangdong

Zhejiang

Hui Yongming, MD

Huo Yong, MD

Ji Zhenguo, MD

Ji Zheng, MD

Jia Guoliang, MD

Jia Shaobin, MD

Jia Yongping, MD

Jiang Hong, MD

Jiang Shisen, MD

Jiang Dongju, MD

Jiang Jian, MD

Jiang Tiemin, MD

Jiang Chenyang, MD

Jiang Jinfa, MD

Jiang Junhao, MD

Jiang Jun, MD

Jiang Mi'er, MD

Jiang Shiliang, MD

Jiang Xiongjing, MD

Jin Huigen, MD

Jin Mei, MD

Jin Qinhua, MD

Jin Yuanzhe, MD

Jin Zening, MD

Jin Jun, MD

Jin Lijun, MD

Jing Quanmin, MD

Ke Yongsheng, MD

Kong Xiangqing, MD

Li Hui, MD

Li Bao, MD

Li Chengxiang, MD

Li Chuanchang, MD

Li Fen, MD

Li Guangping, MD

Li Guishuang, MD

Li Guoqing, MD

Li Hongwei, MD

Li Hu, MD

Li Jifu, MD

Li Jianjun, MD

Li Jianping, MD

Li Kang, MD

Li Lang, MD

Li Li, MD

Li Li, MD

Li Li, MD

Li Ling, MD

Li Lu, MD

Li Shumei, MD

Li Shufeng

Li Sijin, MD

Li Tianchang, MD

Li Wei, PhD

Li Weijie, MD

Li Weiming, MD

Li Xiaodong, MD

Li Xinming, MD

Li Xuebin, MD

Li Xueqi, MD

Li Yaming, MD

Li Yan, MD

Li Yi, MD

Li Yi, MD

Li Yigang, MD

Li Yongjun, MD

Li Yue, MD

Li Zhanquan, MD

Li Zhizhong, MD

Lian Zhexun, MD

Liang Chun, MD

Liang Yanchun, MD

Xinjiang

Beijing

Guangdong

Shandong

Beijing

Beijing

Beijing

Guangxi

Guangdong

Shanghai

Hebei

Henan

Liaoning

Jilin

Heilongjiang

Shanxi

Beijing

Beijing

Shaanxi

Shanghai

Liaoning

Shanghai

Beijing

Heilongjiang

Liaoning

Shaanxi

Guangdong

Liaoning

Shanghai

Hebei

Heilongjiang

Liaoning

Beijing

Shandong

Shanghai

Liaoning

Lin Rong, MD

Lin Wenhua, MD

Lin Xianhe, MD

Lin Yingzhong, MD

Liu Bin, MD

Liu Changwei, MD

Liu Chaozhong, MD

Liu Fan, MD

Liu Haibo, MD

Liu Heping, MD

Liu Hongbin, MD

Liu Hongxu, MD

Liu Hui, MD

Liu Huiliang, MD

Liu Jian, MD

Liu Jianping, MD

Liu Meilin, MD

Liu Qiang, MD

Liu Quan, MD

Liu Shaowen, MD

Liu Tongku, MD

Liu Xingpeng, MD

Liu Xu, MD

Liu Xuebo, MD

Liu Yan, RN

Liu Yin, MD

Liu Yuyang, MD

Liu Zhenyu, MD

Liu Hong, MD

Liu Jinghua, MD

Lu Caiyi, MD

Lu Changlin, MD

Lu Chengzhi, MD

Lu Lin, MD

Lu Zhigang, MD

Lu Qinghua, MD

Fujian

Tianjin

Anhui

Guangxi

Jilin

Beijing

Beijing

Hebei

Beijing

Jilin

Beijing

Beijing

Henan

Beijing

Beijing

Chongqing

Beijing

Guangdong

Jilin

Shanghai

Jilin

Beijing

Shanghai

Shanghai

Beijing

Tianjin

Beijing

Beijing

Beijing

Beijing

Beijing

Beijing

Tianjin

Shanghai

Shanghai

Shandong

Beijing

Beijing

Hebei

Hebei

Guangdong

Ningxia

Shanxi

Hubei

Jiangsu

Liaoning

Liaoning

Tianjin

Zhejiang

Shanghai

Shanghai

Zhejiang

Shanghai

Beijing

Beijing

Shanghai

Beijing

Beijing

Liaoning

Beijing

Chongqing

Guangdong

Liaoning

Anhui

Jiangsu

Heilongjiang

Shanxi

Shaanxi

Hunan

Shanghai

Tianjin

Shandong

ORGANIZATION


016

Lu Anlin, MD

Lu Bin, MD

Lu Jiyuan, MD

Lu Shuzheng, MD

Luo Jianfang, MD

Luo Qiyi, MAS

Ma Changsheng, MD

Ma Genshan, MD

Ma Jian, MD

Ma Likun, MD

Ma Liping, MD

Ma Yitong, MD

Ma Yingyan, MD

Man Ronghai, MD

Mao Jingyuan, MD

Miao Lifu, MD

Mu Chaowei, MD

Nie Ruqiong, MD

Nie Shaoping, MD

Ning Guang, MD

Niu Suocheng, MD

Pan Xin, MD

Pang Wenyue, MD

Peng Jianjun, MD

Pu Jielin, MD

Pu Kui, MD

Qi Guoxian, MD

Qi Xiangqian, MD

Qi Xiaoyong, MD

Qian Jie, MD

Qian Juying, MD

Qian Mingyang, MD

Qiao Shubin, MD

Qin Jun, MD

Qin Lei, MD

Qin Qin, MD

Shaanxi

Beijing

Shanxi

Beijing

Guangdong

Shanghai

Beijing

Jiangsu

Beijing

Anhui

Henan

Xinjiang

Liaoning

Neimenggu

Tianjin

Beijing

Beijing

Guangdong

Beijing

Shanghai

Henan

Shanghai

Liaoning

Beijing

Beijing

Tianjin

Liaoning

Tianjin

Hebei

Beijing

Shanghai

Guangdong

Beijing

Chongqing

Henan

Tianjin

Qin Yongwen, MD

Qin Yuming, MD

Qiu Chunguang, MD

Qiu Yumin, MD

Qu Peng, MD

Qu Xinkai, MD

Qu Xiufen, MD

Ru Leisheng, MD

Shan Jiping, MD

Shan Qijun, MD

Shan Shoujie, MD

Shen Chengxing, MD

Shen Farong, MD

Shen Weifeng, MD

Shen Xiangqian, MD

Shen Zhujun, MD

Sheng Guotai, MD

Shi Haifeng, MD

Shi Haiming, MD

Shi Hongcheng, MD

Shi Dongmei, MD

Shi Xinli, MD

Shu Chang, MD

Song Xiantao, MD

Song Yaoming, MD

Song Zhiyuan, MD

Su Xi, MD

Su Yangang, MD

Sun Fucheng, MD

Sun Huabao, MD

Sun Ningling, MD

Sun Yingxian, MD

Sun Yong_HEB, MD

Sun Yong_HZ, MD

Tan Ning, MD

Tang Baopeng, MD

Shanghai

Jiangsu

Henan

Ningxia

Liaoning

Shanghai

Heilongjiang

Hebei

Shandong

Jiangsu

Jiangsu

Shanghai

Zhejiang

Shanghai

Hunan

Beijing

Jiangxi

Shanghai

Shanghai

Shanghai

Beijing

Beijing

Hunan

Beijing

Chongqing

Chongqing

Hubei

Shanghai

Beijing

Guangdong

Beijing

Liaoning

Heilongjiang

Zhejiang

Guangdong

Xinjiang

Tang Fakuan, MD

Tang Jifei, MD

Tang Lijiang, MD

Tang Liangqiu, MD

Tang Qiang, MD

Tang Yida, MD

Tang Yuansheng, MD

Tao Guizhou, MD

Tao Jun, MD

Tao Ling, MD

Tian Hongyan, MD

Tian Jun, MD

Tian Ye, MD

Wan Zheng, MD

Wang Fang, MD

Wang Bin, MD

Wang Changqian, MD

Wang Dongmei, MD

Wang Dongqi, MD

Wang Feng, MD

Wang Geng, MD

Wang Guangyi, MD

Wang Guisong, MD

Wang Haichang, MD

Wang Hao, MD

Wang Huifeng, MD

Wang Jiguang, MD

Wang Jian’an, MD

Wang Jingfeng, MD

Wang Jingping, MD

Wang Kai, MD

Wang Lefeng, MD

Wang Lei, MD

Wang Ningfu, MD

Wang Qian, MD

Wang Qibing, MD

Beijing

Zhejiang

Zhejiang

Guangdong

Beijing

Beijing

Shandong

Liaoning

Guangdong

Shaanxi

Shaanxi

Tianjin

Heilongjiang

Tianjin

Shanghai

Beijing

Shanghai

Hebei

Shaanxi

Guangxi

Liaoning

Beijing

Beijing

Shaanxi

Beijing

Shanxi

Shanghai

Zhejiang

Guangdong

Shanxi

Neimenggu

Beijing

Beijing

Zhejiang

Beijing

Shanghai

ORGANIZATION


017

Beijing

Zhejiang

Zhejiang

Guangdong

Beijing

Beijing

Shandong

Liaoning

Guangdong

Shaanxi

Shaanxi

Tianjin

Heilongjiang

Tianjin

Shanghai

Beijing

Shanghai

Hebei

Shaanxi

Guangxi

Liaoning

Beijing

Beijing

Shaanxi

Beijing

Shanxi

Shanghai

Zhejiang

Guangdong

Shanxi

Neimenggu

Beijing

Beijing

Zhejiang

Beijing

Shanghai

Wang Qiguang, MD

Wang Qingsheng, MD

Wang Qiong, MD

Wang Shouli, MD

Wang Wei, MD

Wang Wei, MD

Wang Wei, MD

Wang Weimin, MD

Wang Xian, MD

Wang Xiaozeng, MD

Wang Yan, MD

Wang Yong, MD

Wang Yong, MD

Wang Yu, MD

Wang Yuetao, MD

Wang Yulin, MD

Wang Yutang, MD

Wang Zhen, MD

Wang Zhifang, MD

Wang Zulu, MD

Wei Meng, MD

Wen Shangyu, MD

Weng Shaoxiang, MD

Wu Chun, MD

Wu Keng, MD

Wu Liqun, MD

Wu Ming, MD

Wu Qiming, MD

Wu Shulin, MD

Wu Tongguo, MD

Wu Xiaofan, MD

Wu Yongjian, MD

Wu Guangwei, MD

Wu Weifeng, MD

Xia Yong, MD

Xiang Dingcheng, MD

Xiang Meixiang, MD

Xiao Chun, MD

Xin Shuanli, MD

Xu Biao, MD

Xu Bo, MBBS

Xu Kai, MD

Xu Wei, MD

Xu Yawei, MD

Xu Yanmin, MD

Xu Yingjia, MD

Xu Zesheng, MD

Xu Zhongying, MD

Xu Feng, MD

Xu Jing, MD

Xu Lishu, MD

Xu Liang, RT

Xue Chaoyang, MD

Xue Yuzeng, MD

Yan Ji, MD

Yan Hongbing, MD

Yan Zhencheng, MD

Yang Bo, MD

Yang Chengming, MD

Yang Handong, MD

Yang Jiefu, MD

Yang Junqing, MD

Yang Lixia, MD

Yang Ming, MD

Yang Ping, MD

Yang Pingzhen, MD

Yang Shengli, MD

Yang Shusen, MD

Yang Tianhe, MD

Yang Tingshu, MD

Yang Weixian, MD

Yang Xiangjun, MD

Guangdong

Guangdong

Hebei

Jiangsu

Beijing

Liaoning

Jiangsu

Shanghai

Tianjin

Shanghai

Hebei

Beijing

Beijing

Tianjin

Xinjiang

Beijing

Ningxia

Shandong

Anhui

Beijing

Chongqing

Neimenggu

Chongqing

Hubei

Beijing

Guangdong

Yunnan

Beijing

Jilin

Guangdong

Beijing

Heilongjiang

Guizhou

Beijing

Beijing

Jiangsu

Yang Xinchun, MD

Yang Yanzong, MD

Yang Yining, MD

Yang Yongjian, MD

Yang Yuejin, MD

Yang Zhijian, MD

Yang Zhiming, MD

Yao Min, MD

Yao Yan, MD

Yao Zhuhua, MD

Ye Fei, MD

Ye Honghua, MD

Ye Meng, MD

Ye Ping, MD

Yi Qijian, MD

Yin Rongxiu, MD

Yin Yuehui, MD

You Shijie, MD

You Bei'an, MD

Yu Bo, MD

Yu Hua, MD

Yu Mengyue, MD

Yuan Hong, MD

Yuan Jinqing, MD

Yuan Yong, MD

Yuan Zuyi, MD

Zeng Hesong, MD

Zeng Qiutang, MD

Zeng Yujie, MD

Zeng Zhi, MD

Zhang Bin, MD

Zhang Dadong, MD

Zhang Daifu, MD

Zhang Fuchun, MD

Zhang Gangcheng, MD

Zhang Gaoxing, MD

Beijing

Liaoning

Xinjiang

Sichuan

Beijing

Jiangsu

Shanxi

Beijing

Beijing

Tianjin

Jiangsu

Zhejiang

Shanghai

Beijing

Chongqing

Beijing

Chongqing

Beijing

Shandong

Heilongjiang

Anhui

Beijing

Hunan

Beijing

Guangdong

Shaanxi

Hubei

Hubei

Beijing

Sichuan

Guangdong

Shanghai

Shanghai

Beijing

Hubei

Guangdong

Liaoning

Hebei

Shaanxi

Beijing

Beijing

Tianjin

Guangdong

Beijing

Beijing

Liaoning

Fujian

Beijing

Shandong

Beijing

Jiangsu

Shangdong

Beijing

Hebei

Henan

Liaoning

Shanghai

Heilongjiang

Zhejiang

Guangdong

Guangdong

Shanghai

Hainan

Beijing

Guangdong

Guangdong

Beijing

Beijing

Guangxi

Guangxi

Jiangsu

Guangdong

ORGANIZATION


018

Zhang Gejun, MD

Zhang Huan, MD

Zhang Jun, MD

Zhang Junjie, MD

Zhang Liting, MD

Zhang Minzhou, MD

Zhang Ming, MD

Zhang Ping, MD

Zhang Qi, MD

Zhang Qing, MD

Zhang Ruiyan, MD

Zhang Shu, MD

Zhang Shulin, MD

Zhang Shuyang, MD

Zhang Weihua, MD

Zhang Weize, MD

Zhang Xiwei, MD

Zhang Yaojun, MD

Zhang Yushun, MD

Zhang Zheng, MD

Zhang Zhiwei, MD

Zhao Quanming, MD

Zhao Shihua, MD

Zhao Xianxian, MD

Zhao Yelin, MD

Zhao Yingxin, MD

Zhao Zhijing, MD

Zheng Jingang, MD

Zheng Liangrong, MD

Zheng Qiangsun, MD

Zheng Yang, MD

Zheng Zhe, MD

Zhou Binquan, MD

Zhou Daxin, MD

Zhou Guowei, MD

Zhou Lijun, MD

Beijing

Tianjin

Hebei

Jiangsu

Guangdong

Guangdong

Liaoning

Beijing

Shanghai

Shanghai

Shanghai

Beijing

Beijing

Beijing

Yunnan

Gansu

Jiangsu

Jiangsu

Shaanxi

Gansu

Guangdong

Beijing

Beijing

Shanghai

Beijing

Beijing

Shaanxi

Beijing

Zhejiang

Shaanxi

Jilin

Beijing

Zhejiang

Shanghai

Shanghai

Heilongjiang

Zhou Shenghua, MD

Zhou Xuchen, MD

Zhou Yingling, MD

Zhou Yujie, MD

Zhu Guoying, MD

Zhu Jianhua, MD

Zhu Jun, MD

Zhu Xianyang, MD

Zhu Yonghong, MD

Zhuang Shaowei, MD

Zi Zhenjun

Zou Jiangang, MD

Zou Yangchun, MD

Zou Yinghua, MD

Hunan

Liaoning

Guangdong

Beijing

Hubei

Zhejiang

Beijing

Liaoning

Guangdong

Shanghai

Shanghai

Jiangsu

Beijing

Beijing

Secretariat

Chen KaiDeputy Secretary General

Dai Lifeng

Gao Yan

Feng Zhiyong

Huang Wan

Li Hongyue

ORGANIZATION


019

Hongbing Yan

Jiefu Yang

Xinchun Yang

Yuejin Yang

Cheuk-Man Yu

Jinqing Yuan

Qi Zhang

Shu Zhang

Yun Zhang

David X. M. Zhao

Shihua Zhao

Xianxian Zhao

Yelin Zhao

Yujie Zhou

Jianhua Zhu

Wenling Zhu

Abstract Reviewers

Takashi Akasaka

Joseph D. Babb

Jacques Busquet

Feng Cao

Kejiang Cao

Davide Capodanno

Buxing Chen

Fang Chen

Jack P. Chen

Jiyan Chen

Keping Chen

Lianglong Chen

Shaoliang Chen

Yundai Chen

Kenneth Chin

Ramesh B. Daggubati

Justin E. Davies

Kefei Dou

Zhimin Du

Eric Eeckhout

Pihua Fang

Quan Fang

Xianghua Fu

Luyue Gai

Run-Lin Gao

Wei Gao

Zhan Gao

Junbo Ge

Lei Ge

Juan F. Granada

Liliana R. Grinfeld

Wei Guo

Wenyi Guo

Hyeon-Cheol Gwon

Yaling Han

Ben He

Qing He

Dongming Hou

Wei Hua

Congxin Huang

Dejia Huang

Lan Huang

Yong Huo

Fumiaki Ikeno

Yang-Soo Jang

Nigel Jepson

Shiliang Jiang

Xiongjing Jiang

Zening Jin

Adnan Kastrati

Hyo-Soo Kim

Young-Hak Kim

Spencer B. King III

Ajay J. Kirtane

Xiangqing Kong

Jan Kovac

Takashi Kubo

Yat-Yin Lam

Alexandra J. Lansky

Michael Kang-Yin Lee

Hongwei Li

Jianjun Li

Lang Li

Yi Li

Michael Lim

Richard Lim

Yean-Leng Lim

Jian Liu

Xuebo Liu

Yan Liu

Sidney Tsz Ho Lo

William L. Lombardi

Lin Lu

Jianfang Luo

Shuzheng Lu

Changsheng Ma

Jieming Mao

Roxana Mehran

Christoph K. Naber

Aravinda Nanjundappa

Swee Choon Ng

Thach Nguyen

Raghotham R. Patlola

Jie Qian

Juying Qian

Shubin Qiao

Jenny Zhen Qin

Xuewen Qin

Bruno Scheller

Weifeng Shen

Kui-Hian Sim

Pieter C. Smits

Goran Stankovic

Seung-Jea Tahk

Huay Cheem Tan

Yida Tang

Ling Tao

Ye Tian

Marco Wainstein

Ron Waksman

Haichang Wang

Jian'an Wang

Jie Wang

Kai Wang

Shing-Chiu Wong

Xiaofan Wu

Yawei Xu

ORGANIZATION


020

Case Reviewers

Fang Chen

Jilin Chen

Yundai Chen

Kefei Dou

Zhimin Du

Guosheng Fu

Lei Ge

Ning Guo

Wenyi Guo

Wei Hua

Guoliang Jia

Shiliang Jiang

Xiongjing Jiang

Zening Jin

Quanmin Jing

Lang Li

Weimin Li

Zhanquan Li

Jian Liu

Xuebo Liu

Jianfang Luo

Shuzheng Lu

Gary S. Mintz

Chaowei Mu

Juying Qian

Shubin Qiao

Xuewen Qin

Haichang Wang

Lefeng Wang

Weimin Wang

Xiaofan Wu

Yongjian Wu

Yawei Xu

Yingjia Xu

Hongbing Yan

Weixian Yang

Yuejin Yang

Bin Zhang

Junjie Zhang

Qi Zhang

Shu Zhang

Yelin Zhao

Zhijing Zhao

Yujie Zhou

CMJ-CIT Theme Issue Reviewers

Shaoliang Chen

Xianghua Fu

Luyue Gai

Run-Lin Gao

Junbo Ge

Yaling Han

Yong Huo

Jianjun Li

Changsheng Ma

Weifeng Shen

Moyue Wang

Jian'an Wang

GENERAL INFORMATION


021

1. Registration O�ce and Opening Hours

Lobby, Shanghai Convention & Exhibition CenterTel: +86 21 32576900Opening Hours:March 19, 2014 10:00-18:00March 20, 2014 08:00-17:30March 21, 2014 07:30-17:30March 22, 2014 08:00-17:30March 23, 2014 08:00-11:30

2. On-Site Registration Fees (in RMB)

Full Participant 3,600Nurse/Technologist 1,800Student 2,800Accompanying Person 2,000Note: if you register as a student, a verification letter is required.

3. Registration Entitlements

Delegate Nurse/Technologist Student Accompanying

Person

Scientific Sessions * * *

Abstracts Book & Program Book * * *

Exhibition * * * *

Congress Bag * * *

Certificate of Attendance * * *

Sponsored Symposia * * *

4. Participant Identi�cation

Please wear your Congress badge for all Congress activities. Red: Faculty Blue: Delegate Green: Exhibitor & Accompanying Person Yellow: Staff Grey: Media White: Daily Registration (for local delegate ONLY)

General Information

Dates: March 20-23, 2014Venue: Shanghai Convention & Exhibition Center of International Sourcing (SHCEC) No. 35, Zhongjiang Road, Putuo District, Shanghai 200062, China Tel: +86 21 6029 0070 Website: www.sourcing.org.cn

Language English is the official language. Sessions with the Sign (see left) marked in the detailed program will be provided with simultaneous interpretation from English to Chinese.

Session with the sign "P" (see left) marked in the program will be provided with bilingual PowerPoint slides.

Banks and CurrencyMajor credit cards like Master, American Express and Visa are acceptable in most big shopping centers and hotels. Major foreign currencies can be changed to the Chinese currency RMB at the airport, Bank of China or hotels.

Business CenterThere is a business center on the 1st mezzanine of the SHCEC that provides services such as copying, fax transmittal and receiving and general office supplies.

Certi�cate of AttendanceAll registered delegate will be provided a certificate of attendance. The certificate will be found inside the congress bag.

CIT Co�ee StationAll delegates that fully participate for CIT2014 will be provided with TWO complimentary Coffee Coupons. Each coupon can be

used for exchange of one cup of coffee at the CIT Coffee Station inside the Congress Exhibit Hall, level one, SHCEC.

Cyber Station & WIFI ServiceThe Cyber Station will be located in the Exhibit Hall, Level 1 of the SHCEC that provide access to internet. WIFI service will be provided inside the Congress Venue. Please pay attention to the WIFI name & password announced on-site.

MealsAll luncheon industrial satellite symposia provide meals for participants. Please use the Lunch Coupons for admission. On March 21-23, 2014, breakfast meetings will be held on Level 2&3 from 07:00-08:00. Breads, juices and yogurts will be provided outside the meeting rooms for participants.

ExhibitionExhibit Hall, Level 1, SHCECExhibit Hours: 12:30-18:00 March 20, 2014 09:00-17:00 March 21-22, 2014

GENERAL INFORMATION


022

Faculty LoungeFaculty Lounge located at the Lobby of SHCEC is prepared for all faculty members and invited guests to have a rest during the Congress. Coffee, tea, snacks and Internet service will be served in the room. It will open at:

Thursday, March 20 8:00 AM – 5:30 PM

Friday, March 21 8:00 AM – 5:30 PM

Saturday, March 22 8:00 AM – 5:30 PM

Sunday, March 23 8:00 AM –11:30 AM

AccommodationsFor any enquires about hotel rooms, please go to Housing Desk for information (see Opening Hours at Registration).

Post-Congress InquiryCIT2014Chinese Medical Association42 Dongsi Xidajie, Beijing 100710, ChinaTel.: +86 10 8515 8473Fax: +86 10 6512 3754Email: [email protected]

Important Event1.Opening Ceremony & Plenary Lectures

Place: Pearl Hall, Level 3, SHCEC Time: 08:00 AM-12:30 PM, Friday, March 21, 2014

Scienti�c InformationTo All Chairs and Speakers

Please refer to relevant parts in this section for information on Speaker Ready Room and AV equipment.

Speaker Ready Room (Slides and MS PowerPoint Preview)

Lobby, SHCECTel: +86 21 32576901

Open hours:

Wednesday, March 19th 2:00 p.m. – 7:00 p.m.

Thursday, March 20th 7:30 a.m. – 6:30 p.m.

Friday, March 21st 6:30 a.m. – 6:30 p.m.

Saturday, March 22nd 6:30 a.m. – 6:30 p.m.

Sunday, March 23rd 6:30 a.m. – 11:30 a.m.

Please hand in your slides to the sta� in the Speaker Ready Room at least 3 hours before your presentation.

AV EquipmentLCD projector(s) will be available in the meeting room.

Moderated Poster Session and E-Case PresentationThis year, CIT's Poster display will be carried out with moderated discussions. This special session will be arranged at 16:00-18:00,

March 20, 2014 at the Poster Area, Exhibit Hall, Level 1. The Congress will close most of the concurrent sessions to encourage our participants to go to the Moderated Poster Session during which, there are moderators or supervisors to ask relevant questions.

Electronic Case PresentationCIT2014 submitted cases will be displayed electronically at the Atrium, Level 3. Your active participation is highly welcome.

Display time:

Thursday, March 20 8:30 AM – 5:30 PM

Friday, March 21 8:30 AM – 5:30 PM

Saturday, March 22 8:30 AM – 5:30 PM

Sunday, March 23 8:30 AM –11:30 AM

CIT On-demand, did you miss a session or a talk?At CIT all participants will receive a complimentary one-year access card at the registration. With the card and the printed individual access code all participants will be able to review all presentations that have been held during the conference. CIT on-demand booth will be located at the Exhibit Hall, Level 1, SHCEC which includes eight computer terminals and qualified service personnel, the participants will be guided through the easy and free registration process.

GENERAL INFORMATION


023

024

PROGRAM AT A GLANCE


07:0

0 AM

07:3

0 AM

08:0

0 AM

08:3

0 AM

09:0

0 AM

09:3

0 AM

10:0

0 AM

10:3

0 AM

11:0

0 AM

11:3

0 AM

12:0

0 PM

12:3

0 PM

01:0

0 PM

01:3

0 PM

02:0

0 PM

02:3

0 PM

03:0

0 PM

03:3

0 PM

04:0

0 PM

04:3

0 PM

05:0

0 PM

05:3

0 PM

Thur

sday

, Mar

ch 2

0, 2

014

Roo

m 2

01

Roo

m 2

02

Roo

m 2

03

Roo

m 2

04

Roo

m 2

05

Roo

m 2

07

Roo

m 2

08

Roo

m 3

05A

Roo

m 3

05B

Roo

m 3

02A

Roo

m 3

02B

Roo

m 3

07

Roo

m 3

M5

Exh

ibit

ion

H

all,

Lev

el 1

Mez

zan

ine,

L

evel

3

Roo

m 2

06

Tran

scat

hete

r Va

lve

Ther

apie

s (w

ith L

ive

Cas

e 3:

Fu

Wai

Hos

pita

l)

Bio

reso

rbab

le V

ascu

lar

Sca

ffol

ds WIN

at C

IT

Mod

erat

ed A

bstr

act P

oste

r (E

xhib

ition

Hal

l, Le

vel 1

) and

E

lect

roni

c C

ase

Pre

sent

atio

ns

(Atr

ium

, Lev

el 3

)

Inte

grat

ing

FF

R, I

VUS

, OC

T, a

nd M

ore

to Im

prov

e P

atie

nt

Out

com

es

The

6th C

linic

al R

esea

rch

Wor

ksho

p

Abs

trac

t Ora

l Pre

sent

atio

n

Abs

trac

t Ora

l Pre

sent

atio

n

Abs

trac

t Ora

l Pre

sent

atio

n

CIT

Edu

catio

nal C

ase

Aw

ard

- C

ase

Pre

sent

atio

n

CIT

Edu

catio

nal C

ase

Aw

ard

- C

ase

Pre

sent

atio

n

CIT

Edu

catio

nal C

ase

Aw

ard

- C

ase

Pre

sent

atio

n

CIT

Edu

catio

nal C

ase

Aw

ard

- C

ase

Pre

sent

atio

n

Exh

ibiti

on

CIT

Han

ds-o

n C

ente

r

Abs

trac

t Ora

l Pre

sent

atio

n

Live

Cas

e 1:

Fu

Wai

Hos

pita

l w

ith F

eatu

red

Lect

ures

The

6th C

linic

al R

esea

rch

Wor

ksho

p

Inte

grat

ing

FF

R, I

VUS

, OC

T, a

nd M

ore

to Im

prov

e P

atie

nt

Out

com

es

Left

Mai

n an

d B

ifurc

atio

ns

Car

diac

Cat

hete

riza

tion

Bas

ics

PC

I Tec

hniq

ues

and

Out

com

es

Was

hing

ton

DC

ME

DS

TAR

S

ympo

sium

at C

IT

Live

Cas

e 2:

Fu

Wai

Hos

pita

l w

ith F

eatu

red

Lect

ures

HK

STE

NT

at C

IT

Lunc

heon

Sat

ellit

e S

ympo

sium

- Q

inm

ing

Med

ical

Lunc

heon

Sat

ellit

e Sy

mpo

sium

- A

sahi

&St

ar P

rogr

ess

Lu

nch

eon

Sat

ellit

e S

ympo

siu

m

- B

Bra

un

Lu

nch

eon

Sat

ellit

e S

ympo

siu

m

- M

aqu

etL

un

cheo

n S

atel

lite

Sym

posi

um

-

Bra

ccoS

ine

Ren

al D

ener

vati

on L

un

cheo

n

Sym

posi

um

Lu

nch

eon

Sat

ellit

e S

ympo

siu

m-

Mic

roP

ort

Inte

rven

tion

al In

nov

atio

n in

C

hin

a-C

urr

ent

and

Futu

re

Lan

dsca

pe

025

PROGRAM AT A GLANCE


07:0

0 AM

07:3

0 AM

08:0

0 AM

08:3

0 AM

09:0

0 AM

09:3

0 AM

10:0

0 AM

10:3

0 AM

11:0

0 AM

11:3

0 AM

12:0

0 PM

12:3

0 PM

01:0

0 PM

01:3

0 PM

02:0

0 PM

02:3

0 PM

03:0

0 PM

03:3

0 PM

04:0

0 PM

04:3

0 PM

05:0

0 PM

05:3

0 PM

Frid

ay, M

arch

21,

201

4

The

Pea

rl

Hal

l

Roo

m 2

01

Roo

m 2

02

Roo

m 2

03

Roo

m 2

04

Roo

m 2

06

Roo

m 2

07

Roo

m 2

08

Exh

ibit

ion

H

all,

Lev

el 1

Mez

zan

ine,

L

evel

3

Roo

m 2

05

Ope

ning

of C

IT 2

014

in P

artn

ersh

ip w

ith T

CT

and

Ple

nary

Ses

sion

(w

ith L

ive

Cas

e 4:

Col

umbi

a U

nive

rsity

Med

ical

Cen

ter)

Late

Bre

akin

g Cl

inic

al T

rials

EA

PC

I-E

uroP

CR

at C

IT (w

ith L

ive

Cas

e 7:

S

t Tho

mas

' Hos

pita

l)

Live

Cas

e 9:

Rui

jin H

ospi

tal

with

Fea

ture

d Le

ctur

es

The

5th R

otab

latio

n W

orks

hop

Pra

ctic

al C

ours

e on

PC

I - H

ow to

Tre

at: C

ompl

ex C

ase

Dis

cuss

ions

Live

Cas

e 8:

Zho

ngsh

an

Hos

pita

l with

Fea

ture

d Le

ctur

es

Inte

rven

tiona

l Car

diol

ogy

Hot

To

pics

Inte

grat

ing

FF

R, I

VUS

, OC

T, a

nd M

ore

to Im

prov

e P

atie

nt

Out

com

es

Non

-ST-

Seg

men

t Ele

vatio

n A

cute

Cor

onar

y S

yndr

omes

Hea

rt R

hyth

m

Str

uctu

ral H

eart

Dis

ease

Bas

ics

and

Med

ical

The

rapi

es

ISE

S a

t CIT

(with

Liv

e C

ase

10: Z

hong

shan

Hos

pita

l)

Dru

g-E

lutin

g S

tent

s -

App

ropr

iate

Util

izat

ion

of C

urre

nt

Gen

erat

ion

Dev

ices

Lear

ning

Tec

hniq

ues

from

CTO

Spe

cial

ists

: A

Ste

p by

Ste

p C

ase

Rev

iew

s

Exh

ibiti

on

CIT

Han

ds-o

n C

ente

r

Left

Mai

n an

d B

ifurc

atio

ns

Bre

akfa

st

Cas

e R

evie

ws

Hea

rt R

hyth

m

Lear

ning

Tec

hniq

ues

from

CTO

Spe

cial

ists

: A

Ste

p by

Ste

p C

ase

Rev

iew

s

TRI C

lub

Roo

m 3

05A

Roo

m 3

05B

Roo

m 3

02A

Roo

m 3

02B

Roo

m 3

07

Roo

m 3

M5

Liv

e C

ase

5:

Ru

ijin

Hos

pita

l (P

erip

her

al)

Lu

nch

eon

Sat

ellit

e S

ympo

siu

m

- M

icro

Por

tL

un

cheo

n S

atel

lite

Sym

posi

um

-

Bio

sens

ors

& J

WM

S

Lu

nch

eon

Sat

ellit

e S

ympo

siu

m

- A

bbot

t Va

scu

lar

Lu

nch

eon

Sat

ellit

e S

ympo

siu

m

- B

osto

n S

cien

tific

Lu

nch

eon

Sat

ellit

e S

ympo

siu

m

- M

edtr

onic

Lu

nch

eon

Sat

ellit

e S

ympo

siu

m

- M

edfa

vou

rL

un

cheo

n S

atel

lite

Sym

posi

um

-

St.

Ju

deL

un

cheo

n S

atel

lite

Sym

posi

um

-

Ess

enL

un

cheo

n S

atel

lite

Sym

posi

um

-

Ven

us

Med

Tech

Lu

nch

eon

Sat

ellit

e S

ympo

siu

m

- Yi

nyi

Med

ical

Lu

nch

eon

Sat

ellit

e S

ympo

siu

m

- G

E H

ealt

hca

reLu

nche

on S

atel

lite

Sym

posi

um

- Jo

hnso

n &

Joh

nson

Lu

nch

eon

Sat

ellit

e S

ympo

siu

m

- A

stra

Zen

eca

Lu

nch

eon

Sat

ellit

e S

ympo

siu

m

- S

tar

Pro

gres

s

Myo

card

ial I

sch

emia

, D

iagn

osis

an

d Th

erap

y of

C

oron

ary

Art

ery

Dis

ease

Liv

e C

ase

6:

Zh

ongs

han

Hos

pita

l (S

tru

ctu

ral)

Ph

arm

acol

ogic

Sat

ellit

e S

ympo

siu

m

- S

anof

i

Phar

mac

olog

ic Sa

tellit

e Sy

mpo

sium

- S

ervie

r

026

PROGRAM AT A GLANCE


07:0

0 AM

07:3

0 AM

08:0

0 AM

08:3

0 AM

09:0

0 AM

09:3

0 AM

10:0

0 AM

10:3

0 AM

11:0

0 AM

11:3

0 AM

12:0

0 PM

12:3

0 PM

01:0

0 PM

01:3

0 PM

02:0

0 PM

02:3

0 PM

03:0

0 PM

03:3

0 PM

04:0

0 PM

04:3

0 PM

05:0

0 PM

05:3

0 PM

Satu

rday

, Mar

ch 2

2, 2

014

The

Pea

rl

Hal

l

Roo

m 2

01

Roo

m 2

02

Roo

m 2

03

Roo

m 2

04

Roo

m 2

06

Roo

m 2

07

Roo

m 2

08

Exh

ibit

ion

H

all,

Lev

el 1

Mez

zan

ine,

L

evel

3

Roo

m 2

05

Left

Atr

ial A

ppen

dage

Clo

sure

(with

Liv

e C

ase

14: Z

hejia

ng

Uni

vers

ity 2

nd H

ospi

tal)

Pra

ctic

al C

ours

e on

PC

I - C

hron

ic T

otal

Occ

lusi

on

ST-

Seg

men

t Ele

vatio

n M

yoca

rdia

l Inf

arct

ion

Hea

rt R

hyth

m

Str

uctu

ral H

eart

Dis

ease

PC

I Tec

hniq

ues

and

Out

com

es

Per

iphe

ral V

ascu

lar

Ther

apy

Dru

g-C

oate

d B

allo

ons

Trai

ning

Cou

rse

on T

rans

cath

eter

Val

ve T

hera

pies

Exh

ibiti

on

CIT

Han

ds-o

n C

ente

r

Fir

st R

epor

t In

vest

igat

ions

MY

LIVE

at C

IT

Pra

ctic

al C

ours

e on

PC

I - H

ow to

Tre

at: C

ontr

over

sial

Cas

e D

iscu

ssio

ns

Inte

grat

ing

FF

R, I

VUS

, OC

T, a

nd M

ore

to Im

prov

e P

atie

nt

Out

com

es

TRI C

lub

Hea

rt R

hyth

m

Str

uctu

ral H

eart

Dis

ease

Bas

ics

and

Med

ical

The

rapi

es

NC

VH a

t CIT

Dru

g-E

lutin

g S

tent

s -

Bio

abso

rbab

le

Pol

ymer

and

Pol

ymer

-Fre

e

End

ovas

cula

r Fo

rum

on

Aor

tic A

neur

ysm

R

epai

r

Ren

al D

ener

vatio

n Th

erap

y

CC

T at

CIT

(with

Liv

e C

ase

11: Z

hong

shan

Hos

pita

l)

Live

Cas

e 13

: Zh

ejia

ng U

nive

rsity

2nd

Hos

pita

l with

Fe

atur

ed L

ectu

res

Live

Cas

e 16

: Nan

jing

1st H

ospi

tal

EN

CO

RE

at C

IT

Feat

ured

DE

S L

ate

Bre

akin

g Tr

ials

Live

Cas

e 12

: R

uijin

Hos

pita

l with

Fea

ture

d Le

ctur

es

Live

Cas

e 15

: Nan

jing

1st H

ospi

tal

AIC

T at

CIT

Roo

m 3

05A

Roo

m 3

05B

Roo

m 3

02A

Roo

m 3

02B

Roo

m 3

07

Roo

m 3

M5

Lef

t M

ain

an

d B

ifurc

atio

ns

CR

T at

CIT

SC

AI a

t C

ITC

ardi

ovas

cula

r S

um

mit

-

TCTA

P a

t C

IT

Pha

rmac

olog

ic

Sate

llite

S

ympo

sium

-

Bay

er

Ph

arm

acol

ogic

Sat

ellit

e S

ympo

siu

m

- A

stra

Zen

eca

The

9th A

nnua

l Sym

posi

um fo

r N

urse

and

Tec

hnol

ogis

t

Lu

nch

eon

Sat

ellit

e S

ympo

siu

m

- B

osto

n S

cien

tific

Lu

nch

eon

Sat

ellit

e S

ympo

siu

m

- L

epu

Med

ical

Lu

nch

eon

Sat

ellit

e S

ympo

siu

m

- M

edtr

onic

Lu

nch

eon

Sat

ellit

e S

ympo

siu

m

- G

E H

ealt

hca

reL

un

cheo

n S

atel

lite

Sym

posi

um

-

Abb

ott

Vasc

ula

rL

un

cheo

n S

atel

lite

Sym

posi

um

-

Teru

mo

Lu

nch

eon

Sat

ellit

e S

ympo

siu

m

- S

ino

Med

ical

Lu

nch

eon

Sat

ellit

e S

ympo

siu

m

- G

oodm

anL

un

cheo

n S

atel

lite

Sym

posi

um

-

Life

tech

Lu

nch

eon

Sat

ellit

e S

ympo

siu

m -

Vol

can

oL

un

cheo

n S

atel

lite

Sym

posi

um

-

Rie

nte

chL

un

cheo

n S

atel

lite

Sym

posi

um

- S

iem

ens

Lu

nch

eon

Sat

ellit

e S

ympo

siu

m

- S

anof

i

Bre

akfa

st

Cas

e R

evie

ws

Bre

akfa

st

Mee

tin

g -

Teru

mo

Bre

akfa

st

Cas

e R

evie

ws

027

PROGRAM AT A GLANCE


07:0

0 AM

07:3

0 AM

08:0

0 AM

08:3

0 AM

09:0

0 AM

09:3

0 AM

10:0

0 AM

10:3

0 AM

11:0

0 AM

11:3

0 AM

12:0

0 PM

12:3

0 PM

01:0

0 PM

01:3

0 PM

02:0

0 PM

02:3

0 PM

03:0

0 PM

03:3

0 PM

04:0

0 PM

04:3

0 PM

05:0

0 PM

05:3

0 PM

Sund

ay, M

arch

23,

201

4

Roo

m 2

01

Roo

m 2

02

Roo

m 2

03

Roo

m 2

04

Roo

m 2

05

Roo

m 2

07

Roo

m 2

08

Roo

m 2

06

Bes

t of C

CC

/CIS

C

Pra

ctic

al C

ours

e on

PC

I - C

hron

ic T

otal

Occ

lusi

on

The

6th P

CI C

ompl

icat

ions

For

um

Inte

grat

ing

FF

R, I

VUS

, OC

T, a

nd M

ore

to Im

prov

e P

atie

nt

Out

com

es

Clos

ing

Left

Mai

n an

d B

ifurc

atio

ns

Non

-Inv

asiv

e C

ardi

ovas

cula

r Im

agin

g

Com

preh

ensi

ve M

anag

emen

t of C

ardi

ovas

cula

r D

isea

se in

D

iabe

tics

Hea

rt R

hyth

m

Cas

e R

evie

ws

(Cal

l-fo

r-C

ases

)

Cas

e R

evie

ws

(Cal

l-fo

r-C

ases

)

Cas

e R

evie

ws

(Cal

l-fo

r-C

ases

)

Cas

e R

evie

ws

(Cal

l-fo

r-C

ases

)

Cas

e R

evie

ws:

Per

iphe

ral a

nd E

ndov

ascu

lar

Inte

rven

tions

Bes

t of G

AP

-CC

BC

Bre

akfa

st

Cas

e R

evie

ws

Roo

m 3

05A

Roo

m 3

05B

Roo

m 3

02A

Roo

m 3

02B

Roo

m 3

07

Roo

m 3

M5

LIVE CASE SITES


028

InternationalNewYork-Presbyterian Hospital / Columbia University Medical Center, New York, USA

St. Thomas' Hospital, London, United Kingdom

DomesticFu Wai Hospital, National Center for Cardiovascular Diseases, Beijing

Fudan University Zhongshan Hospital, Shanghai

Affiliated Ruijin Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai

Nanjing First Hospital, Nanjing Medical University, Nanjing

Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou



029

Room 201, Level 2

Transcatheter Valve Therapies1:00 PM-6:00 PM

Session I: The Evolution of TAVR - Current Practice and Controversies

Moderators: Martin B. Leon, Eberhard GrubeDiscussants: Philippe Généreux, Michael A. Mussallem, Christoph K. Naber, John G. Webb, Shing-Chiu Wong, David X. M. Zhao

1:00 PM - The Remarkable Odyssey from Surgical Ball-Check Valves to Percutaneous Transcatheter ValvesMichael A. Mussallem

1:12 PM - Current State-of-the-Art: Efficient and Affordable TAVRJohn G. Webb

1:22 PM - The TAVR Evidence-Based Medicine Corner: Clinical Outcomes and ControversiesMartin B. Leon

TAVR Complications Workshop

1:32 PM - Strokes and Stroke PreventionChristoph K. Naber

1:40 PM - Vascular Complications and BleedingPhilippe Généreux

1:48 PM - Paravalvular RegurgitationEberhard Grube

1:56 PM - Panel Discussion

Session II: TAVR in Asia-Pacific

Moderators: Junbo Ge, Alan C. YeungDiscussants: Wacin Buddhari, Paul TL Chiam, Mao Chen, Hyo-Soo Kim, Xiangqing Kong, Jan Kovac, Michael Kang-Yin Lee, Shigeru Saito, Ruiyan Zhang

2:10 PM - Live Case Transmission from Fu Wai Hospital, BeijingThe Self-Expanding Venus-A TAVR SystemOperators: Horst Sievert, Yuejin Yang, Yongjian Wu, Wei Wang

Early TAVR Experiences from…

2:40 PM - ChinaMao Chen

2:48 PM - Hong KongMichael Kang-Yin Lee

2:56 PM - JapanShigeru Saito

3:04 PM - SingaporePaul TL Chiam

3:12 PM - South KoreaHyo-Soo Kim

3:20 PM - ThailandWacin Buddhari


Session III: New TAVR Systems and Indications

Moderators: Martin B. Leon, John G. WebbDiscussants: Alexandre Abizaid, Antonio Colombo, Ted E. Feldman, Eberhard Grube, Ian T. Meredith, Corrado Tamburino, Ron Waksman

New TAVR Systems…

3:38 PM - Next Generation Edwards TAVR DevicesJohn G. Webb

3:46 PM - Next Generation Medtronic TAVR DevicesEberhard Grube

3:54 PM - The Lotus Valve and the REPRISE Clinical ProgramIan T. Meredith

4:02 PM - DirectFlow Medical TAVR Status UpdateAntonio Colombo

4:10 PM - The Symetis TAVR Status Update (TA and TF)Alexandre Abizaid

New Clinical Indications…

4:18 PM - Results from the Global Valve-in-Valve Registry for Bioprosthetic Valve FailureRon Waksman

4:28 PM - TAVR in Moderate Risk Patients: Experiences and StudiesMartin B. Leon


Session IV: Tanscatheter Mitral Valve Therapies

Moderators: Saibal Kar, Ted E. FeldmanDiscussants: Maurice Buchbinder, Charles A. Simonton, Gregg W. Stone, Corrado Tamburino, Hao Wang, Chris Kwok-Yiu Wong, Daxin Zhou

4:48 PM - A Primer on the MitraClip Device: Procedural Considerations and Case SelectionSaibal Kar

4:58 PM - Perspectives on MitraClip Therapy: My Best and Worst Case Outcomes (case examples)Corrado Tamburino

5:06 PM - Clinical Outcomes After MitraClip in High-Risk MR Patients: Lessons from EVEREST and the MitraClip RegistriesCharles A. Simonton

5:16 PM - Asian Experiences with MitraClip in Patients with High-Risk MRChris Kwok-Yiu Wong

5:24 PM - New Studies and Rationale for MitraClip in Functional MR Patients (COAPT and RESHAPE)Gregg W. Stone

5:32 PM - Alternative Transcatheter Mitral Valve Therapies: Difficulties and OpportunitiesTed E. Feldman

5:42 PM - The Next Frontier: Status Update on Transcatheter Mitral Valve ReplacementMaurice Buchbinder


6:00 PM - Adjourn



030

Room 202, Level 2

Live Case Session 1 with Featured Lectures8:30 AM-10:30 AM

Moderators: Je�rey W. Moses, Shubin Qiao, Shigeru SaitoDiscussants: Duncan Hung-Kwong Ho, Zening Jin, Lang Li, Richard Lim, Kenan Ovunc, Su�a Rahman, Ling Tao, Kin-Lam Tsui, Wan Azman Wan Ahmad

8:30 AM - Live Case Transmission from Fu Wai Hospital, BeijingLeft Main and Chronic Total OcclusionOperators: Yuejin Yang, Etsuo Tsuchikane, Yongjian Wu, and Colleagues

10:00 AM - PCI Is a Definitive Alternative for Unprotected Left Main Stem StenosisMarco Wainstein

10:15 AM - How to Treat Patients with Severe Left Ventricular Dysfunction?Liliana R. Grinfeld

Live Case Session 2 with Featured Lectures10:30 AM-12:30 PM

Moderators: Jiyan Chen, William L. Lombardi, Shuzheng LuDiscussants: Debabrata Dash, Ömer Göktekin, Tetsuya Hata, Hweung Kon Hwang, Fumiaki Ikeno, Swee Choon Ng, Fei Ye, Shusen Yang, Qi Zhang

10:30 AM - Live Case Transmission from Fu Wai Hospital, BeijingChronic Total OcclusionsOperators: Satoru Sumitsuji, Toshiya Muramatsu, Yongjian Wu, and Colleagues

12:00 PM - Hybrid Approach to CTO PCI: State of ArtWilliam L. Lombardi

12:15 PM - IVUS, FFR, or OCT: Which Should I Use for PCI?Debabrata Dash

12:30 PM - Break

Bioresorbable Vascular Scaffolds1:00 PM-6:00 PM

Session I: Basics on BRS

Moderators: Alexandre Abizaid, Run-Lin GaoDiscussants: Patrick W. Serruys, Gregg W. Stone, Renu Virmani, Ron Waksman

1:00 PM - Science Behind Bioresorbable Vascular ScaffoldsRenu Virmani

1:12 PM - From Coronary Revascularization to Vascular Restoration: Why Do We Need BRS?Gregg W. Stone

Flash Debate

1:24 PM - Why Do I Prefer Metallic BRS?Ron Waksman

1:32 PM - Polymeric BRS Are the Way to Go!Patrick W. Serruys


Session II: Current Practice with BRS

Moderators: Alexandre Abizaid, Ian T. MeredithDiscussants: Antonio Colombo, Christoph K. Naber, Patrick W. Serruys, Charles A. Simonton, Pieter C. Smits, Corrado Tamburino, Huay Cheem Tan, Yaojun Zhang

1:52 PM - Update on the ABSORB Clinical ProgramAlexandre Abizaid

2:07 PM - BRS for Bifurcations and Complex LesionsAntonio Colombo

2:19 PM - Clinical Outcomes with BRS in Long Lesions and Overlapping ScaffoldsPieter C. Smits

2:29 PM - Single Center Experience with the First 400 Implantations of BRSChristoph K. Naber

2:39 PM - Clinical Outcomes with BRS in Unselected "Real-World" PracticeCorrado Tamburino

2:49 PM - BRS in Acute Myocardial InfarctionHuay Cheem Tan

2:59 PM - Addressing the New Enemies: In-BRS Restenosis, Thrombosis, Fractures and Beyond!Patrick W. Serruys


Session III: BRS in Asia-Pacific

Moderators: Ashok Seth, Weifeng Shen, Duncan Hung-Kwong HoDiscussants: Wacin Buddhari, Kenneth Chin, Nigel Jepson, Vincent On-Hing Kwok, Michael Lim, Shubin Qiao, Teguh Santoso

"Real-World" Experiences (focus on discussion of case selection for BRS) from…

3:30 PM - AustraliaNigel Jepson

3:38 PM - Hong KongVincent On-Hing Kwok

3:46 PM - SingaporeMichael Lim

3:54 PM - IndiaAshok Seth

4:02 PM - IndonesiaTeguh Santoso

4:10 PM - MalaysiaKenneth Chin

4:18 PM - ThailandWacin Buddhari

4:26 PM - ChinaShubin Qiao




031

Room 203, Level 2

The 6th Clinical Research Workshop8:30 AM-4:00 PM

8:30 AM - Welcome, Introduction and ObjectivesRoxana Mehran

Session I: Road to Excellence in Clinical Research - How to Become a Premier Research Center

Moderators: Alexandra J. Lansky, Donald E. CutlipDiscussants: Yaling Han, Mitchell W. Kruco�, Wei Li, Shuzheng Lu, Jenny Zhen Qin, Roxana Mehran, Haichang Wang, Yaojun Zhang, Zhe Zheng

8:35 AM - How to Start and Set up a Thriving Clinical Research Program: The Basics and MoreRoxana Mehran

8:45 AM - Guiding Principles in Clinical Research: The Cardinal Rules (GCP, IRB, Informed Consent, Quality Assurance)Alexandra J. Lansky

8:55 AM - How to Be a Key Enroller in Clinical Trials: Bringing Your Colleagues TogetherRoxana Mehran

9:05 AM - Global Collaboration in Medical Device Research: The Key to the Future of InnovationMitchell W. Kruco�

9:15 AM - Statistical Considerations of Non-Randomized Clinical Study for Medical DeviceWei Li

9:30 AM - Featured Lecture: Lessons Learned from My Personal Experience in Clinical ResearchYaling Han

9:45 AM - Panel Discussion with Audience Q&A

Session IV: Future of BRS

Moderators: Martin B. Leon, Bo XuDiscussants: Jean Fajadet, Run-Lin Gao, Junbo Ge, Juan F. Granada, Ron Waksman

Future Technologies

4:50 PM - Update on DESolve Nx Clinical ProgramMartin B. Leon

5:00 PM - The PLLA ART BRSJean Fajadet

5:10 PM - The XINSORB Sirolimus BRSJunbo Ge

5:20 PM - The PLLA Amaranth BRSJuan F. Granada

5:30 PM - The Lifetech Iron-Based BRSRun-Lin Gao

5:40 PM - The DREAMS Sirolimus Magnesium BRSRon Waksman


6:00 PM - Adjourn

Session II: Establishing Research Paradigms at the Cutting Edge of Interventional Cardiology - Case Studies

Case Study #1 Bioresorbable Scaffolds

Moderators: Roxana Mehran, Patrick W. SerruysDiscussants: Davide Capodanno, Jiyan Chen, Ajay J. Kirtane, Mitchell W. Krucoff, Alexandra J. Lansky, Ian T. Meredith, Marie-Angèle Morel, Gregg W. Stone, Ron Waksman

10:00 AM - Bioresorbable Scaffolds: Where We Came from and Where We Are GoingGregg W. Stone

10:12 AM - Panel Discussion: Ongoing and Future Studies with Bioresorbable Scaffolds - What Studies Need to Be Done in China and Beyond?

Case Study #2 Renal Denervation Therapies

Moderators: Ajay J. Kirtane, Felix MahfoudDiscussants: Yundai Chen, Murray D. Esler, Xiongjing Jiang, Jan Kovac, Shaowen Liu, Atul Pathak, Sean Salmon, Jie Wang, Yi-Ming Yang

10:30 AM - How to Set up the Interdisciplinary Team to Screen and Treat the Right PatientsAtul Pathak

10:40 AM - Renal Denervation Therapies: Where We Came from and What Questions Require AnsweringAjay J. Kirtane

10:52 AM - Panel Discussion: Ongoing and Future Studies with Renal Denervation Devices - What Studies Need to Be Done in China and Beyond?

11:10 AM - Featured Lecture: China FDA's Perspectives on Regulatory Pathway for Bioresorbable Scaffolds and Transcatheter Structural Heart DevicesXinli Shi



032

Session III: Clinical Trial Interpretation - Strengths and Weaknesses of Controversial Interventional Trials of the Last Year

Moderators: Run-Lin Gao, Alexandra J. LanskyDiscussants: Donald E. Cutlip, Philippe Généreux, Liliana R. Grinfeld, Ajay J. Kirtane, Martin B. Leon, Roxana Mehran, Juying Qian, Patrick W. Serruys, John G. Webb, Hongbing Yan

11:30 AM - PRAMIAjay J. Kirtane

11:38 AM - Panel Discussion: Criticisms and Strengths - Impact on Clinical Practice

11:50 AM - OPTIMIZERoxana Mehran

11:58 AM - Panel Discussion: Criticisms and Strengths - Impact on Clinical Practice

12:10 PM - CoreValve Extreme Risk and New PARTNER StudiesMartin B. Leon

12:18 PM - Panel Discussion: Criticisms and Strengths - Impact on Clinical Practice

12:30 PM - Lunch Break

Session IV: Roundtable Discussion - How to Be Effective at Publishing and Presenting Your Research

Moderators: Gary S. Mintz, Shaoliang ChenDiscussants: Feng Cao, Paul Cummins, Anthony DeMaria, Spencer B. King III, Ajay J. Kirtane, Roxana Mehran, Roberto Patarca, Ling Tao, Cheuk-Man Yu

2:00 PM - Lessons Learned from Years of Mentoring Future ResearchersPatrick W. Serruys

2:15 PM - My Top Tips for Abstract Preparation, Submission, and PresentationRoxana Mehran

2:25 PM - How to Edit a Manuscript and Get It Ready for SubmissionGary S. Mintz

2:35 PM - My Top Tips for Manuscript Submission of Original Articles: JACC PerspectiveAnthony DeMaria

2:50 PM - My Top Tips for Manuscript Submission of Original Articles: European Heart Journal PerspectiveCheuk-Man Yu

3:05 PM - My Top Tips for Preparation and Submission of Review ArticlesSpencer B. King III

3:20 PM - How to Respond to a Critical Review of a ManuscriptAjay J. Kirtane

3:30 PM - How to Get Your Interventional Manuscripts Published at EuroIntervention: Managing Editor's PerspectivePaul Cummins

3:40 PM - Panel Discussion with Audience Q&A

Women in Innovation (WIN) at CIT4:00 PM-5:40 PM

Moderators: Roxana Mehran, Yaling HanDiscussants: Feng Cao, Jue Chen, Yundai Chen, Wei Gao, Wenyi Guo, Lijun Guo, Ning Guo, Qing He, Juying Qian, Ling Tao, Jingping Wang, Xiaofan Wu, Weixian Yang, Shuyang Zhang, Yingling Zhou

4:00 PM - Cessation of Dual Antiplatelet Therapy and Cardiac Events After Percutaneous Coronary Intervention in Women: Results from PARIS StudyRoxana Mehran


4:20 PM - Short-Term Statin Therapy for Prevention of Contrast Induced Acute Kidney Injury in Women: Results from TRACK-D StudyYaling Han


4:40 PM - Lipid-Modifying Therapy in High-Risk Female PatientsPing Ye


5:00 PM - Women Subgroup Analysis of FIRE2-DIABETES StudyYan Li


5:20 PM - Transradial Intervention in WomenLi Li


5:40 PM - Adjourn



033

Room 204, Level 2

Integrating FFR, IVUS, OCT, and More to Improve Patient Outcomes Part I8:30 AM-12:30 PM

Session I: Introduction

Moderators: Liliana R. Grinfeld, Juying Qian

8:30 AM - How to Perform and Interpret FFR?Nico H. J. Pijls

8:45 AM - How to Perform and Interpret IVUS?Jie Qian

9:00 AM - How to Perform and Interpret RF (VH) IVUS?William Kongto Hau

9:15 AM - How to Perform and Interpret OCT?Takashi Akasaka

9:30 AM - How to Perform and Interpret NIRS?Akiko Maehara

Session II: Assessment of the Intermediate Lesion

FFR

Moderators: Nico H. J. Pijls, Jian'an Wang

9:45 AM - Use of FFR During Non-Left Main ProceduresBernard De Bruyne

10:00 AM - Use of FFR When Treating Multivessel Disease, Tandem Lesions, Bifurcations, etcNico H. J. Pijls

10:15 AM - Use of FFR During Left Main ProceduresSeung-Jung Park

Case Presentations Focusing on FFR and Intermediate Lesions (15 minutes each including Q&A)

Discussants: Bernard De Bruyne, Guisong Wang, Junqing Yang

10:30 AM - IM-0110: A Case of FFR Guided PCIHua Yan

10:45 AM - IM-0105: Utility of FFR in Three Vessel DiseaseJiangang Jiang

IVUS and OCT

Moderators: Takashi Akasaka, Philip Hung-Chung Wong

11:00 AM - Can IVUS Be Used to Assess Intermediate Non-Left Main Lesions?Seung-Jea Tahk

11:15 AM - Is OCT Any Better Than IVUS in Assessing Intermediate Non-Left Main Lesions?Fernando Alfonso

11:30 AM - What About Assessing Intermediate Left Main Lesions?Soo-Jin Kang

11:45 AM - What Might VH-IVUS or NIRS Add to the Assessment of Intermediate Lesions?Akiko Maehara

Case Presentations Focusing on Imaging and Intermediate Lesions (15 minutes each including Q&A)

Discussants: Fernando Alfonso, Jun Guo, Yong He

12:00 PM - IM-0040: Role of IVUS in the Diagnosis of Uncertain Lesions by CAGYong Dong

12:15 PM - IM-0112: Multivessel PCI Guided by FFRGuoxing Zuo

12:30 PM - Break

Luncheon Satellite SymposiumSponsored by Qinming MedicalPacing Life with Innovation12:40 PM-1:55 PM

Chairmen: Zheng Zhang, Jing Xu, Jialiang Mao, Zhigang Liu

12:40 PM - Pacing Life with InnovationLijun Wang

12:50 PM - Qinming Dual-Chamber Pacemaker Animal and Clinical StudyDongqi Wang

1:05 PM - Qinming Dual-Chamber Pacemaker Clinical TrialXiang Gu

1:20 PM - Clinical Experience of Qinming Single-Chamber PacemakerYong Peng

1:35 PM - Clinical Experience of Qinming Single-Chamber PacemakerBin Ma


1:55 PM - Break

Integrating FFR, IVUS, OCT, and More to Improve Patient Outcomes Part II2:00 PM-6:15 PM

Session III: ACS and the Vulnerable Plaque

Assessing Patients with an Acute Coronary Syndrome

Moderators: Yundai Chen, Myeong-Ki Hong

2:00 PM - IVUS: Uses and Limitations in Assessing ACS PatientsJian Liu

2:15 PM - OCT: Identification of the Culprit Lesion, Its Underlying Morphology, and New Strategies for OCT-Based TreatmentsAkiko Maehara



034

2:30 PM - NIRS: Current Findings in Patients with ACSRyan D. Madder

2:45 PM - FFR: When and How to Use FFR in Assessing Either the Infarct Related or Non-Infarct Related ArteriesPieter C. Smits

Case Presentations of ACS Patients, Patients with Unusual Angiographic Findings, or Patients with Vulnerable Plaques (15 minutes each including Q&A)

Discussants: Jian Liu, Ryan D. Madder

3:00 PM - IM-0001: IVUS Guided Emergency PCIJing Bai

3:15 PM - IM-0121: Where Is the Culprit Lesion?Ning Guo

3:30 PM - IM-0046: ACS Caused by Spontaneous LMCA DissectionJun Pu

The Vulnerable Plaque Mini-Summit

Moderators: Akiko Maehara, Jingbo Hou, Fumiaki Ikeno

3:45 PM - Can Greyscale IVUS Detect Vulnerable Plaque?Fumiaki Ikeno

4:00 PM - Can OCT Detect Vulnerable Plaque?Sudhir Rathore

4:15 PM - Can RF (VH) IVUS Detect Vulnerable Plaque?Akiko Maehara

4:30 PM - Can NIRS Detect Vulnerable Plaque?Ryan D. Madder

4:45 PM - The Role of Hemodynamics in Plaque DestabilizationBernard De Bruyne

5:00 PM - Featured Lecture 1: What Did We Learn from PROSPECT I and an Introduction to PROSPECT IIGregg W. Stone

5:15 PM - Featured Lecture 2: Can We Really Detect Clinically Relevant Vulnerable Plaques by Imaging?Patrick W. Serruys

More Case Presentations of ACS Patients, Patients with Unusual Angiographic Findings, or Patients with Vulnerable Plaques (15 minutes each including Q&A)

Discussants: Stephen Wai-Luen Lee, Jun Pu, Sudhir Rathore

5:30 PM - IM-0033: A Special Lesion in Proximal RCAXiaoyan Zhao

5:45 PM - IM-0055: ACS with Thrombosis in Left Main BifurcationQiyong Li

6:00 PM - IM-0079: "Spontaneous Dissection" Observed by IVUS and OCTLiang Dong

6:15 PM - Adjourn

Room 205, Level 2

Left Main and Bifurcations Part ITreatment of Bifurcation Lesions: Techniques and Strategies8:30 AM-12:30 PM

Session I: Technical Considerations

Moderators: Philippe Généreux, Wenyi Guo, Nigel JepsonDiscussants: Gim-Hooi Choo, Rajesh Dave, Soo-Jin Kang, Lijiang Tang, Junjie Zhang

8:30 AM - Impact of Asymmetrical Expansion Induced by Kissing Balloon Inflation on Mid-Term Results of Bifurcation InterventionJunjie Zhang

8:42 AM - Technical Guiding Principles in Left Main PCIRajesh Dave

8:54 AM - Carina / Plaque Shift, and Implications on a Provisional StrategyGim-Hooi Choo

9:06 AM - Case Presentation 1: Left Main Bifurcation Treated with Integrated Imaging ModalitiesFei Ye

9:14 AM - Discussion

9:19 AM - Case Presentation 2: OCT Findings After Stenting Complex BifurcationJunjie Zhang


9:32 AM - Integrated Assessment of IVUS and FFR in Bifurcation PCISoo-Jin Kang




035

Session II: Advanced and Practical Key Points of Stenting Bifurcation Lesions

Moderators: Yong Huo, Shing-Chiu Wong, Robaayah ZambahariDiscussants: Jingbo Hou, Teguh Santoso, Imad Sheiban, Mengyue Yu, Junjie Zhang

9:52 AM - Bifurcation Lesion Preparations, Kissing Balloon Inflation, and Proximal Optimization Treatment: How to Do?Teguh Santoso

10:07 AM - Find the Right Cells for Rewiring Side Branch: Mandatory to Provisional or Complex Stenting TechniquesJunjie Zhang

10:17 AM - Case Presentation 3: Pattern of KBT Depends on Bifurcation AngleGuisong Wang


10:30 AM - Case Presentation 4: OCT Guidance of Side Branch Rewiring and What Happened?Jingbo Hou


10:43 AM - Bifurcation PCI: Tips and Tricks in Side Branch WorkSeung-Jea Tahk

10:55 AM - Single Stenting for Distal Left Main Bifurcation: When, How, and Long-Term Clinical OutcomesImad Sheiban


Session III: Step-by-Step Reviews to Understand Stenting Techniques and Platforms

Moderators: Shaoliang Chen, Jack P. Chen, Thach NguyenDiscussants: Lianglong Chen, Antonio Colombo, Jean Fajadet, Josef Ludwig, Aravinda Nanjundappa

11:17 AM - Non-Left Main Provisional Stenting with and without 2nd Stent in Side Branch (with case examples)Aravinda Nanjundappa

11:27 AM - DK Culotte in Left Main Bifurcation (with case examples)Lianglong Chen

11:37 AM - How to Perform a Planned Two-Stent Techniques? (with case examples)Antonio Colombo

11:47 AM - A Modified Two-Wire Technique to "Cut" the Ostial Stenosis of Side Branch through the Main Vessel Stent (with case examples)Josef Ludwig

11:57 AM - Bioresobable Scaffolds in Ostial Lesions and/or LAD-Diagonal Bifurcation Lesions (with case examples)Jean Fajadet

12:09 PM - Special Lecture: Bench Test Results with BRS in Bifurcations with OCT and Micro-CT AnalysisPieter C. Smits


12:30 PM - Break

Luncheon Satellite SymposiumSponsored by Asahi and Star ProgressHalf of the Successful Intervention Depends on Devices12:40 PM-1:55 PM

Chairmen: Jiyan Chen, Yong Sun, Yujie Zhou

12:40 PM - Opening Remarks

12:45 PM - Learning to the Next: SION TECCEisho Kyo

1:00 PM - Introduction to Asahi's New Devices in CTOLei Ge

1:15 PM - "Sharp Tools Make Good Work": Asahi GuildewiresFei Miao

1:30 PM - The Benefit and Advantage of Asahi Sheathless Guiding Catheter in TRIHui Chen


1:55 PM - Break

Abstract Oral Presentation Part I2:00 PM-4:00 PM

Moderators: Yong Huo, Yean-Leng Lim, Jiyan Chen, Donald E. Cutlip, Davide Capodanno, Zhe Zheng

2:00 PM - AS-0666: Confirmation and Validation of the Prognostic Capability of the SYNTAX Score-II Among 1,528 Patients Who Underwent Left Main PCIYelin Zhao

2:09 PM - Q&A

2:12 PM - AS-0724: Long-Term Results of One-Stop Hybrid Coronary Revascularization vs. Coronary Artery Bypass Graft and Percutaneous Coronary Intervention for the Treatment of Multivessel Coronary Artery DiseaseLiuzhong Shen

2:21 PM - Q&A

2:24 PM - AS-0638: Comparison of One-Stent vs. Two-Stent Technique for Treatment of Left Main Bifurcation Lesions: Data Derived from a Large Single Center Left Main Percutaneous Coronary Intervention RegistryZhan Gao

2:33 PM - Q&A

2:36 PM - AS-0126: Transradial vs. Transfemoral Intervention for Left Main Coronary Artery Disease: A Propensity Score Adjusted and Matched AnalysisJing Kan

2:45 PM - Q&A

2:48 PM - AS-0400: Optimal vs. Standard Antiplatelet Therapy on Platelet Function and Long-Term Clinical Outcomes in Patients with High On-Treatment Platelet Reactivity: 2-Year Outcomes of the Multicenter, Randomized Optimal Antiplatelet Therapy (OPT) TrialYi Li

2:57 PM - Q&A

3:00 PM - AS-0071: The Relationship between Revascularization Extent and Long-Term Prognosis of Patients with Stable Angina Pectoris and Three-Vessel Disease Treated by Percutaneous Coronary InterventionQuan Li



036

3:09 PM - Q&A

3:12 PM - AS-0463: Impact of Successful Staged Revascularization of a Chronic Total Occlusion in the Non-Infarct-Related Artery on Long-Term Outcome in Patients with Acute ST-Segment Elevation Myocardial InfarctionZhenkun Yang

3:21 PM - Q&A

3:24 PM - AS-0682: Efficacy and Safety of Transradial Approach PCI vs. Transfemoral Approach PCI for coronary Heart DiseaseJun Pang

3:33 PM - Q&A

3:36 PM - AS-0737: Long-Term Clinical Outcomes of 'Complete, Reasonable Complete, and Incomplete' Revascularization After Percutaneous Intervention of Unprotected Left Main Coronary Artery Disease with Drug-Eluting StentsYaojun Zhang

3:45 PM - Q&A

3:48 PM - AS-0731: The Impact of Biodegradable vs. Durable Polymer Drug-Eluting Stents on Stent Thrombosis in Patients with Coronary Artery Disease: A Meta-Analysis of 15 Randomized TrialsYaojun Zhang

3:57 PM - Q&A

4:00 PM - Adjourn

Room 206, Level 2

Mastering Cardiac and Vascular ComplicationsA Washington DC MEDSTAR Symposium at CIT8:30 AM-10:30 AM

Moderators: Nelson Bernardo, Shaoliang Chen, Weiguo Fu, Aravinda NanjundappaDiscussants: Thach Nguyen, Yang Wang, Hesong Zeng, David X. M. Zhao

8:30 AM - Course Opening: Introduction and One Case ReviewNelson Bernardo


8:42 AM - An Unexpected Coronary CatastropheFei Ye


8:54 AM - Retrograde Iatrogenic Coronary Embolism During Primary PCIThach Nguyen


9:06 AM - Iatrogenic Coronary Perforation and Dissection: How Do I Manage?Ramesh B. Daggubati


9:18 AM - Retroperitoneal Bleeding: Identification and CorrectionNelson Bernardo


9:30 AM - My Worst Case Scenario in a TAVR PatientEberhard Grube


9:42 AM - Superficial Femoral Artery Complications: Dissection, Perforation or OcclusionJunhao Jiang


9:54 AM - Vascular Access and Closure Device ComplicationAravinda Nanjundappa


10:06 AM - Carotid ComplicationsYang Wang


10:18 AM - EVAR ComplicationsNelson Bernardo


HKSTENT at CIT10:30 AM-12:30 PM

Moderators: Martin B. Leon, Ian T. Meredith, Michael Kang-Yin Lee

10:30 AM - Welcome AddressMichael Kang-Yin Lee

Part I: What's Hot - Challenge of Triple Anticoagulants?

Discussants: Alan Ka-Chun Chan, Chi-Kin Chan, Rosli Mohd Ali, Kyung-Woo Park, Hongbing Yan

10:33 AM - Case Scenario: Setting the Stage for DiscussionAlan Ka-Chun Chan

10:38 AM - What Do the Guidelines Suggest?Rosli Mohd Ali

10:48 AM - What Do the Guidelines NOT Cover?Kyung-Woo Park

10:58 AM - What Is the Practical Approach Beyond Guidelines?Hongbing Yan

11:08 AM - Panel Discussion

Part II: Best of CICF 2014

Discussants: Lei Ge, Eberhard Grube, Kin-Lam Tsui, Edmond Wong, Bin Zhang

Case 1: AMI Complication

11:18 AM - Case ScenarioTak-Shun Chung



037

11:21 AM - How Would I Treat?Ian T. Meredith

11:29 AM - How Did I Treat?Tak-Shun Chung


Case 2: CTO Complication

11:41 AM - Case ScenarioLi-Wah Tam

11:44 AM - How Would I Treat?Lei Ge

11:52 AM - How Did I Treat?Li-Wah Tam


Case 3: TAVI Complication

12:04 PM - Case ScenarioJason Leung-Kwai Chan

12:07 PM - How Would I Treat?Eberhard Grube

12:15 PM - How Did I Treat?Jason Leung-Kwai Chan


12:27 PM - Closing RemarkChi-Kin Chan

12:30 PM - Break

Luncheon Satellite SymposiumSponsored by B BraunSeQuent® Please: The "New" Standard for In-Stent Restenosis12:40 PM-1:55 PM

Chairmen: Run-Lin Gao, Jian'an Wang, Shaoliang Chen, Shubin Qiao, Bruno Scheller


12:45 PM - Drug-Coated Balloon: Clinical Results Update and Consensus RecommendationsBruno Scheller

1:05 PM - Update of PEPCAD China ISR Trial: 9-Month Angiographic, 12-Month Clinical, and Subgroup Analysis ResultsBo Xu

1:20 PM - Case Presentation 1 with Angiographic Follow-Up from PEPCAD China ISRZhigang Lu

1:32 PM - Case Presentation 2 with Angiographic Follow-Up from PEPCAD China ISRBinquan Zhou


1:55 PM - Break

Abstract Oral Presentation Part II2:00 PM-4:00 PM

Moderators: Alexandra J. Lansky, Xianghua Fu, Yujie Zhou, Bruno Scheller, Jenny Zhen Qin

2:00 PM - AS-0668: Safety and Efficacy of a Novel Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent in Patients with Diabetes Mellitus: 12-month Results from the Prospectively Patient-Level Pooled Analysis of the TARGET I and TARGET II TrialsDong Yin

2:09 PM - Q&A

2:12 PM - AS-0601: First Randomized Evaluation of the Extent of Neointimal Formation between Two Types of Sirolimus-Eluting Stents Having Different Biodegradable Polymer Coatings: The BuMA-OCT TrialJie Qian

2:21 PM - Q&A

2:24 PM - AS-0756: Reendotheliaization Conditions of Biodegradable Polymer Stent and Durable Polymer Stent Compared with Bare Metal Stent After PCI in Acute Myocardial Infarction PatientsQinhua Jin

2:33 PM - Q&A

2:36 PM - AS-0555: One-Year Clinical Results of Everolimus-Eluting Stents for Treatment of Small Vessel Disease: A Subgroup Analysis of the Prospective Multicenter SEEDS StudyChaowei Mu

2:45 PM - Q&A

2:48 PM - AS-0557: Paclitaxel-Coated Balloon vs. Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis in Diabetics: A Substudy of PEPCAD China ISR TrialJie Qian

2:57 PM - Q&A

3:00 PM - AS-0567: Drug-Eluting Balloon Only in Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction: The Results of a Prospective RegistryPieter R. Stella

3:09 PM - Q&A

3:12 PM - AS-0060: Target Lesion Revascularization Is Very High in Patients Undergoing Repeated Drug-Eluting Stent for Treatment of Early In-Stent Restenosis After Drug-Eluting Stent ImplantationLin Zhao

3:21 PM - Q&A

3:24 PM - AS-0566: Fractional Flow Reserve Calculation from 3-Dimensional Quantitative Coronary Angiography and TIMI Frame Count: A Fast Computer Model to Quantify the Functional Significance of Moderately Obstructed Coronary ArteriesShengxian Tu

3:33 PM - Q&A

3:36 PM - AS-0670: The Safety of Deferring PCI Based on FFR in the Ischemia-Induced Lesions Estimated by IVUSKe Cao

3:45 PM - Q&A

3:48 PM - AS-0603: Coronary Computed Tomography Angiography Guided Percutaneous Coronary Intervention for Patients with Chronic Total Occlusion: A Pilot StudyJunjie Yang

3:57 PM - Q&A

4:00 PM - Adjourn



038

10:30 AM - How to Utilize and Interpret MSCT?Jingyu Hang

10:45 AM - Q&A

10:50 AM - How to Utilize and Interpret IVUS?Xiaofan Wu

11:05 AM - Q&A

11:10 AM - How to Utilize and Interpret OCT?Qinhua Jin

11:25 AM - Q&A

11:30 AM - How to Utilize and Interpret FFR?Guisong Wang

11:45 AM - Q&A

11:50 AM - IABP: Indication, Implantation, and ManagementBin Liu

12:05 PM - Q&A

12:10 PM - How to Use Thrombus Aspiration Catheter: Tip and TricksZening Jin

12:25 PM - Q&A

12:30 PM - Break

Luncheon Satellite SymposiumSponsored by MaquetClinical Application of IABP and Clearway12:40 PM-1:55 PM

Chairmen: Yaling Han, Fang Chen, Zuyi Yuan, Yuguo Chen


12:45 PM - Clinical Application of IABPLefeng Wang

1:05 PM - Recent Advances and New Insights in IABP TherapyNico H.J. Pijls

1:25 PM - Experience with Clinical Application of ClearwayRajesh Dave


1:55 PM - Break

Abstract Oral Presentation Part III2:00 PM-4:00 PM

Moderators: Jean Marco, Jian'an Wang, Chung-Seung Chiang, Thach Nguyen, Ye Tian, Chris Kwok-Yiu Wong

2:00 PM - AS-0563: Preliminary Safety, Autonomic and BP Results from the REALISE Trial: Renal DenervatIon by Ultrasound Transcatheter EmissionAtul Pathak

2:09 PM - Q&A

2:12 PM - AS-0773: Sheathless Technique of Femoral Approach in Transcatheter Aortic Valve ImplantationHanjun Pei

2:21 PM - Q&A

2:24 PM - AS-0787: Three-Dimensional Aortic Root Reconstruction Derived from Rotational Angiography for Transcatheter Balloon-Expandable Aortic Valve Implantation GuidancePieter R. Stella

2:33 PM - Q&A

2:36 PM - AS-0667: The MitraClip Procedure for Mitral Regurgitation Results in a Significant Improvement in Procedural HemodynamicsWen Loong Yeow

2:45 PM - Q&A

2:48 PM - AS-0299: Long-Term Efficiency of Percutaneous Transluminal Septal Myocardial Ablation for Hypertrophic Obstructive CardiomyopathyXiaozeng Wang

2:57 PM - Q&A

3:00 PM - AS-0351: Percutaneous Closure of Ruptured Sinus of Valsalva Aneurysm: Results from a Multicenter ExperienceSuxuan Liu

3:09 PM - Q&A

Room 207, Level 2

Cardiac Catheterization Basics8:30 AM-12:30 PM

Session I

Moderators: Xuewen Qin, Haiming Shi, Yong Sun, Qibing Wang, Daifu Zhang

8:30 AM - Indications and Contraindications for Coronary AngiographyQi Zhang

8:45 AM - Q&A

8:50 AM - Radial Artery Puncture: Tips, Common Difficulties, and ComplicationsXianghua Fu

9:05 AM - Q&A

9:10 AM - Basic Skill of Diagnostic Catheterization: Coronary Anatomic VariantsQing Zhang

9:25 AM - Q&A

9:30 AM - How to Interpret Coronary Angiogram?Xinkai Qu

9:45 AM - Q&A

9:50 AM - Tips and Tricks of Guiding Catheter Selections and ManipulationChaowei Mu

10:05 AM - Q&A

10:10 AM - Tips and Tricks of Guidewire Selections and ManipulationLei Ge

10:25 AM - Q&A

Session II

Moderators: Shubin Qiao, Changqian Wang, Wenyue Pang, Wei Wang



039

3:12 PM - AS-0462: Beneficial Effects of Intracoronary Tirofiban Bolus Administration Following Upstream Intravenous Treatment in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The ICT-AMI StudyTianqi Zhu

3:21 PM - Q&A

3:24 PM - AS-0745: The Effects of Preventive Intracoronary Administration of Anisodamine on Myocardial Microcirculation Perfusion After Primary Percutaneous Coronary Intervention in Acute ST-Elevation Myocardial InfarctionQingmin Wei

3:33 PM - Q&A

3:36 PM - AS-0633: Effectiveness of Thrombus Aspiration for Acute ST-Segment Elevation Myocardial Infarction: A Meta-AnalysisXiang Ma

3:45 PM - Q&A

3:48 PM - AS-0743: Short-Term Percutaneous Coronary Intervention for Non-Infarction Related Artery in Acute Myocardial InfarctionQingsheng Wang

3:57 PM - Q&A

4:00 PM - Adjourn


Session II

Moderators: Xianghua Fu, Chunguang Qiu, Junyu Cui, Lixia Yang, Xianhe Lin

9:54 AM - Procedural Complications: Devices Loss and RetrievalImad Sheiban


10:06 AM - Treatment Strategy of Highly Angulated and Calcified LesionGenshan Ma


10:18 AM - Stent Cannot Pass through the Lesion: Why and How to Deal with?Dadong Zhang


10:30 AM - Transradial Interventions: Are the Clinical Benefits Real?Rakesh K. Jaswal


10:42 AM - Tricks and Technical Considerations for PCI of Coronary AnomaliesQing Zhang


10:54 AM - How to Manage Patients with Thrombocytopenia After PCI?Haichang Wang


11:06 AM - Hybrid Approach in Cardiovascular CareDavid X. M. Zhao


Session III

Moderators: Chung-Seung Chiang, Feng Cao, Seung-Ho Hur, Ruqiong Nie, Mujeeb Ul-Haq

11:18 AM - Management of STEMI: Century Long SagaVinay K. Bahl

Room 208, Level 2

PCI Technique and Outcome Part I8:30 AM-12:30 PM

Session I

Moderators: Fang Chen, Luyue Gai, Qing He, Ju-Pin Pan, Zhigang Lu

8:30 AM - Fractional Flow Reserve as the New Cardiologist's Comfort Zone: Is It Really Comfortable?Costantino R. Costantini


8:42 AM - Role of OCT in Calcified LesionsChi-Kin Chan


8:54 AM - Oral Immunosuppressive Therapy to Prevent In-Stent Restenosis: A Patient-Level Meta-Analysis of Seven Randomized TrialsAlfredo E. Rodriguez


9:06 AM - Comparison of Long-Term Clinical and Angiographic Outcomes Following Implantation of Bare Metal Stents and Drug-Eluting Stents in Coronary Ostial LesionsChing-Chang Fang


9:18 AM - When Do We Really Need Retrograde Technique in CTO?Ömer Göktekin


9:30 AM - Clinical Thinking of the Recanalization of CTO via MicrochannelWeimin Li


9:42 AM - Application of Microcatheter in PCIJifei Tang



040

1:50 PM - Take-Home Message

1:55 PM - Break

Abstract Oral Presentation Part IV2:00 PM-3:48 PM

Moderators: Ben He, Dongming Hou, Jie Wang, Hong Yuan, Chengzhi Lu, Ningfu Wang

2:00 PM - AS-0127: Inhibition of Thioredoxin by Thioredoxin-Interacting Protein Mediates the Impairment of Ischemia-Induced Angiogenesis in Diabetic MyocardiumTao Yin

2:09 PM - Q&A

2:12 PM - AS-0272: Over Restrictive Salt Diet Promotes Atherosclerotic Plaque Growth and Instability Through PCSK9 in ApoE Knockout MiceNan Zhu

2:21 PM - Q&A

2:24 PM - AS-0089: Effects of Macrophages Phagocytizing Mesenchymal Stem Cells on the Repair of Infarcted Myocardium and Possible MechanismsWenbin Lu

2:33 PM - Q&A

2:36 PM - AS-0342: Association between CYP2C19*2/*3 Polymorphism and Cardiovascular Events in a Chinese Han PopulationYingying Zhang

2:45 PM - Q&A

2:48 PM - AS-0366: Shedding of Syndecan-4 from Vascular Endothelial Cells Induces Endothelial Dysfunction and Impaired Angiogenesis in Diabetes MellitusJun Xie

2:57 PM - Q&A

3:00 PM - AS-0097: In vivo Evaluation of a New Activable MRI Contrast Agent to Target Matrix Metalloproteinases in the Early-Stages of Abdominal Aortic AneurysmsYuyu Yao

3:09 PM - Q&A


11:30 AM - Late Acquired Incomplete Stent Apposition After Everolimus-Eluting Stent vs. Sirolimus-Eluting Stent Implantation in Patients with Acute Myocardial Infarction: The APPOSITION-AMI TrialSeung-Ho Hur


11:42 AM - Self Expandable Stents in Primary PCI for Acute Myocardial Infarction: Insight from a Single Center ExperiencePietro Vandoni


11:54 AM - Management of Incomplete Revascularization in Primary PCIRichard Lim

12:04 PM - Discussion

12:06 PM - Application of Thrombus Aspiration Catheter in Primary PCI for STEMIYi Li


12:18 PM - Cardiogenic Shock and Percutaneous Ventricular Assist DevicesRamesh B. Daggubati


12:30 PM - Break

Luncheon Satellite SymposiumSponsored by BraccoSineThe Choice of Contrast Media in the Cardiac Catheterization Laboratory12:40 PM-1:55 PM

Chairmen: Weifeng Shen, Ben He


12:45 PM - Can We Actually Prevent CIN? An Update on Type of Contrast Media and Impact on CINRoxana Mehran

1:25 PM - Contrast Induced Nephropathy: State of the ArtBen He

3:12 PM - AS-0507: Effects of Renal Sympathetic Denervation on Ventricular Remodeling and Sympathetic Neural Remodeling in CanineChengzhi Lu

3:21 PM - Q&A

3:24 PM - AS-0274: Coronary Artery Calcium Score Predicts the Complexity of Percutaneous Coronary Intervention in Patients with Multivessel DiseaseLiyun He

3:33 PM - Q&A

3:36 PM - AS-0136: The Efficacy and Safety of Short-Term Intensive Statin Therapy in Acute Coronary Syndrome: SISTA-I StudyNingfu Wang

3:45 PM - Q&A

3:48 PM - Adjourn



041

3:40 PM - Q&A

3:45 PM - CS-0279: Severe Ostial Stenosis Treated by DES Implantation in a Young Male Patient: Atypical Takayasu Arteritis?Yingguang Shan

3:55 PM - Q&A

4:00 PM - Adjourn

Room 305A, Level 3

CIT Educational Case AwardCase Presentation Part IACS and Special Cases2:00 PM-4:00 PM

Moderators: Hongbing Yan, Luyue Gai, Jifei Tang, Lijiang Tang, Wenyue Pang, Guoxian Qi, Guanchang Cheng

2:00 PM - CS-0136: Misjudgment of LAD During Primary PCILei Gao

2:10 PM - Q&A

2:15 PM - CS-0144: Multivessel Simultaneously Acute ThrombusLixin Wang

2:25 PM - Q&A

2:30 PM - CS-0033: Transcatheter Embolization for Acute Gastrointestinal Bleeding After Primary PCIZhaoqing Sun

2:40 PM - Q&A

2:45 PM - CS-0225: Balloon Assisted Accurate Positioning for the Treatment of Ostial LesionShengwen Liu

2:55 PM - Q&A

3:00 PM - CS-0266: RDN Therapy for a Patient with ESRD and Renal HypertensionZhenchi Sang

3:10 PM - Q&A

3:15 PM - CS-0086: PCI for End-Staged Coronary Artery DiseaseLang Hong

3:25 PM - Q&A

3:30 PM - CS-0222: Uncomplicated Right Radial Access for PCIRenata Rogacka

Room 305B, Level 3

Renal Denervation Luncheon Symposium12:00 PM-2:00 PM

Moderators: Pingjin Gao, Xiongjing JiangDiscussants: Yundai Chen, Chengzhi Lu, Xinkai Qu, Ningling Sun, Jie Wang, Zhencheng Yan

12:00 PM - Device Therapies to Rebalance Sympathetic Tone: Origin, Physiologic Rationale and ExtensionJie Wang

12:15 PM - Overview of Various Renal Denervation TherapiesChengzhi Lu

12:30 PM - Renal Denervation Therapy for the Treatment of Resistant Hypertension: Evidence and ControversiesYundai Chen

12:45 PM - Renal Denervation Therapy for the Treatment of Resistant Hypertension: China Hypertension League's Position and ProposalNingling Sun

1:00 PM - Renal Denervation Therapy for the Treatment of Resistant Hypertension: Experiences of Patient Screening and Peri-Procedural ManagementZhencheng Yan

1:15 PM - Renal Denervation with Dedicated Devices: Preliminary Results of Clinical Studies in ChinaXiongjing Jiang

1:30 PM - Role of Intravascular Imaging in Renal DenervationXinkai Qu




042

CIT Educational Case AwardCase Presentation Part IILeft Main PCI and TAVR2:00 PM-4:00 PM

Moderators: Weimin Wang, Juying Qian, Yingzhong Lin, Huigen Jin, Yuqing Hou, Xuewen Qin, Quanming Zhao

2:00 PM - CS-0243: Successful Rescue for Severe Iatrogenic Left Main DissectionChengqian Yin

2:10 PM - Q&A

2:15 PM - CS-0101: Left Main RotablationU Po Lam

2:25 PM - Q&A

2:30 PM - CS-0369: Left Main Quadrifurcation Lesion: Dilemma of RevascularizationJian Liu

2:40 PM - Q&A

2:45 PM - CS-0316: Rotational Atherectomy for Severe Calcified Left Main Bifurcation LesionJun Jiang

2:55 PM - Q&A

3:00 PM - CS-0175: IVUS Guided Left Main Bifurcation PCI with Mini-Culotte TechniqueXuebo Liu

3:10 PM - Q&A

3:15 PM - CS-0059: Left Atrium Enlargement and Left Main Compression: Causes of ACSYan Wang

3:25 PM - Q&A

3:30 PM - CS-0249: Postprocedural Management: A Challenging TAVR CaseYuan Feng

3:40 PM - Q&A

3:45 PM - CS-0164: Transcatheter Valve-in-Valve Implantation in a Patient with Bicuspid Aortic ValveMao Chen

3:55 PM - Q&A

4:00 PM - Adjourn

2:15 PM - CS-0015: Acute Left Main Thrombus After PCI for LADQi Zhang

2:25 PM - Q&A

2:30 PM - CS-0224: LCX Stent Dislodgement Complicating Implanted Stent Move-Out from LADQuanmin Jing

2:40 PM - Q&A

2:45 PM - CS-0190: A Case of Acute Cardiac Tamponade After Coronary AngiographyGeng Wang

2:55 PM - Q&A

3:00 PM - CS-0221: Rescue PCI Complicating Aortic DissectionHua Xiao

3:10 PM - Q&A

3:15 PM - CS-0238: From Trouble to DisasterHuiping Zhang

3:25 PM - Q&A

3:30 PM - CS-0182: Aortocoronary Dissection During PCI for RCA CTOJiyi Zhao

3:40 PM - Q&A

3:45 PM - IM-0023: Successful Treatment of Acute Thrombosis During PCIGang Zhao

3:55 PM - Q&A

4:00 PM - Adjourn

Room 302A, Level 3

Interventional Innovation in China: Current and Future Landscape12:40 PM-1:55 PM

Moderators: Juan F. Granada, Yuval Binur, Shu ZhangDiscussants: Shaoliang Chen, Xiangqing Kong, Qiyi Luo, Zhenjun Zi

12:40 PM - IntroductionJuan F. Granada

12:50 PM - Basic Concepts of Medical Device Innovations and Importance of the Physician's RoleYuval Binur

1:00 PM - Innovations in China: Current Perspectives and ChallengesXiangqing Kong

1:10 PM - Funding Strategies and OpportunitiesZhenjun Zi

1:20 PM - Case Study of China-Based Innovation: Target Eluting StentQiyi Luo

1:30 PM - Case Study of China-Based Innovation: Pulmonary Artery DenervationShaoliang Chen


1:55 PM - Break

CIT Educational Case AwardCase Presentation Part IIIComplications2:00 PM-4:00 PM

Moderators: Shuzheng Lu, Wenyi Guo, Pingshuan Dong, Jihong Gan, Tongguo Wu, Yongjun Li, Zhenguo Ji

2:00 PM - CS-0194: How Did I Deal with This Coronary Artery Perforation?Sanjay Mehrotra

2:10 PM - Q&A



043

2:15 PM - CS-0371: Retrograde Guidewire Entrapment in CTO Lesion: Attempts to Retrieve and Reflects on ProcedureLihua Xie

2:25 PM - Q&A

2:30 PM - CS-0377: Retrograde PCI for RCA CTO via Vein GraftChengxiang Li

2:40 PM - Q&A

2:45 PM - IM-0071: PCI for Complex LAD CTO under IVUS GuidanceJiming Li

2:55 PM - Q&A

3:00 PM - CS-0230: Retrograde PCI for RCA Tortuous CTOQuanmin Jing

3:10 PM - Q&A

3:15 PM - CS-0147: Retrograde PCI for CTO Lesion with Single Guide CatheterJiancheng Xiu

3:25 PM - Q&A

3:30 PM - CS-0219: IVUS Guided PCI for LAD CTOChaowei Mu

3:40 PM - Q&A

3:45 PM - CS-0156: RCA CTO Case: When Subintimal Stents Were ExistedGuowei Zhou

3:55 PM - Q&A

4:00 PM - Adjourn

Room 302B, Level 3

Luncheon Satellite SymposiumSponsored by MicroPort (1)Pointing to the Sky: Ten Years' Journey of FIREBIRD Series12:40 PM-1:55 PM

Chairmen: Junbo Ge, Haichang Wang, Costantino R. Costantini, Liliana R. Grinfeld, Jinghua Liu


12:45 PM - 2-Year Follow-Up Results of FIRE2-DIABETES RegistryYan Li

1:00 PM - 3-Year Follow-Up Results of FOCUS RegistryFeng Zhang

1:15 PM - Revascularization Strategy for Patients with Multivessel Disease in the "Real World" Using FIREBIRD 2 Co-Cr Alloyed Sirolimus-Eluting Stent: The ERACI IV RegistryAlfredo E. Rodriguez

1:30 PM - FIREBIRD 2 Co-Cr Alloyed Sirolimus-Eluting Stent in Thailand: One-Year Results of FOCUS-T RegistryWasan Udayachalerm


1:55 PM - Break

CIT Educational Case AwardCase Presentation Part IVChronic Total Occlusions2:00 PM-4:00 PM

Moderators: Guosheng Fu, Lei Ge, Yong Wang, Xuefeng Guang, Chaolian Huang, Qiangsun Zheng, Hu Li

2:00 PM - CS-0381: PCI for LAD CTO: Succeeded After Several AttemptsHongtao Liao

2:10 PM - Q&A



044

The Pearl Hall, Level 3

Opening of CIT 2014 and Plenary Session8:00 AM-12:30 PM

Session I: Spotlight Live Case Session

Moderators: Martin B. Leon, Antonio Colombo, Eberhard GrubeDiscussants: Maurice Buchbinder, Jean Fajadet, William F. Fearon, Ted E. Feldman, Saibal Kar, Ian T. Meredith, Corrado Tamburino, John G. Webb, Yuejin Yang, Alan C. Yeung, David X. M. Zhao

8:00 AM - Live Case Transmission from NewYork-Presbyterian Hospital / Columbia University Medical Center, New YorkTranscatheter Aortic Valve Replacement (New Device)Operators: Susheel Kodali, Mathew Williams, Rebecca Hahn, and Colleagues

Session II: Opening of CIT 2014 in Partnership with TCT

Moderators: Run-Lin Gao, Bo XuDiscussants: Alexandre Abizaid, Anthony DeMaria, Jean Fajadet, Junbo Ge, Shengshou Hu, Spencer B. King III, Martin B. Leon, Yean-Leng Lim, Masahiko Ochiai, Seung-Jung Park, Patrick W. Serruys, Ashok Seth, Gregg W. Stone

8:45 AM - Welcome AddressRun-Lin Gao

8:55 AM - TCT at 25 Years: The Explosive Growth of Interventional Cardiovascular MedicineMartin B. Leon

9:10 AM - Roundtable Discussion from Regions Around the Globe: The Most Impactful Advances in Interventional Cardiovascular MedicineLead Discussants: Martin B. Leon, Gregg W. Stone

Session III: Approach to Refractory Hypertension - Case-Based Discussion

Moderators: Ajay J. Kirtane, Horst SievertDiscussants: Justin E. Davies, Murray D. Esler, Juan F. Granada, Xiongjing Jiang, David E. Kandzari, Jan Kovac, Felix Mahfoud, Jean Marco, Atul Pathak, Marco Wainstein, Jiguang Wang, Shing-Chiu Wong

9:30 AM - Case Presentation and CommentaryAjay J. Kirtane

9:40 AM - Renal Denervation Therapy: Resistant Hypertension and BeyondFelix Mahfoud


Session IV: STEMI - New Pharmacology and Devices

Moderators: Roxana Mehran, Yong HuoDiscussants: Joseph D. Babb, Donald E. Cutlip, Liliana R. Grinfeld, Yaling Han, Adnan Kastrati, Mitchell W. Kruco�, Akiko Maehara, Nico H. J. Pijls, Weifeng Shen, Pieter C. Smits, Harry Suryapranata, Robaayah Zambahari

10:15 AM - Case Presentation and CommentaryPhilippe Généreux

10:25 AM - STEMI Approaches: Current State and Future DevelopmentsGregg W. Stone


Session V: Bioresorbable Scaffold - Will This Be the Default Therapy of the Next Decade?

Moderators: Gregg W. Stone, Patrick W. SerruysDiscussants: Alexandre Abizaid, Jiyan Chen, Shaoliang Chen, Tian-Hai Koh, Alexandra J. Lansky, Ian T. Meredith, Marie-Claude Morice, Christoph K. Naber, Charles A. Simonton, Huay Cheem Tan, Renu Virmani, Ron Waksman

11:00 AM - Case Presentation and CommentaryAntonio Colombo

11:10 AM - The Promise and Proof of BRS: A Real World PerspectivePatrick W. Serruys


Session VI: Cath Lab of the Future - Innovation in the Making

Moderators: Martin B. Leon, Gary S. MintzDiscussants: Stephan Achenbach, Yundai Chen, Keith D. Dawkins, Bernard De Bruyne, Peter J. Fitzgerald, John McB. Hodgson, Michael Kang-Yin Lee, Chaim S. Lotan, Michael A. Mussallem, Sean Salmon, Haichang Wang, Jian'an Wang

11:45 AM - Models of InnovationChaim S. Lotan

11:55 AM - IT Meets MedTech: The Integration of IT in Our Daily Clinical PracticePeter J. Fitzgerald

12:05 PM - Translational Medicine: From Concept to RealityJuan F. Granada


12:30 PM - Adjourn



045

Room 201, Level 2

Live Case Session 5Peripheral Vascular InterventionAffiliated Ruijin Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai9:30 AM-11:00 AM

Moderators: Rajesh Dave, Jianfang LuoDiscussants: Anil Chagarlamudi, Eric Dippel, W. Britton Eaves, Richard C. Kovach, Carlos Mena, Thomas Shimshak, Neil E. Strickman, Yan Wang, Yinghua ZouOperators: Craig M. Walker, Ruiyan Zhang, and Colleagues

Live Case Session 6Structural Heart DiseaseFudan University Zhongshan Hospital, Shanghai11:00 AM-12:30 PM

Moderators: Shiliang Jiang, Horst Sievert, Shu ZhangDiscussants: Jacek Bialkowski, Saibal Kar, Xiangqing Kong, Yat-Yin Lam, Matthew J. Price, Witold Ruzyllo, Guangyi Wang, Jiangtao Yu, Zhiwei ZhangOperators: Maurice Buchbinder, Junbo Ge, Ziyad M. Hijazi, Daxin Zhou, and ColleaguesLeft Atrial Appendage Closure, Transcatheter Pulmonary Valve Replacement, and VSD/ASD

Luncheon Satellite SymposiumSponsored by MicroPort (2)A New Era of Target Eluting Stent: Update on FIREHAWK Preclinical and Clinical Program12:40 PM-1:55 PM

Chairmen: Run-Lin Gao, Martin B. Leon, Weifeng Shen, Alexandra J. Lansky, Shangyu Wen

12:40 PM - Objectives and IntroductionMartin B. Leon

12:45 PM - Development of FIREHAWK with the New Concept of Target Eluting StentQiyi Luo

1:00 PM - A Novel Technology of the Target Eluting Stent: Insights from FIREHAWK Preclinical StudyRenu Virmani

1:15 PM - Update on the Randomized TARGET I Trial: 9-Month Angiographic and 2-Year Clinical Results, and BeyondRun-Lin Gao

1:30 PM - FIREHAWK in More Complex Patients and Lesions: 2-Year Results of TARGET II and 3-Year Results of Long Stent RegistryShaoliang Chen


1:55 PM - Break

Late Breaking Clinical Trials2:00 PM-3:00 PM

Moderators: Patrick W. Serruys, Gregg W. StoneDiscussants: Shaoliang Chen, Ted E. Feldman, Yaling Han, Adnan Kastrati, Spencer B. King III, William L. Lombardi, Marie-Claude Morice, Matthew J. Price

2:00 PM - BRIGHT: A Prospective, Randomized Trial of Bivalirudin vs. Heparin Monotherapy and Glycoprotein IIb/IIIa plus Heparin for Patients with Acute Myocardial Infarction Undergoing Coronary StentingYaling Han


2:20 PM - AIR-CTO: A Prospective, Randomized Trial Comparing Angiography- and Intravascular Ultrasound-Guided Stent Implantation for Coronary Chronic Total OcclusionsShaoliang Chen


2:40 PM - A Prospective, Randomized Trial of Chinese Medicine Tongxinluo to Attenuate High On-Treatment Platelet Reactivity in Patients After Percutaneous Coronary InterventionYi Li


EAPCI-EuroPCR at CITBioresorbable Scaffolds for the Treatment of Coronary Artery Disease3:00 PM-6:00 PM

Part I

Moderators: Jean Fajadet, Run-Lin GaoDiscussants: Tian-Hai Koh, Stephen Wai-Luen Lee, Marie-Claude Morice, Christoph K. Naber, Yoshinobu Onuma, Patrick W. Serruys, Ashok Seth, Corrado Tamburino, Yaojun Zhang

3:00 PM - IntroductionRun-Lin Gao, Jean Fajadet

3:05 PM - From Bioresorbable Scaffold to Vascular Reparative TherapyPatrick W. Serruys

3:15 PM - Results from ABSORB StudiesMarie-Claude Morice

3:25 PM - Experience with Other Bioresorbable ScaffoldsCorrado Tamburino

3:35 PM - Experience from ChinaYuejin Yang


3:55 PM - How Imaging Can Guide the Use of Bioresorbable Scaffolds?Yoshinobu Onuma

Bioresorbable Scaffolds in Real World

4:05 PM - Long Lesions and Overlapping ScaffoldsChristoph K. Naber

4:15 PM - Bifurcation LesionsAntonio Colombo




046

Room 202, Level 2

Myocardial Ischemia, Diagnosis and Therapy of Coronary Artery DiseaseSupported by Biosensors and JWMS10:30 AM-12:30 PM

Moderators: Yuejin Yang, Yaming Li, Weiyi Fang, Zuoxiang He

10:30 AM - Application of the Guideline for Noninvasive-Functional Imaging and Clinical Controversies on Coronary Artery DiseaseYundai Chen


10:54 AM - Risk Stratification of Nuclear Medicine Imaging on Diagnosis of Coronary Artery DiseaseSijin Li


11:18 AM - Clinical Value and Development of Fusion Imaging in Diagnosis of Coronary Artery DiseaseQian Wang


11:42 AM - Left Ventricular Systolic Synchrony Assessed by Phase Analysis of Gated Myocardial Perfusion SPECT ImagingYuetao Wang


12:06 PM - Treatment Effect Evaluation of Coronary Artery Disease with Nuclide Myocardial ImagingHongcheng Shi


12:30 PM - Break

Part II

Moderators: Jean Fajadet, Yong HuoDiscussants: Yundai Chen, Antonio Colombo, Guosheng Fu, Wenyi Guo, Marie-Claude Morice, Christoph K. Naber, Teguh Santoso, Patrick W. Serruys, Corrado Tamburino

Live Case Transmission from St. Thomas' Hospital, London

Operators: Martyn R. Thomas, Simon Redwood, and Colleagues

4:35 PM - Live Case1: Long LAD Lesion

5:10 PM - Live Case2: Coronary Bifurcation (LAD / Diagonal)

5:45 PM - Post Live Cases Discussion

5:55 PM - Take-Home MessageJean Fajadet, Yong Huo

6:00 PM - Adjourn

Luncheon Satellite SymposiumSponsored by Biosensors & JWMSEvolutionary Dual Golden Standard: Functional-Anatomical Mapping for CHD12:40 PM-1:55 PM

Chairmen: Jian'an Wang, Gang Huang, Martin B. Leon, Eberhard Grube, Sijin Li, Bo Xu


12:45 PM - Molecular Imaging Plays a Critical Role in Current CHD DiagnosisZuoxiang He

1:00 PM - Noninvasive Quantitative Measurement of Coronary Flow ReserveRyo Nakazato

1:15 PM - Novel Functional-Anatomical Mapping for Interventional CardiologistsMartin B. Leon

1:30 PM - Clinical Observations from Functional-Anatomical Mapping: An Introduction to the Pivotal Clinical TrialShlomo Ben Haim


1:55 PM - Adjourn

Live Case Session 8 with Featured Lectures2:00 PM-4:00 PM

Moderators: Eberhard Grube, David E. Kandzari, Yean-Leng LimDiscussants: Fernando Alfonso, Fang Chen, Costantino R. Costantini, Shengshou Hu, Chaim S. Lotan, Mitchell W. Kruco�, Xiaoyong Qi, Pieter R. Stella, Jianhua Zhu

2:00 PM - Live Case Transmission from Fudan University Zhongshan Hospital, ShanghaiLeft Main, Bifurcations, and Bioresorbable ScaffoldOperators: Antonio Colombo, Seung-Jung Park, Junbo Ge, Juying Qian, Lei Ge, and ColleaguesIVUS Interpreter: Akiko Maehara

3:30 PM - Hybrid Revascularization for the Treatment of Multivessel Coronary Artery Disease: Current State and ControversyShengshou Hu



047

3:45 PM - Dual Antiplatelet Therapy: How Long Is Long Enough?Donald E. Cutlip

Live Case Session 9 with Featured Lectures4:00 PM-6:00 PM

Moderators: Martin B. Leon, Ian T. Meredith, Yuejin YangDiscussants: Yaron Almagor, Juan F. Granada, Jian Liu, Jinghua Liu, Richard Ng, Masahiko Ochiai, Alfredo E. Rodriguez, Bruno Scheller, Junjie Zhang

4:00 PM - Live Case Transmission from Affiliated Ruijin Hospital of Shanghai Jiao Tong University School of Medicine, ShanghaiLeft Main, Bifurcation, and Chronic Total OcclusionOperators: Je�rey W. Moses, Ajay J. Kirtane, Philippe Généreux, Toshiya Muramatsu, Ruiyan Zhang, Qi Zhang, and ColleaguesIVUS Interpreter: Gary S. Mintz

5:30 PM - Update of Retrograde Approach to CTOMasahiko Ochiai

5:45 PM - Chien Foundation Lectureship AwardAward Presenter: Richard NgAward Recepient: Antonio Colombo

5:50 PM - Chien Foundation Lecture: My View of the Future of Interventional CardiologyAntonio Colombo

6:00 PM - Adjourn

2:05 PM - How Would I Treat?Junjie Zhang

2:10 PM - How Would I Treat?Kefei Dou

2:15 PM - Case Presentation: How Did I Treat?Chengxing Shen

2:20 PM - Tips and Tricks for the Treatment of Coronary Ostial LesionWeiyi Guo


Case 2: Thrombus-Containing Lesion

2:40 PM - Case IntroductionYan Li

2:45 PM - How Would I Treat?Zhenyu Liu

2:50 PM - How Would I Treat?Qiang Liu

2:55 PM - Case Presentation: How Did I Treat?Yan Li

3:00 PM - Tips and Tricks for the Treatment of Thrombus-Containing LesionLefeng Wang


Session II

Moderators: Lijun Jin, Lang LiDiscussants: Xuebin Cao, Zhujun Chen, Chaozhong Liu, Ruqiong Nie, Yanmin Xu, Zesheng Xu

Case 3: Small Vessel / Long Lesion

3:20 PM - Case IntroductionJingyu Hang

3:25 PM - How Would I Treat?Ruqiong Nie

3:30 PM - How Would I Treat?Zhujun Chen

3:35 PM - Case Presentation: How Did I Treat?Jingyu Hang

Room 203, Level 2

Luncheon Satellite SymposiumSponsored by Abbott Vascular (1)Practice, Evidence, Technology: Lead the Way of DES12:40 PM-1:55 PM

Chairmen: Yaling Han, Fang Chen, Jiyan Chen, Shaoliang Chen, Lefeng Wang


12:45 PM - Biodegradable Polymer DES or Durable Polymer DES? Evidence from Multiple Clinical Trials and Meta-AnalysisPieter C. Smits

1:00 PM - First Report of DAPT and CoCr Everolimus-Eluting Stent in Chinese Population: 2-Year Results from the Prospective Multicenter SEEDS StudyBo Xu

1:15 PM - Conquer Challenges in Clinical Dilemma with CoCr Everolimus-Eluting StentWei-Hsian Yin

1:30 PM - The Revolutions of New Generation CoCr Everolimus-Eluting StentChaowei Mu


1:55 PM - Break

Practical Course on PCI Part IHow to Treat: Complex Case Discussions2:00 PM-6:00 PM

Session I

Moderators: Weiyi Guo, Lefeng WangDiscussants: Feng Bai, Kefei Dou, Zhanying Han, Qiang Liu, Zhenyu Liu, Junjie Zhang

Case 1: Ostial Lesion

2:00 PM - Case IntroductionChengxing Shen



048

3:40 PM - Tips and Tricks for the Treatment of Small Vessel and Long LesionLijun Jin


Case 4: DES Restenosis

4:00 PM - Case IntroductionXiantao Song

4:05 PM - How Would I Treat?Chaozhong Liu

4:10 PM - How Would I Treat?Yanmin Xu

4:15 PM - Case Presentation: How Did I Treat?Xiantao Song

4:20 PM - Strategy and Technique for the Treatment of DES RestenosisLang Li


Session III

Moderators: Shubin Qiao, Weiyi FangDiscussants: Bing Fan, Lang Hong, Jinfa Jiang, Zhigang Lu, Haiming Shi, Huifeng Wang

Case 5: Calcified Lesion

4:40 PM - Case IntroductionQiong Wang

4:45 PM - How Would I Treat?Zhigang Lu

4:50 PM - How Would I Treat?Lang Hong

4:55 PM - Case Presentation: How Did I Treat?Qiong Wang

5:00 PM - Tips and Tricks for the Treatment of Calcified LesionShubin Qiao


Case 6: Tortuous / Angulated Lesion

5:20 PM - Case IntroductionJun Pu

5:25 PM - How Would I Treat?Haiming Shi

5:30 PM - How Would I Treat?Bing Fan

5:35 PM - Case Presentation: How Did I Treat?Jun Pu

5:40 PM - Tips and Tricks for the Treatment of Tortuous / Angulated LesionWeiyi Fang


6:00 PM - Adjourn

Room 204, Level 2

Breakfast Case Reviews 1Acute Coronary Syndromes7:00 AM-8:15 AM

Moderators: Fei Ye, Zhenguo Ji, Yong He

7:00 AM - CS-0012: Acute Inferior Myocardial Infarction in a Patient 10 Months After LAD PCIZhenguo Ji

7:10 AM - Q&A

7:15 AM - CS-0213: Acute Myocardial Infarction with Cardiac ArrhythmiaYuquan Xie

7:25 AM - Q&A

7:30 AM - CS-0236: Emergent PCI in Patient with NSTEMIYunjun Ruan

7:40 AM - Q&A

7:45 AM - CS-0259: PCI for Non-IRA in an AMI PatientKefu Feng

7:55 AM - Q&A

8:00 AM - CS-0292: Primary PCI for RCA and Left Main CTO at One StageDapeng Chen

8:10 AM - Q&A

8:15 AM - Adjourn

Luncheon Satellite SymposiumSponsored by Boston Scientific (1)The Must-Know Devices "Tailored" for Optimal PCI Therapy of Complex Cases12:40 PM-1:55 PM

Chairmen: Ben He, Lianglong Chen, Yitong Ma, Zhimin Du, Jue Chen, Xuebo Liu




049

12:45 PM - Case Report of PROMUS Element Plus PtCr EESQuanmin Jing

1:00 PM - Not Only for Restenosis! Case Report of Flextome Cutting BalloonShaoping Nie

1:15 PM - Case Report of Rotablation in Complex Calcified LesionsZhujun Chen

1:30 PM - Case Report of IVUS Guided Left Main Bifurcation Lesion PCIXuebo Liu


1:55 PM - Break

Integrating FFR, IVUS, OCT, and More to Improve Patient Outcomes Part III2:00 PM-6:00 PM

Session IV: Pre-Intervention Assessment

Moderators: John McB. Hodgson, Xuebo Liu

2:00 PM - When and How to Use of FFR?Shoujie Shan

2:15 PM - Instantaneous Wave-Free Ratio (iFR) and Hybrid iFR/FFR Strategies: Do They Replace FFR?Justin E. Davies

2:30 PM - CT-FFR: An UpdateCampbell Rogers

2:45 PM - Pre-Intervention Imaging and Stent Sizing by IVUSSoo-Jin Kang

3:00 PM - Pre-Intervention Imaging and Stent Sizing by OCTJingbo Hou

3:15 PM - Predicting Peri-Procedural MI: Role of Grayscale IVUS, RF (VH) IVUS, OCT, and NIRSXiaofan Wu

Case Presentations Illustrating Pre-PCI Assessment or Stent Sizing (15 minutes each including Q&A)

Discussants: Justin E. Davies, Seung-Jea Tahk, Yingjia Xu

3:30 PM - IM-0059: Plaque Characteristics and No-Reflow Phenomenon in STEMI Patient Undergoing Primary PCIPeiren Shan

3:45 PM - IM-0082: IVUS in Rotational AtherectomyKai Xu

4:00 PM - IM-0087: Left Main PCI Guided by IVUSLei Zhao

Session V: Stent Optimization

Moderators: Costantino O. Costantini, Alan C. Yeung

4:15 PM - Stent Optimization by IVUSNing Guo

4:30 PM - Stent Optimization by OCTYang-Soo Jang

4:45 PM - Stent Optimization and Assessment of Jailed Side Branches by FFRBon-Kwon Koo

5:00 PM - Featured Lecture: The Evidence That IVUS (or OCT) Guidance Improves OutcomesJohn McB. Hodgson

Case Presentations Illustrating Stent Optimization (15 minutes each including Q&A)

Discussants: Debabrata Dash, Bon-Kwon Koo, Zhijing Zhao

5:15 PM - IM-0024: Intramural Hematoma After PCIXintian Zheng

5:30 PM - IM-0050: Subacute Thrombosis Caused by Stent Underexpansion in Severely Calcified LesionJing Bai

5:45 PM - IM-0109: FFR Guidance in Bifurcation LesionHua Yan

6:00 PM - Adjourn



050

1:15 PM - Balloon Experience Sharing in BifurcationChengxiang Li

1:30 PM - Balloon Tips and Skills in CTO LesionQing Yang


1:55 PM - Break

Left Main and Bifurcations Part IITreatment of Bifurcation Lesions: Insights into Emerging Data2:00 PM-6:00 PM

Session I: Contemporary Concept of Simple vs. Complex Bifurcations

Moderators: Alexandra J. Lansky, Imad Sheiban, Ramesh B. DaggubatiDiscussants: Ning Guo, Bon-Kwon Koo, Li Li, Jinghua Liu, Jie Qian

2:00 PM - Anatomical, Physiological and Clinical Relevance of a Bifurcation LesionBon-Kwon Koo

2:12 PM - Are Current Bifurcation Studies Guiding Our Practices: Differences in Study DesignRamesh B. Daggubati

2:24 PM - Update on Bifurcation PCI 2013: Literature ReviewsJinghua Liu

2:36 PM - Case Presentation 1: One-Stent for Simple Bifurcation without Kissing Balloon InflationNing Guo


2:49 PM - Case Presentation 2: One-Stent for Complex Bifurcation with Kissing Balloon InflationJie Qian


3:02 PM - Case Presentation 3: Classical Crush for Complex Bifurcation with Failure of KBTLi Li


3:15 PM - Case Presentation 4: Modified Culotte Technique for Complex BifurcationShangyu Wen


3:28 PM - DEFINITION Study: Define Simple vs. Complex BifurcationShaoliang Chen


Session II: Prior to Stenting Techniques: Importance of Side Branch

Moderators: Shuzheng Lu, Rajesh Dave, Yutaka HikichiDiscussants: Chi-Kin Chan, Feng Cao, Kefei Dou, Hyeon-Cheol Gwon, Shoujie Shan

3:58 PM - Side Branch Occlusion: Mechanisms, Clinical Impact, and How to Avoid ItHyeon-Cheol Gwon

4:10 PM - How to Save the Side Branch of Difficult Bifurcation Lesions?Chi-Kin Chan

4:22 PM - Impact of Bifurcation Angle on IVUS-Guided Provisional StentingShoujie Shan


4:44 PM - Treatment of Side Branch: The Simpler the Better?Shuanli Xin

4:56 PM - Treatment Strategy of Side Branch Restenotic Occlusion After Bifurcation PCIFeng Cao

5:08 PM - Protection of Side Branch with Jailed Balloon Technique: When and How?Jianfang Luo


5:30 PM - My Approach to Ostial LesionJilin Chen

5:42 PM - How to Prevent Side Branch Occlusion: Tips and TricksShuzheng Lu


6:00 PM - Adjourn

Room 205, Level 2


Moderators: Shijie You, Keng Wu, Qin Qin

7:00 AM - CS-0294: Fatal AMI with Infarct Artery and Noninfarct Artery Achieved Completely Revascularization at One StageKeng Wu

7:10 AM - Q&A

7:15 AM - CS-0301: Non-Target Vessel Acute Closure During Primary AngioplastyGuowei Zhou

7:25 AM - Q&A

7:30 AM - IM-0048: ACS Caused by Multiple Plaque RuptureJun Pu

7:40 AM - Q&A

7:45 AM - CS-0019: Non-Infarct Related Artery Treatment in the Emergent PCI and Follow-UpYuxin Zhao

7:55 AM - Q&A

8:00 AM - Adjourn

Luncheon Satellite SymposiumSponsored by Medtronic (1)Challenge the Complex, Confidence in Device12:40 PM-1:55 PM

Chairmen: Guosheng Fu, Jinghua Liu, Yan Wang, Dingcheng Xiang, Shijie You


12:42 PM - Advanced Manipulation Skill of Amplatz Left Guide CatheterGuosheng Fu

1:00 PM - Export AP: From Clinical Data to Clinical PracticeChaowei Mu



051

9:52 AM - Transradial Intervention: Technical Aspects, Results, and RecommendationsJean Fajadet


10:06 AM - Has the Prime Period of Transradial Coronary Intervention Already Come?Yuejin Yang


10:18 AM - Same-Day Discharge Strategy for Transradial InterventionsJack P. Chen


10:30 AM - Femoral vs. Radial Access in PCIShing-Chiu Wong


10:42 AM - Clinical Study Update of Transradial Coronary Angiography and InterventionFei Ye


10:54 AM - Transradial Intervention with Crush and Culotte: Techniques and ApplicationsLianglong Chen


Session II

Moderators: Shubin Qiao, Paul TL Chiam, Tiemin Jiang, Zuyi Yuan, Shijie You, Yi An

11:06 AM - Major Difficulties in Radial Access and Helpful SolutionsShaoxiang Weng


11:18 AM - Transradial PCI with "Slender" Sheathless Guiding CathetersPaul TL Chiam


11:30 AM - How to Solve Delivery Difficulties with Balloon or Stent in TRI?Yue Li


11:42 AM - Tips and Tricks of CTO PCI via Transradial ApproachBin Zhang


11:54 AM - Double Mini-Crush Technique for Trifurcation Lesions by 6Fr TRIKenji Wagatsuma


12:06 PM - Strategies and Techniques of Using 5-in-6 Double Catheter in TRIQi Zhang


12:18 PM - Radiation Exposure: Radial vs. Femoral AccessBinquan Zhou


12:30 PM - Break

Luncheon Satellite SymposiumSponsored by MedfavourNOYA Drug-Eluting Stent in the Real World12:40 PM-1:55 PM

Chairmen: Shuzheng Lu, Yundai Chen, Chuanyu Gao, Yuguo Chen


12:45 PM - Case Reviews with NOYA DES in My Clinical PracticeJue Chen

1:05 PM - Case Reviews with NOYA DES in My Clinical PracticeEnze Jin

1:25 PM - Four-Year Clinical Results of NOYA I TrialYuejin Yang


1:55 PM - Break

Room 206, Level 2


Moderators: Tingshu Yang, Jincheng Guo, Mingsheng Wang

7:00 AM - CS-0056: Successful Use of Intra-Aortic Balloon Pump Therapy for Left Coronary CTO Lesions and Acute Inferior Myocardial Infarction in Patient with Cardiogenic ShockXiang Ma

7:10 AM - Q&A

7:15 AM - CS-0062: Fractionally Treat a Case of Acute Anterior ST-Segment Elevation Myocardial InfarctionHongwu Chen

7:25 AM - Q&A

7:30 AM - CS-0073: Coronary Thrombosis and Unstable Plaque in Nephritic SyndromeLijuan Chen

7:40 AM - Q&A

7:45 AM - CS-0264: Acute Myocardial Infarction Caused by Chronic Two-Vessel Spontaneous Coronary Artery DissectionXingwei He

7:55 AM - Q&A

8:00 AM - Adjourn

TRI Club Part I9:40 AM-12:30 PM

Session I

Moderators: Shuzheng Lu, Yuejie Zhou, Xianghua Fu, Weimin Li, Lijun Guo, Yuyang Liu

9:40 AM - Transradial Intervention: Is 90% Success Dangerous?Mitchell W. Kruco�




052

Non-ST-Segment Elevation Acute Coronary Syndromes2:00 PM-6:00 PM

Part I: Latest Advances in NSTE-ACS

Moderators: Roxana Mehran, Jiyan ChenDiscussants: Ben He, Yue Li, Kai Wang, Hongbing Yan

2:00 PM - Biomarker for ACS and Its Clinical RelevanceKai Wang

2:12 PM - Is Bivalirudin the First Choice of Anticoagulant Therapy in NSTE-ACS?Roxana Mehran

2:24 PM - Bridging Antithrombotic Therapy in Patients Undergoing Cardiac and Noncardiac SurgeryDavide Capodanno

2:36 PM - Highlights of the Guidelines for NSTE-ACS and Current Practice in ChinaBen He

2:48 PM - Different Treatment Strategies in Low vs. High Risk NSTE-ACS PatientsYue Li

3:00 PM - PLATO and Beyond PLATOHongbing Yan


Part II: NSTE-ACS Debate - Current Controversies

Moderators: Lefeng Wang, Shaoping Nie, Ning Tan, Ningfu Wang

Debate 1

3:26 PM - Ticagrelor Is the Choice for Most PatientsYonghong Zhu

3:36 PM - No, Clopidogrel Is Still an Option for Most Chinese PatientsYida Tang

3:46 PM - Panel DiscussionDiscussants: Yida Tang, Yonghong Zhu

5:42 PM - Case 3: A Patient with History of ACS/PCI and Presented with New Onset AFPing Yang


6:00 PM - Adjourn

Debate 2

3:51 PM - Six-Month DAPT Duration Is Long EnoughQuanmin Jing

4:01 PM - No, DAPT Duration Should Be Based on Individuals and StentsShubin Qiao

4:11 PM - Panel DiscussionDiscussants: Quanmin Jing, Shubin Qiao

Debate 3

4:16 PM - GRACE Score Is the Gold Standard of Risk Stratification for AllLijun Guo

4:26 PM - No, TIMI Score Is More Practical in ChinaYihong Hua

4:36 PM - Panel DiscussionDiscussants: Lijun Guo, Hong Jiang, Yihong Hua

Debate 4

4:41 PM - Manual Aspiration Is Lack of Evidence in NSTE-ACS PatientsYu Wang

4:51 PM - No, Organized Thrombus Is Still ActiveMeng Wei

5:01 PM - Panel DiscussionDiscussants: Yu Wang, Meng Wei

Part III: NESTE-ACS Tough Case Reviews

Moderators: Yongjian Wu, Hongwei Li, Shaobin Jia, Kai Wang, Minzhou Zhang

5:06 PM - Case 1: GP IIb/IIIa Inhibitors Related ThrombocytopeniaYihong Hua


5:24 PM - Case 2: An AF Patient Presented with ACSHesong Zeng




053

1:00 PM - Classical Case 1: Application of ADO II in Complicated Congenital Heart DiseaseMei Jin

1:15 PM - Classical Case 2: Application of ADO II in Complicated Congenital Heart DiseaseKun Sun

1:30 PM - The Conclusion of Clinical Practice and Application Trend Analysis of ADO IIZhongying Xu


1:55 PM - Break

Pharmacologic Satellite SymposiumSupported by SanofiThrombosis Forum2:00 PM-5:00 PM

Moderators: Yong Huo, Weifeng Shen, Jingxuan Guo, Wei Cui, Chuanyu Gao, Zhimin Du

2:00 PM - History and Key Achievement of Percutaneous Coronary Intervention in ChinaRun-Lin Gao

2:30 PM - Development and Opportunity of Percutaneous Coronary Intervention in ChinaYong Huo

3:00 PM - View of Antiplatelet Treatment in Asian PCI PatientsShuyang Zhang

3:20 PM - Strategy of Antiplatelet Therapy in Peri-PCI OperationYaling Han

3:40 PM - State of the Art in ACS Antiplatelet TherapyShuzheng Lu

4:00 PM - Principle of Antiplatelet Treatment in PCI Patients under Special CircumstanceGuosheng Fu

4:20 PM - Status and Management of Antiplatelet Therapy in ACS Patients with BleedingHongliang Cong

4:40 PM - Can Platelet Functional Test Implement the Clinical Practice Strategy?Xubo Shi

Pharmacologic Satellite SymposiumSupported by ServierComprehensive Management of Ischemic Heart Disease5:00 PM-6:00 PM

Moderators: Run-Lin Gao, Wenhang Qi, Jun Huang


5:05 PM - Cardiac Rehabilitation Management and Metabolic TherapyFuchun Zhang

5:25 PM - Heart Rate Management of Cardiovascular DiseaseMulei Chen


6:00 PM - Adjourn

Room 207, Level 2

Breakfast Case Reviews 4Left Main Disease7:00 AM-8:00 AM

Moderators: Jifei Tang, Huifeng Wang, Bin Wang

7:00 AM - CS-0128: Revascularization to Left Main Calcified CTO Lesion with RotablatorHongyu Shi

7:10 AM - Q&A

7:15 AM - CS-0080: Severe Stenosis in Left Main Bifurcation Accompanied by Severe Diffuse Stenosis in RCATao Yin

7:25 AM - Q&A

7:30 AM - CS-0041: OCT-Guided PCI for Ostial Left Main in a Young Female Patient with Takayasu ArteritisLin Zhao

7:40 AM - Q&A

7:45 AM - CS-0083: Stent Dislodgement in Left Main Bifurcation PCI for an Elderly PatientBing Liu

7:55 AM - Q&A

8:00 AM - Adjourn

Luncheon Satellite SymposiumSponsored by St. JudeUnderstanding ADO II Comprehensively12:40 PM-1:55 PM

Chairmen: Bo Yu, Xianyang Zhu, Shiliang Jiang, Zhiwei Zhang


12:45 PM - Design Concept and Clinical Practice Benefits of ADO IIWei Gao



054


10:06 AM - Leadless Pacemaker: Technology Revolution of Mature TherapyKeping Chen


10:24 AM - Vagal Nerve Stimulation in Heart Failure TreatmentYehui Yin


10:42 AM - Impact of Spinal Cord Stimulation on Heart FailureLiqun Wu


Session II

Moderators: Changsheng Ma, Kejiang Cao, Shenghua Zhou, Jianzeng Dong, Bin Liu

11:00 AM - What Will Rotor Bring About for AF?Yan Yao


11:18 AM - Management of Ventricular Tachycardia with Vagal Nerve StimulationYigang Li


11:36 AM - Treatment of AF with Radiofrequency Renal Artery DenervationQijun Shan


11:54 AM - What Hope Does Contact Force Sensing Catheter Bring for the Treatment of AF?Jian Ma


12:12 PM - Less Is More: A Zero Radiation Workflow for PV IsolationTom De Potter


12:30 PM - Break

Luncheon Satellite SymposiumSponsored by Essen TechnologyUpdate on TIVOLI DES Clinical Data12:40 PM-1:55 PM

Chairmen: Yaling Han, Haichang Wang, Lang Li, Jinghua Liu, Bo Xu


12:45 PM - Background, Design Rationale and 1-Month Outcome Update of I-LOVE-IT 2 TrialYaling Han

1:00 PM - One-Year Clinical Results of VIRTURE StudyLei Ge

1:15 PM - Clinical Application of TIVOLI DES in Diabetic Patients with Small Vessel DiseaseLixia Yang

1:30 PM - Case Reviews of TIVOLI DESZhaohui Jiang


1:55 PM - Break

Heart Rhythm Part IIAtrial Fibrillation2:00 PM-6:00 PM

Session I: Clinical Practice of AF Management - How to Cope with These Situations in Clinical Practice?

Moderators: Yan Yao, Jianzeng Dong, Li Li, Haifeng Shi, Chenyang Jiang, Lianjun Gao

2:00 PM - How to Manage Thromboembolic Events When INR Was Well Controlled?Xingpeng Liu


2:20 PM - How to Manage Patients with Atrial Fibrillation Complicating with Acute Coronary Syndrome and Required Emergent Stent Implantation?Guangping Li


Room 208, Level 2


Moderators: Lei Wang, Hui Chen, Hongbin Liu

7:00 AM - CS-0178: PCI on Left Main Quadrifurcation with 7.5F Sheathless GCHui Chen

7:10 AM - Q&A

7:15 AM - CS-0185: Distal Left Main Disease with Angulated LCX OriginationXincai Zhang

7:25 AM - Q&A

7:30 AM - CS-0229: PCI in Left Main DiseaseWei Wang

7:40 AM - Q&A

7:45 AM - CS-0176: FFR-Guided PCI in AMI with Complex Anatomy Including Calcified Left Main Bifurcation and Multiple Intermediate LesionsTao Yin

7:55 AM - Q&A

8:00 AM - Adjourn

Heart Rhythm Part INew Technologies9:30 AM-12:30 PM

Session I

Moderators: Congxin Huang, Dejia Huang, Xiaoshu Cheng, Yingxian Sun, Dongmei Wang

9:30 AM - Will SICD Change the Prevention and Treatment of Sudden Cardiac Death in China?Wei Hua


9:48 AM - Cardiac Contractility Modulation in Heart Failure TherapyFarong Shen



055

Room 305A, Level 3


Moderators: Yin Liu, Ming Yang, Huabao Sun

7:00 AM - CS-0244: Left Main PCI with Angulated TrifurcationJing Yang

7:10 AM - Q&A

7:15 AM - CS-0251: PCI for Left Main Trifurcation with LAD CTOHua Yu

7:25 AM - Q&A

7:30 AM - IM-0019: Acute Left Main OcclusionXuguang Qin

7:40 AM - Q&A

7:45 AM - CS-0237: FFR-Guided Intervention in Jailed Side Branch After Main Branch StentingXiaozeng Wang

7:55 AM - Q&A

8:00 AM - Adjourn

Luncheon Satellite SymposiumSponsored by Venus MedTechTranscatheter Valve Innovations in China12:40 PM-1:55 PM

Chairmen: Yuejin Yang, Shiliang Jiang, Xiangqing Kong, Wei Wang


12:43 PM - Venus Aortic Valve and Delivery SystemHorst Sievert

12:55 PM - Update of Venus A-Valve Study in ChinaYuejin Yang

2:40 PM - How to Manage Newly Diagnosed Atrial Fibrillation in Patients with CHADS2 VASC Score of 1?Yanzong Yang


3:00 PM - How to Manage Atrial Fibrillation in Patients with CHADS2 VASC Score of 3 and Intracranial Hemorrhage 4-5 Years Ago?Yansheng Ding


3:20 PM - How to Manage Patients Who Were on Oral Anticoagulants and Prepared to Accept Radiofrequency Ablation?Shufeng Li


3:40 PM - Atrial Fibrillation Management Using Device Recorded Atrial FibrillationChu-Pak Lau


Session II: Radiofrequency Ablation for Atrial Fibrillation in Special Population

Moderators: Xinchun Yang, Qiangsun Zheng, Pingzhen Yang, Pihua Fang, Weize Zhang, Zheng Zhang

4:00 PM - Patients with Valvular Heart DiseaseXu Liu


4:20 PM - Patients with Hypertrophic CardiomyopathyShaowen Liu


4:40 PM - Patients with Chronic Renal DiseaseZulu Wang


5:00 PM - Patients with Systolic Heart FailureHong Jiang


5:20 PM - Patients with Sleep ApneaJian Jiang


5:40 PM - Left Atrial Appendage Closure: Opportunities and Challenges for AF ManagementHe Huang


6:00 PM - Adjourn



056


3:15 PM - Transcatheter Closure of Pulmonary Arterio-Venous FistulaZhongying Xu


3:30 PM - Status Update on Percutaneous Mitral TherapiesTed E. Feldman


3:45 PM - Transcatheter Closure of Ventricular Septal Perforation After Myocardial Infarction: Chinese ExperienceXianyang Zhu


Session II

Moderators: Shiliang Jiang, Xianyang Zhu, Witold Ruzyllo, Shihua Zhao, Xin Pan, Kelvin Chan

4:00 PM - Is LAA Closure an Acceptable or Preferable Alternative to Pharmacotherapy?Matthew J. Price


4:15 PM - Outcomes of the Edwards SAPIEN Valve in the Pulmonic Valve PositionSaibal Kar


4:30 PM - Self-Expandable Transcatheter Pulmonary Valve (Venus P Valve) for Patients with a Large Patched and Dysfunctional RVOTYat-Yin Lam


4:45 PM - Percutaneous Pulmonary Valve Implantation: Chinese ExperienceDaxin Zhou


5:00 PM - Transcatheter Closure of Ruptured Valsalva Sinus AneurysmYongwen Qin


5:15 PM - Transcatheter Intervention of Complex Congenital Heart DiseaseZhiwen Zhang


5:30 PM - Intervention for Postoperative Complications of Cardiovascular SurgeryGejun Zhang


5:45 PM - The Biology Response Differences Following Watchman and Amplatzer Cardiac Plug in a Canine Left Atrial Appendage ModelDongming Hou


6:00 PM - Adjourn

1:07 PM - Singer-Center Clinical Experience of Venus A-ValveMao Chen

1:19 PM - Venus Pulmonary Valve and Delivery SystemZiyad M. Hijazi

1:31 PM - Initial Clinical Results of Venus P-Valve StudyDaxin Zhou


1:55 PM - Break

Structural Heart Disease Part I2:00 PM-6:00 PM

Session I

Moderators: Aiqing Zhou, Jacek Bialkowski, Yongwen Qin, Xiangqing Kong, Guangyi Wang, Malgorzata Szkutnik

2:00 PM - Meta-Analysis of 3 Randomized Clinical Trials and 11 Observational Studies of PFO Closure vs. Medical Therapy in Patients with Cryptogenic ShockDavide Capodanno


2:15 PM - Experiences with Different PFO OccludersHorst Sievert


2:30 PM - Valve in Valve Therapy of Failed Surgical Aortic and Mitral Bioprosthetic ValvesJohn G. Webb


2:45 PM - Dilatation of Coarctation of the Aorta with Bare Metal and Covered StentsJacek Bialkowski


3:00 PM - Coarctation of the Aorta: Optimal Treatment StrategyZiyad M. Hijazi



057

1:30 PM - Use of Yinyi PTCA Balloon in Clinical PracticeQuanmin Jing


1:55 PM - Break

Basics and Medical Therapies Part I2:00 PM-6:00 PM

Session I

Moderators: Haozhu Chen, Shuguang Lin, Junzhu Chen, Baoqi Jiang, Dingyin Zeng, Hongwei Li

Mechanism in Atherosclerosis and Clinics: 2013 Update

2:00 PM - Pathogenic Study in Atherosclerosis and ClinicsYun Zhang

2:15 PM - Novel Knowledge of Lipid-Induced Atherosclerosis and ClinicsJianjun Li

2:30 PM - New Biomarkers in Atherosclerosis and ClinicsJun Tao

2:45 PM - Oxidative Stress in Atherosclerosis and ClinicsLianglong Chen

Atherosclerotic Plaque and Clinics: 2013 Update

3:00 PM - Concept of Vulnerable Plaque in Atherosclerosis and ClinicsLan Huang

3:15 PM - Concept of Plaque Progression in Atherosclerosis and ClinicsFeng Cao

3:30 PM - Concept of Plaque Stabilization in Atherosclerosis and ClinicsBen He

3:45 PM - Concept of Plaque Regression in Atherosclerosis and ClinicsPing Ye

Session II

Moderators: Dejia Huang, Yuannan Ke, Jianjun Li, Ye Tian, Tingshu Yang, Kai Wang

Myocardial Ischemia, Necrosis and Clinics: 2013 Update

4:00 PM - Etiology of Myocardial Ischemia and ClinicsJian'an Wang

4:15 PM - Consequence of Myocardial Ischemia and ClinicsPeng Qu

4:30 PM - Classification of Myocardial Necrosis and ClinicsJianjun Li

4:45 PM - Detection of Myocardial Necrosis and ClinicsShuyang Zhang

Pharmacological Therapy in Coronary Artery Disease and Clinics: 2013 Update

5:00 PM - Pharmacological Intervention in Stable Coronary Artery Disease and ClinicsJianhua Zhu

5:15 PM - Pharmacological Intervention in Acute Myocardial Infarction and ClinicsMeilin Liu

5:30 PM - Pharmacological Intervention in Variant Angina and ClinicsMeng Wei

5:45 PM - Pharmacological Intervention in Microvascular Angina and ClinicsDingcheng Xiang

6:00 PM - Adjourn

Room 305B, Level 3

Breakfast Case Reviews 7Bifurcations7:00 AM-8:00 AM

Moderators: Xuebo Liu, Jun Tian

7:00 AM - CS-0275: Use of Jailed Balloon Technique in LAD CTO PCIPengcheng He

7:10 AM - Q&A

7:15 AM - CS-0205: LAD Bifurcation PCI with Proximal Total Occlusion LesionYujie Xing

7:25 AM - Q&A

7:30 AM - CS-0228: PCI in LAD BifurcationBin Wang

7:40 AM - Q&A

7:45 AM - CS-0131: IVUS Guidance of PCI for LAD Bifurcation LesionYan Lai

7:55 AM - Q&A

8:00 AM - Adjourn

Luncheon Satellite SymposiumSponsored by Yinyi12:40 PM-1:55 PM

Chairmen: Meng Wei, Juying Qian, Ruiyan Zhang, Likun Ma, Hong Jiang


12:45 PM - Understanding Paclitaxel CorrectlyHongbing Yan

1:00 PM - Treatment of Coronary Aneurysm and Slow-Flow Lesion with Yinlong DESLeisheng Ru

1:15 PM - Use of Yinlong DES in Single CenterXuchen Zhou



058


1:55 PM - Break

ISES at CITCurrent Endovascular Approach to Aortic Aneurysms2:00 PM-6:00 PM

Part I: Introduction and General Considerations

Moderators: Jacques Busquet, Weiguo FuDiscussants: Cli�ord Buckley, Zhong Chen, Wei Guo, Marvin L. Woodall

2:00 PM - Opening of ISES at CIT2014: Introduction to Current and Future PlansMarvin L. Woodall

2:10 PM - International Development of ISES with a Special Focus on ChinaJacques Busquet

2:22 PM - Aortic Aneurysms in China: Epidemiology and StatisticsWei Guo

2:34 PM - The New Concepts of Endografts: Description and Future ApplicationsCli�ord Buckley

2:46 PM - Team Organization in the Modern Endovascular RoomWeiguo Fu


Part II: Thoracic Aneurysms and TEVAR

Moderators: Cli�ord Buckley, Wei GuoDiscussants: Guangqi Chang, Qian Chang, Changwei Liu, Chang Shu

3:08 PM - Complications of TEVAR: How to Manage?Cli�ord Buckley

3:20 PM - Hybrid or Total Endovascular Repair for Aortic Arch Disease?Qian Chang

3:32 PM - Current Endovascular Strategy for Complex Thoraco-Abdominal AneurysmsChangwei Liu

3:44 PM - Use of Chimney Technique in Complex Aortic DiseaseChang Shu

3:56 PM - TEVAR Complex Case Reviews 1Guangqi Chang

4:06 PM - TEVAR Complex Case Reviews 2Cli�ord Buckley


Part III: Abdominal Aneurysms and EVAR

Moderators: Cli�ord Buckley, Wei GuoDiscussants: Zhong Shen, Guangqi Chang, Qian Chang, Changwei Liu, Aravinda Nanjundappa, Won-Heum Shim, Eak-Kyun Shin, Chang Shu

4:26 PM - Patient and Graft Selection for EVARCli�ord Buckley

4:38 PM - Detection and Management of Post-EVAR EndoleaksZhong Chen

4:50 PM - Live Case Transmission from Fudan University Zhongshan Hospital, ShanghaiOperators: Weiguo Fu, Jacques Busquet, and Colleagues

5:25 PM - Comparative Study of Chimney vs. Fenestration for AAA Hostile NeckWei Guo

5:37 PM - EVAR Complex Case ReviewsJianfang Luo


5:57 PM - Take-Home MessageCli�ord Buckley, Wei Guo

6:00 PM - Adjourn

Room 302A, Level 3

Breakfast Case Reviews 8Complex Lesion PCI7:15 AM-8:00 AM

Moderators: Zhijian Yang, Jian Liu, Xinkai Qu

7:15 AM - CS-0169: Rota Stenting in Diffuse, Calcified LAD and Stenting of Diffuse, Calcified Tortuous LCXSridhar Kasturi

7:25 AM - Q&A

7:30 AM - CS-0196: Complication with Left Main PCI for AMIAbhay Somani

7:40 AM - Q&A

7:45 AM - CS-0370: Strategy Selection for the Treatment of Important Side Branch - Primary PCI in High Risk STEMI with Clinical Follow-UpJian Liu

7:55 AM - Q&A

8:00 AM - Adjourn

Luncheon Satellite SymposiumSponsored by GE Healthcare (1)Cardiovascular Hybrid OR Solutions and Practice12:40 PM-1:55 PM

Chairmen: Yong Huo, Je�rey W. Moses, Bernard De Bruyne


12:45 PM - Coronary Artery Disease and TAVR Hybrid Surgical Practice in ChinaYongjian Wu

1:05 PM - Discovery IGS 730 Cardiovascular HOR SolutionMin Zhong

1:35 PM - Build a Professional Cardiac Interventional Center with GEXia Yan



059

2:20 PM - Status Update on DES in the EU: Where We Stand and What 5 Things Are Unresolved or NeededPieter C. Smits

2:30 PM - Status Update on DES in India: Where We Stand and What 5 Things Are Unresolved or NeededAshok Seth

2:40 PM - Status Update on DES in China: Where We Stand and What 5 Things Are Unresolved or NeededWeifeng Shen

2:50 PM - Panel DiscussionDiscussants: Liliana R. Grinfeld, Ashok Seth, Weifeng Shen, Pieter C. Smits, Alan C. Yeung

3:00 PM - PCI vs. CABG for Multivessel Disease and in Diabetics: How Can We Achieve Optimal Outcomes for Patients?Zhe Zheng

3:12 PM - Current State of the Evidence for Duration of DAPT After DES ImplantationYundai Chen

3:24 PM - Use of DES in Complex Clinical Scenarios: Non-Cardiac Surgery, High Bleeding Risk, and Questions of AdherenceDavide Capodanno

3:36 PM - Restenosis and Stent Thrombosis: Mechanistic Insights Based upon Intravascular ImagingMyeong-Ki Hong

3:48 PM - Panel DiscussionDiscussants: Davide Capodanno, Yundai Chen, Myeong-Ki Hong, Zhe Zheng

Session II

Moderators: Kam-Tim Chan, Gim-Hooi Choo, Xunchen ZhouDiscussants: Ching-Chang Fang, Sidney Tsz Ho Lo, Imad Sheiban, Harry Suryapranata, Rurus Suryawan

4:00 PM - Technical Considerations When Performing DES PCI for Complex Multivessel and LMCA DiseaseImad Sheiban

4:12 PM - Case Presentation 1: DES in Multivessel Disease (non-LMCA with CTO / bifurcations)Chun Liang


4:24 PM - Case Presentation 2: DES in LMCA DiseaseYan Li


4:36 PM - Should DES Be Used in STEMI Patients?Harry Suryapranata

4:48 PM - Case Presentation 3: DES in a Complex STEMI LesionJingyu Hang


Session III

Moderators: Jack P. Chen, Swee Choon Ng, Xiwei DengDiscussants: B. K. Goyal, Lang Li, Michael Lim, Thomas M. Tu, Youhong Zhu

5:00 PM - Managing DES Failures When They Occur: ISR, Thrombosis, and Mechanical IssuesLang Li

5:13 PM - Case Presentation 4: 2 Cases of DES Restenosis (first time and recurrent)Weixian Yang


5:29 PM - Case Presentation 5: 2 Cases of Stent Thrombosis (subacute and late)Zening Jin


5:45 PM - Featured Lecture: Comparing Different DESs in Different Settings - The ISAR Clinical TrialsAdnan Kastrati

6:00 PM - Adjourn

Room 302B, Level 3

Luncheon Satellite SymposiumSponsored by Johnson & JohnsonSimplify the Complex, Control the Intervention: Cordis EMPIRA Symposium12:40 PM-1:55 PM

Chairmen: Wei Gao, Juying Qian, Shubin Qiao, Weimin Wang


12:45 PM - Application of EMPIRA in Challenge CasesLang Li

1:00 PM - Introduction and Case Sharing of EMPIRA NCBin Liu

1:15 PM - Application of EMPIRA in CTO LesionsBin Zhang

1:30 PM - Accurate Expansion: Use of EMPIRA SeriesJie Qian


1:55 PM - Break

Drug-Eluting Stents: Appropriate Utilization of Current Generation Devices2:00 PM-6:00 PM

Session I

Moderators: Chung-Seung Chiang, Jilin Chen, Chuen-Den Tseng

2:00 PM - Status Update on DES in the US: Where We Stand and What 5 Things Are Unresolved or NeededAlan C. Yeung

2:10 PM - Status Update on DES in South America: Where We Stand and What 5 Things Are Unresolved or NeededLiliana R. Grinfeld



060

Luncheon Satellite SymposiumSponsored by AstraZenecaACS Antiplatelet Therapy12:40 PM-1:55 PM

Chairmen: Changsheng Ma, Jian'an Wang, Zuyi Yuan


12:45 PM - New Era of ACS Antiplatelet TherapyYundai Chen

1:10 PM - Learning from STEMI Guidelines and Cases SharingChuanyu Gao

1:30 PM - Optimization of ACS Antiplatelet Therapy and Cases SharingShaoping Nie


1:55 PM - Break

Learning Techniques from CTO Specialists: A Step by Step Case Reviews2:00 PM-6:00 PM

Session IV

Moderator: Tongku Liu

2:00 PM - My Most Impressive Failed CTO CaseQuanmin Jing

2:20 PM - Q&A

2:30 PM - My Most Impressive Successful CTO CaseQuanmin Jing

2:50 PM - Q&A

Session V

Moderator: Ling Tao

3:00 PM - My Most Impressive Failed CTO CaseChengxiang Li

3:20 PM - Q&A

3:30 PM - My Most Impressive Successful CTO CaseChengxiang Li

3:50 PM - Q&A

Session VI

Moderator: Jingang Zheng

4:00 PM - My Most Impressive Failed CTO CaseBin Zhang

4:20 PM - Q&A

4:30 PM - My Most Impressive Successful CTO CaseBin Zhang

4:50 PM - Q&A

Session VII

Moderator: Xiantao Song

5:00 PM - My Most Impressive Failed CTO CaseYue Li

5:20 PM - Q&A

5:30 PM - My Most Impressive Successful CTO CaseYue Li

5:50 PM - Q&A

6:00 PM - Adjourn

Room 307, Level 3

Learning Techniques from CTO Specialists: A Step by Step Case Reviews9:30 AM-12:30 PM

Session I

Moderator: Zhimin Du

9:30 AM - My Most Impressive Failed CTO CaseJiyan Chen

9:50 AM - Q&A

10:00 AM - My Most Impressive Successful CTO CaseJiyan Chen

10:20 AM - Q&A

Session II

Moderator: Weimin Wang

10:30 AM - My Most Impressive Failed CTO CaseGuosheng Fu

10:50 AM - Q&A

11:00 AM - My Most Impressive Successful CTO CaseGuosheng Fu

11:20 AM - Q&A

Session III

Moderator: Dadong Zhang

11:30 AM - My Most Impressive Failed CTO CaseLei Ge

11:50 AM - Q&A

12:00 PM - My Most Impressive Successful CTO CaseLei Ge

12:20 PM - Q&A

12:30 PM - Break



061


2:55 PM - Take-Home MessageWeimin Wang

Part II: New Concept of Contrast Media Injection and Application

Moderators: Yujie Zhou, Zhimin Du

3:00 PM - Objective and IntroductionYujie Zhou

3:05 PM - New Concept of Contrast Media InjectionTianchang Li


3:30 PM - Mechanisms of CIN: Evidence and ControversyMao Chen


3:55 PM - Take-Home MessageZhimin Du

The 5th Rotablation Workshop4:00 PM-6:00 PM

Moderators: Wei Gao, Weimin Wang, Shangyu Wen, U Po Lam, Jun Tian, Bin Wang

4:00 PM - Role of Rotational Atherectomy in the Treatment of Calcified Lesions in DES EraWei Gao


4:14 PM - Basic Techniques of Rotational Atherectomy: Access, Guiding Catheter, Guidewire, and Burr SelectionsWeimin Wang


4:28 PM - Complications and Management of Rotational AtherectomyWen-Lieng Lee


4:42 PM - Strategy and Technique of Rotational Atherectomy in Left Main Calcified LesionJianfang Luo


4:54 PM - Strategy and Technique of Rotational Atherectomy in Non-Left Main Calcified Bifurcation LesionJue Chen


5:06 PM - How to Overcome Very Severely Calcified Lesion Which Could Not Be Crossed by 1.25 Burr Rotational Atherectomy?Nae Hee Lee


5:18 PM - Treatment of Complex Calcified Lesion with Rotational Atherectomy in Elderly PatientsQiang Liu


5:30 PM - IVUS Guided Rotational AtherectomyYong Sun


5:42 PM - Featured Lecture: How to Use Cutting/Scoring Balloons and Rotational Atherectomy for Plaque Modification: Data, Experience and Common SenseSamuel K. Mathew


6:00 PM - Adjourn

Room 3M5, Mezzanine, Level 3

Luncheon Satellite SymposiumSponsored by Star ProgressThrombus Aspiration Is Absolutely Necessary!12:40 PM-1:55 PM

Chairmen: Hongbing Yan, Xinkai Qu, Yingzhong Lin


12:45 PM - Advantages of Kaneka Dual Lumen Microcatheter on Bifurcation PCIEisho Kyo

1:00 PM - Thrombus Aspiration Is Necessary to ACS-PCIJian Liu

1:15 PM - Thrombuster II Application in Acute Myocardial InfarctionJinchuan Yan

1:30 PM - The Necessity of Thrombus II and ExperienceQing Xu


1:55 PM - Break

Interventional Cardiology Hot TopicsSupported by Bayer2:00 PM-4:00 PM

Part I: STEMI and Thrombectomy

Moderators: Hongbing Yan, Weimin Wang

2:00 PM - Objective and IntroductionHongbing Yan

2:05 PM - Thrombectomy in STEMIJoseph D. Babb


2:30 PM - Coronary Thrombus Removing: Experiences with AngioJet® ThrombectomyJian'an Wang



062

Session II

Moderators: Felix Mahfoud, Atul Pathak, Ruiyan ZhangDiscussants: Justin E. Davies, Peter J. Fitzgerald, Nina Goodheart, David E. Kandzari, Jean Marco, Horst Sievert, Wan Azman Wan Ahmad, Jie Wang

10:20 AM - Case Presentation 1: Focus on Patient SelectionLang Li

10:28 AM - Finding the Best Candidates for Renal Denervation TherapiesJean Marco

10:40 AM - Case Presentation 2: Focus on Tips and TricksWan Azman Wan Ahmad

10:48 AM - Tips and Tricks When Performing Renal Denervation ProceduresHorst Sievert

How Should We Define and Evaluate Responsiveness to Renal Denervation Therapies?

11:00 AM - Case Presentation 3: Patient with LV Mass Regression But No Blood Pressure Change After DenervationFelix Mahfoud

11:10 AM - Case Presentation 4: Antiarrhythmic Effects of Renal DenervationAtul Pathak


11:34 AM - Radiofrequency Ablation and Beyond: New Approaches to RDN We Should Expect to See in the Not-so-Distant FuturePeter J. Fitzgerald

11:46 AM - Beyond Hypertension: Other Potential Indications for Renal Denervation TherapiesJustin E. Davies

11:58 AM - Pulmonary Artery Denervation for Pulmonary Hypertension: Experimental Study, PADN-1 Results, and Future DirectionShaoliang Chen

12:10 PM - Keynote Lecture: Putting It All Together - My Predictions Regarding Renal Denervation Therapy in the Next 5-10 YearsDavid E. Kandzari


12:30 PM - Adjourn

The Pearl Hall, Level 3

Renal Denervation Therapy8:30 AM-12:30 PM

Session I

Moderators: Martin B. Leon, Run-Lin Gao, Murray D. EslerDiscussants: Pingjin Gao, Nina Goodheart, Juan F. Granada, Dongfeng Gu, Xiongjing Jiang, Ajay J. Kirtane, Felix Mahfoud, Martin T. Rothman, Marco Wainstein

8:30 AM - The Growing Global Problem of HypertensionDongfeng Gu

8:45 AM - Physiologic Rationale for Renal Sympathetic Denervation in Hypertension and Heart FailureMurray D. Esler

9:00 AM - Translational Medicine and Renal Denervation: Preclinical Animal Models and HistoanatomyJuan F. Granada

9:12 AM - Update on Presented and Published Clinical Trials of Renal DenervationMurray D. Esler

9:27 AM - How Has the Report of the Results of SYMPLICITY HTN-3 Affected the Field: Perspectives on a Press ReleaseAjay J. Kirtane


9:53 AM - Renal Denervation in China: Current Platforms and Status UpdateXiongjing Jiang

10:08 AM - Measuring the Effectiveness of and Response to Renal Denervation Therapies: From Surrogate Endpoints to Clinical OutcomesFelix Mahfoud



063

Live Case Demonstration and Featured Lectures III

Moderators: Masahisa Yamane, Guosheng Fu, Toshiya MuramatsuDiscussants: Xueqi Li, William L. Lombardi, Jianfang Luo, Motomaru Masutani, Zhujun Shen, Akihiko Takahashi, Shouli Wang, Fuminobu Yoshimachi, Jingang Zheng

11:10 AM - Live Case from Fudan University Zhongshan Hospital, ShanghaiOperator: Yasumi IgarashiIVUS Interpreter: Yoshito Yamamoto

11:55 AM - Management of Complications During CTO-PCIToshiya Muramatsu

12:10 PM - Radial Approach in CTO-PCIFuminobu Yoshimachi


12:30 PM - Break

Luncheon Satellite SymposiumSponsored by Boston Scientific (2)Innovative Breakthrough Technology from Boston Scientific12:40 PM-1:55 PM

1st Half Session

Chairmen: Shaoliang Chen, Mao Chen, Fucheng Sun


12:45 PM - The Latest Interventional Cardiology Technology from Boston ScientificKeith D. Dawkins

1:00 PM - Innovation in Renal Denervation: Unique Bipolar RF TechnologyHorst Sievert


2nd Half Session

Chairmen: Junbo Ge, Shu Zhang

1:20 PM - Evolution of CTO PCI: Rationale and Lessons from the Hybrid RegistryWilliam L. Lombardi

1:35 PM - A New Breakthrough for the Prevention of Sudden Cardiac Death: Subcutaneous Defibrillator S-ICDYangang Su


1:55 PM - Break

Left Atrial Appendage Closure2:00 PM-6:00 PM

Session I: Background and Rationale for LAA Closure

Moderators: Congxin Huang, Shu ZhangDiscussants: Ted E. Feldman, Dongming Hou, Shaowen Liu, Changsheng Ma, Shulin Wu, Yanzong Yang, Zhe Zheng, Jun Zhu

2:00 PM - Stroke, Bleeding and Risk Scores in Atrial FibrillationChangsheng Ma

2:10 PM - Current Use of Coumadin in Clinical PracticeJun Zhu

2:20 PM - Surgical Methods and Outcomes for LAA ClosureZhe Zheng

2:30 PM - Benefits and Limitations of New Oral AnticoagulantsTed E. Feldman

2:40 PM - What Is in the Guidelines?Congxin Huang


Session II: The Evidence for LAA Closure

Moderators: Horst Sievert, Dejia HuangDiscussants: Maurice Buchbinder, Keith D. Dawkins, Wei Hua, Wolfgang Schillinger

3:00 PM - Clinical Results with the Watchman Device: PROTECT AF, CAP, and PREVAILKeith D. Dawkins

3:15 PM - Clinical Results with the Amplatzer Cardiac Plug (ACP)Wolfgang Schillinger

Room 201, Level 2

CCT at CIT8:30 AM-12:30 PM

Live Case Demonstration and Featured Lectures I

Moderators: Eisho Kyo, Junbo Ge, Yutaka HikichiDiscussants: Yuji Hamazaki, Quanmin Jing, Chaowei Mu, Masaaki Okutsu, Xiantao Song, Sudhir Rathore, Kenji Wagatsuma, Yong Wang, Bin Zhang

8:30 AM - Live Case from Fudan University Zhongshan Hospital, ShanghaiOperator: Etsuo TsuchikaneIVUS Interpreter: Yoshito Yamamoto

9:15 AM - When Do We Switch to Retrograde Approach?Masahisa Yamane

9:30 AM - Tips and Tricks in Reverse CART TechniqueYuji Hamazaki


Live Case Demonstration and Featured Lectures II

Moderators: Satoru Otsuji, Jiyan Chen, Shinjo SonodaDiscussants: Paul Hsien-Li Kao, Nae Hee Lee, Chengxiang Li, Tianchang Li, Yue Li, Xuebo Liu, Jie Qian, Satoru Sumitsuji, Masamichi Takano

9:50 AM - Live Case from Fudan University Zhongshan Hospital, ShanghaiOperator: Yasushi AsakuraIVUS Interpreter: Yoshito Yamamoto

10:35 AM - What Can We Know from Multislice CT for CTO Lesions?Satoru Sumitsuji

10:50 AM - Imaging Modality: Up-to-DateShinjo Sonoda




064

3:25 PM - Is LAA Closure Today Already an Alternative to Oral Anticoagulation in Lone Atrial Fibrillation?Maurice Buchbinder


Session III: How to Close the LAA

Moderators: Maurice Buchbinder, Horst SievertDiscussants: Minglong Chen, Tom De Potter, Pihua Fang, Yat-Yin Lam, Changsheng Ma, Yutang Wang, Zulu Wang, Yan Yao, Cheuk-Man Yu, Jiangtao Yu

3:51 PM - TEE Before, During, and After LAA ClosureCheuk-Man Yu

4:01 PM - Procedural Techniques with Watchman and Other DevicesJiangtao Yu

4:16 PM - Rotational Angiography Guidance in LAAC ProcedureTom De Potter


4:32 PM - Video Taped Case 1: Fu Wai HospitalYan Yao

4:42 PM - Video Taped Case 2: An Zhen HospitalJianzeng Dong, Changsheng Ma

4:52 PM - Live Case Transmission from the 2nd Affiliated Hospital of Zhejiang University School of Medicine, HangzhouOperators: Matthew J. Price, Jian'an Wang, and Colleagues

5:22 PM - How to Avoid and Manage Complications?Horst Sievert

5:32 PM - Early Experience with the Lifetech LAA OccluderYat-Yin Lam

5:42 PM - Other New Devices on the HorizonHorst Sievert


6:00 PM - Adjourn

12:15 PM - Latest Advances in STEMI PCI: From Aspiration, Hemodynamic Support to Intralesion Drug DeliveryRajesh Dave

12:30 PM - Break

Luncheon Satellite SymposiumSponsored by Lepu MedicalWitness Innovation, Witness Reality: Latest Clinical Research Advances of NANO Polymer-Free Sirolimus-Eluting Stent12:40 PM-1:55 PM

Chairmen: Yaling Han, Jinghua Liu, Lang Li, Yaojun Zhang


12:45 PM - Update of NANO OCT Study in EuropeBenit Edouard

1:00 PM - Explore the Polymer-Free Drug-Eluting Stent with OCTXinqun Hu

1:15 PM - NANO Case ReviewsQinghua Lu

1:30 PM - NANO Polymer-Free Drug-Eluting Stent in Complex PCIWeijie Li


1:55 PM - Break

Live Case Session 152:00 PM-3:30 PM

Moderators: Shaoliang Chen, Ajay J. Kirtane, Lei GeDiscussants: Theodore A. Bass, Rajesh Dave, B. K. Goyal, Yan Li, Yi Li, Aravinda Nanjundappa, Thach Nguyen, Yee Guan Yap, Yining Yang

2:00 PM - Nanjing First Hospital, Nanjing Medical University, NanjingLeft Main Bifurcation and Pulmonary Artery DenervationOperators: Imad Sheiban, Fei Ye, Junjie Zhang, Fengfu Zhang, and ColleaguesIVUS Interpreter: Shoujie Shan

Room 202, Level 2

Live Case Session 12 with Featured Lectures8:30 AM-10:30 AM

Moderators: Marie-Claude Morice, Patrick W. Serruys, Weifeng ShenDiscussants: Buxing Chen, Jack P. Chen, Bernard De Bruyne, Zhimin Du, Timothy Dy, Weijie Li, Sidney Tsz Ho Lo, Kui-Hian Sim, Pietro Vandoni

8:30 AM - Live Case Transmission from Affiliated Ruijin Hospital of Shanghai Jiao Tong University School of Medicine, ShanghaiComplex Lesion PCIOperators: Jean Fajadet, Costantino R. Costantini, Costantino O. Costantini, Qi Zhang, and Colleagues

10:00 AM - Revascularization as the First Choice in Stable Ischemic Heart DiseaseJe�rey W. Moses

10:15 AM - Intraprocedural Stent Thrombosis and Intraprocedural Thrombotic Embolization Complications During PCIPhilippe Généreux

Live Case Session 13 with Featured Lectures10:30 AM-12:30 PM

Moderators: Maurice Buchbinder, Ted E. Feldman, Wei GaoDiscussants: Lianglong Chen, Hyeon-Cheol Gwon, Young-Hak Kim, Wolfgang Schillinger, Magnus Settergren, Charles A. Simonton, Guisong Wang, Wasan Udayachalerm, Chiung-Jen Wu

10:30 AM - Live Case Transmission from the 2nd Affiliated Hospital of Zhejiang University School of Medicine, HangzhouComplex Lesion PCI and Transcatheter Mitral Valve TherapyOperators: Masahiko Ochiai, Jian'an Wang, and Colleagues

12:00 PM - Use of Coronary Physiology for Decision MakingAmir Lerman



065

First Report Investigations3:30 PM-4:30 PM

Moderators: Spencer B. King III, Alexandra J. LanskyDiscussants: Kam-Tim Chan, Donald E. Cutlip, Hyeon-Cheol Gwon, I-Chang Hsieh, Ajay J. Kirtane, Josef Ludwig, Thach Nguyen, Pieter C. Smits

3:30 PM - XIENCE V China RCT: A Prospective, Randomized Trial Assessing the Safety and Effectiveness of XIENCE V Everolimus-Eluting Stent Compared to CYPHER Sirolimus-Eluting Stent in Chinese Patients with Coronary Artery Disease - 2-Year ResultsRun-Lin Gao


3:45 PM - A Prospective, Randomized Trial of Dual-Axis Rotational vs. Standard Coronary AngiographyHuiliang Liu


4:00 PM - RESOLUTE China Registry: A Prospective, Observational Study of RESOLUTE Zotarolimus-Eluting Stent in an All-Comers Population in ChinaShaoliang Chen


4:15 PM - An Angiographic Tool for Risk Prediction of Side Branch Occlusion in Coronary Bifurcation Intervention: The RESOLVE Score SystemKefei Dou


Live Case Session 164:30 PM-6:00 PM

Moderators: Jilin Chen, Jean Fajadet, Haichang WangDiscussants: Wai-Kwong Chan, Ben He, Amir Lerman, Haibo Liu, Thomas M. Tu, Rajesh Vijayvergiya, Meng Wei, Joo-Young Yang, Jianhua Zhu

4:30 PM - Nanjing First Hospital, Nanjing Medical University, NanjingLeft Main / BifurcationsOperators: Ramesh B. Daggubati, Samuel K. Mathew, Fei Ye, Junjie Zhang, and ColleaguesIVUS Interpreter: Shoujie Shan

6:00 PM - Adjourn

Session III: Complications

Moderators: Quanmin Jing, Ning TanDiscussants: Jue Chen, Ningfu Wang, Feng Xu, Ming Yang, Bin Zhang

10:30 AM - CS-0209: Calcified and Angulated Multivessel Disease: Thrombus Formation After Rotablation and Stent ImplantationJun Pu


11:00 AM - CS-0203: Acute Stent Thrombosis in Non-Infarct-Related Artery in AMIQiyong Li


Session IV: Complications

Moderators: Shuzheng Lu, Weimin LiDiscussants: Weijian Huang, Hongbin Liu, Xiangqian Qi, Changqian Wang

11:30 AM - CS-0074: Death Case Review: The Causes?Yulin Chen


12:00 PM - CS-0167: Acute Stent Thrombosis in Non-Infarct-Related Vessel in Elective Procedure After Acute Anterior STEMI Treated with Primary PCIFenghua Ding


12:30 PM - Break

Luncheon Satellite SymposiumSponsored by Medtronic (2)Evidence for Confidence, Safety for Success: State of the Art with RESOLUTE12:40 PM-1:55 PM

Chairmen: Ajay J. Kirtane, David E. Kandzari, Ben He, Shaobin Jia, Bo Xu


12:42 PM - Guidance Comes from Confident Data: CE Mark for RESOLUTE 1-Month DAPTChunguang Qiu

Room 203, Level 2

Practical Course on PCI Part IIHow to Treat: Controversial Case Discussions8:30 AM-12:30 PM

Session I: Acute Coronary Syndromes

Moderators: Guoliang Jia, Hongbing YanDiscussants: Shisen Jiang, Fucheng Sun, Guizhou Tao, Yujie Zeng, Lijun Zhou

8:30 AM - CS-0138: Primary PCI for AMI Patient with Chronic Renal Dysfunction: How to Deal with Huge Thrombus?Zhangqiang Chen


9:00 AM - CS-0313: Repeated No-Reflow During Primary PCIXiaolong Gu


Session II: Left Main and Chronic Total Occlusion

Moderators: Weimin Wang, Yongjian WuDiscussants: Xuefeng Guang, Chaolian Huang, Guoqing Li, Xiaoyong Qi, Quanming Zhao

9:30 AM - CS-0046: From Provisional T to Culotte: Left Main Bifurcation PCI Guided by IVUSLei Gao


10:00 AM - CS-0042: PCI in Patient with LAD/LCX Occlusions and RCA Severe StenosisZhongsheng Zhu




066

1:00 PM - Case Presentation: Patient with DAPT InterruptionZening Jin

1:15 PM - China Study Findings: RESOLUTE China RCT and RegistryJingbo Hou

1:30 PM - Perspectives on Medtronic Innovations: Embracing the FutureDavid E. Kandzari


1:55 PM - Break

Practical Course on PCI Part IIIAn Expert Tutorial on Chronic Total Occlusion2:00 PM-6:00 PM

Session I

Moderators: Jiyan Chen, Eisho Kyo, Shuzheng Lu, Satoru OtsujiDiscussants: Stephan Achenbach, Paul Hsien-Li Kao, Je�rey W. Moses, Sudhir Rathore

2:00 PM - Histopathology Is Key to Success of CTO PCISatoru Sumitsuji

2:15 PM - CTA for CTO: What CT Can Do for CTO Recanalization?Stephan Achenbach

2:30 PM - Rationale for CTO PCIJe�rey W. Moses

2:45 PM - Antegrade Approach to CTO: Impact of Novel Guidewire TechniquesSudhir Rathore

3:00 PM - Retrograde Approach to CTO: 2014 UpdateYasushi Asakura

3:15 PM - Challenging CTO Case Reviews 1: My Tips and TricksEtsuo Tsuchikane

3:30 PM - Challenging CTO Case Reviews 2: My Tips and TricksPaul Hsien-Li Kao


Session II

Moderators: Weiyi Fang, Lijun Jin, Tongku Liu, Anlin Lu, Leisheng Ru, Guowei Zhou

4:00 PM - Featured Lecture: Current State and Future Direction of CTO PCI in ChinaJunbo Ge

4:15 PM - How to Become a CTO Specialist from the Beginner?Shuzheng Lu

4:30 PM - How to Best Make Your Plan Before CTO Angioplasty?Jiyan Chen

4:45 PM - My CTO Procedures: Where to Start? When to Stop?Guosheng Fu

5:00 PM - A Pivotal Role of IVUS in CTO PCIYuejin Yang

5:15 PM - How to Reasonably Select Devices in My CTO Procedures?Quanmin Jing

5:30 PM - How to Reasonably Utilize Retrograde Approach in My CTO Procedures?Bin Zhang

5:45 PM - Recanalizing CTO by Retrograde Approach: 200 Cases from a Single Center ExperienceChengxiang Li

6:00 PM - Adjourn

Room 204, Level 2

Breakfast Case Reviews 10Complications7:00 AM-8:15 AM

Moderators: Weimin Li, Tiemin Jiang, Jinqing Yuan

7:00 AM - CS-0014: Treatment and Follow-Up of Very Late Stent ThrombosisTongku Liu

7:10 AM - Q&A

7:15 AM - CS-0065: LAD Has FallenQing He

7:25 AM - Q&A

7:30 AM - CS-0082: Successful PCI After Left Main ThrombosisBing Liu

7:40 AM - Q&A

7:45 AM - CS-0100: Stent FracturePeng Zhang

7:55 AM - Q&A

8:00 AM - CS-0110: Retrograde Approach to Acute Occlusion Caused by Ostial RCA DissectionYang Cao

8:10 AM - Q&A

8:15 AM - Break



067

10:45 AM - IM-0092: No-Reflow After Angioplasty of ISR Lesion - IVUS AnalysisQinhua Jin

11:00 AM - IM-0030: Acute Stent Thrombosis After PCI in AMIBili Zhang

11:15 AM - IM-0036: A Case of Chronic Stent FractureHao Zhu

Session VII: Final Thoughts

Moderators: John McB. Hodgson, Ron WaksmanDiscussants: Akiko Maehara, Gary S. Mintz, Johan H. C. Reiber

11:30 AM - Rational Integration of FFR, IVUS, OCT, and More into the Modern Cath Lab EnvironmentGary S. Mintz

11:50 AM - A Modern Cath Lab Based Imaging ServiceAkiko Maehara

12:00 PM - Co-Registration of 3D X-Ray Angiography and 3D OCT to Support Interventional ProceduresJohan H. C. Reiber


12:30 PM - Break

Luncheon Satellite SymposiumSponsored by GE Healthcare (2)Endothelial Protection, Interventional Preferred12:40 PM-1:55 PM

Chairmen: Shuzheng Lu, Haichang Wang

12:40 PM - Opening RemarksShuzheng Lu

12:45 PM - Less Endothelial Injury, More Cardio Renal ProtectionChengzhi Lu

1:05 PM - From Clinical Trial to Clinical Practice: An Iodixanol Study with 20185 PatientsYawei Xu

1:25 PM - Case Reviews: Utility of Iodixanol in Diabetic PatientsWenhui Huang

Integrating FFR, IVUS, OCT, and More to Improve Patient Outcomes Part IV8:30 AM-12:30 PM

Session VI: Stent Thrombosis, In-Stent Restenosis, and Long-Term Follow-Up Studies - Integrating Knowledge from IVUS, OCT, and More

Moderators: Fernando Alfonso, Stephen Wai-Luen LeeDiscussants: Ning Guo, Soo-Jin Kang, Yoshinobu Onuma, Masamichi Takano

8:30 AM - Mechanisms and Predictors of In-Stent RestenosisGary S. Mintz

8:45 AM - Mechanisms and Predictors of Early Stent ThrombosisFernando Alfonso

9:00 AM - Mechanisms and Predictors of Late and Very Late Stent ThrombosisSoo-Jin Kang

9:15 AM - Neoatherosclerosis: Is This the Final Pathway to Stent Failure (Stent Restenosis and Thrombosis)?Masamichi Takano

9:30 AM - Does Acute or Late Malapposition Matter?Ning Guo

9:45 AM - Role of Physiologic Assessment in the Patient Presenting with In-Stent Restenosis: To Treat or Not to Treat?William F. Fearon

10:00 AM - Featured Lecture: What Have We Learned about BVS from Serial Physiologic, IVUS, and OCT Studies?Yoshinobu Onuma


Case Presentations of Patients with In-Stent Restenosis or Stent Thrombosis (15 minutes each including Q&A)

Moderators: Fernando Alfonso, Ning GuoDiscussants: Yong He, Myeong-Ki Hong, Junqing Yang

10:30 AM - IM-0117: Understanding and Treatment of Ostial LAD Lesion by FFR and IVUSQiong Wang

1:35 PM - Case Reviews: Utility of Iodixanol in Elderly PatientsWen Lu


1:50 PM - Take-Home MessageHaichang Wang

1:55 PM - Break

AICT at CITSTEMI Update and Relevance in Asia2:00 PM-3:30 PM

Moderators: Huay Cheem Tan, Junbo Ge, Roxana MehranDiscussants: Chi-Kin Chan, Fazila Tun Nesa Malik, Kui-Hian Sim, Wasan Udayachalerm


2:03 PM - Update of STEMI Network in ChinaYong Huo

2:13 PM - Novel Stents, Bioresorbable Vascular Scaffold and Drug-Coated Balloon in Primary PCIHuay Cheem Tan

2:23 PM - Cell Therapy After AMI: Optimal Timing of Delivery, Types of Cells, and EffectivenessAnthony DeMaria


Flash Debate: Use of Thrombus Aspiration Device in PPCI

2:43 PM - It Is Over with TASTE TrialAdnan Kastrati

2:50 PM - Don't Throw It Out Yet: There Is Still a RoleRosli Mohd Ali

2:57 PM - Discussion and Consensus

STEMI Case Reviews

3:03 PM - Interesting Case Presentation 1Wacin Buddhari


3:15 PM - Interesting Case Presentation 2Paul TL Chiam



068

4:45 PM - Coronary Bifurcation Stenting Strategies in ChinaShaoliang Chen


5:02 PM - Chronic Total Occlusion: The Chinese WayLei Ge

5:14 PM - Chronic Total Occlusion: The Korean WayHyo-Soo Kim


5:31 PM - Calcified Tortuous Lesion: How to Overcome It?Tae-Hoon Ahn

5:43 PM - Imaging Guided PCIMyeong-Ki Hong


6:00 PM - Adjourn



MY LIVE at CITLeft Main Stem and Bifurcation PCI3:30 PM-4:30 PM

Moderators: Robaayah Zambahari, Bo XuDiscussants: Gim-Hooi Choo, Jianping Li, Jian Liu, Rosli Mohd Ali, Wan Azman Wan Ahmad, Qi Zhang

Left Main Stem PCI: What Can Go Wrong?

3:30 PM - Case PresentationWan Azman Wan Ahmad

3:40 PM - CommentaryJian Liu

Left Main Stem Intervention in ACS

3:45 PM - Case PresentationGim-Hooi Choo

3:55 PM - CommentaryJianping Li

Double Bifurcation PCI with a Twist at the End!

4:00 PM - Case PresentationRosli Mohd Ali

4:10 PM - CommentaryQi Zhang


ENCORE at CITComplex Coronary Lesion Subsets: Strategies in Korea4:30 PM-6:00 PM

Moderators: Hyeon-Cheol Gwon, Bo XuDiscussants: Tae-Hoon Ahn, Shaoliang Chen, Zhan Gao, Lei Ge, Myeong-Ki Hong, Yan Li, Hyo-Soo Kim

4:30 PM - Introduction

4:33 PM - Coronary Bifurcation Stenting Strategies in KoreaHyeon-Cheol Gwon

Room 205, Level 2


Moderators: Zuyi Yuan, Shouli Wang, Yu Wang

7:00 AM - CS-0146: PCI for CTO Accompanied with Acute Coronary Thrombus FormationHuiqiang Zhao

7:10 AM - Q&A

7:15 AM - CS-0165: Stent Loss in Left MainBili Zhang

7:25 AM - Q&A

7:30 AM - CS-0240: Staged PCI for Two-Vessel Disease with Coronary PerforationZhiyong Wu

7:40 AM - Q&A

7:45 AM - CS-0274: Ruptured Coronary Artery Embolization by Soluble Gelatin SpongeHanjun Zhao

7:55 AM - Q&A

8:00 AM - CS-0255: Subacute Stent Thrombosis and Severe Thrombocytopenia Caused by Glycoprotein IIb/IIIa Inhibitors in Patient with Retrograde Wire TechniqueQuanmin Jing

8:10 AM - Q&A

8:15 AM - Break



069

9:46 AM - FFR-Guided Should Be ConsideredBon-Kwon Koo


CRT at CITIn-Stent Restenosis 201410:00 AM-11:00 AM

Moderators: Junbo Ge, Ron WaksmanDiscussants: Akiko Maehara, Huay Cheem Tan, Renu Virmani

10:00 AM - In-Stent Restenosis 2014: State of the ProblemJunbo Ge

10:10 AM - Stent Neoatherosclerosis and Its Contribution to Late RestenosisRenu Virmani

10:20 AM - Mechanical Considerations to Minimize Restenosis: Fractures and Stent Design, Polymer etc.Ron Waksman

10:30 AM - Imaging of Restenosis by Angiogram, IVUS and OCT, and Their Impact on Therapy?Akiko Maehara

10:40 AM - How to Treat ISR in 2014: DCB, DES, or BRS?Huay Cheem Tan


SCAI Quality Symposium at CITIntroducing the American and Chinese Perspectives and Solutions11:00 AM-12:30 PM

Moderators: Theodore A. Bass, Run-Lin GaoDiscussants: Joseph D. Babb, Ajay J. Kirtane, Lang Li, Thach Nguyen, Thomas M. Tu, Haichang Wang

Strategies

11:00 AM - Which Quality Initiatives Are Needed in the American Cardiac Catheterization Laboratories? How to Use the Quality Initiatives in Order to Change the Work Culture and Outcomes at a Local CCL? (5 practical suggestions)Theodore A. Bass

Cardiovascular Summit - TCTAP at CITLeft Main and Bifurcation Summit: Integrated Use of FFR and IVUS8:30 AM-10:00 AM

Moderators: Gary S. Mintz, Seung-Jung Park, Gregg W. StoneDiscussants: Jung-Min Ahn, William F. Fearon, David E. Kandzari, Young-Hak Kim, Bon-Kwon Koo, Akiko Maehara

8:30 AM - Welcome and IntroductionSeung-Jung Park

FFR Guided Clinical Practice!

8:32 AM - Trends in the Treatment Outcomes with Routine Use of FFR in Real PracticeJung-Min Ahn

8:40 AM - Future Study: FAME 3William F. Fearon


Functionally Insignificant Vulnerable Plaque: Do You Want to Treat?

8:54 AM - Yes!Akiko Maehara

9:02 AM - No!Seung-Jung Park


Left Main Disease Is Not Surgical Disease Any More

9:16 AM - Current Status of PCI vs. CABG in Left Main DiseaseYoung-Hak Kim

9:24 AM - EXCEL StudyGregg W. Stone


When and How: Side Branch Treatment of Bifurcation PCI

9:38 AM - Angiography Is Enough! Don't Waste Time and MoneyDavid E. Kandzari

Tactics 1

11:10 AM - How to Develop and Implement a Successful Quality Improvement in American CCL? (5 practical suggestions)Ajay J. Kirtane

11:20 AM - How to Develop and Implement a Successful Quality Improvement in a Chinese CCL? (5 practical suggestions)Yuejin Yang


Tactics 2

11:35 AM - How to Assure the Quality of the Procedure and the Safety of the Patients in New, Investigational Difficult and Complex Procedures?Thomas M. Tu

11:45 AM - Chinese Reply: How to Assure the Quality of the Procedure and the Safety of the Patients in CTO Angioplasty? (focus on retrograde approach)Jiyan Chen


Tactics 3

12:00 PM - A High Volume Operator Has High Complication Rate Because of the Clinical and Angiographic Complexity of the Cases: How to Solve the Problem?Haichang Wang

12:10 PM - American Reply: How to Solve the Problem? (5 practical suggestions)Thach Nguyen


Conclusion

12:25 PM - How to Improve the Quality: A Future PerspectiveTheodore A. Bass

12:30 PM - Break



070

Luncheon Satellite SymposiumSponsored by Abbott Vascular (2)Innovative Technologies Change the Future12:40 PM-1:55 PM

Chairmen: Yuejin Yang, Weimin Wang, Bo Yu, Shaoping Nie


12:45 PM - My Experience of a New Workhorse GuidewireJianfang Luo

1:05 PM - Real World Experience of BVS from Hong KongVincent On-Hing Kwok

1:25 PM - A New Therapy for Mitral RegurgitationWolfgang Schillinger


1:55 PM - Break

Left Main and Bifurcations Part IIILeft Main Revascularization: Clinical Data, Risk Stratification, and Technical Considerations2:00 PM-6:00 PM

Session I: Emerging Data and Clinical Decision-Making

Moderators: Liliana R. Grinfeld, Marie-Angèle Morel, Haichang WangDiscussants: Davide Capodanno, Wai-Kwong Chan, Philippe Généreux, Wei Wang, Yaojun Zhang

2:00 PM - Rapid Review of the World's Essential Left Main Publications and Abstracts from the Last YearDavide Capodanno

2:15 PM - Featured Lecture: So Many Risk Models, So Little Time: A Practical Guide to Choose between CABG and PCIPatrick W. Serruys

2:35 PM - Validation and Comparison of the Long-Term Prognostic Capability of the SYNTAX Score II Among 1,528 Consecutive Patients Who Underwent Left Main PCIPhilippe Généreux

2:50 PM - What You Should Learn About NERS II Score: A Novel Stratification Tool from ChinaYaojun Zhang

3:05 PM - Subgroup Analysis of Left Main and Multivessel Population within the COMPARE TrialPieter C. Smits

3:17 PM - DES Type and SYNTAX Score: Lessons from ISAR-LEFT MAIN 1 and 2Adnan Kastrati

3:29 PM - A Thoughtful Surgeon's Approach to Left Main PCI vs. CABG Clinical Decision-MakingWei Wang


Session II: Left Main PCI Strategies and Techniques

Moderators: Seung-Jung Park, Yujie Zhou, Chien-Ming HuangDiscussants: Jinghua Liu, Gary S. Mintz, Marie-Claude Morice, Jeffrey W. Moses, Yuejin Yang

4:00 PM - Basis of Reasoning for the Treatment of Distal Left Main BifurcationJean Fajadet

4:15 PM - Provisional Stenting for Distal Left Main Bifurcation: Case Examples and DataMarie-Claude Morice

4:30 PM - Planned Two-Stent Techniques for Distal Left Main Bifurcation: Case Examples and DataYuejin Yang

4:45 PM - Left Main Bifurcation PCI: What Are the Special Considerations During Periprocedure?Jinghua Liu

4:57 PM - When Is Hemodynamic Support Needed for Left Main PCI, and Which Method?Je�rey W. Moses

5:09 PM - FFR Guided Clinical Practice of Left Main PCI Has Emerged as the Standard!Seung-Jung Park

5:21 PM - IVUS Guided Clinical Practice of Left Main PCI Should Remain the Standard!Gary S. Mintz

5:33 PM - Final Thoughts: How Do the Data of Strategy and Technique Trials Apply to My Practice of Left Main PCI?Shaoliang Chen


6:00 PM - Adjourn



071


9:06 AM - Should Radial Artery Be the Default Access for Primary PCI?Huiliang Liu


9:18 AM - Experience of Left Main PCI via Transradial ApproachZhujun Shen


Session II

Moderators: Haichang Wang, Huiliang Liu, Gianluca Rigatelli, Guisong Wang, Ping-Han Lo

9:30 AM - Current State of Radial Access Coronary Interventions in the United States and Its Outlook in the FutureYi-Ming Yang


9:42 AM - Transradial vs. Transfemoral Approach for Rotational AtherectomyWei-Hsian Yin


9:54 AM - Complex Problem Solving with Post-CABG Patients from the Radial ApproachMitchell W. Kruco�


10:06 AM - PCI Skills in Complex Coronary Artery Disease by Radial ApproachLong Hong


10:18 AM - How to Improve Backup Support in TRI?Qing Zhang


Session III

Moderators: Yawei Xu, Haibo Liu, Peng Qu, Rurus Suryawan, Dongmei Shi

10:30 AM - Transradial PCI for CTO: Antegrade ApproachGuosheng Fu


10:42 AM - Transradial PCI for CTO: Retrograde ApproachChien-Ming Huang


10:54 AM - Transradial vs. Transfemoral Approach in One-Stage PCI for Three-Vessel Disease: Comparison of Immediate and Long-Term OutcomesKefei Dou


11:06 AM - Transradial vs. Transfemoral Method of Two-Stent Implantation for True Bifurcation Lesions: Comparison of Immediate and Long-Term OutcomesZhan Gao


11:18 AM - Tips and Tricks of PCI for CTO Using Retrograde Technique via Bilateral Radial ApproachZesheng Xu


Session IV

Moderators: Xianghua Fu, Min Yao, Gustavo Samaja, Ruqiong Nie, Dongju Jiang

11:30 AM - TRA in Little Old Ladies: Tips and TricksGustavo Samaja


11:42 AM - Radial vs. Femoral for PCI: The Disadvantages of BothJosef Ludwig


11:54 AM - Prevention of Radial Artery InjurySudhir Rathore


12:06 PM - How to Successfully Cannulate Catheter via Anatomically and Morphologically Complex Radial Access?Chengxiang Li

Room 206, Level 2

Breakfast MeetingSponsored by TerumoThrombus Treatment for AMI7:00 AM-8:00 AM

Chairmen: Hongbing Yan, Quanmin Jing, Juying Qian

7:00 AM - Opening Remarks

7:05 AM - Principle of Thrombus Treatment for AMIXiantao Song

7:20 AM - Strategies of Thrombus Treatment for AMIBinquan Zhou

7:35 AM - Treatment of Thrombotic Complications During AMIZaixin Yu


8:00 AM - Break

TRI Club Part II8:30 AM-12:30 PM

Session I

Moderators: Yuejin Yang, Chiung-Jen Wu, Lei Wang, Yu Wang, Yuqing Hou

8:30 AM - Key Points of Transradial Coronary Intervention in Very Elderly PatientsYujie Zhou


8:42 AM - Synergy of Transradial Intervention and Same Day Discharge: Why and for Whom?Matthew J. Price


8:54 AM - Can We Treat Complex Bifurcation Lesions via Transradial Approach?Jian Liu



072


12:18 PM - Closing of TRI Club at CIT2014: Society Perspective on TRI Program in the FutureXianghua Fu


12:30 PM - Break

Luncheon Satellite SymposiumSponsored by TerumoSelecting Suitable Guiding Catheters12:40 PM-1:55 PM

Chairmen: Shuzheng Lu, Weimin Wang, Yujie Zhou, Ruiyan Zhang


12:45 PM - Principles of Handling Guiding Catheters in PCIYuchen Zhang

1:05 PM - Selecting Suitable Guiding Catheters for Radial ApproachMin Yao

1:25 PM - Selecting Suitable Guiding Catheters for Treatment of Complex CasesQing Zhang


1:55 PM - Break

ST-Segment Elevation Myocardial Infarction2:00 PM-6:00 PM

Part I: Latest Advances in STEMI

Moderators: Hongbing Yan, Alan C. YeungDiscussants: Teguh Santoso, Patrick W. Serruys, Marco Wainstein, Lefeng Wang, David X. M. Zhao

2:00 PM - Inflammation and Plaque Vulnerability During Acute Coronary Syndrome: From Bench to BedsideMarco Wainstein

2:10 PM - Adjunctive Pharmacotherapy in Primary PCI: From HORIZONS-AMI to EUROMAXGregg W. Stone

2:25 PM - Update on STEMI PCI: Aspiration, Hemodynamic Support, and Local Drug DeliveryAlan C. Yeung

2:40 PM - Update on Percutaneous Circulatory Assist DevicesDavid X. M. Zhao

2:50 PM - Management of STEMI with Large Thrombus Burden: What's New?Teguh Santoso

3:00 PM - Randomized Study to Assess the Effect of Thrombus Aspiration on Flow Area in Patients with STEMI: Insights from the TROFI TrialPatrick W. Serruys

3:10 PM - STEMI Therapy: Different Time, Different Culprit Lesion, and Different StrategyLefeng Wang


Part II: STEMI Debate - Current Controversies

Moderators: Roxana Mehran, Weifeng ShenDiscussants: Zening Jin, Fazila Tun Nesa Malik, Seung-Jea Tahk, Hongbing Yan

Debate 1

3:36 PM - Thrombosuction in STEMI: Should It Be Routine?Seung-Jea Tahk

3:46 PM - Yes, Clinical Practice against Clinical Trials!Hongbing Yan


Debate 2

4:06 PM - "Staged" PCI Is Still Appropriate for Most STEMI Patients with Multivessel DiseaseFazila Tun Nesa Malik

4:16 PM - "One-Stop" Strategy Is an Evidence-Based Option for MostZening Jin


Part III: STEMI Therapy Practice - A Case-Based Discussion

Moderators: Xinchun Yang, Bao LiDiscussants: Yuguo Chen, Jicheng Guo, Weiming Li, Yitong Ma, Guizhou Tao, Biao Xu

4:36 PM - Case 1: Tele-ECG System to Improve D2B Time and Long-term Outcome in STEMI PatientWei-Hsian Yin


4:50 PM - Case 2: Impact of Chest Pain Center Standardization on Shortening Reperfusion Time in STEMIDingcheng Xiang


5:04 PM - Case 3: How to Define Thrombus Burden?Hanjun Zhao


5:18 PM - Case 4: Intracoronary GP IIb/IIIa Inhibitor plus Thrombosuction in STEMI PatientYongsheng Ke


5:32 PM - Case 5: Application of ECMO and IABP in STEMI Patient with Cardiogenic ShockShouli Wang


5:46 PM - Case 6: Role of Thrombolytic Therapy for STEMI in the Era of DESGenshan Ma


6:00 PM - Adjourn



073

Pharmacologic Satellite SymposiumSupported by AstraZenecaPCI Pharmacologic Managements8:30 AM-11:30 AM

Moderator: Run-Lin Gao, Yaling Han, Shuzheng Lu, Weifeng Shen, Dejia Huang

Statin Therapy in PCI


8:35 AM - Intensive LDL-C Lowering: A Foundation Stone in Cardiovascular Disease TreatmentXue-Qiao Zhao

9:00 AM - Perioperative Use of Statin in PCI: What Course to Follow?Yongjian Wu

9:25 AM - The Latest Data of Statin in the Prevention of Contrast-Induced NephropathyYaling Han


ACS Antiplatelet Therapy


10:05 AM - From Mechanism to Clinic: New in Antiplatelet TherapyNengneng Cheng

10:35 AM - Risk Stratification and Optimization of Antiplatelet Therapy in ACSHuiliang Liu

11:00 AM - Learning from STEMI GuidelinesZhimin Du


11:30 AM - Break

Luncheon Satellite SymposiumSponsored by Sino MedicalBreaking New Evidences in Creation! The Latest Results and Designs of BuMA Trials12:40 PM-1:55 PM

Chairmen: Run-Lin Gao, Hong Jiang, Bin Liu, Meng Wei


12:45 PM - Latest Experimental Data of Endothelial Response Following BuMA ImplantationsRenu Virmani

1:00 PM - A Prospective, Multicenter, Observational Study Assessing the Safety and Effectiveness of BuMA DES in Real World: Results of PANDA II RegistryJianping Li

1:15 PM - Results of BuMA-OCT and Updates of the Pivotal PANDA III Randomized TrialsJie Qian

1:30 PM - Rationale and Design of the Prospective, Multicenter, Randomized Trial of BuMA DES in EuropePatrick W. Serruys


1:55 PM - Break

Pharmacologic Satellite SymposiumSupported by BayerAnticoagulant Forum2:00 PM-3:00 PM

Moderator: Yujie Zhou, Zulu Wang

2:00 PM - New Treatment Strategies in ACS Secondary PreventionYujie Zhou

2:20 PM - Oral Anticoagulation in ACS: A Clinical UpdateShuyang Zhang

2:40 PM - Cardiovascular Protective Profile of Novel Oral Anticoagulants: Implications for Clinical PracticeXubo Shi

3:00 PM - Adjourn

Room 207, Level 2


Moderators: Dongqi Wang, Tianchang Li, Yingling Zhou

7:00 AM - CS-0281: Acute Stent Thrombosis Caused by Clopidogrel ResistanceYingyan Ma

7:10 AM - Q&A

7:15 AM - CS-0310: How to Take Out the Broken GW from Coronary Artery?Weiming Li

7:25 AM - Q&A

7:30 AM - CS-0324: Successful Retrieval of an Entrapped Rotablator Burr Using 5F-in-6F Guiding Catheter TechniqueYuquan He

7:40 AM - Q&A

7:45 AM - CS-0325: A Case of Dislodged Coronary StentShaofeng Guan

7:55 AM - Q&A

8:00 AM - CS-0327: Acute Myocardial Infarction with Simultaneous Occlusions of Two Major Coronary Arteries (LAD and RCA) Due to Very Late Stent ThrombosisYuquan He

8:10 AM - Q&A

8:15 AM - Break



074

8:50 AM - Is RV Pacing Compulsory? Or Will LV Pacing Alone Suffice?Yutang Wang


9:10 AM - Should Patients with RBBB Be Considered for CRT or Not?Baopeng Tang


9:30 AM - Ablation Strategies in CRT CandidatesJiangang Zou


9:50 AM - Cardiac Resynchronization: Will It Be Useful to Pacing Population?Cheuk-Man Yu


10:10 AM - Break

Session II: Optimizing Benefit from CRT

Moderators: Farong Shen, Xuebin Li, Chunguang Qiu, Jing Xu, Dongqi Wang

10:30 AM - Optimization Strategies in CRT PatientsJiefu Yang


10:50 AM - Left Ventricular Endocardial Pacing TechnologyYangang Su


11:10 AM - Phrenic Nerve Stimulation Management in CRT PatientsJi Yan


11:30 AM - Role of Hemodynamic Indices to Predict Long-Term Outcomes in Patients Receiving Cardiac Resynchronization TherapyKeping Chen


11:50 AM - CRT Response in Patients Implanted with a Quadripolar LV Lead: Are Four Poles Better than Two?Wei Hua


12:10 PM - Break

Luncheon Satellite SymposiumSponsored by Goodman and Supported by MicroPortNSE: Novel Concept Dilatation Catheter12:40 PM-1:55 PM

Chairmen: Eisho Kyo, Jiyan Chen, Shubin Qiao


12:45 PM - From Concept to Clinical Use: An Evolution in DilatationShigeru Nakamura

1:15 PM - NSE Case Reviews 1Jun Dai

1:25 PM - NSE Case Reviews 2Zhujun Chen



1:55 PM - Break

Heart Rhythm Part IVICD and Pacing2:00 PM-5:40 PM

Session I: ICD in Inherited Arrhythmia

Moderators: Fangzheng Wang, Guangping Li, Jielin Pu, Kui Hong, Qijun Shan

2:00 PM - ICD in Preventing Sudden Cardiac Death of Long QT SyndromeKejiang Cao


2:20 PM - Risk Stratification and ICD Therapy in Brugada SyndromeXinchun Yang


Room 208, Level 2


Moderators: Bo Yu, Biao Xu, Anlin Lu

7:00 AM - CS-0364: Retrieval of an Entrapped (partially dilated) Balloon in LADWei Liu

7:10 AM - Q&A

7:15 AM - IM-0026: Anterior MI After RCA Occlusion RecanalizationXiaowan Wang

7:25 AM - Q&A

7:30 AM - IM-0028: Retroperitoneal Hematoma in Elderly Man with Transradial PCILiping Ding

7:40 AM - Q&A

7:45 AM - IM-0044: Accordion-Stent-Deformity by Retrieving Side Branch Protective Guide Wire (SBW)Yu-Lin Ko

7:55 AM - Q&A

8:00 AM - Break

Heart Rhythm Part IIICRT8:30 AM-12:10 PM

Session I: Toward Personalized Pacing Strategy

Moderators: Shu Zhang, Yutang Wang, Xi Su, Yangang Su, Yanchun Liang

8:30 AM - Choosing Right Patients for CRT: A Key Factor for Improved ResponseDejia Huang




075

Structural Heart Disease Part II8:30 AM-12:30 PM

Session I

Moderators: Zhiyuan Song, Weifeng Wu, Gejun Zhang, Daxin Zhou, Wei Gao, Weihua Zhang

8:30 AM - Prevention and Management of Unusually Late Complications After Transcatheter Intervention of Congenital Heart DiseaseShiliang Jiang


8:45 AM - Transcatheter Pulmonary Valve Replacement: Current Valves and ExperienceZiyad M. Hijazi


9:00 AM - Transcatheter Pulmonary Valve Implantation: A Single Center 5 Year ExperienceWitold Ruzyllo


9:15 AM - Transcatheter Pulmonary Valve Implantation: Future PerspectivesXiangqing Kong


9:30 AM - Percutaneous Mitral Balloon Valvuloplasty: Current Status in ChinaZhi Zeng


9:45 AM - European MitraClip Experience: Lessons Learned from RegistriesWolfgang Schillinger


10:00 AM - Value of Imaging in Transcatheter Mitral Valve RepairXinming Li


10:15 AM - Challenging Case: Platypnea Orthodeoxia Following Surgical ASD Closure and Saved by Percutaneous ClosureMagnus Settergren


2:40 PM - ICD in Patients with Hypertrophic CardiomyopathyJingfeng Wang


3:00 PM - ICD in Patients with Catecholaminergic Polymorphic Ventricular TachycardiaQuan Fang


3:20 PM - Preventing Sudden Cardiac Death of ARVC: Catheter Ablation or ICD?Minglong Chen


3:40 PM - Break

Session II: Pacemaker Therapy - Indication and Follow-Up

Moderators: Quan Fang, Zheng Wan, Ming Wu, Xiufen Qu, Wei Xu

4:00 PM - Is Remote Monitoring for Bradycardia Devices Really Beneficial?Keping Chen


4:20 PM - Ventricular Pacing Avoidance Algorithms: Indications and ContraindicationsLin Chen


4:40 PM - Programming Rate-Adaptive Sensors: Is There a Best Practice?Liangrong Zheng


5:00 PM - Should Pacemaker Selection and Programming in the Very Elderly (> 80 years) Be Simpler?Ping Zhang


5:20 PM - How to Improve Response Force to CRT?Tao Guo


5:40 PM - Adjourn

Room 305A, Level 3

Breakfast Case Reviews 14Structural Heart Disease7:00 AM-8:30 AM

Moderators: Xiangqing Kong, Zhongyin Xu, Daxin Zhou, Guotai Sheng

7:00 AM - CS-0121: Two Capture Devices Catch the Amplatzer occluder That Has Fallen OffZhanying Han

7:10 AM - Q&A

7:15 AM - CS-0160: Ambrisentan Combined Interventional Treatment of Atrial Septal Defect with Severe Pulmonary HypertensionYou Chen

7:25 AM - Q&A

7:30 AM - CS-0232: Transcatheter Occlusion of Huge Pulmonary Arteriovenous Fistula Affiliated Ventricular Septal DefectGuangwei Wu

7:40 AM - Q&A

7:45 AM - CS-0239: Rupture of Aortic Sinus AneurysmYong Sun

7:55 AM - Q&A

8:00 AM - CS-0268: Transcatheter Closure of Ventricular Septal Perforation and PCI in AMI with 3 Years Follow-UpYuying Zhao

8:10 AM - Q&A

8:15 AM - CS-0280: Complex Mitral Paravalvular Leak ClosureWen-Loong Yeow

8:25 AM - Q&A



076

Session II

Moderators: Zhi Zeng, Yat-Yin Lam, Zhiwei Zhang, Zhongying Xu, Yimin Hua, Zishan Hou

10:30 AM - Dilatation of Pulmonary Arteries with Stent and Balloon Angioplasty: A Single Center ExperienceMalgorzata Szkutnik


10:45 AM - Integrating Balloon-Expandable and Self-Expanding TAVR Systems into Clinical PracticeJan Kovac


11:00 AM - Impact of Etiology of Pulmonary Hypertension on Post-Procedural Management and Outcomes in Patients Undergoing Transcatheter Aortic Valve ReplacementShing-Chiu Wong


11:15 AM - Left Ventricular Partitioning with the PARACHUTE Device: A New Percutaneous Treatment for Heart FailureRobaayah Zambahari


11:30 AM - Transcatheter Closure of Interatrial Shunt with ICE Monitoring: Tip and TricksGianluca Rigatelli


11:45 AM - Interpretation of the Guideline for PTSMA in Hypertrophic CardiomyopathyZhanquan Li


12:00 PM - Transcatheter Closure of PFO: Chinese ExperienceYushun Zhang


12:15 PM - Left Atrial Appendage Closure: When and How to Close Residual LeaksSimon Cheung-Chi Lam

2:40 PM - Case PresentationJun Qin

2:48 PM - Case PresentationMei Jin

2:56 PM - Case PresentationZhi Chen

3:04 PM - Case PresentationYuan Feng

3:12 PM - Case PresentationYingzhang Cheng

3:20 PM - Case PresentationXiangqian Shen

3:28 PM - Case PresentationWeifeng Wu


Session II: Case Reviews - Challenging Case of Structural and Congenital Heart Disease

Moderators: Shiliang Jiang, Yong Sun, Xiangqian Shen, Mei Jin, Guangwei Wu, Guishuang Li

4:00 PM - Case PresentationGejun Zhang

4:08 PM - Case PresentationYulin Wang

4:16 PM - Case PresentationGangcheng Zhang

4:24 PM - Case PresentationFen Li

4:32 PM - Case PresentationZhiyuan Song

4:40 PM - Case PresentationWeihua Zhang

4:48 PM - Case PresentationXianxian Zhao

4:56 PM - Case PresentationZhen Wang

5:04 PM - Case PresentationQijian Yi


12:30 PM - Break

Luncheon Satellite SymposiumSponsored by Lifetech12:40 PM-1:55 PM

Chairmen: Zhiwei Zhang, Shiliang Jiang, Xiangqing Kong, Daxin Zhou, Yat-Yin Lam


12:45 PM - A New Atrial Appendage Occluder LAmbre and Clinical Evidence UpdatesJai-Wun Park

1:00 PM - Clinical Updates on Cera Occluder Application Trial (COAT)Zhiwei Zhang

1:15 PM - Perimembranous VSD Closure Using Cera DevicesCésar A. Esteves

1:30 PM - Experience with Cera DevicesLuiz Carlos Giuliano


1:55 PM - Break

Structural Heart Disease Part III2:00 PM-6:00 PM

Session I: Case Reviews - Challenging Case of Structural and Congenital Heart Disease

Moderators: Xianxian Zhao, Fen Li, Tianhe Yang, Yulin Wang, Zhen Wang, Guotai Sheng

2:00 PM - Case PresentationYimin Hua

2:08 PM - Case PresentationYitong Ma

2:16 PM - Case PresentationQiguang Wang

2:24 PM - Case PresentationBo Yu

2:32 PM - Case PresentationGuotai Sheng



077

5:12 PM - Case PresentationMingyang Qian

5:20 PM - Case PresentationYuming Qin

5:28 PM - Case PresentationJiping Shan


6:00 PM - Adjourn

9:00 AM - Correlation between the Diversity of Platelet Reactivity and Cardiovascular EventsYitong Ma

9:10 AM - Controversy on the Treatment of Stable Coronary Artery Disease: Optimized Medical Therapy or PCI?Weiming Li


Session II: Clinical Application of Cardiovascular Diagnostic and Therapeutic Technology

Moderators: Zhanquan Li, Patrick Tak-Him Ko, Hui Li, Yingling Zhou, Qiutang Zeng

9:30 AM - Is the Era of Endothelial Function Monitoring Coming?Ping Yang

9:40 AM - Can Platelet Function Testing Be Certainly Used to Guide Clinical Decision Making?Hongliang Cong

9:50 AM - Application of the Average Volume of Platelet in the Diagnosis and Treatment of Coronary Artery DiseaseYining Yang

10:00 AM - Myocardial Repair Therapy for Acute Myocardial InfarctionBiao Xu

10:10 AM - A Novel Subtype of Microvascular Angina: Coronary Slow FlowZhiming Yang


Session III: Acute Coronary Syndrome and Clinics

Moderators: Jinqing Yuan, Yongming Hui, Feng Wang, Honghua Ye, Yanguang Feng

10:30 AM - Research Advance of IIb/IIIa Receptor Antagonists in Patients with Moderate- or High-Risk Acute Coronary SyndromeChuanyu Gao

10:40 AM - Individualized Antiplatelet Therapy in Acute Coronary Syndrome with Gastrointestinal BleedingHaichang Wang

Room 305B, Level 3


Moderators: Fucheng Sun, Kang Li, Shulin Zhang

7:00 AM - IM-0051: Immediate Stent ThrombosisXue Yu

7:10 AM - Q&A

7:15 AM - IM-0056: Stent Intimal TearMing Long

7:25 AM - Q&A

7:30 AM - IM-0075: Left Main Re-Occlusion Immediately After Emergent PCIBo Luan

7:40 AM - Q&A

7:45 AM - IM-0099: Stent Loss and Delivery System Fracture During PCI for Calcified Left Main BifurcationZhenhong Fu

7:55 AM - Q&A

8:00 AM - Break

Basics and Medical Therapies Part II8:30 AM-12:30 PM

Session I: New Understanding of Atherosclerosis

Moderators: Yun Zhang, Jieming Mao, Wenling Zhu, Shumei Li, Zhijian Yang

8:30 AM - The Latest Understanding of Dyslipidemia and Coronary Artery DiseaseJianjun Li

8:40 AM - Pattern Recognizing Receptors and Inflammatory Mechanisms of AtherosclerosisPeng Qu

8:50 AM - Advances in Molecular Imaging in the Biological Therapy of Ischemic Heart DiseaseFeng Cao



078

10:50 AM - Preventive Management of Bleeding in Antiplatelet Therapy of Acute Coronary SyndromeGuoqing Li

11:00 AM - Current Knowledge of Medical and Interventional Therapies for Elderly Patients with Acute Coronary SyndromeShaobin Jia

11:10 AM - Evidence and Selection of Novel Antithrombotic Medications in Patients with Acute Coronary SyndromeLikun Ma


Session IV: Pharmacotherapeutics of Coronary Artery Disease

Moderators: Jingxuan Guo, Changcong Cui, Lixian Han, Qin Qin, Ming Zhang

11:30 AM - Oral Anticoagulant Therapy in Patients with Coronary Artery DiseaseMao Chen

11:40 AM - Issues Related to Antithrombotic Therapy for Elderly PatientsMeilin Liu

11:50 AM - Triple Anticoagulant Therapy in Clinical PracticeXianxian Zhao

12:00 PM - Safety and Efficacy of Intensive Short-Term Statin Therapy on Acute Coronary SyndromeNingfu Wang

12:10 PM - Efficacy and Safety of Statins: Insight into the Molecular StructureXiangjun Yang


12:30 PM - Break

Luncheon Satellite SymposiumSponsored by VolcanoLatest Advances of Invasive Imaging and Physiology12:40 PM-1:55 PM

Chairmen: John McB. Hodgson, Yongjian Wu, William Kongto Hau


12:45 PM - IVUS Guided Stent Implantations: An Update of Meta-Analysis and Recent StudiesGary S. Mintz

1:00 PM - Using IVUS to Assess and Guide PCIJohn McB. Hodgson

1:15 PM - Clinical Trial Update for Instantaneous Wave-Free Ratio (iFR): Past and PresentJustin E. Davies

1:30 PM - iFR: Fu Wai's ExperienceYongjian Wu


1:55 PM - Break

PCI Technique and Outcome Part II2:00 PM-6:00 PM

Session I

Moderators: Yean-Leng Lim, Yaron Almagor, Chengxing Shen, Nazir Ahmed, Shih-Pu Wang

2:00 PM - Treatment of Multivessel Disease: Update 2014Je�rey W. Moses


2:12 PM - Role of IVUS in Management of PCI ComplicationKam-Tim Chan


2:24 PM - Embolic Protection During Primary PCIChaim S. Lotan


2:36 PM - Evaluating the Microvasculature in the Cath LabWilliam F. Fearon


2:48 PM - Longitudinal Deformation of the Newest DESHyo-Soo Kim


3:00 PM - Long-Term Outcomes of Drug-Eluting Stents vs. Bare Metal Stents in Large Coronary ArteriesI-Chang Hsieh


3:12 PM - Can We Further Improve Drug Management in IHD Patients?Nazir Ahmed Memon


Session II

Moderators: Likun Ma, Shisen Jiang, Kang Li, Qingsheng Wang

3:24 PM - Treatment Strategy of AMI Complicating Cardiogenic ShockYitong Ma


3:36 PM - Integrated Application of OCT and FFR in Specific CasesJingbo Hou


3:48 PM - Selection and Evaluation of the Preparation Approach to Calcified LesionsShaoping Nie


4:00 PM - PCI Strategy of Bypass Grafted LesionsYin Liu


4:12 PM - Strategy and Technique of PCI in Ostial LesionsShengli Yang


4:24 PM - Guidewire Curving Skills: Secret of PCI SuccessWeijie Li



079


4:36 PM - Identification and Management of No-Reflow in PCIFenghuan Hu


Session III

Moderators: Guoliang Jia, Lianqun Cui, Shanglang Cai, Guoqing Li, Jifu Li

4:48 PM - Research Progress of Integrated Chinese and Western Medicine on Myocardial Protection Peri-PCIHongxu Liu


5:00 PM - PCI in Patients with Cerebrovascular DiseaseHui Chen


5:12 PM - Treatment Strategy of AMI Complicating Ventricular Septal PerforationLefeng Wang


5:24 PM - Complete vs. Incomplete Revascularization: Update 2014Fang Chen


5:36 PM - Feasibility and Efficacy of Hybrid Coronary Revascularization in Elderly Patients with Complex LesionsCaiyi Lu


5:48 PM - Defining Predictive Values by Using Three Different Platelet-Function Tests for CYP2C19 Phenotype Status on Maintenance of DAPT After PCIShi'an Huang


6:00 PM - Adjourn

9:00 AM - Interventions for Aortoiliac Occlusive DiseaseW. Britton Eaves

9:15 AM - Case Reviews 1: Complex Interventions in Lower Extremity ArteryYongquan Gu

9:30 AM - Tips and Tricks in Femoropopliteal InterventionAnil Chagarlamudi

9:45 AM - Infrapopliteal Intervention in Critical Limb IschemiaThomas Shimshak

10:00 AM - Case Reviews 2: Complex Interventions in Lower Extremity ArteryMeng Ye


10:30 AM - Break

10:45 AM - Interventional Therapy of Occluded Bypass GraftsRichard C. Kovach

11:00 AM - Case Reviews 3: Complex Interventions in Lower Extremity ArteryMier Jiang

11:15 AM - Treating DVT and Central Vein OcclusionsCarlos Mena

11:30 AM - Ablative Venous Therapy for Venous InsufficiencyEric Dippel

11:45 AM - Case Reviews 4: Complex Interventions for Venous DiseaseHongyan Tian


12:15 PM - Closing Remarks: What's New on the Vascular Horizon?Craig M. Walker

12:30 PM - Break

Room 302A, Level 3


Moderators: Huiliang Liu, Xiaoshu Cheng, Lianqun Cui

7:00 AM - CS-0031: Extremely Tortuous RCA and Diffuse LesionYining Yang

7:10 AM - Q&A

7:15 AM - CS-0162: Ostial LIMA Total OcclusionHui Chen

7:25 AM - Q&A

7:30 AM - CS-0188: IVUS Guided PCI in Ostial LCX Occlusion with Dual Ostia of LAD and LCXYi'an Yao

7:40 AM - Q&A

7:45 AM - CS-0227: Complete Revascularization for TVD with Two Occluded Vessels and the Role of Szabo Technique in PCI for Ostial Occluded LesionPengcheng He

7:55 AM - Q&A

8:00 AM - Break

NCVH at CITLower Extremity Artery and Venous Disease8:30 AM-12:30 PM

Moderator: Craig M. WalkerDiscussants: Anil Chagarlamudi, Eric Dippel, W. Britton Eaves, Yongquan Gu, Richard C. Kovach, Chaozhong Liu, Carlos Mena, Thomas Shimshak

8:30 AM - Opening Remarks / Keynote Address: PAD as a Predictor for CADCraig M. Walker

8:45 AM - New Techniques in Exotic AccessCarlos Mena



080

Luncheon Satellite SymposiumSponsored by RientechDrug-Release Optimized for the Perfect, Cordimax Setting up for the Health12:40 PM-1:55 PM

Chairmen: Junbo Ge, Weiyi Fang, Xueqi Li


12:45 PM - Innovation and Features of CordimaxHongbing Yan

1:00 PM - Clinical Experiences with CordimaxLianqun Cui

1:15 PM - Case Reviews of STEMI and NSTEMILefeng Wang

1:30 PM - Common Complications in PCIJuying Qian


1:55 PM - Break

Peripheral Vascular Therapy2:00 PM-6:00 PM

Session I: Carotid Artery Disease

Moderators: Yan Wang, Yinghua Zou, Buxing Chen, Neil E. Strickman

2:00 PM - Carotid Artery Stenting 2014Neil E. Strickman


2:15 PM - Predictors for Successful Recanalization in Carotid Artery OcclusionPaul Hsien-Li Kao


2:28 PM - Simultaneous Bilateral Carotid Artery Stenting: Early and Long-Term ResultsXiongjing Jiang


2:41 PM - Radial Artery Access for Carotid Artery Interventions: Advantages and PitfallsGianluca Rigatelli


2:54 PM - Complications During Carotid Stenting: Prevention and Management StrategiesYinghua Zou


3:07 PM - Subclavian and Innominate Artery InterventionJacques Busquet


Session II: Renal Artery Disease and Hypertension

Moderators: Xiongjing Jiang, Ruiyan Zhang, Caiyi Lu, Neil E. Strickman

3:20 PM - Renal Denervation: When and How?Carlos Mena


3:35 PM - Renal Denervation Is Already a Reality for Uncontrolled Hypertension?Marco Wainstein


3:48 PM - Preferred Treatment of Renal Artery StenosisNeil E. Strickman


4:01 PM - Renal Artery Stenting in Patients with Cardiac Disturbance SyndromeRuiyan Zhang


4:14 PM - Percutaneous Intervention of Transplanted Renal Artery StenosisRajesh Vijayvergiya


4:27 PM - Management of Acute Hypertension in Cardiac Catheterization LaboratoryJoseph Varon


Session III: Other Endovascular Hot Topics

Moderators: Jianfang Luo, Raghotham R. Patlola, Jun Jin, Won-Heum Shim, Haizal Haron Kamar

4:40 PM - Role of Atherectomy in Peripheral Vascular InterventionsRaghotham R. Patlola


4:55 PM - Beyond Eluting Balloons: Novel Drug Delivery Devices for Peripheral VesselsRichard C. Kovach


5:08 PM - Endovascular Repair of Abdominal Aortic AneurysmEak-Kyun Shin


5:21 PM - Endovascular Stent Graft for Mycotic AneurysmsAravinda Nanjundappa


5:34 PM - Overview of Venous Disease: State of the ArtRaghotham R. Patlola


5:47 PM - Role of Inferior Vena Cava Filter in Treatment of Complex VTE PatientsHongyan Tian


6:00 PM - Adjourn



081

8:54 AM - Are There Real Differences between Bioabsorbable Polymer DES and Durable Polymer DES?Alan C. Yeung

9:06 AM - Current Perspectives on DES Outcomes: Why We Need to Continue Development of Next Generation DES Systems?Mitchell W. Kruco�

9:18 AM - Newer Bioabsorbable Polymer and Polymer-Free DESAlexandra J. Lansky

9:30 AM - Panel DiscussionDiscussants: Mitchell W. Kruco�, Alexandra J. Lansky, Ron Waksman, Alan C. Yeung

9:42 AM - Update on Chinese Bioabsorbable Polymer DES in 2014Juying Qian

9:54 AM - Update on Chinese Polymer-Free DES in 2014Xuchen Zhou

10:06 AM - Case Presentation 6: Use of a Bioabsorbable Polymer DES in Patient at High-Risk for BleedingYi Li

10:13 AM - Case Presentation 7: Use of a Polymer-Free DES with Early Discontinuation of DAPTLing Tao

10:20 AM - Panel DiscussionDiscussants: Yi Li, Juying Qian, Ling Tao, Xuchen Zhou

10:30 AM - Industrial Perspective on Novel Bioabsorbable Polymer DES TechnologyKeith D. Dawkins

10:42 AM - Industrial Perspective on Novel Polymer-Free DES TechnologySean Salmon

10:54 AM - Panel DiscussionDiscussants: Keith D. Dawkins, Sean Salmon

Featured DES/DCB Clinical Trials11:00 AM-12:30 PM

Moderators: Roxana Mehran, Bo XuDiscussants: Philippe Généreux, Liliana R. Grinfeld, Yang-Soo Jang, Stephen Wai-Luen Lee, Marie-Angèle Morel, Bruno Scheller

11:00 AM - FREEDOM: A Prospective, Randomized Trial of YINYI Polymer-Free Paclitaxel-Eluting Stent vs. Durable Polymer Sirolimus-Eluting Stent in the Treatment of Coronary Artery DiseaseJianping Li


11:18 AM - French GARO Registry: A Prospective, Observational Study of Paclitaxel-Coated Balloon Angioplasty in an Unselected Patient Population with Drug-Eluting Stent In-Stent RestenosisMarc Bedossa


11:36 AM - SEEDS: A Prospective, Observational Study to Evaluate the Safety and Effectiveness of Everolimus-Eluting Stent in Chinese Patients with Complex Coronary Lesions - 2-Year ResultsYelin Zhao


11:54 AM - BuMA-OCT: A Randomized Trial of OCT Assessment of a PLGA-Polymer with Electro-Grafting Base Layer vs. a PLA-Polymer Sirolimus-Eluting Stent at 3 Months Follow-UpYaojun Zhang


12:12 PM - CREDIT I: A First-in-Human Study of the Second Generation EXCEL Biodegradable Polymer Sirolimus-Eluting Stent - 4-Month Clinical, Angiographic, and OCT ResultsGeng Wang


12:30 PM - Break

Room 302B, Level 3


Moderators: Lang Li, Weijie Li, Quanming Zhao

7:00 AM - CS-0376: Ischemic Cardiomyopathy with MVD Treated with Multiple StentsQiong Wang

7:10 AM - Q&A

7:15 AM - CS-0379: "Stent-Jailed-Wire" Technique in Stent Unpassable LesionLi Sheng

7:25 AM - Q&A

7:30 AM - IM-0100: Reasonable Strategy for Complex LesionXinqun Hu

7:40 AM - Q&A

7:45 AM - CS-0305: Successful Rotational Atherectomy in Calcified and Tortuous LesionWeiming Li

7:55 AM - Q&A

8:00 AM - Break

Drug-Eluting Stents: Bioabsorbable Polymer and Polymer-Free8:30 AM-11:00 AM

Moderators: Adnan Kastrati, Wenyi Guo, Ping-Tim Tsui, Benit Edouard

8:30 AM - Strut Architecture and Polymer Configuration Modulate Device Outcomes: Current Nonabsorbable DES Systems Will Be Difficult to Improve Upon!Ron Waksman

8:42 AM - Vascular Healing and the Evolution of DES Technologies: Experimental Insights Translated into Human Clinical TrialsJuan F. Granada



082

Luncheon Satellite SymposiumSponsored by Siemens HealthcareHybrid Approach on Cardiothoracic Surgery12:40 PM-1:55 PM

Chairmen: Georg Nollert, Mao Chen, Zhinong Wang


12:45 PM - Hybrid Approach on Cardiothoracic SurgeryGeorg Nollert

1:05 PM - The Key to Successful Hybrid Room PlanningJia Mao

1:25 PM - Low Dose Solution of International Cardiology from SiemensZhiguo Zhang


1:55 PM - Break

Drug-Coated Balloons (DCB): Clinical Data and Applications2:00 PM-6:00 PM

Moderators: Bruno Scheller, Juan F. Granada

Session I

Discussants: Tae-Hoon Ahn, Jacques Berland, Fang Chen, Kenneth Chin, Pieter R. Stella

DCB Basic Concepts

2:00 PM - The DCB Technology Landscape: Ongoing Challenges and Future OpportunitiesJuan F. Granada

2:12 PM - Vessel Healing Following Paclitaxel Delivery via Balloon Coating: Biological Implications for Device DevelopmentRenu Virmani


DCB in Coronary De Novo Lesions

2:30 PM - Case Presentation: DCB in De Novo Coronary Lesions - Stent or Not to Stent?Wan Azman Wan Ahmad

2:40 PM - Clinical Trial Update: DCB plus Adjunctive Bare Metal Stenting in De Novo LesionsBruno Scheller

Other Coronary Indications

2:52 PM - Bifurcations and Small VesselsNigel Jepson

3:04 PM - Diabetic PatientsAlfredo E. Rodriguez

3:16 PM - Acute Coronary Syndromes Including STEMIPieter R. Stella


Session IIDCB in Coronary In-Stent Restenosis

Discussants: Fernando Alfonso, Jacques Berland, Bing Fan, Jun Jiang, Adnan Kastrati, Yelin Zhao

3:36 PM - Featured Lecture: Critical Review of Data for Coronary ISR ApplicationAdnan Kastrati

3:48 PM - Update of PEPCAD China ISR TrialYelin Zhao

4:00 PM - Other ISR DCB Trials Update: ISAR-DESIRE 3, RIBS IV and BeyondFernando Alfonso

4:12 PM - Case presentation: DCB in ISR in Multiple Clinical SettingsJun Jiang


Session IIIDCB in Peripheral Interventions

Discussants: Eric Dippel, Wei Guo, Xiongjing Jiang, Carlos Mena, Meng Ye

4:30 PM - Case Presentation: Technical Tips and Pitfalls of SFA Intervention Using DCBMeng Ye

4:40 PM - DCB and SFA Intervention: Update of Ongoing Clinical ProgramsJuan F. Granada

4:52 PM - China SFA Trial Design and Clinical UpdateWei Guo

5:04 PM - Atherectomy and DCB: Device Selection, Technical Pitfalls, and Available DataEric Dippel

5:16 PM - DES versus DCB for SFA InterventionBruno Scheller

5:28 PM - Case Presentation: Technical Approaches to BTK Intervention - Implications for DCB DevelopmentXiongjing Jiang

5:38 PM - Featured Lecture: A Synthesis of the Available DCB Clinical Data in BTK InterventionCarlos Mena


6:00 PM - Adjourn



083

Luncheon Satellite SymposiumSponsored by Sanofi12:40 PM-1:55 PM

Chairmen: Weifeng Shen, Shuyang Zhang


12:45 PM - Evidence-Based Road of ClopidogrelJuying Qian

1:15 PM - Choice of Antiplatelet Medications in PCI PatientsZhimin Du


1:55 PM - Break

Training Course on Transcatheter Valve TherapiesSponsored by China TVI LeagueSupported by GE Healthcare2:00 PM-6:00 PM

Session I: Preparation, Coordination, and Implementation of New Technology

Moderators: Yuejin Yang, Wei Wang, Ruiyan Zhang

2:00 PM - Inspiration of the First Domestic ValveYuejin Yang

2:10 PM - Q&A

2:13 PM - CT of the Aortic Toot: From Technology to AnalysisBin Lu

2:23 PM - Q&A

2:26 PM - Considerations of TAVR AnesthesiaLei Zhang

2:36 PM - Q&A

2:39 PM - Experience and International Multicenter Data of Bicuspid Aortic ValveMao Chen

2:49 PM - Q&A

2:52 PM - Progress of Transcatheter Pulmonary Valve ReplacementDaxin Zhou

3:02 PM - Q&A

3:05 PM - Transcatheter Mitral Valve Repair with MitraClip System: A Single Center ExperienceXianbao Liu

3:15 PM - Q&A

Session II: TAVR Case Reviews

Moderators: Xiangqing Kong, Daxin Zhou, Bin Lu

Most Successful TAVR Case…

3:20 PM - From Fu Wai HospitalYongjian Wu

3:30 PM - Q&A

3:33 PM - From West China HospitalMao Chen

3:43 PM - Q&A

Failed TAVR Case…

3:46 PM - Confusion, Failure……DeathHanjun Pei

3:56 PM - Q&A

3:59 PM - Valve Dislocation……FailureHaitao Zhang

4:09 PM - Q&A

Session III: TAVR Access Selections and Management of Postprocedural Complications

Moderators: Yongjian Wu, Mao Chen

4:15 PM - TAVR via Left Subclavian Artery ApproachYuan Feng

4:25 PM - Q&A

4:28 PM - Experience of Transaortic Approach in 5 CasesWei Wang

4:38 PM - Q&A

4:41 PM - From Femoral Artery to Ascending AortaRuiyan Zhang

4:51 PM - Q&A

Room 307, Level 3

Endovascular Forum on Aortic Aneurysm RepairChallenging Case Reviews and DiscussionsSupported by MicroPort Endovascular8:30 AM-11:30 AM

Moderators: Wei Guo, Chang Shu, Lianjun Huang, Xiwei Zhang, Weiguo Fu, Xi Su

8:30 AM - Case Reviews from Chinese PLA General HospitalWei Guo

8:55 AM - Q&A

9:00 AM - Case Reviews from the 2nd Xiangya Hospital of Central South UniversityChang Shu

9:25 AM - Q&A

9:30 AM - Case Reviews from Affiliated An Zhen Hospital of Capital Medical UniversityLianjun Huang

9:55 AM - Q&A

10:00 AM - Case Reviews from Jiangsu Provincial HospitalXiwei Zhang

10:25 AM - Q&A

10:30 AM - Case Reviews from Zhongshan Hospital Fudan UniversityWeiguo Fu

10:55 AM - Q&A

11:00 AM - Case Reviews from Wuhan Asia Heart HospitalXi Su

11:25 AM - Q&A

11:30 AM - Break



084

4:54 PM - A Case of Postprocedural ComplicationYanhui Sheng

5:04 PM - Q&A

Session IV: Workstation Training

5:10 PM - Discovery IGS 730 Valve Disease Total SolutionGuozhong Li

5:55 PM - Closing RemarksRun-Lin Gao

6:00 PM - Adjourn

11:40 AM - Status Update of Bioresorbable Vascular ScaffoldsZhongwei Sun

12:00 PM - Lunch Break

Session III: Lunch Technological Seminar

Moderators: Fei Li, Yuzheng Yang, Huizhu Li, Shurong Li

12:15 PM - Clinical Application of IVUS ExaminationJing Kan

12:30 PM - Intraprocedural Nursing Cooperation of Rotational AtherectomyJun Liu

12:45 PM - Significance of FFR and Intraprocedural Nursing CooperationLimin Jing

1:00 PM - Utility of IABPYuehong Qiu


Session IV: Cath Lab Management

Moderators: Xiaofang Gu, Xiaoyan Wang, Zirong Qi, Sumei Tong, Jihua Qiu

1:30 PM - Consumable Material ManagementYunlan Lu

1:50 PM - Comparison of Different Hand Sterilization Materials in the Cath LabKun Zhang

2:10 PM - Key Issues of Quality Control in the Cath LabSuyu Yao

2:30 PM - Verification of Transfer and Delivery for Patients Undergoing Catheterization ProceduresYing Wang

2:50 PM - Influence of Pre-Intervention VisitLin Wang

3:10 PM - Break

Room 3M5, Mezzanine, Level 3

The 9th Annual Symposium for Nurse and Technologist8:30 AM-6:00 PM

8:30 AM - Opening Remarks: History of Annual Symposia for Nurse and Technologist at CITBo Xu

Session I: Featured Lectures

Moderators: Yunxia Hao, Jingxuan Guo, Xuehui Hu, Hongmei Zhang, Wen Wang

8:45 AM - How to Perfectly Support Interventional Therapy?Changzhao Liao

9:05 AM - Objectives and Plans of Interventional Nursing GroupSu Zhang

9:25 AM - Communication and Nursing SafetyYunxia Hao

9:45 AM - Sustainable Development of Cardiovascular Interventional NursingGuihua Hou

10:05 AM - Skills and Methods of Topic Selections for SCI Nursing PaperHai'ou Zou

10:25 AM - Break

Session II: Novel Interventional Technologies

Moderators: Jie Li, Xia Zhao, Yan Feng, Hong Liu

10:40 AM - Transcatheter Left Ventricular Partitioning with the PARACHUTE DeviceYan Liu

11:00 AM - Transcatheter Left Atrial Appendage ClosureJing Liu

11:20 AM - Transcatheter Aortic Valve ReplacementMingxia Zheng



085

Session V: Experience Sharing and Abstract Oral Presentation

Moderators: Rong Li, Tao Liang, Yanjun Mao, Li Li, Qi Feng, Zhentao Shi

3:30 PM - Discussion on Exposure Dose of Examinee and Operator in Coronary AngiographySang Man Park

3:45 PM - Understanding Left Atrial Appendage Occluder DevicesMin Young Cho

4:00 PM - AS-0004: Groin Dressing Post Cardiac Catheterization: Traditional Pressure vs. Transparent FilmAl-shualah Rokaia

4:15 PM - AS-0092: Nursing Experience of ECMO Support After Coronary Artery Bypass GraftRuijin Pan

4:30 PM - AS-0168: Intensive Nursing Care by an Electronic Follow-Up System to Promote Secondary Prevention After Percutaneous Coronary Intervention: A Randomized TrialXin Hu

4:45 PM - AS-0540: Influence of Remote Home-Monitoring System on the Treatment for Patients with Pacemaker or Cardioverter DefibrillatorZhaoguang Liang

5:00 PM - AS-0114: Comparison of Different Ventilation Modes in Treatment of Hypoxemia after Infant Heart OperationJie Huang

5:15 PM - Audience Q&A

5:40 PM - Take-Home MessageGuihua Hou, Yan Liu

6:00 PM - Adjourn



086


10:06 AM - Left Main Dissection During LAD CTO PCI with Antegrade TechniqueXiantao Song


10:22 AM - Retrieval of Lost Coronary Stent with Loop Snare During Interventional ProcedureShangyu Wen


10:38 AM - Focus on Details: One Complication Case of Stent LossBin Nie


10:54 AM - Severe Complication Caused by Guiding: Is the Guiding to Blame?Haitao Zhang


Session III

Moderators: Weifeng Shen, Shaoliang Chen, Juying Qian, Ning Tan, Zheng Zhang, Jianjun Peng

11:10 AM - Stent and Balloon Related Coronary ComplicationMing Bai


11:26 AM - Complication During PCI with Severe Circumflex Calcification LesionJunjie Zhang


11:42 AM - A Case of Burr Entrapment During Rotational AtherectomyFeng Zhang


11:58 AM - Details Easy to Be Ignored During Rotational ProcedurePengcheng He


12:14 PM - Acute Occlusion Due to a Trapped Burr During Rotational Atherectomy for Severe In-Stent RestenosisShaoping Nie


Closing of CIT 2014 in Partnership with TCT12:30 PM-12:45 PM

Moderator: Bo XuDiscussants: Jiyan Chen, Shaoliang Chen, Run-Lin Gao, Junbo Ge, Yaling Han, Guoliang Jia, Shiliang Jiang, Shuzheng Lu, Changsheng Ma, Shubin Qiao, Weifeng Shen, Haichang Wang, Weimin Wang, Yuejin Yang

12:30 PM - Glancing Back at the Moments of CIT 2014

12:45 PM - Announcement of CIT 2015 and Closing

Room 201, Level 2

The 6th PCI Complications Forum8:30 AM-12:30 PM

Session I

Moderators: Yean-Leng Lim, Fang Chen, Guosheng Fu, Xuebo Liu, Feng Xu

8:30 AM - Treatment Strategies for Coronary Perforation: Case ReviewsGuosheng Fu


8:46 AM - Treatment of Coronary Perforation During PCI ProcedureRongchong Huang


9:02 AM - A Case Report of Subacute Stent ThrombosisYukun Luo


9:18 AM - Management of Perforation During PCI for a Large Right Coronary ArteryFenghua Ding


9:34 AM - A Case Report of Refractory Stent Thrombosis After Cross-over Stenting for Treatment of Left Main DiseaseYan Lai


Session II

Moderators: Shuzheng Lu, Weimin Wang, Yujie Zhou, Genshan Ma, Huigen Jin, Jiyuan Lu

9:50 AM - Emergency Situations and Treatment Strategies in Cath LabHaichang Wang



087


10:00 AM - What About Anticoagulation Strategy for Patients with DES Implanted: Warfarin or Pradaxa?Yuyang Liu


10:15 AM - The New Viewpoint of Strategy for ACS Patients: Pay No More Attention to LDL-C?Rongchong Huang


Best of GAP-CCBCHow to Follow and Adjust the Guidelines10:30 AM-12:30 PM

Moderators: Yuejin Yang, Chung-Seung Chiang, Changlin Lu, Yida Tang, U Po Lam, Shaowei Zhuang

10:30 AM - Should We Revascularize Ischemic Cardiomyopathy Patients: Which and How?Yuejin Yang


10:50 AM - Should We Strengthen Post-PCI Anticoagulation for AF Patients?Li Li


11:10 AM - Should We Treat Non-Infarct-Related Lesions / Arteries During Emergent PCI for STEMI Patients?Hongbing Yan


11:30 AM - Should We Routinely Use the Platelet Function and Gene Testing in PCI Patients?Jinqing Yuan


11:50 AM - How to Establish and Manage Regional Collaborative Treatment System for Chest Pain?Yan Wang


Room 202, Level 2

Best of CCC/CISC8:30 AM-10:30 AM

Session I: Practices and Experiences

Moderators: Shuzheng Lu, Weimin Li, Shaoliang Chen, Yujie Zhou

8:30 AM - The Number of Stents During PCI Procedure: Upper Limits or Not?Yue Li


8:45 AM - The Instant Different Outcomes for Rewiring through Proximal or Distal Cell During Two-Stent TechniquesJunjie Zhang


9:00 AM - Revascularization for Bypass Surgery Patients: PCI or Re-CABG? Why and How?Bin Zhang


9:15 AM - How to Deal with Culprit Lesion with Stenosis Less Than 50% After Thrombi Aspiration During Primary PCI for Acute STEMI?Chengzhi Lu


Session II: Strategies and Trends

Moderators: Yaling Han, Yuejin Yang, Jiyan Chen, Lan Huang

9:30 AM - Revascularization for Functional Ischemia Lesion or Vessel Only: The Future of PCI and CABGYongjian Wu


9:45 AM - Strategies for ACS Patients Combined with Hemorrhagic DisordersJianping Li

12:10 PM - How to Prevent and Manage Contrast-Induced Nephrology?Ben He


12:30 PM - Adjourn



088

Session II: Retrograde Approach

Moderators: Jiyan Chen, Chengxiang Li, Xueqi Li, Chaowei Mu

10:35 AM - Introduction and Objectives

10:40 AM - Retrograde Channel SelectionQi Zhang

10:55 AM - How to Wire the Retrograde Channel?Quanmin Jing

11:10 AM - Microcatheter in Retrograde CTO AngioplastyYue Li

11:25 AM - Retrograde Wire Crossing and Kissing Wire TechniqueXueqi Li

11:40 AM - CART, Reverse CART, and Knuckle Wire TechniquesChengxiang Li

11:55 AM - Tips and Tricks of Roundezvous and Wire ExternalizationJiyan Chen

12:10 PM - How to Prevent and Manage Complications of Retrograde Approach?Lei Ge


12:30 PM - Adjourn

Room 203, Level 2

Practical Course on PCI Part IVA Beginner's Tutorial on Chronic Total Occlusion8:30 AM-12:30 PM

Session I: Antegrade Approach

Moderators: Guoliang Jia, Dadong Zhang, Jun Dai, Keng Wu

8:30 AM - Introduction and Objectives

8:35 AM - Evolution of Guidewire Selections in CTO AngioplastyJunbo Ge

8:50 AM - Tips and Tricks of CTO Angioplasty by Transradial ApproachJie Qian

9:05 AM - Crucial Role of Contralateral Injection in CTO AngioplastyJingang Zheng

9:20 AM - Current Wiring Techniques in Antegrade ApproachAnlin Lu

9:35 AM - Intima, Subintima, and Wire ReentryJian'an Wang

9:50 AM - Role of IVUS in CTO PCILiang Xu

10:05 AM - How to Manage When Balloon Failed to Cross CTO?Shouli Wang

10:20 AM - Take-Home Message

10:25 AM - Break

Room 204, Level 2

Breakfast Case Reviews 18Chronic Total Occlusions7:00 AM-8:15 AM

Moderators: Zhizhong Li, Shusen Yang, Binquan Zhou

7:00 AM - CS-0027: CTO - Twists and TurnsYongsheng Ke

7:10 AM - Q&A

7:15 AM - CS-0058: Retrograde Approach to CTORisto Jussila

7:25 AM - Q&A

7:30 AM - CS-0013: CTO Lesion Combined with LV FistulaTongku Liu

7:40 AM - Q&A

7:45 AM - CS-0097: Recanalization of RCA CTO in Post-CABG Patient with Severe Renal InsufficiencyBinquan Zhou

7:55 AM - Q&A

8:00 AM - CS-0112: Recanalization of Ostial CTO by Transradial Retrograde ApproachRong Tang

8:10 AM - Q&A

8:15 AM - Break



089

Room 205, Level 2


Moderators: Zesheng Xu, Zhujun Shen, Shaoping Nie

7:00 AM - CS-0120: Complex CTO PCIZesheng Xu

7:10 AM - Q&A

7:15 AM - CS-0125: Side Branch Dilation and Reverse Guide Wire Shaping Techniques to Treat CTOXuebo Liu

7:25 AM - Q&A

7:30 AM - CS-0150: Lowered BP in Combination with Increased HR During PCI for CTOJingtao Xu

7:40 AM - Q&A

7:45 AM - CS-0173: IVUS-Guided Retrograde Recanalization of LAD Stumpless CTO with Rescue Stenting into Diagonal Branch Across the Struts of LAD Subintimal StentTao Yin

7:55 AM - Q&A

8:00 AM - CS-0220: Retrograde PCI for an Angled CTO through Highly Tortuous CollateralChunjian Li

8:10 AM - Q&A

8:15 AM - Break

Case Presentation II (15 minutes each including Q&A)

Moderators: Akiko Maehara, Jian LiuDiscussants: Jun Guo, Simon Cheung-Chi Lam, Qinhua Jin, Yingjia Xu, Zhijing Zhao

10:30 AM - IM-0083: IVUS Guided Treatment of RCA Abrupt ClosureQuanmin Jing

10:45 AM - IM-0084: Chronic Thrombus in RCAHonghua Ye

11:00 AM - IM-0070: AMI Caused by Thrombus in the Aneurysm Artery?Jiming Li

11:15 AM - IM-0102: DK Crush in Left MainFeng Zhang

11:30 AM - IM-0107: Two Cases of PCI by FFR GuidanceKai Cui

11:45 AM - IM-0106: Double-Culotte Technique by FFR GuidanceFuyuan Liu

12:00 PM - IM-0113: Strategy of Multivessel PCI: Integrated Use of IVUS and FFRJian Liu

12:15 PM - IM-0116: FFR Guided PCI in Tandem LesionDongfang He

12:30 PM - Adjourn

Integrating FFR, IVUS, OCT, and More to Improve Patient Outcomes Part V8:30 AM-12:30 PM

Session VIII: Case Submissions - FFR, IVUS, RF (VH) IVUS, OCT, and NIRS

Case Presentation I (15 minutes each including Q&A)

Moderators: Gary S. Mintz, Ning GuoDiscussants: Kelvin Chan, Yong He, Jun Pu, Xiaofan Wu, Kai Xu

8:30 AM - IM-0007: A Case Report of Acute Myocardial Infarction in Young WomenJing Bai

8:45 AM - IM-0013: Spontaneous Recanalization After Myocardial Infarction - Features with IVUS and OCTXiankai Li

9:00 AM - IM-0031: Catheter-Induced Coronary DissectionQi Zhang

9:15 AM - IM-0034: IVUS Guided Entry-Point Penetration for Non-Stump Total OcclusionJancheng Xiu

9:30 AM - IM-0045: A Case of Subintimal Stenting with One Year Angiographic Follow-UpLihua Xie

9:45 AM - IM-0047: Attenuated Plaque, Plaque Rupture, and No-ReflowJun Pu

10:00 AM - IM-0053: A Special Coronary Lesion - OCT FindingsXiaozeng Wang

10:15 AM - IM-0074: Nightmare of Cath Lab - A Case of Dissection and Intramural Hematoma After StentingHong Qiu



090

Left Main and Bifurcations Part IVChina Experiences of PCI in Left Main and Bifurcations8:30 AM-12:30 PM

Session I: Impact of Bifurcation PCI Strategies on Clinical Outcomes

Moderators: Kefei Dou, Chengheng Hu, Chun Liang

8:30 AM - Long-Term Outcomes of Using Different Two-Stent Techniques for the Treatment of BifurcationsTongku Liu

8:45 AM - One-Stent or Two-Stent? New Evidence RevisitedYongming Hui

9:00 AM - Impact of Bifurcation Anatomy, Angle and Plaque Characteristics on the Treatment Strategy and ResultsGenshan Ma

9:15 AM - Different Types of Stents for the Treatment of Main Vessel and Side BranchJinghua Liu

9:30 AM - Bifurcation Classifications and Approach SelectionsMengyue Yu


Session II: Impact of Bifurcation PCI Techniques on Clinical Outcomes

Moderators: Likun Ma, Fenghuan Hu, Yangchun Zou

9:50 AM - Tough Bifurcation PCI: How Did I Solve the Problem?Shusen Yang

10:05 AM - Side Branch Protection in Bifurcation PCIYongsheng Ke

10:20 AM - Application of the Modified Culotte TechniqueShaoxiang Weng

10:35 AM - Treatment of Bifurcation by Using Mini-Culotte Technique with Prepositioned Balloon in Main VesselZhiming Yang

10:50 AM - Strategy and Experience of PCI in Coronary Ostial LesionXiaozeng Wang


Session III: Revascularization Strategy and Experience in Left Main Disease

Moderators: Tiemin Jiang, Yan Li, Jun Jin

11:10 AM - Implication and Application of SYNTAX Score in Left Main RevascularizationFang Chen

11:25 AM - Interventional Strategy and Experience of Ostial Left Main LesionFei Ye

11:40 AM - Interventional Strategy and Experience of Left Main BifurcationLianglong Chen

11:55 AM - Interventional Strategy and Experience of Calcified Left Main LesionJun Jiang

12:10 PM - Revascularization Strategy and Experience for Left Main Disease with RCA Total OcclusionYan Li


12:30 PM - Adjourn

Room 206, Level 2


Moderators: Yawei Xu, Xiangqian Qi, Leisheng Ru

7:00 AM - CS-0246: Retrograde Recanalization of Total Occlusion Caused by Dissection During Primary PCIHaiwei Liu

7:10 AM - Q&A

7:15 AM - CS-0282: Utility of Crusade Catheter in Antegrade Approach to CTOLeisheng Ru

7:25 AM - Q&A

7:30 AM - CS-0295: Complete Revascularization of Triple CTO in One PatientYi sik Kim

7:40 AM - Q&A

7:45 AM - CS-0306: PCI for Mid LAD CTO with Marker Wire Technique - Gain and LossPengcheng He

7:55 AM - Q&A

8:00 AM - CS-0319: Retrograde Approach with Reverse CART Technique and Application of IVUS in CTO PCIHong Wang

8:10 AM - Q&A

8:15 AM - Break



091

Part II: Percutaneous Coronary Intervention in Diabetics

Moderators: Haichang Wang, Jianhua Zhu, Xiaodong Li, Xi Su, Yong Xia, Bin Zhang

10:15 AM - PCI or CABG for Diabetic Patients: State of the ArtSpencer B. King III

10:35 AM - PCI Strategy in Diabetics with Multivessel DiseaseHaichang Wang

10:55 AM - Technical Tips and Tricks of PCI in DiabeticsYongjian Wu

11:10 AM - Case Presentation: Bifurcation PCI in a Diabetic PatientZheng Wang


11:30 AM - Case Presentation: CTO PCI in a Diabetic PatientYi Mao


11:50 AM - Case Presentation: NSTEMI-ACS PCI in a Diabetic PatientXiaojun Bai


12:10 PM - Take-Home MessageJianhua Zhu

12:15 PM - Adjourn

Comprehensive Management of Cardiovascular Disease in DiabeticsSupported by Medtronic8:30 AM-12:15 PM

Part I: Cross-Disciplinary Collaboration to Manage Diabetes

Moderators: Guang Ning, Weifeng Shen, Ruiyan Zhang, Chengzhi Lu, Xian Wang

8:30 AM - Opening: It's Time for Cross-Disciplinary Collaboration to Manage DiabetesWeifeng Shen

8:35 AM - Blood Glucose Management in Cardiovascular Patients with Different Risk StratificationsGuang Ning

8:55 AM - New Advances in the Treatment of Peripheral Vascular Disease Complicated with DiabetesCraig M. Walker

9:15 AM - Enhanced PCI for Diabetics with Coronary Angiogram: Facts and FantasyJian Liu

9:30 AM - Management of Vascular Complications in DiabeticsLin Lu

9:45 AM - PCI and Postoperative Management in Type II Diabetic PatientJian An


Room 207, Level 2


Moderators: Xueqi Li, Zhujun Chen, Jun Dai

7:00 AM - CS-0360: Recanalization of RCA CTOWeiting Wang

7:10 AM - Q&A

7:15 AM - CS-0361: Antegrade Approach to CTOZhujun Chen

7:25 AM - Q&A

7:30 AM - CS-0374: CTA Guided Long CTO Recannalization by Retrograde ApproachQiong Wang

7:40 AM - Q&A

7:45 AM - CS-0380: Novel Method for Balloon Non-Passable OcclusionJingyi Xue

7:55 AM - Q&A

8:00 AM - IM-0080: IVUS Guided Treatment of Chronic Total OcclusionKai Xu

8:10 AM - Q&A

8:15 AM - Break

Non-Invasive Cardiovascular Imaging8:30 AM-12:30 PM

Session I

Moderators: Yun Zhang, Anthony DeMaria, Shih-Pu Wang, Bin Lu

8:30 AM - Can CT Angiography Detect the "Vulnerable Plaque"?Stephan Achenbach




092

8:50 AM - Current Status of Coronary CTA for the Evaluation of CAD and Prediction of EventsJohn McB. Hodgson


9:10 AM - Role of MSCT as a Primary Screen Method in Acute Coronary SyndromeShih-Pu Wang


9:30 AM - Evaluation of Coronary Stent Fracture and Compression by Coronary CTYoung-Hak Kim


9:50 AM - Automated Assessment and Validation of Coronary Plaque Burden and Composition from MSCTJohan H. C. Reiber


10:10 AM - Cardiac Imaging: The Right Test for the Right IndicationAnthony DeMaria


Session II

Moderators: Shiliang Jiang, Weiyi Fang, Lan Huang, Shihua Zhao

10:30 AM - Risk Stratification for Coronary Artery Disease Before PCIZuoxiang He


10:50 AM - Clinical Implication and Update of FFR-CT: Radiologist's PerspectiveBin Lu


11:10 AM - Clinical Implication and Update of FFR-CT: Cardiologist's PerspectiveYawei Xu


Room 208, Level 2

Breakfast Case Reviews 22Special Cases7:00 AM-8:15 AM

Moderators: Ning Tan, Weijian Huang, Qiutang Zeng

7:00 AM - IM-0076: Retrograde Recanalization of In-Stent CTO in Ostial RCABo Luan

7:10 AM - Q&A

7:15 AM - CS-0004: Anomalous LAD Originates from Proximal RCAXuguang Qin

7:25 AM - Q&A

7:30 AM - CS-0006: IVUS and FFR Guidance of Treatment for Calcified LesionYuxin Zhao

7:40 AM - Q&A

7:45 AM - CS-0025: Severe Coronary Lesions Caused by Kawasaki Disease in AdultYouquan Wei

7:55 AM - Q&A

8:00 AM - CS-0037: Cardiogenic Shock in Acute STEMI Induced by Severe Multivessel SpasmPanpan Hao

8:10 AM - Q&A

8:15 AM - Break

11:30 AM - Stress Echocardiography for Patients with Severe Aortic Stenosis Combining with Left Ventricular DysfunctionHao Wang


11:50 AM - A TAVI-Based Diagnostic Imaging MethodologyShihua Zhao


12:10 PM - Detection and Invasive Passivation of Future Culprit PlaquesJinfa Jiang


12:30 PM - Adjourn



093

Heart Rhythm Part VAbstract Oral Presentations and Case Reviews8:30 AM-12:30 PM

Session I: Abstract Oral Presentations

Moderators: Jiefu Yang, Shulin Wu, Yutang Wang, Fang Wang

8:30 AM - AS-0036: Nonresponse and Mortality in Patients Receiving Cardiac Resynchronization Therapy in ChinaDongmei Wang


8:45 AM - AS-0254: Electrophysiological Characteristic and Ablation of Epicardial Idiopathic Ventricular Arrhythmias Arising Around Left Fibrous TriangleGuitang Yang


9:00 AM - AS-0452: Refined Algorithm for Ablating Orthodromic Reciprocating Tachycardia Using Left Accessory Pathways Guided by Reversal BipoleZheng Liu


9:15 AM - AS-0703: Bayesian Models Based on Heart-Rate Dynamics for Prediction of Sudden Cardiac Death After Acute Myocardial InfarctionTao Song


9:30 AM - AS-0711: Electrophysiological Characteristics and Radiofrequency Catheter Ablation of Supraventricular Tachycardia in Patients with Congenitally Corrected Transposition of Great ArteriesXiaogang Guo


9:45 AM - AS-0751: Long-term Effects of Cardiac Resynchronization Therapy in Patients with Chronic Heart Failure - A Single Center 10 Years ExperienceYu Zhang


12:00 PM - CS-0288: LV Lead Implantation Using PTCA Technique in CRT-D ProcedureWenzheng Li


12:15 PM - CS-0307: Brugada SyndromePengfei Wang


12:30 PM - Adjourn

Session II: Case Reviews

Moderators: Kejiang Cao, Zulu Wang, Yigang Li, Pihua Fang, Meixiang Xiang

10:00 AM - CS-0017: A Case of VT Due to VSAXiaoliang Luo


10:15 AM - CS-0038: Pulmonary Vein Stenosis and Occlusion After Radiofrequency Catheter Ablation for Atrial FibrillationJinchuan Yan


10:30 AM - CS-0040: Loss of Cardiac Resynchronization During DDD PacingYun Tian


10:45 AM - CS-0092: A Case of Implanting ICD by Hybrid OperationZhaoguang Liang


11:00 AM - CS-0093: A Case of Late Perforation of Right Ventricular Caused by ElectrodeZhaoguang Liang


11:15 AM - CS-0163: A Case of Cardiac Resynchronization Therapy for Left Ventricular Non-Compaction - 15-Month Follow-Up by Quantitative Tissue Velocity ImagingJialiang Mao


11:30 AM - CS-0207: Widespread ST-Segment Elevation Following Direct Current Cardioversion Mimicking Acute Myocardial InfarctionPeiren Shan


11:45 AM - CS-0258: Heart Failure with Long QT Syndrome - A Case ReportTianjie Feng




094

Room 305A, Level 3


Moderators: Caiyi Lu, Xiangjun Yang, Yang Zheng

7:00 AM - CS-0064: AMI Caused by Chronic Two-Vessel Spontaneous DissectionXingwei He

7:10 AM - Q&A

7:15 AM - CS-0079: Percutaneous Treatment of Multiple Coronary-Pulmonary Artery FistulasLiming Gao

7:25 AM - Q&A

7:30 AM - CS-0109: Coronary Artery Ectasia of Kawasaki Disease in AdultQiang Zhu

7:40 AM - Q&A

7:45 AM - CS-0158: Autoexpandable Coronary Stents for Aneurismatic Coronary Artery DiseaseRenata Rogacka

7:55 AM - Q&A

8:00 AM - CS-0189: Recurrent Syncope Due to Anomalous RCA and Two Years Follow-UpYi'an Yao

8:10 AM - Q&A

8:15 AM - Break

Case Reviews (Call-for-Cases) Part IAcute Coronary Syndromes8:30 AM-12:30 PM

Session I

Moderators: Zhizhong Li, Xiaohua Guo, Jun Zhang, Lu Li, Yuanzhe Jin, Jianbin Gong, Ronghai Man

10:40 AM - Q&A

10:45 AM - CS-0197: The Ideal and RealityYuhua Zhao

10:55 AM - Q&A

Session III

Moderators: Xuewen Qin, Chengjun Guo, Yingxin Zhao, Yingyan Ma, Yongping Jia, Chun Wu, Jingyuan Mao

11:00 AM - CS-0116: How Should I Treat Large Thrombus Burden in the Dominant RCA?Shoujie Shan

11:10 AM - Q&A

11:15 AM - CS-0113: PCI for Anterior AMI: Full of Twists and TurnsLiming Gao

11:25 AM - Q&A

11:30 AM - CS-0103: Successful Rescue of Patient with Acute Left Main ClosureJunsong Liu

11:40 AM - Q&A

11:45 AM - CS-0032: Cardiac Arrest After Primary PCI for Anterior Myocardial InfarctionZhaoqing Sun

11:55 AM - Q&A

12:00 PM - CS-0060: Primary PCI for a Patient with Anomalous Left Main OriginBin Wang

12:10 PM - Q&A

12:15 PM - CS-0089: Which Is the Culprit Vessel?Xia Zhang

12:25 PM - Q&A

12:30 PM - Adjourn

8:30 AM - CS-0215: High Risk STEMI: Emergency Treatment StrategyXiaohua Guo

8:40 AM - Q&A

8:45 AM - CS-0159: A Case of Embolic Myocardial Infarction and Coronary Artery EctasiaYan Lai

8:55 AM - Q&A

9:00 AM - IM-0022: Acute Left Main ClosureJun Jin

9:10 AM - Q&A

9:15 AM - CS-0206: A Complicated Case with AMI, VT, Shock, and Diffuse / CTO LesionsRuey-Hsing Chou

9:25 AM - Q&A

9:30 AM - CS-0378: ACS Patient with "Normal" Coronary AngiogramWeiping Zhang

9:40 AM - Q&A

Session II

Moderators: Bao Li, Fakuan Tang, Liangqiu Tang, Qiming Wu, Lishu Xu, Yang Zheng

9:45 AM - CS-0170: Acute Anterior Myocardial Infarction Complicated with Right Coronary ThrombusXinghua Jiang

9:55 AM - Q&A

10:00 AM - CS-0289: Super-Selective Angiography with Aspiration Device in NSTEMI PatientHongbing Yan

10:10 AM - Q&A

10:15 AM - CS-0290: Combined Use of Aspiration Devices in STEMI PatientHongbing Yan

10:25 AM - Q&A

10:30 AM - CS-0192: Acute Stent Thrombosis After PCI for Acute Myocardial Infarction Complicated with Pulmonary EmbolismDefeng Pan



095

Room 305B, Level 3


Moderators: Hesong Zeng, Lijun Zhou, Changlin Lu

7:00 AM - CS-0318: Cardiac Tamponade Caused by Rupture of Valsalva SinusYunqi Shi

7:10 AM - Q&A

7:15 AM - IM-0008: Wandering between Guideline and RealityJinsong Xu

7:25 AM - Q&A

7:30 AM - IM-0039: IVUS Findings of Two-Vessel Aneurysm DiseaseXiaoqun Zheng

7:40 AM - Q&A

7:45 AM - IM-0041: PCI with Stenting of Acute Stent Thrombosis of Unexpanded Proximal LAD Stent in Acute AW STEMI Who Underwent PCI of LAD One Week EarlierSridhar Kasturi

7:55 AM - Q&A

8:00 AM - IM-0069: Percutaneous Intervention on Anomalous Left Coronary ArteryLian Wang

8:10 AM - Q&A

8:15 AM - Break

Case Reviews (Call-for-Cases) Part IILeft Main, Bifurcation, and Special Cases8:30 AM-12:30 PM

Session I

Moderators: Weimin Wang, Fei Ye, Lei Qin, Yaoming Song, Ling Li, Kui Pu, Hong Liu

10:45 AM - CS-0044: Provisional T-Stenting in Left Main Distal Bifurcation with Severe Tortuosity and CalcificationTao Yin

10:55 AM - Q&A

Session III

Moderators: Xuewen Qin, Chengjun Guo, Yingxin Zhao, Yingyan Ma, Yongping Jia, Chun Wu, Jingyuan Mao

11:00 AM - CS-0315: PCI for Complex Lesion Guided with IVUS and FFRZhehao Piao

11:10 AM - Q&A

11:15 AM - CS-0193: FFR Guided PCI in Multiple LesionsXinyang Hu

11:25 AM - Q&A

11:30 AM - CS-0142: Restenosis and Aneurysm in DESWeixian Yang

11:40 AM - Q&A

11:45 AM - CS-0187: Subacute Stent Thrombosis After PCI for Restenosis in a Patient with Triple Vessel Disease and Hypertrophic Cardiomyopathy - 7 Years Follow-Up ResultLiansheng Wang

11:55 AM - Q&A

12:00 PM - CS-0011: PCI for Left Main Bifurcation in a Patient with Cardio-Renal FailureTongku Liu

12:10 PM - Q&A

12:15 PM - CS-0055: A High Risk Patient with Multi-Bifurcation Lesions Treated with Different Strategies Guided by IVUS/FFRJunjie Zhang

12:25 PM - Q&A

12:30 PM - Adjourn

8:30 AM - CS-0372: PCI for Extremely Angulated Bifurcation with Reversed Guidewire TechniqueChaowei Mu

8:40 AM - Q&A

8:45 AM - CS-0263: Rotational Atherectomy and Cutting Balloon for Calcified Left Main Bifurcation Lesion: Utility of IVUSQuanmin Jing

8:55 AM - Q&A

9:00 AM - CS-0029: De Novo or Restenosis?Yongsheng Ke

9:10 AM - Q&A

9:15 AM - CS-0235: Unusual Coronary LesionsXiaozeng Wang

9:25 AM - Q&A

9:30 AM - CS-0115: Complex Trifurcation LesionSubhash Chandra

9:40 AM - Q&A

Session II

Moderators: Jilin Chen, Dongju Jiang, Jifu Li, Jun Guan, Chengming Yang, Biao Cheng, Hui Liu

9:45 AM - CS-0273: Balloon-Stent Kissing to Protect Side Branch After CTO RecanalizationJingang Cui

9:55 AM - Q&A

10:00 AM - CS-0226: PCI for Complex Left Main LesionShaoyi Guan

10:10 AM - Q&A

10:15 AM - CS-0145: TRI for Double Bifurcation LesionsYin Zhang

10:25 AM - Q&A

10:30 AM - CS-0250: PCI for LM and Triple Vessel Disease - Resulted in Reduplicated Heart FailureHui Li

10:40 AM - Q&A



096

Room 302A, Level 3

Case Reviews (Call-for-Cases) Part IIIComplications8:30 AM-12:30 PM

Session I

Moderators: Lefeng Wang, Zhuhua Yao, Quan Liu, Jianping Liu, Liping Ma, Bo Yang, Shujuan Cheng

8:30 AM - CS-0127: Femoral Access Complication During PCI: Retroperitoneal HematomaZhujun Chen

8:40 AM - Q&A

8:45 AM - CS-0087: Treatment of Dislodged Stent During PCIBei Ge

8:55 AM - Q&A

9:00 AM - CS-0278: Rota Wire Fracture During RotablationPengcheng He

9:10 AM - Q&A

9:15 AM - CS-0321: Retrieval of Entrapped IVUS Catheter After Stent Deployment by Guideliner CatheterHsuan-Fu Kuo

9:25 AM - Q&A

9:30 AM - Break

Session II

Moderators: Wenyi Guo, Handong Yang, Yuquan He, Rong Lin, Yong Yuan, Gaoxing Zhang, Chun Xiao

9:45 AM - CS-0094: Simple Lesion, Complex Procedure!Songhua Li

9:55 AM - Q&A

10:00 AM - CS-0036: A Case of Subacute Stent ThrombosisYawei Luo

10:10 AM - Q&A

10:15 AM - CS-0124: Iatrogenic Coronary DissectionHongyu Shi

10:25 AM - Q&A

10:30 AM - CS-0034: Right Coronary Spiral Dissection Caused by Left Coronary Guiding CatheterLei Song

10:40 AM - Q&A

10:45 AM - CS-0375: Fatal Femoral Hematoma After Successful PCI for Calcified LesionQiong Wang

10:55 AM - Q&A

Session III

Moderators: Haibo Liu, Qingsheng Wang, Heping Liu, Wei Wang, Wenhua Lin, Qiang Tang, Bei'an You

11:00 AM - CS-0135: Perforation During PCIYong Yang

11:10 AM - Q&A

11:15 AM - CS-0108: LAD Retrograde Dissection After PCIHaihua Zhang

11:25 AM - Q&A

11:30 AM - IM-0081: IVUS Finding in a Female Patient with Moyamoya DiseaseKai Xu

11:40 AM - Q&A

11:45 AM - CS-0291: Recurrent Stent Fracture in LADPeng Zhang

11:55 AM - Q&A

12:00 PM - CS-0276: Loss of Obtuse Marginal Branch in Staged PCI Resulted in Cardiac RuptureHanjun Zhao

12:10 PM - Q&A

12:15 PM - IM-0077: Very Late Stent Thrombosis in an Elderly FemaleQingsheng Wang

12:25 PM - Q&A

12:30 PM - Adjourn



097

Room 302B, Level 3

Case Reviews (Call-for-Cases) Part IVChronic Total Occlusions8:30 AM-12:15 PM

Session I

Moderators: Lei Ge, Chengxiang Li, Wenqiang Chen, Qinghua Lu, Zhexun Lian, Yuzeng Xue

8:30 AM - CS-0326: Retrograde PCI for RCA Ostial CTOYuquan He

8:40 AM - Q&A

8:45 AM - CS-0071: Retrograde PCI for RCA Ostial Total OcclusionChengxiang Li

8:55 AM - Q&A

9:00 AM - CS-0254: Challenging Retrograde Recanalization of RCA CTO Lesion by Wire Externalization Even After Previous Failed Attempt Due to Wire-induced Extensive DissectionYisik Kim

9:10 AM - Q&A

9:15 AM - CS-0102: RCA CTO Managed by Reverse CARTTsung-Lin Yang

9:25 AM - Q&A

9:30 AM - CS-0149: Retrograde PCI for LAD CTO via Transseptal PathwayZhan Gao

9:40 AM - Q&A

Session II

Moderators: Yue Li, Leisheng Ru, Yuansheng Tang, Fan Liu, Yumin Qiu, Yong Wang, Huan Zhang

9:45 AM - CS-0277: PCI for Calcified Small Vessel CTOLang Hong

12:00 PM - CS-0247: PCI Strategy for a Very Elderly Patient with Complex Coronary Artery DiseaseXin Zhao

12:10 PM - Q&A

12:15 PM - Adjourn

9:55 AM - Q&A

10:00 AM - CS-0076: Complex CTOTao Hu

10:10 AM - Q&A

10:15 AM - IM-0054: Complex Retrograde PCI for CTO - From LCX to RCAZening Jin

10:25 AM - Q&A

10:30 AM - CS-0253: PCI for RCA In-Stent Total Occlusion Combined with Contralateral Angiogram and IVUSHaiwei Liu

10:40 AM - Q&A

10:45 AM - CS-0354: Retrograde PCI for LM CTO via Different Collateral ChannelsLeisheng Ru

10:55 AM - Q&A

Session III

Moderators: Dadong Zhang, Guowei Zhou, Shifang Ding, Li Li, Hua Yu, Zhifang Wang, Suocheng Niu

11:00 AM - CS-0191: LAD CTO Recanalized by Antegrade MC Mounted on Retrograde WireGeng Wang

11:10 AM - Q&A

11:15 AM - CS-0129: Left Main Related CTO - Treatment Options?Keng Wu

11:25 AM - Q&A

11:30 AM - CS-0174: Multiple Strategies to Treat a CTO LesionJunqing Yang

11:40 AM - Q&A

11:45 AM - CS-0184: RCA CTO Intervention Complicated with Profound HypotensionGuowei Zhou

11:55 AM - Q&A



098

Room 307, Level 3

Case Reviews: Peripheral and Endovascular Interventions8:30 AM-10:30 AM

Moderators: Xiongjing Jiang, Jianfang Luo, Yan Wang, Yinghua Zou

8:30 AM - CS-0265: How to Select the Access for Severe Lesion in Peripheral Artery?Quanmin Jing

8:40 AM - Q&A

8:45 AM - CS-0035: Endovascular Repair of Abdominal Aortic Aneurysm with Fenestrated Stent-GraftYuguo Xue

8:55 AM - Q&A

9:00 AM - CS-0009: Long Stent Implantation Skills for Severe Stenosis of Middle Cerebral ArteryTongku Liu

9:10 AM - Q&A

9:15 AM - CS-0098: Interventional Therapy for Total Occlusion Lesion in Carotid ArteryBin Yang

9:25 AM - Q&A

9:30 AM - CS-0223: Occluded LIC / LSCA (LVA) with TVDZhonghan Ni

9:40 AM - Q&A

9:45 AM - CS-0262: Percutaneous Super-Selective Adrenal Arterial Embolization as Treatment for Primary AldosteronismHui Dong

9:55 AM - Q&A

10:00 AM - CS-0284: Successful Bilateral Carotid Artery Stenting in a 84-Year-Old ManMeng Peng

10:10 AM - Q&A

10:15 AM - IM-0073: Intervention for Renal Artery OcclusionFeng Guo

10:25 AM - Q&A

10:30 AM - Adjourn

MODERATED POSTER PROGRAM


099

AS-0001: Cutting-balloon plaque modification for drug-eluting stent implantation in severely calcified coronary lesions evaluated by intravascular ultrasoundZhe Tang, et al

AS-0007: The influence of calcium parameters for immediate PCI results: An intravascular ultrasound analysisZhe Tang, et al

AS-0009: Inflamation and endothelial dysfunction: band master of the orcchestra of slow coronary flow phenomenonNaing Zayar, et al

AS-0012: Study of urinary IL-18 on early diagnosis of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention and the intervention of Danhong injectionWen-hua Li, et al

AS-0014: Long-term outcomes after fractional flow reserve-guided percutaneous coronary intervention in patients with severe coronary stenosisJing Li, et al

AS-0015: The synergistic effects of combined Losartan with Simvastatin on PPARγ MCP-1 in atherosclerosis rabbitsYan-min Xu, et al

AS-0019: Influence and significance of plasma superoxide dismutase (SOD) and malondialdehyde (MDA) for ischemic postconditioning on acute myocardial *Supported by Beijing natural science foundation (7122178)Jun Xiao, et al

AS-0021: Influence and significance of brain natriuretic PEPTIDE for ischemic postconditioning on acute myocardial infarction**Supported by Beijing Natural Science Foundation (7122178)Jun Xiao, et al

AS-0022: Explore the effect of hemostasis by gradient deflated method for percutaneous coronary intervention patients with radial artery pathYing-ying Zhou, et al

AS-0029: Endovascular therapy for aortic pseudoaneurysmsYu-guo Xue, et al

AS-0035: High-dose atorvastatin reloading before percutaneous coronary intervention increased circulating endothelial progenitor cells and reduced inflammatory cytokine expression during thePerioperative PeriodHong-hua Ye, et al

AS-0039: Assessment of in-stent neoatherosclerosis after sirolimus eluting Stent (SES) implantation by pptical coherence tomographyLin-xing Feng, et al

AS-0041: Left heart atrioventricular intervals and optimization of cardiac resynchronization therapyYun Tian, et al

AS-0043: Omega-3 polyunsaturated fatty acids may decrease the incidence of clinical postoperative atrial fibrillation: a meta-analysis of randomized controlled trialsXue-yuan Guo, et al

AS-0047: A novel fully bioabsorbable drug-releasing scaffold implanted in the porcine coronaryGao-ke Feng, et al

AS-0051: Effect of quality control on decreasing incidence of ventilator-associated pneumonia in intubated ventilated patients with intracoronary sent implantationYing-ying Zhou, et al

AS-0052: Predictive value of serum N-terminal pro-brain natriuretic peptide on admission in patients with acute ST-elevation myocardial infarction on ST segment resolution after primary percutaneous coronary interventionBin Peng, et al

AS-0053: Recanalization strategy for chronic total occlusions with a new guidewire technique ("improved seesaw-wiring")Keng Wu, et al

AS-0055: The left ventricular lead electrical delay predicts response to cardiac resynchronization therapyHang Zhang, et al

AS-0063: Serum uric acid: a useful biomarker for evaluating the severity of coronary artery disease in patients with obstructive coronary artery diseaseJie Yu, et al

AS-0064: IVUS-based models with fluid-structure interaction and cyclic bending to identify correlations between plaque wall thickness and mechanical stress conditionsRui Fang, et al

AS-0065: Can "Hybrid stent implantation" improve long-term safety without adversely affecting efficacy when treating multilesion coronary artery disease in the drug-eluting stent era?Yi-ping Li, et al

AS-0066: Polymer-free versus permanent polymer drug eluting stents in coronary artery disease: A meta-analysis of 5390 patientsDe-wei Wu, et al

AS-0068: Clinical observation of liquid dressing in phlebitis induced by amiodarone in arrhythmia patientsWei-wei Zhu, et al

AS-0070: Effect of two artificial airway nursing intervention on intubated ventilated patients following percutaneous coronary interventionsYing-ying Zhou, et al

AS-0072: We studied the effect of residue SYNTAX score (rSS) on patients with stable and three-vessel CAD underwent percutaneous coronary intervention (PCI)Xian-peng Yu, et al

AS-0074: Signal pathways involved in inhibition of berberine on human umbilical vein endothelial cell proliferation induced by oxidized low-density lipoproteinRui-xia Xu, et al

AS-0081: The observation of phosphatase and tensin homolog deleted on chromosome ten (PTEN) activation and its dynamic changes following the coronary microembolizationJiang-you Wang, et al

AS-0084: Left versus right radial approach for coronary angiography in elderly patientsQiang Fu, et al

AS-0087: Imbalanced expression of angiotensin II receptor in left and right atriam in patients of rheumatic heart disease with atrial fibrillation or rheumatic heart disease with sinus rhythmHong Li, et al



100

AS-0090: Impacts of a regional collaborative network on reperfusion time of the patients with ST-segment elevated myocardial infarction presenting to community hospitals without percutaneous coronary intervention capacityTian-bing Duan, et al

AS-0091: Impact of atorvastatin and probucol combination therapy on myocardial injury in Patients with angina pectoris experiencing elective percutanous coronary interventionRui-yan Zhang, et al

AS-0094: Retrograde type a aortic dissection following endovascular stent-graft placement for treatment of type B dissectionWei-guo Fu, et al

AS-0098: Gender-related differences in outcomes after transcatheter aortic valve implantation: A systematic review and meta-analysisYan-biao Liao, et al

AS-0105: Inadequate myocardial perfusion is a determinant of systolic dysfunction in the acute phase of myocardial infarctionJian-qiang Xu, et al

AS-0113: Clinical profile and long-term prognostic factors of young Chinese patients (≤40 Years) having ST-segment elevation myocardial InfarctionGeng Qian, et al

AS-0116: Persistent tricuspid regurgitation and its predictor after percutaneous atrial septal defect closure in patients over 60 years oldLiang Chen, et al

AS-0121: Association of interleukin-33 gene single nucleotide polymorphisms with ischemic stroke in north Chinese populationLiang Guo, et al

AS-0122: True complete left bundle branch block morphology strongly predicts super-response to cardiac resynchronization therapyGa-xue Jiang, et al

AS-0125: Comparison of two- and three-dimensional quantitative coronary angiography to intravascular ultrasound in the assessment of left main bifurcation lesionsJing Kan, et al

AS-0132: Role of all-trans retinoic acid in preventing ischemia/reperfusion injury in aldose reductase transgenic miceZheng-bin Zhu, et al

AS-0140: Comparing the verify Now-P2Y12 assay's capability of detecting the antiplatelet function of clopidogrel with light transmission aggregometry in Chinese elderly patients underwent percutaneous coronary interventionYu Luo, et al

AS-0141: Report of a randomized, controlled study of the long-term efficacy and tolerance profiles of three calcium channel blockers in patients with coronary artery spasmDing-cheng Xiang, et al

AS-0143: Ability of rat BM-MSCs derived exosomes to promote itself myocardial differentiation or reduce apoptosis after different treatmentsLi-ya Gu, et al

AS-0145: Effects of bone narrow mesenchymal stem cells on the electrophysiological characteristics of cardiomyocyte in ratsYang Liu, et al

AS-0149: Myocardium protection of dexmedetomidine in patients with acute myocardial infarction undergoing PCIXiao-wen Wang, et al

AS-0154: Study on the gap junctional intercellular communicational in cardiac biological pacemakerHuan Lin, et al

AS-0155: The accuracy of Warfarin dosage based on CYP2C9 and VKORCIWen-xing Xu, et al

AS-0156: The change of calcium concentration of left ventrucular myocytes in rats after myocardial infarction and the intervention study of apocyninXiao-rui Lv, et al

AS-0157: The changes of potassium channel of left ventrucular myocytes in rats after myocardial infarction and the intervention study of apocyninWei Wang, et al

AS-0158: The clinical influence of right ventricular apical pacing or right ventricular outflow tract pacing on P wave dispersion and ventricular synchronism and cardiac functionHui Li, et al

AS-0163: Effects of electric stimulations applied during absolute refractory period on cardiac function in rabbits with chronic heart failureWen-jing Wang et al

AS-0166: Study of side branch ostial deformation after interventional therapy of coronary bifurcationLi Li, et al

AS-0167: Effect of intensive atorvastatin therapy on periprocedural PDCD4 expression in CD4+T lymphocytes of patients with unstable angina undergoing percutaneous coronary interventionQiang Sun, et al

AS-0170: Comparation of coronary DES and BMS in octogenarians: a systematic review and meta-analysisLei Gao, et al

AS-0171: Long term risk of stroke with percutaneous coronary intervention compared with coronaryartery bypass graft surgery: a systematic review and meta-AnalysisLei Gao, et al

AS-0172: Diplotypes of the CYP2C9 gene is associated with coronary artery disease in the Chinese Han populationQing Zhu, et al

AS-0175: Relationship of anemia and contrast-induced nephropathy in patients with chronic kidney disease undergoing percutaneous coronary interventionYuan-hui Liu, et al

AS-0176: Predictors of side branch occlusion after main vessel stenting in coronary bifurcation lesionsDong Zhang, et al

AS-0177: Incidence and predictors of heart failure hospitalization in right ventricular apical pacingTao Wang, et al



101

AS-0179: Lower preprocedural low-density lipoprotein cholesterol levels are associated with less risk of postprocedural cardiac troponin I elevation following elective percutaneous coronary interventionXiao-lin Li, et al

AS-0187: Mitral annular tissue velocity in the diagnosis of coronary artery diseaseLu-fan Sun, et al

AS-0192: Treatment with simiao yongan decoction suppresses the development of experimental abdominal aortic aneurysm in miceZhen-yu Xu, et al

AS-0195: The short and long-term effect of adjunctive intra-aortic balloon pump for patients undergoing high risk reperfusion therapy: a meta-analysis of 10 international randomized trialsShao-jie Chen, et al

AS-0197: Effects of different nasalcatheter insertion dept in children with congenital heart disease after interventional treatmentTing Dong, et al

AS-0202: Influencing factors of the functional significance in intermediate coronary stenosisLi-jie Sun, et al

AS-0205: Endothelial progenitor cell transplantation for the treatment of myocardial infarctionYan Cheng, et al

AS-0210: Xuezhikang attenuated the functional and morphological impairment of pancreatic islets in diabetic mice via the inhibition of oxidative stressJun Wang, et al

AS-0213: Effect of the differences of age and gender on the association between epicardial adipose tissue volume and coronary heart diseaseLiang-liang Zhou, et al

AS-0217: Appropriate body mass index and waist circumference cutoffs for categorization of overweight and central adiposity among Uighur adults in XinjiangShuo Pan, et al

AS-0218: A novel haplotype in the GOSR2 gene is associated with coronary artery disease in Chinese Han populationShuo Pa, et al

AS-0219: Serum uric acid levels are associated with high blood pressure in Chinese children and adolescents aged 10-15 yearsChun-hui He, et al

AS-0220: Optimal waist to height ratio cutoffs for hypertension, diabetes, and dyslipidemia for the Han and Uighur adults in ChinaChun Hui He, et al

AS-0228: T-wave inversions related to left ventricular basal hypertrophy and myocardial fibrosis in non-apical hypertrophic cardiomyopathy: a cardiovascular magnetic resonance imaging studyXiu-yu Chen, et al

AS-0229: Comparison of circulating dendritic cells and monocyte subsets at different stages of atherosclerosisJian-hui Zhuang, et al

AS-0242: The association of rosuvastatin therapy and high-sensitivity C-reactive protein for prevention the contrast-induced acute kidney injuryMei-ling Ge, et al

AS-0245: Focal atrial tachycardia arising from the atrial appendages: electrophysiologic and electrocardiographic characteristics and radiofrequency catheter ablationWeiping Huang, et al

AS-0248: Clinical characteristics and the efficacy of radiofrequency catheter ablation of ventricular fibrillation/polymorphic ventricular tachycardia triggered by idiopathic premature ventricualr contraction originating from the right ventricular outflow tractYan-chun Liang, et al

AS-0249: Treatment strategy of accessory atrioventricular pathway transient recurrence in patients withpreexcitation syndrome after radiofrequency catheter ablationYan-chun Liang, et al

AS-0250: Electrophysiological characteristics and radiofrequency catheter ablation of atrial septum tachycardia and nearby regionJing-e Ouyang, et al

AS-0251: Electrophysiologic characteristics and radiofrequency catheter ablation of focal atrial tachycardia in posterior septum and nearby regionJing-e Ouyang, et al

AS-0257: Contribution of homeostatic chemokines CCL19 and CCL21 and their receptor CCR7 to coronary artery diseaseWen-zhi Cai, et al

AS-0258: Cellular repressor of E1A-stimulated genes protects against angiotensin II-induced vascular remodeling via degradation of angiotensin II type 1 receptorYang Li, et al

AS-0259: Polymorphisms of PON1 gene are associated with coronary artery diseaseTeng-fei Liu, et al

AS-0261: CREG over-expression in BMSC protect against myocardial infarction via VHL/HIF-1α/VEGF pathway mediated vascularizationCheng-fei Peng, et al

AS-0262: Cellular repressor of E1A stimulated genes antagonizes inflammation of macrophages through lysosome stabilizationMing-yu Sun, et al

AS-0263: CREG promotes vasculogenesis of embryonic stem cells by activating VEGF /PI3K/Akt/ pathwayXiao-xiang Tian, et al

AS-0266: Cellular repressor of E1A-stimulated genes improves heart function in a mouse model of MIJian Zhang, et al

AS-0267: Comparison of radial versus femoral approach for percutaneous coronary intervention in octogenarian with acute coronary syndromeLei Gao, et al

AS-0269: Long-term efficacy of PCI vs. CABG for patients with multiple coronary chronic total occlusionsJian Zhang, et al

AS-0275: An epidemiological survey of stroke among rural Chinese adults results from the Liaoning provinceZao-qing Sun, et al

AS-0276: Investigation of the correlation between norepinephrine transporter gene polymorphisms and essential hypertensionYing Li, et al



102

AS-0295: Effects of omeprazole and pantoprazole on platelet function in acute coronary syndrome patients receiving clopidogrel: a single-center prospective randomized controlled clinical trialsXiao-zeng Wang, et al

AS-0296: Thrombus aspiration followed by direct stenting during primary percutaneous coronary intervention in ST-segment elevation myocardial infarctionHai-wei Liu, et al

AS-0302: Quantitative association between prehypertension and different types of cardiovascular outcomes and diabetes: a systematic review and meta-analysis of prospective studies worldwideXiao-fan Guo, et al

AS-0306: Effects of multisite electric stimulations applied during absolute refractory period on cardiac function of rabbits with heart failureChen Qin, et al

AS-0307: Cardiac magnetic resonance for prediction of outcome in patients with transcoronary ethanol ablation for hypertrophic obstructive cardiomyopathyMin-jie Lu, et al

AS-0309: Successful transradial access percutaneous coronary intervention with judkins left guiding catheter in anomalous right coronary arteries arising from the left sinus of valsalvaYu-ying Zhao, et al

AS-0312: Longitudinal strain assessed by 2D speckle tracking echocardiography predicts microvascular obstruction in patients with ST elevation myocardial infarctionZhi-qing Qiao, et al

AS-0316: Transcatheter closure of patent ductus arteriosus in children With body weight ≤ 8KgQi-guang Wang, et al

AS-0323: The effects of anticoagulant therapy on coagulant state and platelet function following transcatheter closure of atrial septal defectGuo-cai Chen, et al

AS-0325: Effect of different drugs injected intra-microcatheter on no-reflow phenomenon duringpercutaneous coronary interventions for acute myocardial infarctionJi-hong Zhao, et al

AS-0328: eNOS modified endothelial progenitor cells inhibit efficiently neointima formation and enhancement of vascular functionBin Cui, et al

AS-0333: c-Met overexpression promote reendothelialization and inhibit neointimal formation after balloon injuryMing-bao Song, et al

AS-0335: Comparison of dual-axis rotational versus standard coronary angiography: a randomized non-inferiority trialHui-liang Liu, et al

AS-0336: Alteration in right heart function upon high-altitude exposure and its roles in Acute mountain sicknessXi Liu, et al

AS-0338: Safety and efficacy of degradable vs. permanent polymer drug-eluting stents a meta-analysis of 18,395 patients from randomized trialsYu-qing Wang, et al

AS-0339: Monocyte subsets and monocyte-platelet aggregates in patients with troponin negative non-ST-elevation acute coronary syndrome: potential role in risk stratificationXin Zhou, et al

AS-0341: Relationship between monocyte subsets and clopidogrel responsiveness in patients with ST-segment elevation myocardial infarctionXin Zhou, et al

AS-0345: fractional flow reserve guided percutaneous coronary intervention in intermediate coronary artery diseaseQing-sheng Wang, et al

AS-0346: Effects of visfatin on the function of endothelia progenitor cells and the possible mechanismsRong Hu, et al

AS-0349: Experience of improving emergency care of patients with aortic dissectionPing Ren, et al

AS-0355: Features of complementary and alternative medicine use by patients with coronary artery disease in Beijing: a cross-sectional studyFu-yong Chu, et al

AS-0356: Comparison of Transplantation of bone marrow-derived stem cells, adipose-derived stem cells and endometrium- derived stem cells in the Infarcted HeartKan Wang, et al

AS-0360: Prognostic significance of normal serum creatinine level and reduced estimated glomerular filtration rate in patients receiving coronary revascularizationHuang-tai Miao, et al

AS-0362: Phosphatase and tension homolog deleted on chromosome ten (PTEN) downregulation by atorvastatin in a swine model of coronary microembolization, a new mechanism for regulation of apoptosis in the coronary microembolization.Jiang-you Wang, et al

AS-0375: Clinical relevance of angiographic coronary collaterals during primary coronary intervention for acute ST-elevation myocardial infarctionYing Shen, et al

AS-0376: Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusionYing Shen, et al

AS-0381: Epidemiological evidence for the link between sleep duration and high blood pressure: a systematic review and meta-analysisXiao-fan Guo, et al

AS-0383: Long-term clinical efficacy of loading-dose atorvastatin before emergengcy percutaneous coronary intervention in patients with ST elevation myocardial infarctionWei Tang, et al

AS-0392: Analysis of 170 cases with retrograde wire for the treatment of chronic coronary artery occlusionQuan-min Jing, et al

AS-0393: Differences in lifestyle behaviors, dietary habits, and familial factors among normal-weight, overweight, and obese Chinese children and adolescentsXiao-fan Guo, et al



103

AS-0398: Rosuvastatin prevents contrast-induced nephropathy in diabetic nephropathy ratsJie Deng, et al

AS-0399: The impact of endothelial progenitor cell capture stent on the clinical outcomes in patients with coronary artery diseas: a meta-analysisWei Liu, et al

AS-0401: Are biodegradable polymer stents eluting different "limus" drugs associated with different clinical effects? Insights from a meta-analysis of randomized controlled trialsSum-wing Joey, et al

AS-0411: Subtypes of hypertension and risk of stroke in rural Chinese adultsZhao-qing Sun, et al

AS-0413: Randomized comparison of intracoronary tirofiban versus urokinase as an adjunct to primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: results of the ICTUS-AMI trialTian-qi Zhu, et al

AS-0415: Glycation of apoprotein A-I is associated with coronary artery plaque progression in type 2 diabetic patientsLin Lu, et al

AS-0416: Improved outcomes from transradial over transfemoral access in primary percutaneous coronary intervention for patients with acute ST-segment elevation myocardial infarction and upstream use of tirofiban.Qi Zhang, et al

AS-0417: Reduced serum levels of vasostatin-2, an anti-inflammatory peptide derived from chromogranin A, are associated with the presence and severity of coronary artery diseaseLin Lu, et al

AS-0418: The prognostic role of myocardial fibrosis detected by CMR-LGE in hypertrophic cardiomyopathyTao Zhao, et al

AS-0419: Impact of elevated serum glycated albumin levels on contrast-induced acute kidney injury in diabetic patients with moderate to severe renal insufficiency undergoing coronary angiographyFeng-hua Ding, et al

AS-0420: MicroRNA-21 upregulation by atorvastatin in a swine model of coronary microembolization : a new mechanism for anti-apoptosis interventionJiang-you Wang, et al

AS-0421: miR-214 induces ESC cell differentiation into smooth muscle cells by targeting QuakingTing Chen, et al

AS-0424: Gs and Gi pathways contribute oppositely to β2 adrenergic receptor activation-induced cardiac repolarization and arrhythmogenesis in heart failure model of guinea pigsYao Wang, et al

AS-0425: Modified mini-crush versus cullotte techniques in bifurcation lesions of left anterior descending artery: clinical and angiographic long-term outcome after implantation of drug-eluting stentsHai-wei Liu, et al

AS-0426: Clinical outcomes of everolimus-eluting stent versus paclitaxel-eluting stent in patients with diabetes mellitus undergoing percutaneous coronary Interventions. A Meta-Analysis of Clinical TrialsYao-hua Huang, et al

AS-0429: Nicotine inducemast cells degranulation to promotethe atherogenesis andreduce the atherosclerostic plaque stabilityChen Wang, et al

AS-0431: Leptin signaling is required for augmented therapeutic properties of mesenchymal stem cells conferred by hypoxiaXin-yang Hu, et al

AS-0432: Depression, anxiety, and quality of life after catheter ablation in patients with paroxysmal atrial fibrillationCai-hua Sang, et al

AS-0444: Bradykinin prevents oxidative stress induced senescence of endothelial progenitor cells via B2 receptor signal pathwayCong Fu, et al

AS-0445: Effects of intracoronary anesodamine and diltiazem administration during primary percutaneous coronary intervention in acute myocardial infarctionYu-hong Peng, et al

AS-0446: Transradial rotational atherectomy for complex calcified coronary lesions under the guidance of intravascular ultrasoundJun Jiang, et al

AS-0449: Long–term mortality and characteristics of cardiac resynchronization therapy in multi-centerDong-mei Wang, et al

AS-0455: Curative effect and safety of ultrafiltration in treatment of heart failureShu-bin Jiang, et al

AS-0456: Comparison of the effect of rivaroxaban and warfarin treatment on patients with ventricular aneurysm mural thrombusHai-bing Jiang, et al

AS-0457: Bipolar multi-electrode balloon catheter radiofrequency renal denervatin with the vessixsystem: preclinical safety evaluation in procine modelGregory Wilson, et al

AS-0458: Long term follow up of patients undergoing distal left main-bifurcation stenting via transradial versus femoral approachWei Liu, et al

AS-0459: Comparison of long term outcome of cross over stenting versus two stents in left main bifurcation lesions via transradial approachWei Liu, et al

AS-0476: Assessment of early radial injury after transradial coronary intervention by ultrasound biomicroscopeHua Shen, et al

AS-0478: The relationship between atherosclerotic plaque characteristics and extracellular matrix metalloproteinase inducer/urokinase-type plasminogen activator in the patients with coronary artery diseaseLi-xia Yang, et al

AS-0481: Significance of peristrut foamy macrophage clustering for vulnerability of in-stent neoatherosclerosisYan Fang, et al



104

AS-0485: Coverage of neointima in coronary heart disease patients after sirolimus-eluting stents implantation: an optical coherence tomographic studyLei Xing, et al

AS-0488: P-cresyl sulfate accelerates atherosclerosis associated with CKDJin-zhou Zhu, et al

AS-0489: Meta-analysis of randomized controlled trials of intracoronary versus intravenous administration of tirofiban during percutaneous coronary intervention for acute coronary syndromeXiao-mei Li, et al

AS-0491: Bifurcation lesions using mini culotte treatment can improve the rate of expansion eventually kissingZhi-ming Yang, et al

AS-0497: Scattered audio-visual joint intervention in cardiac intervention perioperative nursing of vasovagal reflexHong Wang, et al

AS-0498: Cause analysis and nursing of common discomforts after cardiovascular surgeryShui Yu, et al

AS-0504: Application of time nursing for individual nursing care to interventional treatment of patients with coronary heart diseaseXiao-xing Feng, et al

AS-0509: A randomized comparison for a single-ablation catheter approach and a single-lasso catheter approach to pulmonary vein antrum isolationXian-hui Zhou, et al

AS-0515: The related factors of mental disorder patients after heart operation analysis and nursing countermeasureYan-zhi Li, et al

AS-0525: Magnetic enhancement of cell retention and functional benefit after retrograde coronary venous delivery of mesenchymal stem cells in myocaridal infarctionZhe-yong Huang, et al

AS-0527: Care guidance for post-PCI patients after dischargeQing-bin Lu, et al

AS-0528: High intensity magnetic targeting improves cell retention but has no additional functional benefitYun-li Shen, et al

AS-0530: The effect of cardiac contractility modulation to ventricular fibrillation threshold of chronic heart failure and the approach of correlated mechanismsHao Liang, et al

AS-0532: Emergent activation other than cardiologist activation is associated with process improvement in the care of ST segment elevated myocardial infarction patient: a single center experience in ChinaHong-yu Shi, et al

AS-0538: Rosuvastatin enhances viability of adipose-derived mesenchymal stem cells transplanted in post-infarcted mice heartsShuang Li, et al

AS-0543: Application of breath training device combined with conventional respiratory training in perioperative period of cardiac valve replacementHai-xia Zhang, et al

AS-0544: The expression of microRNA-155 and microRNA-146a in peripheral blood mononuclear cells correlate with atherosclerotic plaque characteristics in the Patients with coronary artery diseaseLi-xia Yang, et al

AS-0548: Performance of 2.25mm diameter FIREHAWK abluminal groove-filled biodegradable polymer sirolimus-eluting stent in very small coronary vessels: 9-month angiographic and 1-year clinical results from the TARGET I and II trialsYe-lin Zhao, et al

AS-0549: Preclinical tools for predicting and optimizing circumferential ultrasound renal denervationKenichi Sakakura, et al

AS-0552: Protective effect of Diazoxide, a mitoKATP opener, on the myocardial mitochondrial functions after asphyxia in neonatal ratsXiao-yi Fang, et al

AS-0553: One year clinical results of everolimus-eluting stents for treatment of long coronary lesions: a subgroup analysis of the prospective multicenter SEEDS studyChao-wei Mu, et al

AS-0556: One year clinical results of everolimus-eluting stents for treatment of multivessel disease: a subgroup analysis of the prospective multicenter SEEDS studyChao-wei Mu, et al

AS-0558: Impact of diabetes status on long-term (6 years) outcomes after percutaneous coronary intervention of left main disease: result from a real world experience of 1,528 consecutive patientsYe-lin Zhao, et al

AS-0560: Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions: 12-month results from the prospectively patient-level pooled analysis of the TARGET I and TARGET II trialsYe-lin Zhao, et al

AS-0562: The role of everolimus-eluting and resolute zotarolimus-eluting stents in the treatment of single chronic total occlusionBing Fan, et al

AS-0572: Clinical outcomes after percutaneous coronary intervention in acute myocardial infarction due to unprotected left main coronary artery diseaseQing Qin, et al

AS-0579: Oversized atrial septal defect (ASD) occluder can lead to incomplete endothelializationTing-ting Zhang, et al

AS-0581: Two-year clinical follow-up of the FIREHAWK abluminal groove-filled biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the TARGET I trialYe-lin Zhao, et al

AS-0589: Influence of ambrisentan on pulmonary vascular smooth muscle cell proliferation and apoptosis in rats with hypoxic pulmonary hypertensionQiang Song, et al

AS-0590: Effects of endovascular placement of stent-grafts on the prognosis of stanford type B aortic dissectionJing-fei Wei, et al



105

AS-0591: Clinical outcomes of overlapping second-generation drug eluting stents in patients with diffuse coronary lesionsFei Gao, et al

AS-0605: A compare of culprit vessel only versus staged percutaneous coronary intervention in ST-segment elevation myocardial infarction patients with multivessel disease for one-year follow-upPei-yuan He, et al

AS-0607: Transradial versus transfemoral percutaneous coronary intervention in elderly patients: a systematic overview and meta-analysisPei-yuan He, et al

AS-0609: High prevalence and risk factors of diabetes mellitus in Chinese rural populationXing-hu Zhou, et al

AS-0610: The effect of sarpogrelate on the platelet function in patients bridging dual-antiplatelet treatment to coronary artery bypass graftingMeng Peng, et al

AS-0611: Can atrial fibrillation alter ventricular repolarization presenting as a shortened QTc interval comparing to sinus rhythm？Song-nan Wen, et al

AS-0613: The prevalence and risk factors of depression symptoms in Chinese rural populationXing-hu Zhou, et al

AS-0616: The relationship between connexin 43 expression and stent restenosisYi-an Yao, et al

AS-0617: Clinical outcomes of individualized catheter ablation strategy in patients with paroxysmal atrial fibrillationDe-yan Yang, et al

AS-0621: Anxiety status in patients undergoing percutaneous coronary interventions in ChinaShui Yu, et al

AS-0622: Using nurse-patient cooperative quality control program on cardiac rehabilitation in patients undergoing percutaneous coronary intervention(PCI)in ChinaCheng-fei Wen, et al

AS-0624: The influence of community nursing intervention in quality of life in elderly patients with chronic heart failureYing Cui, et al

AS-0627: Effects of atorvastatin on contrast-induced nephropathy in patients with acute coronary syndrome undergoing selective coronary angiography or percutaneous coronary interventionXiang-fei Meng, et al

AS-0631: Effects of trimetazidine on hibernating myocardium evaluated by 18FDG PET-CTBo Shao, et al

AS-0632: Comparison of the safety and efficacy of 4-mm irrigated-tip and 8-mm-tip catheters for radiofrequency catheter ablation on persistent atrial fibrillation: lessons from a 5-year follow-upLing-min Wu, et al

AS-0636: Post-conditioning benefits acute myocardial infarction in the short-term during primary percutaneous coronary intervention but not in the long-term: a meta-analysis of randomised trialsZi-xiang Yu, et al

AS-0637: Comparison of transradial versus transfemoral method of percutaneous coronary revascularization for unprotected left main coronary artery disease: data derived from a large single center left main percutaneous coronary intervention registryZhan Gao, et al

AS-0641: Impact of disease extent on patients with unprotected left main coronary artery stenosis treated with drug-eluting stent: data derived from a large single center left main percutaneous coronary intervention registryZhan Gao, et al

AS-0645: Decreased pharmacodynamic effects from switching high-dose atorvastatin to rosuvastatin in senile Chinese patients with high platelet reactivityPing Mao, et al

AS-0646: Long-term outcomes of unprotected left main stenting with drug-eluting stent: data derived from a large single center left main percutaneous coronary intervention registryZhan Gao, et al

AS-0647: Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in ChinesechildrenPei An, et al

AS-0649: Assessment of culprit lesion morphology by IVUS and OCT in acute coronary syndromeYi-an Yao, et al

AS-0651: Paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of DES in-stent restenosis in small coronary arteries: a substudy of PEPCAD China ISR trialJie Qian, et al

AS-0652: Growth differentiation factor-15 genotype and plasma level: associations with coronary artery ectasiaTong Dai, et al

AS-0653: Paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of diffuse DES in-stent restenotic lesions: a substudy of PEPCAD China ISR trialBo Xu, et al

AS-0655: The association between atrial amyloidosis and atrial fibrillationYun-zi, et al

AS-0665: Clinical impact of prolonged dual antiplatelet therapy for true bifurcation coronary artery lesion treated with two-stents strategyWei Han, et al

AS-0680: Efficacy and safety of clopidogrel added proton pump inhibitors vs. clopidogrel in the treatment of cardiovascular patients after PCI: a meta-analysisJun Pang, et al

AS-0687: Association of cigarette consumption and body mass index in the cardiovascular risk surveyYi-ning, Yang, et al

AS-0688: Suv39h1 protects from myocardial ischemia-reperfusion injury in diabetic ratsJing Chen, et al

AS-0690: The efficacy and safety of coronary administration and intravenous administration of platelet glycoprotein IIb/IIIa antagonists in STEMI patients after PCIJun Pang, et al



106

AS-0691: Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of multivessel coronary artery disease: 12-month results from the prospectively oatient-level pooled analysis of the TARGET I and TARGET II trialsDong Yin, et al

AS-0694: Long-term effects of three different therapeutic strategies in patients with myocardial infarction presented with multivessel diseaseLe-feng Wang, et al

AS-0696: Circumferential pulmonary vein isolation guided by overlay Ref for the treatment of paroxysmal atrial fibrillationKai Tang, et al

AS-0701: Effects of absolute refractory period electrical stimulation with different amplitudes on cardiac function of rabbits with chronic heart failureXin-ning Li, et al

AS-0702: Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of long coronary lesions: 12-month results from the prospectively patient-Level pooled analysis of the TARGET I and TARGET II trialsDong Yin, et al

AS-0716: Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of small vessel disease: 12-month results from the prospectively patient-level pooled analysis of the TARGET I and TARGET II trialsDong Yin, et al

AS-0718: Induced pluripotent stem cells reprogrammed from human urine cells as a new strategy for cardiomyocytesYa-feng Zhou, et al

AS-0721: Improved biocompatibility of poly (lactic-co-glycolic acid) and poly-L-lactic acid blended with nanoparticulate amorphous calcium phosphate in vascular stent applicationsXiao-xin Zheng, et al

AS-0725: TREM-1 amplify chronic inflammation in experimental atherosclerosisYun-kai Wang, et al

AS-0728: The long-term effect of Ischaemic postconditioning on recovery of left ventricular contractile function after acute myocardial infarctionYu-xuan Lv, et al

AS-0729: The effect of Neuregulin-1/ErbB on heart structural remodelling and electrical remodelingShao-jun Wang, et al

AS-0731: The impact of biodegradable versus durable polymer drug-eluting stents on stent thrombosis in patients with coronary artery disease: a meta-analysis of 15 randomized trialsYao-jun Zhang, et al

AS-0733: The impact of everolimus versus other rapamycin derivatives eluting stents on clinical outcomes in patients with coronary artery disease: a meta-analysis of 16 randomized trialsYao-jun Zhang, et al

AS-0735: Impaired angiogenesis after hindlimb ischemia in an in vivo rat model with increased p-cresol levelsYa-jun Jing, et al

AS-0736: Long-term prognostic impact of cystatin C on acute coronary syndrome octogenarians with diabetes mellitusZhen-hong Fu, et al

AS-0737: Long-term clinical outcomes of 'complete, reasonable complete, and incomplete' revascularization after percutaneous intervention of unprotected left main coronary artery disease with drug-eluting stentsYao-jun Zhang, et al

AS-0741: Relationship between two-, three-dimensional quantitative coronary angiography and fractional flow reserve in true bifurcation: an accuracy of prediction and correlation assessmentYao-jun Zhang, et al

AS-0742: Decreased serum esRAGE level is associated with coronary artery remodeling in patients with type 2 diabetes: an intravascular ultrasound studyRun Du, et al

AS-0746: Post-procedural care and common complications in patients undergoing transcatheter aortic valve implantation: early single-center experience in 12 patientsHong-xia Niu et al

AS-0749: The procalcitonin could be a reliable marker for differential diagnosis of post-implant syndrome and infection following aortic stent graft placementLing Xue, et al

AS-0750: Synergistic association of DNA repair relevant genes polymorphisms with the risk of coronary artery disease in northeastern Han ChineseXiao-hong Yu, et al

AS-0752: Comparison of intravascular ultrasound versus angiography guided drug-eluting stent implantation: a meta-analysis of one randomized trial and ten observational studies involving 19, 619 patientsYao-jun Zhang, et al

AS-0754: The hemodynamics effects of recombinant human B-type natriuretic peptid on coronary circulation in York pigs model of acute myocardial infarction with heart failureJing Zhang, et al

AS-0755: Postablation neutrophil/lymphocyte ratio is correlated with recurrence after catheter ablation in patients with lone atrial fibrillationXue-yue Guo, et al

AS-0757: Complete atrio-ventricular block after percutaneous closure of perimembranous ventricular septal defect with modified double-disk occluder: a 10-year follow-up studyYuan Bai, et al

AS-0764: The efficacy and safety of prasugrel versus ticagrelor for patients with acute coronary syndrome: a meta analysisJun Pang, et al

AS-0765: The efficacy and safety of drug-eluting vs bare-metal stents in PCI patients: a meta-analysisJun Pang, et al

AS-0774: Transcatheter aortic valve implantation under local anesthesiaYong-jian Wu, et al



107

AS-0775: Impact of the permanent ventricular pacing on left ventricular function in pediatric patients with or without congenital heart defectsJun Yu, et al

AS-0776: Preliminary experience of transcatheter aortic valve implantation by direct aortic approachYong-jian Wu, et al

AS-0777: Relationship between the number of circulating endothelial progenitor cells and coronary vulnerable plaque in diabetic patients with acute coronary syndrome: virtual histology studyHai-bin Wang, et al

AS-0783: The rational usage of human resources and the investigation of nursing workloads of the cardiac care unit (CCU)Xiao-xing Feng, et al

AS-0785: Transcatheter closure of subarterial ventricular septal defect using a modified double-disk occluder: early to mid-term follow-up resultsPan Li, et al

AS-0786: Relationship between hyperglycemia and platelet activity in patients with myocardial infarctionMichal Terlecki, et al

AS-0788: Use of an Embrella embolic deflector system for cerebral protection during transcatheter aortic valve implantationMariam Samim, et al

AS-0789: Silent brain infarction after transcatheter aortic valve implantation: occurrence and distribution on diffusion-weighted MRIMariam Samim, et al

AS-0790: Co-injection basic fibroblast growth factor for adipose derived stem cells transplantation: improved cardiac remodelling and function of myocardial infarctionBao-zhu Wang, et al

E-CASE PRESENTATIONS 电子病例


108

CS-0003：右冠近端闭塞双侧

逆灌显影逆向失败正向开通

一例

吕安林

CS-0008：陷阱病例一例

吴强

CS-0030：严重钙化成角CTO支架不能通过怎么办？

柯永胜

CS-0077：钙化CTO病例胡涛

CS-0078：逆向处理复杂CTO病变

胡涛

CS-0085：左主干支架术后死

亡1例杨成明

CS-0088：支架内锚定技术改

善对吻边支球囊通过性

赵晓辉

CS-0099：解决导管打结的简

单方法

李春坚

CS-0105：首选前行还是逆行

路径？

周斌全

CS-0107：旋磨治疗严重钙化

病变伴夹层一例

曹阳

CS-0111：开通CTO出现夹层

和外膜血肿成功处理一例

吕安林

CS-0118：左主干病变介入治

疗病例

唐良秋

CS-0119：冠脉复杂病变介入

治疗病例

唐良秋

C S - 0 1 2 6：非前降支病变的

Wellens综合征一例胡丹凤

CS-0132：快速进展的动脉粥

样硬化病变：中草药是罪魁祸

首吗？

李崇剑

CS-0137：急性心肌梗死5进6双导管血栓抽吸一例

曹阳

CS-0140：左主干合并心源性

休克介入成功1例王倩

CS-0143：“Jail”球囊技术在

一例LM末端分叉病变PCI术中

的应用

朱中生

CS-0148：CABG术后桥血管闭

塞LM分叉病变的处理

田乃亮

CS-0151：复杂CTO逆向PCI治疗病例

金泽宁

CS-0152：前降支预扩张、夹

层、支架不能通过 - 择期补救

性旋磨1例马玉良

CS-0154：AMI合并多支CTO患者处理策略

周国伟

CS-0155：当急诊室遭遇休克

周国伟

CS-0161：5F ST01指引导管直

接抽吸在右冠急性闭塞患者中

的应用

尤威

C S - 0 1 7 1：C A B G术后应用

Tornus及Corsair前向开通LAD-CTO病变一例

陈晖

CS-0172：应用Corsair前向开

通前降支CTO一例

陈晖

CS-0179：复杂CTO逆向PCI治疗病例

金泽宁

CS-0181：经桡动脉7.5F无鞘指

引导管支持下完成CTO病变

赵慧强、陈晖

CS-0183：前降支重度钙化病

变旋磨后PCI两例

赵继义

CS-0186：前降支分叉病变单

支架策略—分支缺血处理及思

考1例马玉良

CS-0195：急性心肌梗死?重症

心肌炎？

潘德锋

CS-0198：前降支重度钙化病

例一例

朱华刚

CS-0210：2例CTO失败病例

孟舒

C S - 0 2 1 1：双侧造影：冠脉

“真”慢性闭塞性病变PCI的有效工具 - CTO病例报道

刘兵

CS-0233：变异型心绞痛

路雅茹

CS-0241：IABP辅助PCI处理高

龄伴右冠CTO的左主干体部病

变致心源性休克1例李虎

CS-0245：前降支全闭病变：

急性、慢性或是皆有？

杨靖

CS-0257：冠心病严重心力衰

竭介入治疗病例

姜东炬

CS-0261：IVUSE指导下的复杂

病变纪征

CS-0267：Promus Element支架

在分叉病变中纵向缩短一例

陆浩

CS-0271：IVUS指导下CTO介入

治疗1例崔锦钢

CS-0272：一例右冠起源异常

闭塞病变介入治疗李崇剑

CS-0283：球囊扩张导致螺旋

夹层形成病例

马颖艳

C S - 0 2 8 7：正向及逆向治疗

LAD-CTO失败病例

施鸿毓

CS-0293：严重的冠脉血管痉

挛一例

詹小娜

CS-0298：右冠状动脉开口支

架脱载病例

颜红兵

E-CASE PRESENTATIONS 电子病例


109

CS-0299：疑似固定狭窄的前

降支冠状动脉肌桥一例

颜红兵

CS-0300：桡动脉鞘导丝误入

肱动脉抓捕器处理一例

颜红兵

CS-0303：BVS (Absorb) in Young Patient with Diabetes MellitusRakesh. K. Jaswal

CS-0304：FFR联合IVUS评价冠

脉临界病变一例

邓捷

CS-0308：青年女性梅毒性心

脏病累及左主干开口致急性心

肌梗死行介入治疗1例裘毅钢

CS-0317：IVUS指导下切割球囊

治疗前降支支架内再狭窄病变

刘兵

CS-0323：右冠血栓高负荷急

诊处理一例

周卿

CS-0328：介入取出Arrow导管

一例

崔松

CS-0356：前降支CTO逆向介

入治疗病例金琴花

CS-0357：PCI患者肝素诱导血

小板减少一例？

崔松

CS-0362：分叉病变PCI治疗中

FFR的应用

金琴花

CS-0366：透析患者ACS的处理

刘巍

CS-0367：妊娠合并急性心肌

梗死病例

韩立宪

CS-0368：支架内血栓病例

信栓力

IM-0004：IVUS指导右冠CTO介入

柯永胜

IM-0017：IVUS指导下左主干分

叉病变介入治疗

章霞

IM-0021：冠脉夹层病例

宋明宝

IM-0027：酷似急性心肌梗死

的重症心肌心包炎2例陈章强

IM-0029：冠脉三支病变介入

术后出现室颤病例：空气栓

塞、冠脉痉挛？

陈章强

IM-0049：回旋支病变支架置

入术后斑块脱垂OCT指导下介

入治疗一例

赵继义

IM-0052：左室心肌致密化不

全病例

周力

IM-0078：LAD闭塞病变开通后

支架植入后一月支架贴壁不良

鄢华

IM-0101：IVUS指导CTO不同策

略治疗病例

范永臻


110

欢迎辞

尊敬的各位同仁、各位朋友：

我诚挚地欢迎您出席于2014年3月20日至23日在上海跨国采购会展中心举办的第十二届中国介入心脏病学大会（CIT）2014，本次会议由中华医学会主办，国家心血管病中心、中国介入心脏病学大会理事会、中华医学会心血管病学分会和美国心血管研究基金会协办，支持单位包括32家国际与国内专业学会及知名心脏中心。

CIT已进入了第二个十年，除传统的学术交流和技术培训外，新的使命和前景已经出现。从去年开始CIT这三个字母被赋予了新的意义：C-合作、I-创新、T-转化。CIT2014将秉承大会的核心理念与宗旨，在三天半的日程中安排超过1350个讲座 / 发言，超过700篇的论文交流及50例介入病例示教演示。盛大开幕式与全体大会将于2014年3月21日星期五上午举行。其它会议形式将包括口头和壁报论文交流、最新临床试验、专题学术研讨会及同步分会等以展示原创性研究。大会内容还深入涉及心血管介入相关基础研究、实用介入技术、介入药物学、心血管疾病预防及心血管影像等。CIT2014还将努力缩小证据与实践之间的差距，促进和加快经临床试验验证的新治疗方法融入临床实践中。CIT2014的“转化”主题还将突出心血管介入治疗实践当前与未来的发展方向，即从治疗阻塞性血管疾病扩展到其它常见心血管疾病，包括结构性心脏病、心房颤动及顽固性高血压等。

作为亚太地区介入心脏病学领域规模最大的学术会议，预计将有超过7500位心血管病学、放射介入学、血管外科等学科的专家和同道、企业合作伙伴及其他医疗卫生界人士参加本次大会。参会者将借此良机分享科学资讯和最新研究进展，交流介入心脏病学专业知识，同时共叙友谊以加强彼此间的合作。同时，CIT2014为企业搭建了独一无二的平台，用以展示最新技术和产品，促进其与心血管病专家实现更加密切的交流与合作。

十年之后CIT再一次在上海举行。上海是我国最大的城市，是我国最重要的文化、商业、金融、工业和交通中心之一。坐落于黄浦江畔的外滩是上海的标志之一，其各式西洋建筑均建于上世纪三十年代前，可谓“万国建筑博物馆”。黄浦江东岸（浦东）林立的高楼大厦建于1990年后，是改革开放的标志之一。夜幕降临，华灯初上，绚丽的灯光照亮浦江两岸，使上海成为名符其实的东方之珠。

我衷心希望CIT在各位同道、合作伙伴及企业单位的帮助和共同支持下，在未来能够取得更加辉煌的成绩。请允许我再次欢迎您出席第十二届中国介入心脏病学大会，并祝您在上海生活愉快！

高润霖教授中国介入心脏病学大会（CIT）主席

大会组织机构


111

大会主席

高润霖

共同主席

Martin B. Leon

学术委员会主席

霍勇

胡大一

联合主席

陈纪林

陈纪言

陈绍良

Jean Fajadet

葛均波

韩雅玲

黄德嘉

贾国良

蒋世良

Eisho Kyo

Yean-Leng Lim

吕树铮

马长生

Seung-Jung Park

乔树宾

Shigeru Saito

Patrick W. Serruys

沈卫峰

Gregg W. Stone

王海昌

王建安

王伟民

杨跃进

张澍

朱国英

张运

赵炳让

周爱卿

朱文玲

学术委员会

Yasushi Asakura

Maurice Buchbinder

Jacques Busquet

陈方

陈韵岱

Chung-Seung Chiang

Antonio Colombo

Costantino R. Costantini

Bernard De Bruyne

杜志民

Eric Eeckhout

Murray D. Esler

方全

方唯一

傅国胜

傅向华

高炜

Juan F. Granada

Liliana R. Grinfeld

Eberhard Grube

郭文怡

何奔

David E. Kandzari

Adnan Kastrati

Hyo-Soo Kim

Spencer B. King III

Ajay J. Kirtane

Alexandra J. Lansky

李建军

李占全

组织委员会名誉主席

胡盛寿

刘雁飞

祁国明

杨胜利

秘书长

徐波

专家指导委员会

曹克将

陈灏珠

陈君柱

陈树兰

陈在嘉

崔长琮

杜玉环

盖鲁粤

郭静萱

黄从新

蒋宝琦

柯元南

李华泰

李为民

林曙光

刘国树

刘唐威

刘伊丽

毛节明

倪幼方

秦学文

沈潞华

王方正

王凤芝

吴印生

曾定尹

大会组织机构


112

Roxana Mehran

Gary S. Mintz

Marie-Claude Morice

Thach Nguyen

Masahiko Ochiai

Horst Sievert

Huay Cheem Tan

Etsuo Tsuchikane

Renu Virmani

Ron Waksman

Craig M. Walker

王乐丰

Chris Kwok-Yiu Wong

徐亚伟

颜红兵

杨新春

杨延宗

Alan C. Yeung

于波

张瑞岩

周玉杰

组织委员会

陈珏

葛雷

郭伟

华伟

蒋雄京

金泽宁

荆全民

Michael Kang-Yin Lee

李浪

李怡

李悦

刘健

刘学波

刘宇扬

罗建方

聂绍平

钱杰

钱菊英

宋现涛

谭宁

吴永健

袁晋青

张斌

张奇

大会组织机构


113

国外主席团

Alexandre Abizaid巴西

Stephan Achenbach德国

Nazir Ahmed孟加拉国

Jung-Min Ahn韩国

Tae-Hoon Ahn韩国

Takashi Akasaka日本

Fernando Alfonso西班牙

Yaron Almagor以色列

Yasushi Asakura日本

Joseph D. Babb美国

Vinay K. Bahl印度

Theodore A. Bass美国

Marc Bedossa法国

Jacques Berland法国

Nelson Bernardo美国

Jacek Bialkowski波兰

Yuval Binur以色列

Maurice Buchbinder美国

Clifford Buckley美国

Wacin Buddhari泰国

Jacques Busquet法国

Davide Capodanno意大利

Anil Chagarlamudi美国

Jack P. Chen美国

Paul TL Chiam新加坡

Kenneth Chin马来西亚

Min Young Cho韩国

Gim-Hooi Choo马来西亚

Antonio Colombo意大利

Costantino O. Costantini巴西

Costantino R. Costantini巴西

Paul Cummins荷兰

Donald E. Cutlip美国

Ramesh B. Daggubati美国

Debabrata Dash印度

Rajesh Dave美国

Justin E. Davies英国

Keith D. Dawkins美国

Bernard De Bruyne比利时

Tom De Potter比利时

Anthony DeMaria美国

Eric Dippel美国

Timothy Dy菲律宾

W. Britton Eaves美国

Benit Edouard比利时

Murray D. Esler澳大利亚

Jean Fajadet法国

William F. Fearon美国

Ted E. Feldman美国

Peter J. Fitzgerald美国

Philippe Généreux美国

Ömer Göktekin土耳其

Nina Goodheart美国

B. K. Goyal印度

Juan F. Granada美国

Liliana R. Grinfeld阿根廷

Eberhard Grube德国

Hyeon-Cheol Gwon韩国

Yuji Hamazaki日本

Tetsuya Hata日本

Ziyad M. Hijazi美国

Yutaka Hikichi日本

John McB. Hodgson美国

Myeong-Ki Hong韩国

Dongming Hou美国

Seung-Ho Hur韩国

Hweung Kon Hwang韩国

Yasumi Igarashi日本

大会组织机构


114

Fumiaki Ikeno日本

Yang-Soo Jang韩国

Rakesh K. Jaswal印度

Nigel Jepson澳大利亚

Haizal Haron Kamar马来西亚

David E. Kandzari美国

Soo-Jin Kang韩国

Saibal Kar美国

Adnan Kastrati德国

Hyo-Soo Kim韩国

Young-Hak Kim韩国

Spencer B. King III美国

Ajay J. Kirtane美国

Tian-Hai Koh新加坡

Bon-Kwon Koo韩国

Jan Kovac英国

Richard C. Kovach美国

Mitchell W. Krucoff美国

Eisho Kyo日本

Alexandra J. Lansky美国

Nae Hee Lee韩国

Martin B. Leon美国

Amir Lerman美国

Michael Lim新加坡

Richard Lim澳大利亚

Yean-Leng Lim澳大利亚

Sidney Tsz Ho Lo澳大利亚

William L. Lombardi美国

Chaim S. Lotan以色列

Josef Ludwig德国

Ryan D. Madder美国

Akiko Maehara美国

Felix Mahfoud德国

Fazila Tun Nesa Malik孟加拉国

Jean Marco法国

Motomaru Masutani日本

Samuel K. Mathew印度

Roxana Mehran美国

Nazir Ahmed Memon巴基斯坦

Carlos Mena美国

Ian T. Meredith澳大利亚

Gary S. Mintz美国

Rosli Mohd Ali马来西亚

Marie-Angèle Morel荷兰

Marie-Claude Morice法国

Jeffrey W. Moses美国

Toshiya Muramatsu日本

Michael A. Mussallem美国

Christoph K. Naber德国

Aravinda Nanjundappa美国

Richard Ng新加坡

Swee Choon Ng马来西亚

Thach Nguyen美国

Masahiko Ochiai日本

Masaaki Okutsu日本

Yoshinobu Onuma荷兰

Satoru Otsuji日本

Kenan Ovunc土耳其

Jai-Wun Park德国

Kyung-Woo Park韩国

Sang Man Park韩国

Seung-Jung Park韩国

Roberto Patarca美国

Atul Pathak法国

Raghotham R. Patlola美国

Nico H. J. Pijls荷兰

Matthew J. Price美国

Jenny Zhen Qin美国

大会组织机构


115

Sufia Rahman孟加拉国

Sudhir Rathore英国

Johan H. C. Reiber荷兰

Gianluca Rigatelli意大利

Alfredo E. Rodriguez阿根廷

Campbell Rogers美国

Martin T. Rothman美国

Witold Ruzyllo波兰

Shigeru Saito日本

Sean Salmon美国

Gustavo Samaja阿根廷

Teguh Santoso印度尼西亚

Bruno Scheller德国

Wolfgang Schillinger德国

Patrick W. Serruys荷兰

Ashok Seth印度

Magnus Settergren瑞典

Imad Sheiban意大利

Won-Heum Shim韩国

Thomas Shimshak美国

Eak-Kyun Shin韩国

Horst Sievert德国

Kui-Hian Sim马来西亚

Charles A. Simonton美国

Pieter C. Smits荷兰

Shinjo Sonoda日本

Pieter R. Stella荷兰

Gregg W. Stone美国

Neil E. Strickman美国

Satoru Sumitsuji日本

Harry Suryapranata荷兰

Rurus Suryawan印度尼西亚

Malgorzata Szkutnik波兰

Seung-Jea Tahk韩国

Akihiko Takahashi日本

Masamichi Takano日本

Corrado Tamburino意大利

Huay Cheem Tan新加坡

Etsuo Tsuchikane日本

Thomas M. Tu美国

Wasan Udayachalerm泰国

Mujeeb Ul-Haq巴基斯坦

Pietro Vandoni意大利

Joseph Varon美国

Rajesh Vijayvergiya印度

Renu Virmani美国

Kenji Wagatsuma日本

Marco Wainstein巴西

Ron Waksman美国

Craig M. Walker美国

Wan Azman Wan Ahmad马来西亚

Jie Wang美国

Kai Wang美国

John G. Webb加拿大

Shing-Chiu Wong美国

Marvin L. Woodall美国

Yoshito Yamamoto日本

Masahisa Yamane日本

Joo-Young Yang韩国

Yi-Ming Yang美国

Yee Guan Yap马来西亚

Alan C. Yeung美国

Fuminobu Yoshimachi日本

Jiangtao Yu德国

Robaayah Zambahari马来西亚

David X. M. Zhao美国

大会组织机构


116

港澳台主席团

Alan Ka-Chun Chan香港, 中国

Chi-Kin Chan香港, 中国

Jason Leung-Kwai Chan香港, 中国

Kam-Tim Chan香港, 中国

Kelvin Chan香港, 中国

Wai-Kwong Chan香港, 中国

Chung-Seung Chiang香港, 中国

Tak-Shun Chung香港, 中国

Xiwei Deng澳门, 中国

Ching-Chang Fang台湾, 中国

William Kongto Hau香港, 中国

Duncan Hung-Kwong Ho香港, 中国

I-Chang Hsieh台湾, 中国

Chien-Ming Huang台湾, 中国

Paul Hsien-Li Kao台湾, 中国

Patrick Tak-Him Ko香港, 中国

Vincent On-Hing Kwok香港, 中国

Simon Cheung-Chi Lam香港, 中国

U Po Lam澳门, 中国

Yat-Yin Lam香港, 中国

Chu-Pak Lau香港, 中国

Michael Kang-Yin Lee香港, 中国

Stephen Wai-Luen Lee香港, 中国

Wen-Lieng Lee台湾, 中国

Changzhao Liao台湾, 中国

Ping-Han Lo台湾, 中国

Ju-Pin Pan台湾, 中国

Li-Wah Tam香港, 中国

Chuen-Den Tseng台湾, 中国

Kin-Lam Tsui香港, 中国

Ping-Tim Tsui香港, 中国

Shih-Pu Wang台湾, 中国

Chris Kwok-Yiu Wong香港, 中国

Edmond Wong香港, 中国

Philip Hung-Chung Wong香港, 中国

Chiung-Jen Wu台湾, 中国

Wei-Hsian Yin台湾, 中国

Cheuk-Man Yu香港, 中国

大会组织机构


117

国内主席团

安健（山西）

安毅（山东）

白锋（甘肃）

卜军（上海）

蔡尚郎（山东）

曹丰（陕西）

曹雪滨（河北）

常光其（广东）

常谦（北京）

陈步星（北京）

陈方（北京）

陈晖（北京）

陈纪林（北京）

陈纪言（广东）

陈珏（北京）

陈柯萍（北京）

陈良龙（福建）

陈林（福建）

陈茂（四川）

陈明龙（江苏）

陈绍良（江苏）

陈文强（山东）

陈玉国（山东）

陈韵岱（北京）

陈智（湖南）

陈忠（北京）

陈竹君（广东）

程标（四川）

程冠昌（河南）

程姝娟（北京）

程晓曙（江西）

程应樟（江西）

丛洪良（天津）

崔俊玉（北京）

崔连群（山东）

戴军（北京）

党群（天津）

丁世芳（湖北）

丁燕生（北京）

董建增（北京）

董平栓（河南）

窦克非（北京）

杜志民（广东）

樊冰（上海）

方丕华（北京）

方全（北京）

方唯一（上海）

冯燕光（河北）

冯沅（四川）

傅国胜（浙江）

傅向华（河北）

符伟国（上海）

甘继宏（新疆）

高传玉（河南）

高连君（辽宁）

高平进（上海）

高润霖（北京）

高伟（上海）

高炜（北京）

高展（北京）

葛均波（上海）

葛雷（上海）

宫剑滨（江苏）

顾东风（北京）

谷涌泉（北京）

管军（山东）

光雪峰（云南）

郭成军（北京）

郭金成（北京）

郭军（北京）

郭丽君（北京）

郭宁（陕西）

郭涛（云南）

郭伟（北京）

郭文怡（陕西）

郭晓华（内蒙古）

韩立宪（河北）

韩雅玲（辽宁）

韩战营（河南）

杭靖宇（上海）

郝云霞（北京）

何奔（上海）

何青（北京）

何作祥（北京）

贺勇（四川）

贺玉泉（吉林）

洪葵（江西）

洪浪（江西）

侯桂华（北京）

侯静波（黑龙江）

侯玉清（广东）

侯子山（山东）

胡承恒（广东）

胡大一（北京）

胡奉环（北京）

胡盛寿（北京）

华伟（北京）

华倚虹（北京）

华益民（四川）

黄超联（北京）

黄德嘉（四川）

黄鹤（湖北）

黄岚（重庆）

黄连军（北京）

黄榕翀（辽宁）

黄石安（广东）

黄伟剑（浙江）

惠永明（北京）

霍勇（北京）

籍振国（河北）

纪征（河北）

贾国良（广东）

贾绍斌（宁夏）

贾永平（山西）

江洪（湖北）

江时森（江苏）

姜东炬（辽宁）

姜建（辽宁）

姜铁民（天津）

蒋晨阳（浙江）

蒋金法（上海）

蒋俊豪（上海）

蒋峻（浙江）

蒋米尔（上海）

蒋世良（北京）

蒋雄京（北京）

金惠根（上海）

金梅（北京）

金琴花（北京）

金元哲（辽宁）

金泽宁（北京）

晋军（重庆）

靳立军（广东）

荆全民（辽宁）

柯永胜（安徽）

孔祥清（江苏）

黎辉（黑龙江）

李保（山西）

李成祥（陕西）

大会组织机构


118

李传昶（湖南）

李奋（上海）

李广平（天津）

李贵双（山东）

李国庆（新疆）

李虹伟（北京）

李虎（广东）

李继福（山东）

李建军（北京）

李建平（北京）

李康（北京）

李浪（广西）

李丽（广东）

李莉（上海）

李莉（河北）

李凌（河南）

李潞（辽宁）

李淑梅（吉林）

李述峰（黑龙江）

李思进（山西）

李田昌（北京）

李卫（北京）

李伟杰（陕西）

李伟明（上海）

李晓东（辽宁）

李新明（上海）

李学斌（北京）

李学奇（黑龙江）

李亚明（辽宁）

李妍（陕西）

李怡（广东）

李毅（辽宁）

李毅刚（上海）

李拥军（河北）

李悦（黑龙江）

李占全（辽宁）

李志忠（北京）

廉哲勋（山东）

梁春（上海）

梁延春（辽宁）

林荣（福建）

林文华（天津）

林先和（安徽）

林英忠（广西）

刘斌（吉林）

刘昌伟（北京）

刘朝中（北京）

刘凡（河北）

刘海波（北京）

刘和平（吉林）

刘宏斌（北京）

刘红旭（北京）

刘慧（河南）

刘惠亮（北京）

刘健（北京）

刘建平（重庆）

刘梅林（北京）

刘强（广东）

刘全（吉林）

刘少稳（上海）

刘同库（吉林）

刘兴鹏（北京）

刘旭（上海）

刘学波（上海）

刘焱（北京）

刘寅（天津）

刘宇扬（北京）

刘震宇（北京）

柳弘（北京）

柳景华（北京）

卢才义（北京）

卢长林（北京）

卢成志（天津）

陆林（上海）

陆志刚（上海）

鹿庆华（山东）

吕安林（陕西）

吕滨（北京）

吕吉元（山西）

吕树铮（北京）

罗建方（广东）

罗七一（上海）

马长生（北京）

马根山（江苏）

马坚（北京）

马礼坤（安徽）

马利平（河南）

马依彤（新疆）

马颖艳（辽宁）

满荣海（内蒙古）

毛静远（天津）

苗立夫（北京）

慕朝伟（北京）

聂如琼（广东）

聂绍平（北京）

宁光（上海）

牛锁成（河南）

潘欣（上海）

庞文跃（辽宁）

彭建军（北京）

浦介麟（北京）

浦奎（天津）

齐国先（辽宁）

齐向前（天津）

齐晓勇（河北）

钱杰（北京）

钱菊英（上海）

钱明阳（广东）

乔树宾（北京）

覃军（重庆）

秦雷（河南）

秦勤（天津）

秦永文（上海）

秦玉明（江苏）

邱春光（河南）

仇玉民（宁夏）

曲鹏（辽宁）

曲新凯（上海）

曲秀芬（黑龙江）

汝磊生（河北）

单继平（山东）

单其俊（江苏）

单守杰（江苏）

沈成兴（上海）

沈法荣（浙江）

沈卫峰（上海）

沈向前（湖南）

沈珠军（北京）

盛国太（江西）

施海峰（上海）

施海明（上海）

石洪成（上海）

史冬梅（北京）

史新立（北京）

舒畅（湖南）

宋现涛（北京）

宋耀明（重庆）

宋治远（重庆）

苏晞（湖北）

宿燕岗（上海）

大会组织机构


119

孙福成（北京）

孙华保（广东）

孙宁玲（北京）

孙英贤（辽宁）

孙勇（黑龙江）

孙勇（浙江）

谭宁（广东）

汤宝鹏（新疆）

唐发宽（北京）

唐疾飞（浙江）

唐礼江（浙江）

唐良秋（广东）

唐强（北京）

唐熠达（北京）

唐元升（山东）

陶贵周（辽宁）

陶军（广东）

陶凌（陕西）

田红燕（陕西）

田军（天津）

田野（黑龙江）

万征（天津）

汪芳（上海）

王斌（北京）

王长谦（上海）

王冬梅（河北）

王东琦（陕西）

王风（广西）

王耿（辽宁）

王广义（北京）

王贵松（北京）

王海昌（陕西）

王浩（北京）

王慧峰（山西）

王继光（上海）

王建安（浙江）

王景峰（广东）

王敬蓱（山西）

王凯（内蒙古）

王乐丰（北京）

王雷（北京）

王宁夫（浙江）

王蒨（北京）

王齐兵（上海）

王琦光（辽宁）

王庆胜（河北）

王琼（陕西）

王守力（北京）

王巍（北京）

王伟（天津）

王玮（广东）

王伟民（北京）

王显（北京）

王效增（辽宁）

王焱（福建）

王勇（北京）

王勇（山东）

王禹（北京）

王跃涛（江苏）

王玉林（山东）

王玉堂（北京）

王震（河北）

王志方（河南）

王祖禄（辽宁）

魏盟（上海）

温尚煜（黑龙江）

翁少翔（浙江）

吴淳（广东）

吴铿（广东）

吴立群（上海）

吴明（海南）

吴其明（北京）

吴书林（广东）

吴同果（广东）

吴小凡（北京）

吴永健（北京）

伍广伟（广西）

伍伟锋（广西）

夏勇（江苏）

向定成（广东）

项美香（广东）

肖纯（广东）

信栓力（河北）

徐标（江苏）

徐波（北京）

徐凯（辽宁）

徐伟（江苏）

徐亚伟（上海）

徐延敏（天津）

徐迎佳（上海）

徐泽升（河北）

徐仲英（北京）

许锋（北京）

许静（天津）

许力舒（新疆）

许亮（北京）

薛朝阳（宁夏）

薛玉增（山东）

严激（安徽）

颜红兵（北京）

闫振成（重庆）

杨波（内蒙古）

杨成明（重庆）

杨汉东（湖北）

杨杰孚（北京）

杨峻青（广东）

杨丽霞（云南）

杨明（北京）

杨萍（吉林）

杨平珍（广东）

杨胜利（北京）

杨树森（黑龙江）

杨天和（贵州）

杨庭树（北京）

杨伟宪（北京）

杨向军（江苏）

杨新春（北京）

杨延宗（辽宁）

杨毅宁（新疆）

杨永健（四川）

杨跃进（北京）

杨志健（江苏）

杨志明（山西）

姚民（北京）

姚焰（北京）

姚朱华（天津）

叶飞（江苏）

叶红华（浙江）

叶猛（上海）

叶平（北京）

易岂建（重庆）

尹荣秀（北京）

殷跃辉（重庆）

尤士杰（北京）

由倍安（山东）

于波（黑龙江）

余华（安徽）

俞梦越（北京）

袁洪（湖南）

袁晋青（北京）

大会组织机构


120

袁勇（广东）

袁祖贻（陕西）

曾和松（湖北）

曾秋棠（湖北）

曾玉杰（北京）

曾智（四川）

张斌（广东）

张大东（上海）

张代富（上海）

张福春（北京）

张刚成（湖北）

张高星（广东）

张戈军（北京）

张寰（天津）

张军（河北）

张俊杰（江苏）

张励庭（广东）

张敏州（广东）

张明（辽宁）

张萍（北京）

张奇（上海）

张清（上海）

张瑞岩（上海）

张澍（北京）

张树林（北京）

张抒扬（北京）

张伟华（云南）

张卫泽（甘肃）

章希炜（江苏）

张瑶俊（江苏）

张玉顺（陕西）

张钲（甘肃）

张智伟（广东）

赵全明（北京）

赵世华（北京）

赵仙先（上海）

赵叶琳（北京）

赵迎新（北京）

赵志敬（陕西）

郑金刚（北京）

郑良荣（浙江）

郑强荪（陕西）

郑杨（吉林）

郑哲（北京）

周斌全（浙江）

周达新（上海）

周国伟（上海）

周立君（黑龙江）

周胜华（湖南）

周旭晨（辽宁）

周颖玲（广东）

周玉杰（北京）

朱国英（湖北）

朱建华（浙江）

朱俊（北京）

朱鲜阳（辽宁）

朱永宏（广东）

庄少伟（上海）

訾振军（上海）

邹建刚（江苏）

邹阳春（北京）

邹英华（北京）

秘书处

陈凯副秘书长

戴丽峰

高妍

冯志勇

黄婉

李弘玥

会议信息


121

1．会议时间 2014年3月20-23日

2．会议地点上海跨国采购会展中心

上海市普陀区中江路35号

电话：021- 6029 0070

3．代表报到

注册台开放时间

2014年3月19日 10:00AM – 9:00 PM

2014年3月20日 07:30AM – 9:00 PM

2014年3月21-22日 08:00AM – 5:30 PM

2014年3月23日 08:00AM – 11:00 AM

现场注册费标准：RMB1300.00注册台电话：+86 21 32576900

4．会议语言

CIT2014会议正式语言为英、中双语，会议期间，部分会场将配

备专业级现场英中或中英同声翻译（详情请查看详细日程中标

记为【同传耳机标示】的内容），届时请在会议厅门口办理同

传耳机租用手续。

凡是日程中标记为＂Ｐ＂的会场，届时将提供中英双语的幻

灯片。

5．代表标识

胸卡是参会代表的标识。请在参加会议活动和使用茶点时佩戴胸卡。没有

佩带胸卡的代表将无法进入会场听会。

佩戴红色胸卡绳的为会议主席团成员，

佩戴蓝色胸卡绳的为会议正式代表，

佩戴绿色胸卡绳的为参展公司代表，

佩戴黄色胸卡绳的为会议工作人员，

佩戴白色胸卡绳的为听课证代表

6．CIT咖啡站

今年的CIT大会将为每位正式的参会代表发放两张免费的咖啡换

取券。每张咖啡券可换取一杯美式咖啡。CIT咖啡站设在一层展

区内。

7．用餐

本次会议进餐地点如下，请凭餐券就餐。

早餐午餐晚餐

3月19日上海跨国采购会展中心二层侧廊自助餐

上海跨国采购会展中心二层侧廊自助餐

3月20日代表所在酒店用餐参加早间会的代表可在

会场内用早餐

上海跨国采购会展中心午餐盒



会场内用早餐




会场内用早餐




会场内用早餐


8．展览

本次会议期间同时举行心脏介入相关医药器械等方面的展览。

展览地点：上海跨国采购会展中心一层展厅

展览时间： 3月20日 12:30 PM-6:00 PM

3月21-22日 9:00 AM-5:00 PM

9．会议重要活动安排

开幕式及全体大会

地点：上海跨国采购会展中心三层明珠厅

时间：2014年3月21日8:00 AM-12:30 PM

10．学术交流

A．学术交流日程

学术交流完全按大会最终日程册安排进行，请发言的代表注意自己的发言

日期和时间并提前作好准备。

B．幻灯片

本次大会备有试片室（上海跨国采购会展中心一层大厅），请发言的代表

在发言前至少三小时前往试片室递交幻灯片（上午发言的请于前一天下午

递交）。

会议信息


122

C．试片室开放时间

3月19日星期三 2:00 PM – 7:00 PM

3月20日星期四 7:30 PM – 6:30 PM

3月21日星期五 6:30 AM – 6:30 PM

3月22日星期六 6:30 AM – 6:30 PM

3月23日星期日 6:30 AM – 11:30 AM

电话: +86 21 32576901

D．免费上网和WIFI大会在一层展厅内设立了免费上网区，欢迎参会代表使用。同时，在上海

跨国采购会展中心内大会提供免费WIFI网络。请留意现场公布的上网注意

事项。

11．主席团休息室

主席团休息室位于上海跨国采购会展中心一层大厅，对大会主席团成员和

特邀嘉宾开放。并免费提供茶水、咖啡、甜点及上网服务。

12.．主持壁报交流

CIT2014的壁报交流将回归传统方式，并以主持及问答的形式展

开。为了体现大会对CIT2014壁报交流的重视，大会届时将关

闭大多数分会场，鼓励参会者都去参加壁报交流，并且有主持

人在现场进行监场和提问。为此，大会将要求代表在指定时间

内前往壁报区张贴壁报，并在壁报交流期间站在壁报前参与问答的交流环

节。主持壁报交流将于2014年3月20日下午16:00-18:00在一层展区内的壁报

区开展，欢迎各位代表前往参与交流。

13.．电子病例交流区

CIT2014的电子病例交流区设在会议三层的中庭区内。欢迎代表前往观摩及

参与交流。

14．TCTMD中文网页发布

为了让更多的国内代表更快更全面的了解国际资讯，美国TCT大会的学术教育网站www.tctmd.com 的中文网页将在CIT大会期间首

次发布。代表现在可以通过登录该网页的中文页面，查看该网

站发布的心血管介入领域最新学术论文的中文翻译。TCTMD in Chinese将在

大会的一层展厅设服务区，欢迎代表前往观摩学习。

15．CIT On-demand服务区/CIT在线，从容参会再不“分身乏术”

随着CIT会议规模的不断扩大，学术会场的不断增多，在同一时间，代表都

会面临只能参加一个会场而错过其他会场精彩日程的困难，为了更好的解

决这一问题，CIT2014大会将首次启用日程实时视频回放系统，旨在帮助代

表更加全面的了解在CIT各会场发布的各项最新学术内容，从而达到参会学

习的目的。

从2014年3月21日开始，代表可在CIT On-demand服务区通过登录网站

www.citondemand.org 输入登录卡上的密码来浏览CIT前一天的所有学术

会场的实时日程回放。代表可以有选择的浏览因为时间关系错过的精彩

日程。

注意：

代表手持的登录卡均配备登录密码，可随时登录www.citondemand.org查看

日程视频回放（并不只限于在会议期间），但是该登录卡一旦使用，在一

年内有效。

16．返程票预定

大会将在报到现场为代表提供办理机票和火车票的代理商的联系方式，请

需要的代表于报到当日到大会注册台咨询。

123

日程一览表


124

日程一览表


07:0

0 AM

07:3

0 AM

08:0

0 AM

08:3

0 AM

09:0

0 AM

09:3

0 AM

10:0

0 AM

10:3

0 AM

11:0

0 AM

11:3

0 AM

12:0

0 PM

12:3

0 PM

01:0

0 PM

01:3

0 PM

02:0

0 PM

02:3

0 PM

03:0

0 PM

03:3

0 PM

04:0

0 PM

04:3

0 PM

05:0

0 PM

05:3

0 PM

2014

年3月

20日　星期四

201

会议室

202

会议室

203

会议室

204

会议室

205

会议室

207

会议室

208

会议室

305A

会议室

305B

会议室

302A

会议室

302B

会议室

307

会议室

3M5

会议室

一层

展厅

三层

夹层

206

会议室

经导管瓣膜治疗（转播

3：阜外医院）

生物可吸收血管支架

WIN

at

CIT

主持壁报交流（一层展厅）和

电子病例讨论（三层中庭）

整合应用

FF

R、

IVU

S、

OC

T及其他以改善患者疗效

第六届临床研究专题研讨峰会

摘要口头报告

摘要口头报告

摘要口头报告

最具教育意义病例竞赛




展览

实习中心

摘要口头报告

转播

1：阜外医院及特色报告

第六届临床研究专题研讨峰会

整合应用

FF

R、

IVU

S、

OC


午间卫星会

- 秦

明医疗

午间卫星会

- A

sah

i和星进

午间卫星会

- 贝朗

午间卫星会

- 迈柯唯

午间卫星会

- 博莱科信谊

去肾神经化技术

午间研讨会

午间卫星会

- 微

创

中国介入创新的

现状和未来

左主干和分叉病变

心导管术基础

PC

I技术和疗效

Was

hin

gton

DC

ME

DS

TAR

S

ympo

siu

m a

t C

IT

转播

2：阜外医院及特色报告

HK

STE

NT

at C

IT

125

日程一览表


07:0

0 AM

07:3

0 AM

08:0

0 AM

08:3

0 AM

09:0

0 AM

09:3

0 AM

10:0

0 AM

10:3

0 AM

11:0

0 AM

11:3

0 AM

12:0

0 PM

12:3

0 PM

01:0

0 PM

01:3

0 PM

02:0

0 PM

02:3

0 PM

03:0

0 PM

03:3

0 PM

04:0

0 PM

04:3

0 PM

05:0

0 PM

05:3

0 PM

2014

年3月

21日　星期五

明珠厅

201

会议室

202

会议室

203

会议室

204

会议室

206

会议室

207

会议室

208

会议室

305A

会议室

305B

会议室

302A

会议室

302B

会议室

307

会议室

3M5

会议室

一层

展厅

三层

夹层

205

会议室

CIT

2014

开幕式和全体大会（转播

4：哥伦比亚医学中心）

最新临床试验

EA

PC

I-E

uro

PC

R a

t C

IT（转播

7：圣托马斯医院）

转播

9：瑞金医院及特色报告

第五届旋磨技术小型研讨会

冠脉介入实用教程

- 怎

么做：复杂病例讨论

转播

8：中山医院及特色报告

介入心脏病学热点

整合应用

FF

R、

IVU

S、

OC


非S

T段抬高型急性冠脉综合征

药物学研讨会

- 赛诺菲

药物学研讨会

- 施维雅

心律失常

结构性心脏病

基础与药物

ISE

S a

t C

IT（转播

10：中山医院）

药物洗脱支架

- 当

代器械的适当使用

向C

TO专家学技术：逐步病例回顾

展览

实习中心


转播

5：瑞金医院

（外周血管疾病）

午间卫星会

- 微创

午间卫星会

- 柏盛和吉威

午间卫星会

- 雅培血管仪器部

午间卫星会

- 波士顿科学

午间卫星会

- 美敦力

午间卫星会

- 万瑞飞鸿

午间卫星会

- 圣犹达

午间卫星会

- 易生科技

午间卫星会

- 启明医疗

午间卫星会

- 垠艺

午间卫星会

-

GE医疗

午间卫星会

- 强生

午间卫星会

- 阿斯利康

午间卫星会

- 星进

病例早餐会

心律失常

向C

TO专家学技术：逐步病例回顾

心肌缺血和冠心病诊断治疗

转播

6：中山医院

（结构性心脏病）

TRI俱

乐部

126

日程一览表


07:0

0 AM

07:3

0 AM

08:0

0 AM

08:3

0 AM

09:0

0 AM

09:3

0 AM

10:0

0 AM

10:3

0 AM

11:0

0 AM

11:3

0 AM

12:0

0 PM

12:3

0 PM

01:0

0 PM

01:3

0 PM

02:0

0 PM

02:3

0 PM

03:0

0 PM

03:3

0 PM

04:0

0 PM

04:3

0 PM

05:0

0 PM

05:3

0 PM

2014

年3月

22日　星期六

明珠厅

201

会议室

202

会议室

203

会议室

204

会议室

206

会议室

207

会议室

208

会议室

一层

展厅

三层

夹层

205

会议室

左心耳封堵（转播

14：浙大二院）


- 慢

性完全闭塞

ST段抬高型心肌梗死


药物学

研讨会

- 拜

耳

心律失常

结构性心脏病

PC

I技术和疗效

外周血管治疗

药物涂层球囊

经导管瓣膜治疗培训课程

展览

实习中心

CR

T at

CIT

特色研究首次

公布

MY

LIV

E a

t C

IT


- 怎

么做：争议病例讨论

整合应用

FF

R、

IVU

S、

OC


SC

AI a

t C

IT

TRI俱

乐部

药物学研讨会

- 阿

斯利康

心律失常

结构性心脏病

基础与药物

NC

VH a

t C

IT

药物洗脱支架

- 生

物可降解聚合物和无聚

合物支架

主动脉瘤腔内治疗论坛

第九届护士和技术人员研讨会

去肾神经化治疗

CC

T at

CIT（转播

11：中山医院）

午间卫星会

- 波士顿科学

午间卫星会

- 乐普医疗

午间卫星会

- 美敦力

午间卫星会

-

GE医疗

午间卫星会

- 雅培血管仪器部

午间卫星会

- 泰尔茂

午间卫星会

- 赛诺医疗

午间卫星会

- 戈德曼

午间卫星会

- 先健科技

午间卫星会

- 火山

午间卫星会

- 瑞安泰

午间卫星会

- 西门子

午间卫星会

- 赛诺菲

病例早餐会

早餐会

- 泰尔茂

病例早餐会

转播

13：浙大二院及特色报告

转播

16：南京市一

EN

CO

RE

at

CIT

特色药物洗脱支架最新

试验

转播

12：瑞金医院及特色报告

Car

diov

ascu

lar

Su

mm

it

- T

CTA

P a

t C

IT

转播

15：南京市一

AIC

T at

CIT

305A

会议室

305B

会议室

302A

会议室

302B

会议室

307

会议室

3M5

会议室

127

日程一览表


07:0

0 AM

07:3

0 AM

08:0

0 AM

08:3

0 AM

09:0

0 AM

09:3

0 AM

10:0

0 AM

10:3

0 AM

11:0

0 AM

11:3

0 AM

12:0

0 PM

12:3

0 PM

01:0

0 PM

01:3

0 PM

02:0

0 PM

02:3

0 PM

03:0

0 PM

03:3

0 PM

04:0

0 PM

04:3

0 PM

05:0

0 PM

05:3

0 PM

2014

年3月

23日　星期日

201

会议室

202

会议室

203

会议室

204

会议室

205

会议室

207

会议室

208

会议室

206

会议室

CC

C/C

ISC精选


- 慢

性完全闭塞

第六届冠脉介入治疗“精选”并发症论坛

整合应用

FF

R、

IVU

S、

OC


闭幕式


心血管无创影像

心血管疾病合并糖尿病患者的综合管理

心律失常

征集病例讨论

征集病例讨论

征集病例讨论

征集病例讨论

病例讨论：外周和腔内血管介入

GA

P-C

CB

C精选

病例早餐会

305A

会议室

305B

会议室

302A

会议室

302B

会议室

307

会议室

3M5

会议室

示教演示中心


128

国际美国纽约长老会医院 / 哥伦比亚大学医学中心

英国伦敦圣托马斯医院

国内国家心血管病中心阜外医院

复旦大学附属中山医院

上海交通大学医学院附属瑞金医院

南京医科大学附属南京市第一医院

浙江大学医学院第二附属医院


129


二层201会议室

经导管瓣膜治疗1:00 PM-6:00 PM

第一场：经导管主动脉瓣置换 - 当前实践和争议

主持人：Martin B. Leon, Eberhard Grube讨论专家：Philippe Généreux, Michael A. Mussallem, Christoph K. Naber, John G. Webb, Shing-Chiu Wong, David X. M. Zhao

1:00 PM - 从外科球体瓣膜到经皮导管置换的卓越征程Michael A. Mussallem

1:12 PM - 当代顶尖水准：经济高效的经导管主动脉瓣置换John G. Webb

1:22 PM - 经导管主动脉瓣置换循证医学：临床结果和争议Martin B. Leon

经导管主动脉瓣置换并发症研讨会

1:32 PM - 卒中及其预防Christoph K. Naber

1:40 PM - 血管性并发症及出血Philippe Généreux

1:48 PM - 瓣周返流Eberhard Grube

1:56 PM - 专家讨论

第二场：亚太地区经导管主动脉瓣置换现状

主持人：葛均波, Alan C. Yeung讨论专家：Wacin Buddhari, Paul TL Chiam, 陈茂, Hyo-Soo Kim, 孔祥清, Jan Kovac, Michael Kang-Yin Lee, Shigeru Saito, 张瑞岩

2:10 PM - 转播：阜外心血管病医院自膨胀型Venus-A经导管主动脉瓣置换系统术者：Horst Sievert, 杨跃进, 吴永健, 王巍

经导管主动脉瓣置换早期经验交流…

2:40 PM - 中国陈茂

2:48 PM - 香港Michael Kang-Yin Lee

2:56 PM - 日本Shigeru Saito

3:04 PM - 新加坡Paul TL Chiam

3:12 PM - 韩国Hyo-Soo Kim

3:20 PM - 泰国Wacin Buddhari


第三场：新型经导管主动脉瓣置换系统和新适应证

主持人：Martin B. Leon, John G. Webb讨论专家：Alexandre Abizaid, Antonio Colombo, Ted E. Feldman, Eberhard Grube, Ian T. Meredith, Corrado Tamburino, Ron Waksman

新型经导管主动脉瓣置换系统…

3:38 PM - 下一代爱德华经导管主动脉瓣置换装置John G. Webb

3:46 PM - 下一代美敦力经导管主动脉瓣置换装置Eberhard Grube

3:54 PM - Lotus瓣膜和REPRISE临床项目Ian T. Meredith

4:02 PM - DirectFlow经导管主动脉瓣置换研发状态更新Antonio Colombo

4:10 PM - Symetis经导管主动脉瓣置换研发状态更新（经心尖和经股动脉装置）Alexandre Abizaid

新的临床适应证…

4:18 PM - 治疗生物瓣失败的全球瓣中瓣登记研究结果Ron Waksman

4:28 PM - 经导管主动脉瓣置换治疗中等度危险患者：临床经验和研究Martin B. Leon


第四场：经导管二尖瓣治疗

主持人：Saibal Kar, Ted E. Feldman讨论专家：Maurice Buchbinder, Charles A. Simonton, Gregg W. Stone, Corrado Tamburino, 王浩, Chris Kwok-Yiu Wong, 周达新

4:48 PM - MitraClip装置入门：操作考虑和病例选择Saibal Kar

4:58 PM - MitraClip治疗展望：我最好和最差的病例Corrado Tamburino

5:06 PM - 高危二尖瓣返流患者MitraClip治疗临床结果：来自于EVEREST和MitraClip登记研究的经验Charles A. Simonton

5:16 PM - 亚洲高危二尖瓣返流患者MitraClip治疗经验Chris Kwok-Yiu Wong

5:24 PM - 功能性二尖瓣返流MitraClip治疗的新研究和基本原理（COAPT和RESHAPE试验）Gregg W. Stone

5:32 PM - 其他经导管二尖瓣治疗方法：困难和机遇Ted E. Feldman

5:42 PM - 未来前沿：经导管二尖瓣置换现状更新Maurice Buchbinder


6:00 PM - 休会


130


二层202会议室

示教演示1及特色讲座8:30 AM-10:30 AM

主持人：Je�rey W. Moses, 乔树宾, Shigeru Saito讨论专家：Duncan Hung-Kwong Ho, 金泽宁, 李浪, Richard Lim, Kenan Ovunc, Su�a Rahman, 陶凌, Kin-Lam Tsui, Wan Azman Wan Ahmad

8:30 AM - 转播：阜外心血管病医院左主干和慢性完全闭塞病变介入治疗术者：杨跃进, Etsuo Tsuchikane, 吴永健及同事

10:00 AM - 介入治疗是无保护左主干狭窄一个明确的治疗选择Marco Wainstein

10:15 AM - 如何对合并严重左心室功能障碍患者行介入治疗？Liliana R. Grinfeld

示教演示2及特色讲座10:30 AM-12:30 PM

主持人：陈纪言, William L. Lombardi, 吕树铮讨论专家：Debabrata Dash, Ömer Göktekin, Tetsuya Hata, Hweung Kon Hwang, Fumiaki Ikeno, Swee Choon Ng, 叶飞, 杨树森, 张奇

10:30 AM - 转播：阜外心血管病医院慢性完全闭塞病变介入治疗术者：Satoru Sumitsuji, Toshiya Muramatsu, 吴永健及同事

12:00 PM - 复合方法行慢性完全闭塞病变介入治疗的最新进展William L. Lombardi

12:15 PM - IVUS、FFR及OCT：冠脉介入治疗中应该应用哪项技术？Debabrata Dash

12:30 PM - 休息

生物可吸收血管支架1:00 PM-6:00 PM

第一场：生物可吸收血管支架基础知识

主持人：Alexandre Abizaid, 高润霖讨论专家：Patrick W. Serruys, Gregg W. Stone, Renu Virmani, Ron Waksman

1:00 PM - 生物可吸收血管支架背后的科学含量Renu Virmani

1:12 PM - 从冠状动脉再血管化到血管修复：我们为何需要生物可吸收血管支架？Gregg W. Stone

辩论

1:24 PM - 我为何倾向金属生物可吸收血管支架？Ron Waksman

1:32 PM - 聚合物型生物可吸收血管支架应当是要走的路！Patrick W. Serruys


第二场：生物可吸收血管支架的当前实践

主持人：Alexandre Abizaid, Ian T. Meredith讨论专家：Antonio Colombo, Christoph K. Naber, Patrick W. Serruys, Charles A. Simonton, Pieter C. Smits, Corrado Tamburino, Huay Cheem Tan, 张瑶俊

1:52 PM - ABSORB临床试验项目更新Alexandre Abizaid

2:07 PM - 生物可吸收血管支架治疗分叉和复杂病变Antonio Colombo

2:19 PM - 长病变和重叠植入生物可吸收血管支架临床结果Pieter C. Smits

2:29 PM - 单中心最初400例生物可吸收血管支架植入经验Christoph K. Naber

2:39 PM - “真实世界”中无限制性应用生物可吸收血管支架的临床结果Corrado Tamburino

2:49 PM - 急性心肌梗死应用生物可吸收血管支架Huay Cheem Tan

2:59 PM - 明确新问题：生物可吸收血管支架内再狭窄、血栓、断裂及其他！Patrick W. Serruys


第三场：亚太地区生物可吸收血管支架应用交流

主持人：Ashok Seth, 沈卫峰, Duncan Hung-Kwong Ho讨论专家：Wacin Buddhari, Kenneth Chin, Nigel Jepson, Vincent On-Hing Kwok, Michael Lim, 乔树宾, Teguh Santoso

来自亚太地区“真实世界”经验（聚焦于生物可吸收血管支架病例选择的讨论）

3:30 PM - 澳大利亚Nigel Jepson

3:38 PM - 香港Vincent On-Hing Kwok

3:46 PM - 新加坡Michael Lim

3:54 PM - 印度Ashok Seth

4:02 PM - 印度尼西亚Teguh Santoso

4:10 PM - 马来西亚Kenneth Chin

4:18 PM - 泰国Wacin Buddhari

4:26 PM - 中国乔树宾


第四场：生物可吸收血管支架的未来

主持人：Martin B. Leon, 徐波讨论专家：Jean Fajadet, 高润霖, 葛均波, Juan F. Granada, Ron Waksman


131


未来技术

4:50 PM - DESolve Nx临床项目更新Martin B. Leon

5:00 PM - PLLA ART生物可吸收血管支架Jean Fajadet

5:10 PM - XINSORB西罗莫司生物可吸收血管支架葛均波

5:20 PM - PLLA Amaranth生物可吸收血管支架Juan F. Granada

5:30 PM - 先健铁基生物可吸收血管支架高润霖

5:40 PM - DREAMS西罗莫司镁制生物可吸收血管支架Ron Waksman


6:00 PM - 休会

二层203会议室

第六届临床研究专题研讨峰会8:30 AM-4:00 PM

8:30 AM - 欢迎致辞、目的简介Roxana Mehran

第一场：临床研究卓越之路 - 怎样成为一流研究中心

主持人：Alexandra J. Lansky, Donald E. Cutlip讨论专家：韩雅玲, Mitchell W. Kruco�, 李卫, 吕树铮, Jenny Zhen Qin, Roxana Mehran, 王海昌, 张瑶俊, 郑哲

8:35 AM - 怎样开始和设立一个蓬勃发展的临床研究项目：基本要素及更多内容Roxana Mehran

8:45 AM - 临床研究的指导原则：基本规则（GCP、IRB、知情同意及质控）Alexandra J. Lansky

8:55 AM - 如何成为临床试验中关键的入选者：带动你的同事一起参加Roxana Mehran

9:05 AM - 医疗器械研究中的全球合作：创新未来的关键Mitchell W. Kruco�

9:15 AM - 非随机对照医疗器械临床试验的统计学考虑李卫

9:30 AM - 特色演讲：临床研究中我的个人经验分享韩雅玲

9:45 AM - 专家讨论及听众问答

第二场：创建介入心脏病学最前沿的研究范例 - 案例剖析

案例剖析1：生物可吸收支架

主持人：Roxana Mehran, Patrick W. Serruys讨论专家：Davide Capodanno, 陈纪言, Ajay J. Kirtane, Mitchell W. Kruco�, Alexandra J. Lansky, Ian T. Meredith, Marie-Angèle Morel, Gregg W. Stone, Ron Waksman

10:00 AM - 生物可吸收支架：我们从哪里来？我们路向何方？Gregg W. Stone

10:12 AM - 专家讨论：正在进行和未来的生物可吸收支架研究 - 什么研究需要在中国及世界进行？

案例剖析2：去肾神经化治疗

主持人：Ajay J. Kirtane, Felix Mahfoud讨论专家：陈韵岱, Murray D. Esler, 蒋雄京, Jan Kovac, 刘少稳, Atul Pathak, Sean Salmon, Jie Wang, Yi-Ming Yang

10:30 AM - 怎样建立跨学科团队及筛选与治疗“正确”的患者？Atul Pathak

10:40 AM - 去肾神经化治疗：我们从哪里来？需要回答什么问题？Ajay J. Kirtane

10:52 AM - 专家讨论：正在进行和未来的去肾神经化器械研究 - 什么研究需要在中国及世界进行？

11:10 AM - 特色演讲：CFDA对生物可吸收支架和结构性心脏病介入器械管理路径的观点史新立

第三场：临床试验解读 - 上一年度发表的争议性介入试验的长处与欠缺

主持人：高润霖, Alexandra J. Lansky讨论专家：Donald E. Cutlip, Philippe Généreux, Liliana R. Grinfeld, Ajay J. Kirtane, Martin B. Leon, Roxana Mehran, 钱菊英, Patrick W. Serruys, John G. Webb, 颜红兵

11:30 AM - PRAMI试验Ajay J. Kirtane

11:38 AM - 专家讨论：点评优缺点及其对临床实践的影响

11:50 AM - OPTIMIZE试验Roxana Mehran

11:58 AM - 专家讨论：点评优缺点及其对临床实践的影响

12:10 PM - CoreValve极高危和新PARTNER试验Martin B. Leon


132


12:18 PM - 专家讨论：点评优缺点及其对临床实践的影响

12:30 PM - 午休

第四场：圆桌讨论 - 怎样有效地发表和介绍你的研究

主持人：Gary S. Mintz, 陈绍良讨论专家：曹丰, Paul Cummins, Anthony DeMaria, Spencer B. King III, Ajay J. Kirtane, Roxana Mehran, Roberto Patarca, 陶凌, Cheuk-Man Yu

2:00 PM - 多年指导未来研究者的经验分享Patrick W. Serruys

2:15 PM - 我对摘要准备、投稿及报告的“秘诀”Roxana Mehran

2:25 PM - 如何编辑手稿及准备投稿？Gary S. Mintz

2:35 PM - 我对原创文章投稿的“秘诀”：美国心脏病学会杂志观点Anthony DeMaria

2:50 PM - 我对原创文章投稿的“秘诀”：欧洲心脏杂志观点Cheuk-Man Yu

3:05 PM - 我对综述文章准备和投稿的“秘诀”Spencer B. King III

3:20 PM - 如何应对严格的审稿意见？Ajay J. Kirtane

3:30 PM - 怎样在欧洲介入杂志发表你的介入文章：编辑部主任的观点Paul Cummins

3:40 PM - 专家讨论及听众问答

WIN at CIT（女性冠心病介入治疗专场）4:30 PM-5:40 PM

主持人：Roxana Mehran, 韩雅玲讨论专家：曹丰, 陈珏, 陈韵岱, 高炜, 郭文怡, 郭丽君, 郭宁, 何青, 钱菊英, 陶凌, 王敬萍, 吴小凡, 杨伟宪, 张抒扬, 周颖玲

4:00 PM - 中断双联抗血小板治疗和PCI术后心脏事件：PARIS研究女性患者结果Roxana Mehran


4:20 PM - 短期他汀治疗预防对比剂引起的急性肾损伤：TRACK-D研究女性患者结果韩雅玲


4:40 PM - 高危女性患者的调脂治疗叶平


5:00 PM - FIRE2-DIABETES研究的女性患者亚组分析李妍


5:20 PM - 女性患者的经桡动脉介入治疗李丽


5:40 PM - 休会

二层204会议室

整合应用FFR、IVUS、OCT及其他以改善患者疗效（一）8:30 AM-12:30 PM

第一场：导论

主持人：Liliana R. Grinfeld, 钱菊英

8:30 AM - 怎样完成和解读FFR？Nico H. J. Pijls

8:45 AM - 怎样完成和解读IVUS？钱杰

9:00 AM - 怎样完成和解读RF（虚拟组织学）IVUS？William Kongto Hau

9:15 AM - 怎样完成和解读OCT？Takashi Akasaka

9:30 AM - 怎样完成和解读NIRS?Akiko Maehara

第二场：临界病变的评估

FFR

主持人：Nico H. J. Pijls, 王建安

9:45 AM - 非左主干术中使用FFRBernard De Bruyne

10:00 AM - 处理多支血管病变、串联病变、分叉等病变时使用FFRNico H. J. Pijls

10:15 AM - 左主干术中使用FFRSeung-Jung Park

聚焦FFR和临界病变的病例讨论（每例报告及讨论15分钟）

讨论专家：Bernard De Bruyne, 王贵松, 杨峻青

10:30 AM - IM-0110：FFR指导一例冠心病患者的介入治疗鄢华


133


10:45 AM - IM-0105：FFR技术在三支病变中的运用蒋建刚

IVUS和OCT

主持人：Takashi Akasaka, Philip Hung-Chung Wong

11:00 AM - IVUS能用于评价非左主干临界病变吗？Seung-Jea Tahk

11:15 AM - 评价非左主干临界病变OCT比IVUS好一些吗？Fernando Alfonso

11:30 AM - 评价左主干临界病变时如何？Soo-Jin Kang

11:45 AM - VH-IVUS或NIRS可以临界病变评价添加什么？Akiko Maehara

聚焦影像和临界病变的病例讨论（每例报告及讨论15分钟）

讨论专家：Fernando Alfonso, 郭军, 贺勇

12:00 PM - IM-0040：IVUS对冠脉造影不确定病变的诊断一例董勇

12:15 PM - IM-0112：多支病变FFR指导介入病例左国兴

12:30 PM - 休息

午间卫星会秦明医疗主办用创新起搏生命12:40 PM-1:55 PM

主席：张钲, 许静, 毛家亮, 刘志刚

12:40 PM - 用创新起搏生命王立军

12:50 PM - 秦明双腔起搏器动物实验和临床试验王东琦

1:05 PM - 秦明双腔起搏器临床试验顾翔

1:20 PM - 秦明单腔起搏器临床应用经验分享彭勇

1:35 PM - 秦明单腔起搏器临床应用经验分享马宾


1:55 PM - 休息

整合应用FFR、IVUS、OCT及其他以改善患者疗效（二）2:00 PM-6:15 PM

第三场：急性冠脉综合征和易损斑块

急性冠脉综合征患者评价

主持人：陈韵岱, Myeong-Ki Hong

2:00 PM - IVUS：评价急性冠脉综合征患者时的应用和局限性刘健

2:15 PM - OCT：识别犯罪病变、基本形态及以OCT为基础的治疗新策略Akiko Maehara

2:30 PM - NIRS：急性冠脉综合征患者目前的发现Ryan D. Madder

2:45 PM - FFR：何时与怎样使用FFR评价梗死相关或非梗死相关动脉Pieter C. Smits

急性冠脉综合征、不寻常造影发现或易损斑块患者的病例讨论（每例报告及讨论15分钟）

讨论专家：刘健, Ryan D. Madder

3:00 PM - IM-0001：IVUS指导的急诊PCI白静

3:15 PM - IM-0121：罪犯病变在哪儿？郭宁

3:30 PM - IM-0046：自发左主干撕裂导致的急性冠脉综合征卜军

易损斑块小型峰会

主持人：Akiko Maehara, 侯静波, Fumiaki Ikeno

3:45 PM - 灰阶IVUS能检出易损斑块吗？Fumiaki Ikeno

4:00 PM - OCT能检出易损斑块吗？Sudhir Rathore

4:15 PM - RF（虚拟组织学）IVUS能检出易损斑块吗？Akiko Maehara

4:30 PM - NIRS能检出易损斑块吗？Ryan D. Madder

4:45 PM - 血流动力学在斑块不稳定中的作用Bernard De Bruyne

5:00 PM - 特色讲座1：我们从PROSPECT I研究中获得了什么及对PROSPECT II研究的介绍Gregg W. Stone

5:15 PM - 特色讲座2：我们真的能通过影像检测临床相关的易损斑块？Patrick W. Serruys

急性冠脉综合征、不寻常造影发现或易损斑块患者的病例讨论（每例报告及讨论15分钟）

讨论专家：Stephen Wai-Luen Lee, 卜军, Sudhir Rathore

5:30 PM - IM-0033：右冠近段特殊病变一例赵晓燕

5:45 PM - IM-0055：ACS伴冠状动脉前三叉血栓一例李其勇

6:00 PM - IM-0079：自发内膜撕裂病例一例董樑

6:15 PM - 休会


134


二层205会议室

左主干和分叉病变第一部分分叉病变治疗的技术和策略8:30 AM-12:30 PM

第一场：技术考虑

主持人：Philippe Généreux, 郭文怡, Nigel Jepson讨论专家：Gim-Hooi Choo, Rajesh Dave, Soo-Jin Kang, 唐礼江, 张俊杰

8:30 AM - 因对吻球囊扩张引起的非对称扩张对分叉病变中期疗效的影响张俊杰

8:42 AM - 左主干介入治疗的技术指导原则Rajesh Dave

8:54 AM - 脊 / 斑块移位及其对即兴支架术策略的意义Gim-Hooi Choo

9:06 AM - 病例报告1：整合影像辅助左主干分叉病变介入治疗叶飞

9:14 AM - 讨论

9:19 AM - 病例报告2：复杂分叉病变支架术后OCT的发现张俊杰

9:27 AM - 讨论

9:32 AM - 分叉病变介入治疗中IVUS和FFR的整合评价Soo-Jin Kang


第二场：分叉病变支架术的高级实用技术要点

主持人：霍勇, Shing-Chiu Wong, Robaayah Zambahari讨论专家：侯静波, Teguh Santoso, Imad Sheiban, 俞梦越, 张俊杰

9:52 AM - 分叉病变准备、对吻球囊扩张及近端优化处理：怎么做？Teguh Santoso

10:07 AM - 分支导丝重新进入时找到正确的网孔：即兴或复杂支架技术的必需张俊杰

10:17 AM - 病例报告3：分叉角度决定了对吻球囊扩张技术的方式王贵松

10:25 AM - 讨论

10:30 AM - 病例报告4: OCT引导分支导丝重新进入及其发现侯静波

10:38 AM - 讨论

10:43 AM - 分叉病变介入治疗：分支工作的技术技巧Seung-Jea Tahk

10:55 AM - 左主干分叉病变的单支架术：何时？怎样？及长期临床疗效Imad Sheiban


第三场：逐步回顾理解支架术式和支架平台

主持人：陈绍良, Jack P. Chen, Thach Nguyen讨论专家：陈良龙, Antonio Colombo, Jean Fajadet, Josef Ludwig, Aravinda Nanjundappa

11:17 AM - 非左主干分叉即兴支架术中分支植入支架与否的处理（包括案例分享）Aravinda Nanjundappa

11:27 AM - 左主干分叉病变中的DK裙裤术式（包括案例分享）陈良龙

11:37 AM - 怎样完成计划中的双支架术式（包括案例分享）Antonio Colombo

11:47 AM - 一种通过主支支架“切割”分支开口狭窄的改良的双导丝技术（包括案例分享）Josef Ludwig

11:57 AM - 生物可吸收支架在开口病变和/或前降支、对角支分叉病变中的应用（包括案例分享）Jean Fajadet

12:09 PM - 特殊讲座：生物可吸收支架在分叉病变中的实验台测试结果（包括OCT和Micro-CT分析）Pieter C. Smits


12:30 PM - 休息

午间卫星会Asahi和星进主办手术成功的一半取决于器械12:40 PM-1:55 PM

主席：陈纪言, 孙勇, 周玉杰

12:40 PM - 开场致辞

12:45 PM - 下一代导丝：SION TECCEisho Kyo

1:00 PM - 慢性完全闭塞新器械介绍葛雷

1:15 PM - “工欲善其事，必先利其器”：冠脉介入之利器 - 导丝缪绯

1:30 PM - 无鞘引导导管用于经桡动脉介入的优势和特点陈晖


1:55 PM - 休息

摘要口头报告第一部分2:00 PM-4:00 PM

主持人：霍勇, Yean-Leng Lim, 陈纪言, Donald E. Cutlip, Davide Capodanno, 郑哲

2:00 PM - AS-0666：在1528名行PCI术的左主干病变患者中验证SYNTAX II评分的预测能力赵叶琳

2:09 PM - 讨论


135


二层206会议室

“征服”心脏和血管并发症华盛顿MEDSTAR病例研讨会8:30 AM-10:30 AM

主持人：Nelson Bernardo, 陈绍良, 符伟国, Aravinda Nanjundappa讨论专家：Thach Nguyen, 王焱, 曾和松, David X. M. Zhao

8:30 AM - 开场致辞：课程简介和一例病例Nelson Bernardo

8:38 AM - 讨论

8:42 AM - 一例意想不到的冠脉灾难叶飞

8:50 AM - 讨论

8:54 AM - 急诊介入中逆行的医源性冠脉栓塞Thach Nguyen

9:02 AM - 讨论

9:06 AM - 医源性冠脉穿孔和夹层：我怎样处理？Ramesh B. Daggubati

9:14 AM - 讨论

9:18 AM - 腹膜后出血：识别和纠正Nelson Bernardo

9:26 AM - 讨论

9:30 AM - 我最糟糕情况下的经导管主动脉瓣置换病例Eberhard Grube

9:38 AM - 讨论

9:42 AM - 股浅动脉并发症：夹层、穿孔及闭塞蒋俊豪

9:50 AM - 讨论

2:12 PM - AS-0724：一站式复合冠状动脉血运重建术与冠脉搭桥术及经皮冠脉介入治疗多支血管病变长期疗效的对比研究沈刘忠

2:21 PM - 讨论

2:24 PM - AS-0638：比较单、双支架术式治疗左主干分叉病变的长期结果：来自大规模单中心左主干病变介入治疗注册研究的数据高展

2:33 PM - 讨论

2:36 PM - AS-0126：比较经桡动脉与经股动脉左主干介入治疗：倾向性评分调整和匹配性分析阚静

2:45 PM - 讨论

2:48 PM - AS-0400：比较在高血小板反应患者中使用优化的抗血小板治疗或传统抗血小板治疗对血小板功能及长期的临床结果的影响：来自多中心、随机对照OPT研究2年的临床结果李毅

2:57 PM - 讨论

3:00 PM - AS-0071：血运重建程度与稳定性心绞痛三支病变患者PCI长期预后的关系李全

3:09 PM - 讨论

3:12 PM - AS-0463：急性ST段抬高心肌梗死患者非梗死相关血管的慢性完全闭塞病变行择期血运重建对长期预后的影响杨震坤

3:21 PM - 讨论

3:24 PM - AS-0682：经桡动脉途径和经股动脉途径行经皮冠脉介入治疗冠心病的有效性和安全性比较庞军

3:33 PM - 讨论

3:36 PM - AS-0737：无保护性左主干病变再血管介入治疗的长期临床效果：完成血运重建、合理性完成血运重建、非完全血运重建张瑶俊

3:45 PM - 讨论

3:48 PM - AS-0731：生物可降解聚合物药物支架和永久聚合物药物支架治疗冠心病的研究进展及荟萃分析张瑶俊

3:57 PM - 讨论

4:00 PM - 休会


136


9:54 AM - 血管通路和闭合装置并发症Aravinda Nanjundappa

10:02 AM - 讨论

10:06 AM - 颈动脉并发症王焱

10:14 AM - 讨论

10:18 AM - 腔内修复术并发症Nelson Bernardo

10:26 AM - 讨论

HKSTENT at CIT10:30 AM-12:30 PM

主持人：Martin B. Leon, Ian T. Meredith, Michael Kang-Yin Lee

10:30 AM - 欢迎致辞Michael Kang-Yin Lee

第一部分：热点聚焦 - 三联抗凝

讨论专家：Alan Ka-Chun Chan, Chi-Kin Chan, Rosli Mohd Ali, Kyung-Woo Park, 颜红兵

10:33 AM - 病例简介：引发讨论Alan Ka-Chun Chan

10:38 AM - 指南是怎样建议的？Rosli Mohd Ali

10:48 AM - 指南没有包括哪些？Kyung-Woo Park

10:58 AM - 指南之外的实践方法颜红兵

11:08 AM - 讨论

第二部分：CICF2014最佳病例讨论

讨论专家：葛雷, Eberhard Grube, Kin-Lam Tsui, Edmond Wong, 张斌

病例1：急性心肌梗死并发症

11:18 AM - 病例简介Tak-Shun Chung

11:21 AM - 我将怎样做？Ian T. Meredith

11:29 AM - 我是怎样做的？Tak-Shun Chung

11:37 AM - 专家讨论

病例2：慢性完全闭塞并发症

11:41 AM - 病例简介Li-Wah Tam

11:44 AM - 我将怎样做？葛雷

11:52 AM - 我是怎样做的？Li-Wah Tam


病例3：经导管主动脉瓣植入并发症

12:04 PM - 病例简介Jason Leung-Kwai Chan

12:07 PM - 我将怎样做？Eberhard Grube

12:15 PM - 我是怎样做的？Jason Leung-Kwai Chan


12:27 PM - 闭幕致辞Chi-Kin Chan

12:30 PM - 休息

午间卫星会贝朗医疗主办SeQuent® Please：治疗支架再狭窄的“新”标准12:40 PM-1:55 PM

主席：高润霖, 王建安, 陈绍良, 乔树宾, Bruno Scheller


12:45 PM - 药物涂层球囊：临床结果更新和共识推荐Bruno Scheller

1:05 PM - PEPCAD China ISR试验更新：9个月造影、12个月临床及亚组分析结果徐波

1:20 PM - 来自PEPCAD China ISR试验中的病例报告1（包括造影复查）陆志刚

1:32 PM - 来自PEPCAD China ISR试验中的病例报告2（包括造影复查）周斌全


1:55 PM - 休息

摘要口头报告第二部分2:00 PM-4:00 PM

主持人：Alexandra J. Lansky, 傅向华, 周玉杰, Bruno Scheller, Jenny Zhen Qin

2:00 PM - AS-0668：单面刻槽生物可降解聚合物雷帕霉素洗脱支架治疗冠心病合并糖尿病患者的安全性及有效性：TARGET I和TARGET II研究前瞻性患者水平汇总分析的12个月结果尹栋

2:09 PM - 讨论

2:12 PM - AS-0601：首次随机对照试验比较采用两种具有不同生物可降解聚合物的雷帕霉素洗脱支架的内膜形成：BuMA-OCT试验钱杰

2:21 PM - 讨论

2:24 PM - AS-0756：比较生物可降解聚合物药物支架、永久聚合物药物支架与金属裸支架在治疗急性心肌梗死后血管的再内皮化情况金琴花

2:33 PM - 讨论

2:36 PM - AS-0555：依维莫司洗脱支架治疗冠状动脉小血管病变一年的临床结果：来自前瞻性多中心SEEDS研究的亚组分析慕朝伟

2:45 PM - 讨论

2:48 PM - AS-0557：比较紫杉醇涂层球囊和紫杉醇洗脱支架治疗糖尿病患者药物洗脱支架内再狭窄的安全性和有效性：PEPCAD China ISR试验亚组分析钱杰

2:57 PM - 讨论


137


3:00 PM - AS-0567：单纯使用药物涂层球囊行急诊经皮冠脉介入治疗急性ST段抬高心肌梗死：一项前瞻性注册研究的结果Pieter R. Stella

3:09 PM - 讨论

3:12 PM - AS-0060：使用药物洗脱支架治疗早期药物洗脱支架内再狭窄后具有非常高的靶病变再次血管重建率赵林

3:21 PM - 讨论

3:24 PM - AS-0566：从三维定量冠状动脉造影和TIMI计帧法计算血流储备分数：一个快速量化中度阻塞冠状动脉功能意义的计算机模型Shengxian Tu

3:33 PM - 讨论

3:36 PM - AS-0670：IVUS评定的缺血驱动病变中基于血流储备分数而延迟经皮冠脉介入治疗的安全性曹轲

3:45 PM - 讨论

3:48 PM - AS-0603：冠脉CT血管造影引导的慢性完全闭塞病变经皮冠脉介入治疗：初步研究杨俊杰

3:57 PM - 讨论

4:00 PM - 休会

二层207会议室

心导管术基础8:30 AM-12:30 PM

第一场

主持人：秦学文, 施海明, 孙勇, 王齐兵, 张代富

8:30 AM - 冠状动脉造影术适应证与禁忌证张奇

8:45 AM - 讨论

8:50 AM - 桡动脉穿刺基本技巧、常见困难及并发症傅向华

9:05 AM - 讨论

9:10 AM - 冠脉变异患者冠脉造影技巧张清

9:25 AM - 讨论

9:30 AM - 如何正确阅读冠状动脉造影？曲新凯

9:45 AM - 讨论

9:50 AM - 指引导管的选择及操作技巧慕朝伟

10:05 AM - 讨论

10:10 AM - 导引钢丝的选择及操作技巧葛雷

10:25 AM - 讨论

第二场

主持人：乔树宾, 王长谦, 庞文跃, 王玮

10:30 AM - 如何正确解读与应用冠脉CT？杭靖宇

10:45 AM - 讨论

10:50 AM - 如何应用与解读IVUS？吴小凡

11:05 AM - 讨论

11:10 AM - 如何应用与解读OCT？金琴花

11:25 AM - 讨论

11:30 AM - 如何应用与解读FFR？王贵松

11:45 AM - 讨论

11:50 AM - IABP适应证及操作要点刘斌

12:05 PM - 讨论

12:10 PM - 血栓抽吸导管的使用技巧金泽宁

12:25 PM - 讨论

12:30 PM - 休息

午间卫星会迈柯唯主办传统新葩：IABP和Clearway的临床应用12:40 PM-1:55 PM

主席：韩雅玲, 陈方, 袁祖贻, 陈玉国


12:45 PM - IABP临床应用王乐丰

1:05 PM - IABP临床研究新进展Nico H.J. Pijls

1:25 PM - Clearway临床应用经验Rajesh Dave


1:55 PM - 休息


138


摘要口头报告第三部分2:00 PM-4:00 PM

主持人：Jean Marco, 王建安, Chung-Seung Chiang, Thach Nguyen, 田野, Chris Kwok-Yiu Wong

2:00 PM - AS-0563：经导管超声发射方法行去肾神经化的初步安全性、植物神经功能及血压结果：REALISE试验Atul Pathak

2:09 PM - 讨论

2:12 PM - AS-0773：经股动脉途径行经导管主动脉瓣植入术中的无鞘管技术裴汉军

2:21 PM - 讨论

2:24 PM - AS-0787：旋转血管造影进行三维主动脉根部重建指导经导管球囊扩张型主动脉瓣植入Pieter R. Stella

2:33 PM - 讨论

2:36 PM - AS-0667：治疗二尖瓣返流的MitraClip修复术能显著改善术中血液动力学Wen Loong Yeow

2:45 PM - 讨论

2:48 PM - AS-0299：经皮腔内室间隔心肌消融术治疗肥厚型梗阻性心肌病的长期有效性王效增

2:57 PM - 讨论

3:00 PM - AS-0351：主动脉窦瘤破裂的经皮闭合：来自多中心的经验刘夙璇

3:09 PM - 讨论

3:12 PM - AS-0462：急诊经皮冠状动脉介入治疗术中冠状动脉内联合静脉内注射盐酸替罗非班的作用：ICT-AMI研究朱天奇

3:21 PM - 讨论

3:24 PM - AS-0745：预防性冠脉内应用山莨菪碱对急性ST段抬高型心肌梗死直接经皮冠脉介入术后心肌微循环灌注的影响魏庆民

3:33 PM - 讨论

3:36 PM - AS-0633：血栓抽吸治疗急性ST段抬高心肌梗死的有效性：荟萃分析马翔

3:45 PM - 讨论

3:48 PM - AS-0743：短期内行择期经皮冠状动脉介入术治疗急性心肌梗死中非梗死相关动脉王庆胜

3:57 PM - 讨论

4:00 PM - 休会

二层208会议室

PCI技术与疗效第一部分8:30 AM-12:30 PM

第一场

主持人：陈方, 盖鲁粤, 何青, Ju-Pin Pan, 陆志刚

8:30 AM - 血流储备分数作为新的心内科医生的“安乐窝”：真的让人舒服吗？Costantino R. Costantini

8:40 AM - 讨论

8:42 AM - OCT在钙化病变中的作用Chi-Kin Chan

8:52 AM - 讨论

8:54 AM - 口服免疫抑制疗法预防支架内再狭窄：七个随机试验患者水平的荟萃分析Alfredo E. Rodriguez

9:04 AM - 讨论

9:06 AM - 冠脉开口病变金属裸支架和药物洗脱支架植入后长期临床与造影疗效的对比研究Ching-Chang Fang

9:16 AM - 讨论

9:18 AM - 何时我们真的需要逆向技术治疗慢性完全闭塞？Ömer Göktekin

9:28 AM - 讨论

9:30 AM - 经微孔道循径正向开通慢性完全闭塞的临床思考李为民

9:40 AM - 讨论

9:42 AM - 微导管在PCI中应用唐疾飞

9:52 AM - 讨论


139


第二场

主持人：傅向华, 邱春光, 崔俊玉, 杨丽霞, 林先和

9:54 AM - 介入术中并发症：器械脱落和收回Imad Sheiban

10:04 AM - 讨论

10:06 AM - 高度成角、钙化病变的处理策略马根山

10:16 AM - 讨论

10:18 AM - 支架不能通过病变的原因和对策张大东

10:28 AM - 讨论

10:30 AM - 经桡动脉介入治疗：真的临床获益吗？Rakesh K. Jaswal

10:40 AM - 讨论

10:42 AM - 冠脉起源异常时介入治疗的技巧和技术上的考虑张清

10:52 AM - 讨论

10:54 AM - PCI术后血小板减少时怎么办？王海昌

11:04 AM - 讨论

11:06 AM - 心血管杂交技术David X. M. Zhao

11:16 AM - 讨论

第三场

主持人：Chung-Seung Chiang, 曹丰, Seung-Ho Hur, 聂如琼, Mujeeb Ul-Haq

11:18 AM - ST段抬高型心肌梗死的管理：长达一个世纪的传奇Vinay K. Bahl

11:28 AM - 讨论

11:30 AM - 急性心肌梗死患者依维莫司洗脱支架和雷帕霉素洗脱支架植入后晚期获得支架贴壁不良：APPOSITION-AMI试验Seung-Ho Hur

11:40 AM - 讨论

11:42 AM - 急性心肌梗死直接PCI中应用自膨胀支架的单中心经验Pietro Vandoni

11:52 AM - 讨论

11:54 AM - 直接PCI中不完全血管重建的管理Richard Lim

12:04 PM - 讨论

12:06 PM - 急性心肌梗死直接PCI术中血栓抽吸导管的应用李怡

12:16 PM - 讨论

12:18 PM - 心源性休克和经皮心室辅助装置Ramesh B. Daggubati

12:28 PM - 讨论

12:30 PM - 休息

午间卫星会博莱科信谊主办心血管介入对比剂安心应用12:40 PM-1:55 PM

主席：沈卫峰, 何奔


12:45 PM - 我们真的能预防对比剂肾病（CIN）吗？不同类型对比剂对CIN发生影响的认识更新Roxana Mehran

1:25 PM - 对比剂肾病的研究进展何奔

1:50 PM - 要点总结

1:55 PM - 休息

摘要口头报告第四部分2:00 PM-3:48 PM

主持人：何奔, Dongming Hou, Jie Wang, 袁洪, 卢成志, 王宁夫

2:00 PM - AS-0127：硫氧还蛋白相互作用蛋白通过抑制糖尿病心肌细胞硫氧还蛋白减少缺血驱使的血管生成尹涛

2:09 PM - 讨论

2:12 PM - AS-0272：ApoE敲除小鼠模型显示过度的低盐饮食通过PCSK9蛋白促进动脉粥样硬化斑块生长和不稳定性朱男

2:21 PM - 讨论

2:24 PM - AS-0089：巨噬细胞吞噬间充质干细胞后对梗死心肌修复作用及可能机制的研究陆文彬

2:33 PM - 讨论

2:36 PM - AS-0342：中国汉族人群CYP2C19*2/*3基因多态性和心血管事件的相关性张莹莹

2:45 PM - 讨论

2:48 PM - AS-0366：血管内皮细胞来源的配体蛋白聚糖-4的脱落导致糖尿病中血管内皮功能障碍和血管生成受损谢峻

2:57 PM - 讨论

3:00 PM - AS-0097：体内评估一种针对腹主动脉瘤的早期阶段基质金属蛋白酶的新型MRI造影剂姚玉宇

3:09 PM - 讨论

3:12 PM - AS-0507：肾交感神经射频消融术对犬心室重构和交感神经重构的影响卢成志

3:21 PM - 讨论


140


3:24 PM - AS-0274：冠状动脉钙化积分预测经皮冠状动脉介入治疗多支血管病变患者的复杂性何立芸

3:33 PM - 讨论

3:36 PM - AS-0136：短期密集使用他汀治疗急性冠脉综合征的疗效和安全性：SISTA-I研究王宁夫

3:45 PM - 讨论

3:48 PM - 休会

三层305A会议室

最具教育意义病例竞赛第一部分急性冠脉综合征和特殊病例2:00 PM-4:00 PM

主持人：颜红兵, 盖鲁粤, 唐疾飞, 唐礼江, 庞文跃, 齐国先, 程冠昌

2:00 PM - CS-0136：急诊介入术中前降支误判高磊

2:10 PM - 讨论

2:15 PM - CS-0144：急性多支冠脉同时发生血栓王立新

2:25 PM - 讨论

2:30 PM - CS-0033：急诊PCI术后上消化道大出血介入栓塞成功止血孙兆青

2:40 PM - 讨论

2:45 PM - CS-0225：球囊辅助开口病变精确定位刘圣文

2:55 PM - 讨论

3:00 PM - CS-0266：尿毒症合并肾性高血压RDN治疗桑震池

3:10 PM - 讨论

3:15 PM - CS-0086：终末期冠心病介入治疗洪浪

3:25 PM - 讨论

3:30 PM - CS-0222：经右桡动脉入径PCIRenata Rogacka

3:40 PM - 讨论

3:45 PM - CS-0279：青年男性双侧冠状动脉开口重度狭窄行药物洗脱支架植入：不典型大动脉炎？单迎光

3:55 PM - 讨论

4:00 PM - 休会


141


三层305B会议室

去肾神经化技术午间研讨会12:00 PM-2:00 PM

主持人：高平进, 蒋雄京讨论专家：陈韵岱, 卢成志, 曲新凯, 孙宁玲, Jie Wang, 闫振成

12:00 PM - 器械疗法平衡交感神经张力：起源、生理基础及扩展Jie Wang

12:15 PM - 各种去肾神经方法概述卢成志

12:30 PM - 去肾交感神经治疗顽固性高血压：证据和争议陈韵岱

12:45 PM - 去肾交感神经治疗顽固性高血压：中国高血压联盟的立场和建议孙宁玲

1:00 PM - 去肾交感神经治疗顽固性高血压：病例筛查经验及围手术期管理闫振成

1:15 PM - 肾动脉专用单极消融导管去肾脏交感神经治疗顽固性高血压：我国临床试验初步结果与正在进行的研究蒋雄京

1:30 PM - 血管内影像学在去肾交感神经化术中的使用价值曲新凯


最具教育意义病例竞赛第二部分左主干介入治疗和经导管主动脉瓣置换2:00 PM-4:00 PM

主持人：王伟民, 钱菊英, 林英忠, 金惠根, 侯玉清, 秦学文, 赵全明

2:00 PM - CS-0243：医源性左主干严重夹层抢救阴赪茜

三层302A会议室

中国介入创新：当前和未来的景观12:40 PM-1:55 PM

主持人：Juan F. Granada, Yuval Binur, 张澍讨论专家：陈绍良, 孔祥清, 罗七一, 訾振军

12:40 PM - 引言Juan F. Granada

12:50 PM - 医疗器械创新的基本概念和医生作用的重要性Yuval Binur

1:00 PM - 中国介入创新：当前观点和挑战孔祥清

1:10 PM - 融资策略和机会訾振军

1:20 PM - 基于中国创新的案例研究：靶向洗脱支架罗七一

1:30 PM - 基于中国创新的案例研究：肺动脉去神经化陈绍良


1:55 PM - 休息

最具教育意义病例竞赛第三部分并发症2:00 PM-4:00 PM

主持人：吕树铮, 郭文怡, 董平栓, 甘继宏, 吴同果, 李拥军, 籍振国

2:00 PM - CS-0194：我如何处理冠脉穿孔？Sanjay Mehrotra

2:10 PM - 讨论

2:15 PM - CS-0015：前降支PCI术后左主干急性血栓张奇

2:25 PM - 讨论

2:10 PM - 讨论

2:15 PM - CS-0101：左主干旋磨U Po Lam

2:25 PM - 讨论

2:30 PM - CS-0369：左主干四分叉病变介入治疗困境刘健

2:40 PM - 讨论

2:45 PM - CS-0316：左主干分叉严重钙化病变旋磨治疗蒋峻

2:55 PM - 讨论

3:00 PM - CS-0175：IVUS指导的左主干分叉病变“微裙裤”支架术刘学波

3:10 PM - 讨论

3:15 PM - CS-0059：巨大左房压迫左主干致急性冠脉综合征一例王焱

3:25 PM - 讨论

3:30 PM - CS-0249：TAVR术后管理：挑战性病例冯沅

3:40 PM - 讨论

3:45 PM - CS-0164：主动脉二叶瓣术后经导管瓣膜内植入瓣膜病例陈茂

3:55 PM - 讨论

4:00 PM - 休会


142


2:30 PM - CS-0224：LCX支架脱载带出LAD原支架荆全民

2:40 PM - 讨论

2:45 PM - CS-0190：冠状动脉造影术后急性心包填塞一例王耿

2:55 PM - 讨论

3:00 PM - CS-0221：挽救性PCI并发主动脉夹层一例肖华

3:10 PM - 讨论

3:15 PM - CS-0238：麻烦是怎样演变成灾难的？张慧平

3:25 PM - 讨论

3:30 PM - CS-0182：右冠CTO介入术中主动脉冠状动脉夹层一例赵继义

3:40 PM - 讨论

3:45 PM - IM-0023：PCI术中急性血栓成功救治赵刚

3:55 PM - 讨论

4:00 PM - 休会

三层302B会议室

午间卫星会微创主办（一）火鸟十年、剑指苍穹：火鸟系列支架十年历程分享12:40 PM-1:55 PM

主席：葛均波, 王海昌, Costantino R. Costantini, Liliana R. Grinfeld, 柳景华


12:45 PM - FIRE2-DIABETES注册研究两年随访结果李妍

1:00 PM - FOCUS注册研究三年随访结果张峰

1:15 PM - “真实世界”中多支血管病变患者应用FIREBIRD 2钴铬合金雷帕霉素洗脱支架的血管重建策略：ERACI IV注册研究Alfredo E. Rodriguez

1:30 PM - 泰国FIREBIRD 2钴铬合金雷帕霉素洗脱支架注册研究：FOCUS-T一年结果Wasan Udayachalerm


1:55 PM - 休息

最具教育意义病例竞赛第四部分慢性完全闭塞2:00 PM-4:00 PM

主持人：傅国胜, 葛雷, 王勇, 光雪峰, 黄超联, 郑强荪, 李虎

2:00 PM - CS-0381：多次努力终获成功 - 前降支慢性完全闭塞开通廖洪涛

2:10 PM - 讨论

2:15 PM - CS-0371：慢性完全闭塞逆向导丝嵌入 - 取出的尝试和操作的反思谢丽华

2:25 PM - 讨论

2:30 PM - CS-0377：经静脉桥血管逆行开通右冠慢性完全闭塞病变李成祥

2:40 PM - 讨论

2:45 PM - IM-0071：IVUS引导下的一例复杂前降支慢性完全闭塞PCI李纪明

2:55 PM - 讨论

3:00 PM - CS-0230：RCA慢性完全闭塞迂曲病变的逆向技术荆全民

3:10 PM - 讨论

3:15 PM - CS-0147：单指引导管前后夹击开通无残端慢性完全闭塞修建成

3:25 PM - 讨论

3:30 PM - CS-0219：IVUS指导前降支慢性完全闭塞介入治疗一例慕朝伟

3:40 PM - 讨论

3:45 PM - CS-0156：RCA慢性完全闭塞 - 假作真时真亦假周国伟

3:55 PM - 讨论

4:00 PM - 休会


143


三层明珠厅

CIT2014开幕式和全体大会8:00 AM-12:30 PM

第一场：热点示教演示

主持人：Martin B. Leon, Antonio Colombo, Eberhard Grube讨论专家：Maurice Buchbinder, Jean Fajadet, William F. Fearon, Ted E. Feldman, Saibal Kar, Ian T. Meredith, Corrado Tamburino, John G. Webb, 杨跃进, Alan C. Yeung, David X. M. Zhao

8:00 AM - 转播：纽约长老会医院 / 哥伦比亚大学医学中心经导管主动脉瓣置换（新器械）术者：Susheel Kodali, Mathew Williams, Rebecca Hahn及同事

第二场：CIT2014开幕式

主持人：高润霖, 徐波讨论专家：Alexandre Abizaid, Anthony DeMaria, Jean Fajadet, 葛均波, 胡盛寿, Spencer B. King III, Martin B. Leon, Yean-Leng Lim, Masahiko Ochiai, Seung-Jung Park, Patrick W. Serruys, Ashok Seth, Gregg W. Stone

8:45 AM - 欢迎致辞高润霖

8:55 AM - TCT25年历程：心血管介入医学的爆炸性增长Martin B. Leon

9:10 AM - 世界各地代表圆桌讨论会：心血管介入医学最具影响力的进展讨论引导者：Martin B. Leon, Gregg W. Stone

第三场：难治性高血压的治疗方法 - 基于病例的讨论

主持人：Ajay J. Kirtane, Horst Sievert讨论专家：Justin E. Davies, Murray D. Esler, Juan F. Granada, 蒋雄京, David E. Kandzari, Jan Kovac, Felix Mahfoud, Jean Marco, Atul Pathak, Marco Wainstein, 王继光, Shing-Chiu Wong

9:30 AM - 病例介绍和评论Ajay J. Kirtane

9:40 AM - 去肾神经化治疗：顽固性高血压及其他疾病Felix Mahfoud


第四场：ST段抬高型心肌梗死 - 新药物和新器械

主持人：Roxana Mehran, 霍勇讨论专家：Joseph D. Babb, Donald E. Cutlip, Liliana R. Grinfeld, 韩雅玲, Adnan Kastrati, Mitchell W. Kruco�, Akiko Maehara, Nico H. J. Pijls, 沈卫峰, Pieter C. Smits, Harry Suryapranata, Robaayah Zambahari

10:15 AM - 病例介绍和评论Philippe Généreux

10:25 AM - ST段抬高型心肌梗死治疗方法：现状及未来发展Gregg W. Stone


第五场：生物可吸收支架 - 这将是下一个十年默认的治疗方法吗？

主持人：Gregg W. Stone, Patrick W. Serruys讨论专家：Alexandre Abizaid, 陈纪言, 陈绍良, Tian-Hai Koh, Alexandra J. Lansky, Ian T. Meredith, Marie-Claude Morice, Christoph K. Naber, Charles A. Simonton, Huay Cheem Tan, Renu Virmani, Ron Waksman

11:00 AM - 病例介绍和评论Antonio Colombo

11:10 AM - 生物可吸收支架的承诺和证据：真实世界的展望Patrick W. Serruys


第六场：未来的导管室 - 在发展中创新

主持人：Martin B. Leon, Gary S. Mintz讨论专家：Stephan Achenbach, 陈韵岱, Keith D. Dawkins, Bernard De Bruyne, Peter J. Fitzgerald, John McB. Hodgson, Michael Kang-Yin Lee, Chaim S. Lotan, Michael A. Mussallem, Sean Salmon, 王海昌, 王建安

11:45 AM - 创新模式Chaim S. Lotan

11:55 AM - 信息技术与医疗技术“相遇”：日常临床实践中的整合Peter J. Fitzgerald

12:05 PM - 转化医学：从概念到现实Juan F. Granada


12:30 PM - 休会


144


二层201会议室

示教演示5外周血管介入治疗上海交通大学医学院附属瑞金医院9:30 AM-11:00 AM

主持人：Rajesh Dave, 罗建方讨论专家：Anil Chagarlamudi, Eric Dippel, W. Britton Eaves, Richard C. Kovach, Carlos Mena, Thomas Shimshak, Neil E. Strickman, 王焱, 邹英华术者：Craig M. Walker, 张瑞岩及同事

示教演示6结构性心脏病复旦大学附属中山医院11:00 AM-12:30 PM

主持人：蒋世良, Horst Sievert, 张澍讨论专家：Jacek Bialkowski, Saibal Kar, 孔祥清, Yat-Yin Lam, Matthew J. Price, Witold Ruzyllo, 王广义, Jiangtao Yu, 张智伟术者：Maurice Buchbinder, 葛均波, Ziyad M. Hijazi, 周达新及同事左心耳封堵、经导管肺动脉瓣置换及室缺/房缺

午间卫星会微创主办（二）靶向时代、鹰之征途：火鹰支架及TARGET系列研究结果分享12:40 PM-1:55 PM

主席：高润霖, Martin B. Leon, 沈卫峰, Alexandra J. Lansky, 温尚煜

12:40 PM - 目的简介Martin B. Leon

12:45 PM - 火鹰支架的研发历程及靶向洗脱支架（TES）的概念罗七一

1:00 PM - 一种新颖的靶向洗脱支架技术：从动物实验深入了解火鹰支架Renu Virmani

1:15 PM - TARGET I随机对照试验更新：9个月造影、2年临床结果及更多未来数据高润霖

1:30 PM - 火鹰支架在更复杂的患者和病变中的应用：TARGET II 2年和长支架注册研究3年结果陈绍良


1:55 PM - 休息

最新临床试验2:00 PM-3:00 PM

主持人：Patrick W. Serruys, Gregg W. Stone讨论专家：陈绍良, Ted E. Feldman, 韩雅玲, Adnan Kastrati, Spencer B. King III, William L. Lombardi, Marie-Claude Morice, Matthew J. Price

2:00 PM - BRIGHT：急性心肌梗死支架植入术患者中比较比伐卢定、肝素单一疗法及糖蛋白IIb/IIIa拮抗剂加肝素的前瞻性、随机对照试验韩雅玲

2:15 PM - 讨论

2:20 PM - AIR-CTO：冠脉慢性完全闭塞病变中比较血管造影引导和血管内超声引导支架植入的前瞻性、随机对照试验陈绍良

2:35 PM - 讨论

2:40 PM - 经皮冠脉介入治疗后患者应用中药通心络以减轻治疗后血小板高反应性的前瞻性、随机对照试验李毅

2:55 PM - 讨论

EAPCI-EuroPCR at CIT冠心病的生物可吸收支架治疗3:00 PM-6:00 PM

第一部分

主持人：Jean Fajadet, 高润霖讨论专家：Tian-Hai Koh, Stephen Wai-Luen Lee, Marie-Claude Morice, Christoph K. Naber, Yoshinobu Onuma, Patrick W. Serruys, Ashok Seth, Corrado Tamburino, 张瑶俊

3:00 PM - 目的简介高润霖, Jean Fajadet

3:05 PM - 从生物可吸收支架到血管修复治疗Patrick W. Serruys

3:15 PM - ABSORB系列研究结果Marie-Claude Morice

3:25 PM - 其它生物可吸收支架的应用经验Corrado Tamburino

3:35 PM - 来自中国的经验杨跃进


3:55 PM - 影像是怎样指导生物可吸收支架应用的？Yoshinobu Onuma

真实世界中的生物可吸收支架

4:05 PM - 长病变和重叠植入生物可吸收支架Christoph K. Naber

4:15 PM - 分叉病变Antonio Colombo


第二部分

主持人：Jean Fajadet, 霍勇讨论专家：陈韵岱, Antonio Colombo, 傅国胜, 郭文怡, Marie-Claude Morice, Christoph K. Naber, Teguh Santoso, Patrick W. Serruys, Corrado Tamburino

转播：伦敦圣托马斯医院

术者：Martyn R. Thomas, Simon Redwood及同事

4:35 PM - 转播病例1：前降支长病变

5:10 PM - 转播病例2：分叉病变（前降支 / 对角支）

5:45 PM - 转播后专家讨论

5:55 PM - 要点总结Jean Fajadet, 霍勇

6:00 PM - 休会


145


二层202会议室

心肌缺血和冠心病诊断治疗柏盛国际和吉威医疗协办10:30 AM-12:30 PM

主持人：杨跃进, 李亚明, 方唯一, 何作祥

10:30 AM - 冠心病无创功能成像的应用指南及临床问题陈韵岱

10:50 AM - 讨论

10:54 AM - 核医学显像对冠心病诊断的危险分层李思进

11:14 AM - 讨论

11:18 AM - 融合影像对冠心病诊断的临床意义及进展王蒨

11:38 AM - 讨论

11:42 AM - 门控心肌灌注断层显像相位分析评价左心室心肌收缩同步性王跃涛

12:02 PM - 讨论

12:06 PM - 应用核素心肌显像评价冠心病的疗效石洪成

12:26 PM - 讨论

12:30 PM - 休息

午间卫星会柏盛国际和吉威医疗联合主办构建解剖和功能影像诊断冠心病的双重金标准12:40 PM-1:55 PM

主席：王建安, 黄钢, Martin B. Leon, Eberhard Grube, 李思进, 徐波


12:45 PM - 分子影像学在现代冠心病诊断中的重要角色何作祥

1:00 PM - 冠脉血流储备的无创定量测量技术Ryo Nakazato

1:15 PM - 新颖的功能解剖复合定位：介入心脏病专家的未来角色Martin B. Leon

1:30 PM - 功能解剖定位的临床观察：一项关键的临床试验介绍Shlomo Ben Haim


1:55 PM - 休会

示教演示8及特色讲座2:00 PM-4:00 PM

主持人：Eberhard Grube, David E. Kandzari, Yean-Leng Lim讨论专家：Fernando Alfonso, 陈方, Costantino R. Costantini, 胡盛寿, Chaim S. Lotan, Mitchell W. Kruco�, 齐晓勇, Pieter R. Stella, 朱建华

2:00 PM - 转播：复旦大学附属中山医院左主干、分叉病变介入治疗及生物可吸收支架术者：Antonio Colombo, Seung-Jung Park, 葛均波, 钱菊英, 葛雷及同事IVUS解说：Akiko Maehara

3:30 PM - “杂交”技术治疗冠脉多支病变：现状与争议胡盛寿

3:45 PM - 双重抗血小板治疗：多长才足够？Donald E. Cutlip

示教演示9及特色讲座4:00 PM-6:00 PM

主持人：Martin B. Leon, Ian T. Meredith, 杨跃进讨论专家：Yaron Almagor, Juan F. Granada, 刘健, 柳景华, Richard Ng, Masahiko Ochiai, Alfredo E. Rodriguez, Bruno Scheller, 张俊杰

4:00 PM - 转播：上海交通大学医学院附属瑞金医院左主干、分叉病变及慢性完全闭塞病变介入治疗术者：Je�rey W. Moses, Ajay J. Kirtane, Philippe Généreux, Toshiya Muramatsu, 张瑞岩, 张奇及同事IVUS解说：Gary S. Mintz

5:30 PM - 慢性完全闭塞病变逆向技术新进展Masahiko Ochiai

5:45 PM - Chien基金会讲师奖颁奖者：Richard Ng领奖者：Antonio Colombo

5:50 PM - Chien基金会讲座：介入心脏病学的未来 - 我的观点Antonio Colombo

6:00 PM - 休会


146


2:05 PM - 我将怎样做？张俊杰

2:10 PM - 我将怎样做？窦克非

2:15 PM - 病例报告：我是怎样做的？沈成兴

2:20 PM - 治疗冠脉开口病变的技术技巧郭文怡


病例2：富含血栓病变

2:40 PM - 病史介绍李妍

2:45 PM - 我将怎样做？刘震宇

2:50 PM - 我将怎样做？刘强

2:55 PM - 病例报告：我是怎样做的？李妍

3:00 PM - 治疗血栓病变的技术技巧王乐丰


第二场

主持人：靳立军, 李浪讨论专家：曹雪滨, 陈竹君, 刘朝中, 聂如琼, 徐延敏, 徐泽升

病例3：小血管、长病变

3:20 PM - 病史介绍杭靖宇

3:25 PM - 我将怎样做？聂如琼

3:30 PM - 我将怎样做？陈竹君

3:35 PM - 病例报告：我是怎样做的？杭靖宇

3:40 PM - 治疗小血管、长病变的技术技巧靳立军


病例4：药物洗脱支架再狭窄

4:00 PM - 病史介绍宋现涛

4:05 PM - 我将怎样做？刘朝中

4:10 PM - 我将怎样做？徐延敏

4:15 PM - 病例报告：我是怎样做的？宋现涛

4:20 PM - 治疗药物洗脱支架再狭窄的策略和技术李浪


第三场

主持人：乔树宾, 方唯一讨论专家：樊冰, 洪浪, 蒋金法, 陆志刚, 施海明, 王慧峰

病例5：钙化病变

4:40 PM - 病史介绍王琼

4:45 PM - 我将怎样做？陆志刚

4:50 PM - 我将怎样做？洪浪

4:55 PM - 病例报告：我是怎样做的？王琼

5:00 PM - 治疗钙化病变的技术技巧乔树宾


病例6：扭曲/成角病变

5:20 PM - 病史介绍卜军

5:25 PM - 我将怎样做？施海明

二层203会议室

午间卫星会雅培血管仪器部主办（一）实践、循证、科技：技领DES之巅12:40 PM-1:55 PM

主席：韩雅玲, 陈方, 陈纪言, 陈绍良, 王乐丰


12:45 PM - 可降解涂层DES和永久性涂层DES哪个更优异？来自多个研究结果和荟萃分析的证据Pieter C. Smits

1:00 PM - 首个钴铬合金依维莫司药物支架在中国患者中的DAPT分析和表现：前瞻性多中心SEEDS研究两年结果徐波

1:15 PM - 在临床困境中应用钴铬合金依维莫司药物支架征服挑战Wei-Hsian Yin

1:30 PM - 新一代钴铬合金依维莫司药物支架的革命慕朝伟


1:55 PM - 休息

冠脉介入实用教程第一部分怎么做：复杂病例讨论2:00 PM-6:00 PM

第一场

主持人：郭文怡, 王乐丰讨论专家：白锋, 窦克非, 韩战营, 刘强, 刘震宇, 张俊杰

病例1：开口病变

2:00 PM - 病史介绍沈成兴


147


5:30 PM - 我将怎样做？樊冰

5:35 PM - 病例报告：我是怎样做的？卜军

5:40 PM - 治疗扭曲/成角病变的技术技巧方唯一


6:00 PM - 休会

二层204会议室

病例早餐会1急性冠脉综合征7:00 AM-8:15 AM

主持人：叶飞, 籍振国, 贺勇

7:00 AM - CS-0012：前降支支架术后10个月下壁心肌梗死一例籍振国

7:10 AM - 讨论

7:15 AM - CS-0213：急性心梗合并心律失常病例解玉泉

7:25 AM - 讨论

7:30 AM - CS-0236：非ST段抬高心肌梗死急诊PCI一例阮云军

7:40 AM - 讨论

7:45 AM - CS-0259：急性心肌梗死患者非梗塞相关血管PCI一例冯克福

7:55 AM - 讨论

8:00 AM - CS-0292：急诊右冠PCI并开通左主干CTO一例陈大鹏

8:10 AM - 讨论

8:15 AM - 休会

午间卫星会波士顿科学主办（一）欲善其事，先利其器：复杂病例PCI的优化治疗12:40 PM-1:55 PM

主席：何奔, 陈良龙, 马依彤, 杜志民, 陈珏, 刘学波


12:45 PM - PE Plus精彩病例分享荆全民

1:00 PM - 切割球囊精彩病例分享：不只是治疗再狭窄！聂绍平

1:15 PM - 复杂钙化病变旋磨治疗精彩病例分享陈竹君

1:30 PM - IVUS指导下前三叉病变精彩病例分享刘学波


1:55 PM - 休息

整合应用FFR、IVUS、OCT及其他以改善患者疗效（三）2:00 PM-6:00 PM

第四场：介入前评估

主持人：John McB. Hodgson, 刘学波

2:00 PM - 何时与怎样使用FFR？单守杰

2:15 PM - iFR与复合iFR/FFR策略：他们会取代FFR吗？Justin E. Davies

2:30 PM - CT-FFR进展更新Campbell Rogers

2:45 PM - 介入前影像及依据IVUS选择支架Soo-Jin Kang

3:00 PM - 介入前影像及依据OCT选择支架侯静波

3:15 PM - 预测围术期心肌梗死：灰阶IVUS、RF（虚拟组织学）IVUS、OCT及NIRS的作用吴小凡

介入术前评估或支架大小选择的示范病例讨论（每例报告及讨论15分钟）

讨论专家：Justin E. Davies, Seung-Jea Tahk, 徐迎佳


148


二层205会议室


主持人：尤士杰, 吴铿, 秦勤

7:00 AM - CS-0294：致命性AMI梗死和非梗死相关血管一次完全PCI吴铿

7:10 AM - 讨论

7:15 AM - CS-0301：急诊PCI非靶血管急性闭塞周国伟

7:25 AM - 讨论

7:30 AM - IM-0048：多发斑块破裂导致的急性冠脉综合征卜军

7:40 AM - 讨论

7:45 AM - CS-0019：急诊同时处理非梗塞血管及随访赵宇新

7:55 AM - 讨论

8:00 AM - 休会

午间卫星会美敦力主办（一）挑战复杂病变，器械成就非凡12:40 PM-1:55 PM

主席：傅国胜, 柳景华, 王焱, 向定成, 尤士杰


12:42 PM - 举重若轻：AL指引导管高阶操控技术傅国胜

1:00 PM - 事半功倍：Export AP - 从临床试验到临床实践慕朝伟

1:15 PM - 智取分叉：分叉病变球囊使用经验李成祥

1:30 PM - 知难而进：慢性完全闭塞病变球囊应用技巧杨清


1:55 PM - 休息

左主干和分叉病变第二部分分叉病变治疗的新数据洞察2:00 PM-6:00 PM

第一场：简单对比复杂分叉病变的当代概念

主持人：Alexandra J. Lansky, Imad Sheiban, Ramesh B. Daggubati讨论专家：郭宁, Bon-Kwon Koo, 李丽, 柳景华, 钱杰

2:00 PM - 分叉病变的解剖、生理及临床相关性Bon-Kwon Koo

2:12 PM - 当前分叉病变研究指导我们的实践吗：研究设计的不同之处Ramesh B. Daggubati

2:24 PM - 分叉病变介入治疗2013更新：文献回顾柳景华

2:36 PM - 病例报告1：单支架治疗简单分叉病变（未行对吻扩张）郭宁

2:44 PM - 讨论

2:49 PM - 病例报告2：单支架治疗复杂分叉病变（行对吻扩张）钱杰

2:57 PM - 讨论

3:02 PM - 病例报告3：经典挤压术式治疗复杂分叉病变（对吻扩张失败）李丽

3:10 PM - 讨论

3:30 PM - IM-0059：从斑块性质看无复流发生单培仁

3:45 PM - IM-0082：IVUS在旋磨术中的应用徐凯

4:00 PM - IM-0087：IVUS指导下改变左主干治疗策略一例赵雷

第五场：支架优化

主持人：Costantino O. Costantini, Alan C. Yeung

4:15 PM - IVUS指导支架优化郭宁

4:30 PM - OCT指导支架优化Yang-Soo Jang

4:45 PM - FFR指导支架优化和被“拘禁”的分支Bon-Kwon Koo

5:00 PM - 特色讲座：IVUS（或OCT）引导介入改善疗效的证据John McB. Hodgson

支架优化示范病例讨论（每例报告及讨论15分钟）

讨论专家：Debabrata Dash, Bon-Kwon Koo, 赵志敬

5:15 PM - IM-0024：PCI后冠脉壁内血肿一例郑心田

5:30 PM - IM-0050：高度钙化病变支架膨胀不良致亚急性支架内血栓一例白静

5:45 PM - IM-0109：FFR在一例冠脉分叉病变中的应用鄢华

6:00 PM - 休会


149


二层206会议室


主持人：杨庭树, 郭金成, 王明生

7:00 AM - CS-0056：成功运用主动脉内球囊泵辅助PCI治疗左侧冠脉CTO病变合并急性下壁心肌梗死伴心源性休克患者一例马翔

7:10 AM - 讨论

7:15 AM - CS-0062：分次处理急性前壁ST段抬高型心肌梗死一例陈鸿武

7:25 AM - 讨论

7:30 AM - CS-0073：肾病综合征患者冠脉血栓与不稳定斑块陈立娟

7:40 AM - 讨论

7:45 AM - CS-0264：两支冠脉血管慢性自发性夹层导致急性心肌梗死贺行巍

7:55 AM - 讨论

8:00 AM - 休会

TRI俱乐部第一部分9:40 AM-12:30 PM

第一场

主持人：吕树铮, 周玉杰, 傅向华, 李为民, 郭丽君, 刘宇扬

9:40 AM - 经桡动脉介入治疗：90%成功危险吗？Mitchell W. Kruco�

9:50 AM - 讨论

3:15 PM - 病例报告4：改良裙裤技术治疗复杂分叉病变温尚煜

3:23 PM - 讨论

3:28 PM - DEFINITION研究：定义简单对比复杂分叉病变陈绍良


第二场：支架术式技术之外分支的重要性

主持人：吕树铮, Rajesh Dave, Yutaka Hikichi讨论专家：Chi-Kin Chan, 曹丰, 窦克非, Hyeon-Cheol Gwon, 单守杰

3:58 PM - 分支闭塞：机制、临床影响及怎样避免Hyeon-Cheol Gwon

4:10 PM - 复杂分叉病变中怎样挽救分支？Chi-Kin Chan

4:22 PM - 分叉角度对IVUS引导的即兴支架术的影响单守杰


4:44 PM - 分支处理越简单越好吗？信栓力

4:56 PM - 分叉病变再狭窄后边支闭塞的处理策略曹丰

5:08 PM -“拘禁”球囊分支保护策略与技术罗建方


5:30 PM - 我处理开口病变的方法陈纪林

5:42 PM - 预防分支闭塞的技术技巧吕树铮


6:00 PM - 休会

9:52 AM - 经桡动脉介入治疗：操作技术、研究结果及当前指南Jean Fajadet

10:04 AM - 讨论

10:06 AM - 经桡动脉冠脉介入治疗的黄金时期已经到来了吗？杨跃进

10:16 AM - 讨论

10:18 AM - 经桡动脉介入治疗当日出院的策略Jack P. Chen

10:28 AM - 讨论

10:30 AM - 经桡、股动脉路径冠脉介入治疗的对比Shing-Chiu Wong

10:40 AM - 讨论

10:42 AM - 经桡动脉冠脉造影和介入临床研究更新叶飞

10:52 AM - 讨论

10:54 AM - 经桡动脉“挤压”和“裙裤”支架术之技术要领与临床应用陈良龙

11:04 AM - 讨论

第二场

主持人：乔树宾, Paul TL Chiam, 姜铁民, 袁祖贻, 尤士杰, 安毅

11:06 AM - 经桡动脉入路的困难和对策翁少翔

11:16 AM - 讨论

11:18 AM - 应用Slender无鞘引导导管行经桡动脉介入治疗Paul TL Chiam

11:28 AM - 讨论

11:30 AM - 经桡动脉介入治疗中如何处理球囊或支架通过困难？李悦


150


11:40 AM - 讨论

11:42 AM - 经桡动脉行冠脉慢性完全闭塞病变介入治疗的提示与技巧张斌

11:52 AM - 讨论

11:54 AM - 经桡动脉应用6F指引导管“微挤压”技术处理三分叉病变Kenji Wagatsuma

12:04 PM - 讨论

12:06 PM - 5进6双导管技术在经桡动脉介入治疗中的应用：策略与技巧张奇

12:16 PM - 讨论

12:18 PM - 桡股路径的放射辐射比较周斌全

12:28 PM - 讨论

12:30 PM - 休息

午间卫星会万瑞飞鸿主办NOYA药物洗脱支架在真实世界的应用12:40 PM-1:55 PM

主席：吕树峥, 陈韵岱, 高传玉, 陈玉国


12:45 PM - 临床实践中应用NOYA药物洗脱支架病例回顾陈珏

1:05 PM - 临床实践中应用NOYA药物洗脱支架病例回顾金恩泽

1:25 PM - NOYA I临床试验4年临床结果公布杨跃进


1:55 PM - 休息

非ST段抬高型急性冠脉综合征2:00 PM-6:00 PM

第一部分：非ST段抬高型急性冠脉综合征最新进展

主持人：Roxana Mehran, 陈纪言讨论专家：何奔, 李悦, Kai Wang, 颜红兵

2:00 PM - 急性冠脉综合征的生物标志物及其临床意义Kai Wang

2:12 PM - 比伐卢定是非ST段抬高型急性冠脉综合征抗凝治疗的第一选择吗？Roxana Mehran

2:24 PM - 心脏和非心脏手术患者抗栓治疗的桥接Davide Capodanno

2:36 PM - 非ST段抬高型急性冠脉综合征指南亮点及当前中国实践何奔

2:48 PM - 对比低危和高危非ST段抬高型急性冠脉综合征患者的不同治疗策略李悦

3:00 PM - PLATO试验及更多的新证据颜红兵


第二部分：非ST段抬高型急性冠脉综合征辩论 - 当前争议

主持人：王乐丰, 聂绍平, 谭宁, 王宁夫

辩论1

3:26 PM - 替卡格雷是大多数患者的选择朱永宏

3:36 PM - 不，氯吡格雷仍然是大多数中国患者的选择唐熠达

3:46 PM - 讨论讨论专家：唐熠达, 朱永宏

辩论2

3:51 PM - 6个月双重抗血小板治疗持续时间已经足够长了荆全民

4:01 PM - 不，双联抗血小板治疗持续时间应基于个体和支架乔树宾

4:11 PM - 讨论讨论专家：荆全民, 乔树宾

辩论3

4:16 PM - GRACE评分是风险分层的金标准郭丽君

4:26 PM - 不，TIMI评分在中国更实用华倚虹

4:36 PM - 讨论讨论专家：郭丽君, 江洪, 华倚虹

辩论4

4:41 PM - 在非ST段抬高型急性冠脉综合征患者中手动抽吸缺乏证据王禹

4:51 PM - 不，机化血栓仍然活跃魏盟

5:01 PM - 讨论讨论专家：王禹, 魏盟

第三部分：非ST段抬高型急性冠脉综合征棘手病例回顾

主持人：吴永健, 李虹伟, 贾绍斌, 王凯, 张敏州

5:06 PM - 病例1：IIb/IIIa受体抑制剂相关的血小板减少症华倚虹

5:14 PM - 讨论

5:24 PM - 病例2：房颤患者的急性冠脉综合征曾和松

5:32 PM - 讨论

5:42 PM - 病例3：具有急性冠脉综合征和介入治疗病史患者新发房颤杨萍

5:50 PM - 讨论

6:00 PM - 休会


151


二层207会议室

病例早餐会4左主干病变7:00 AM-8:00 AM

主持人：唐疾飞, 王慧峰, 王斌

7:00 AM - CS-0128：旋磨治疗左主干钙化性慢性闭塞施鸿毓

7:10 AM - 讨论

7:15 AM - CS-0080：命悬一线的两难抉择 - 前三叉95%合并右冠99%狭窄一例尹涛

7:25 AM - 讨论

7:30 AM - CS-0041：OCT指导下年轻女性大动脉炎患者左主干PCI赵林

7:40 AM - 讨论

7:45 AM - CS-0083：高龄老人左主干分叉病变（1,1,1）PCI术中支架脱载一例刘兵

7:55 AM - 讨论

8:00 AM - 休会

午间卫星会圣犹达主办全面认识ADO II12:40 PM-1:55 PM

主席：于波, 朱鲜阳, 蒋世良, 张智伟


12:45 PM - ADO II的设计理念和临床应用高伟

1:00 PM - 经典病例回顾1：ADO II在复杂先心病中的应用金梅

1:15 PM - 经典病例回顾2：ADO II在复杂先心病中的应用孙锟

1:30 PM - ADO II临床应用总结及应用趋势解析徐仲英


1:55 PM - 休息

药物学研讨会赛诺菲协办血栓论坛2:00 PM-5:00 PM

主持人：霍勇, 沈卫峰, 郭静萱, 崔炜, 高传玉, 杜志民

2:00 PM - 中国冠脉介入发展的历程和主要成就高润霖

2:30 PM - 中国冠脉介入发展未来方向和机遇霍勇

3:00 PM - PCI抗血小板治疗的亚洲及中国的视角张抒扬

3:20 PM - PCI围手术期抗血小板治疗的策略韩雅玲

3:40 PM - 临床视角看待ACS抗血小板药物的选择吕树铮

4:00 PM - 特殊情况下PCI抗血小板治疗的处理原则傅国胜

4:20 PM - ACS患者抗血小板治疗相关出血的现状和处理丛洪良

4:40 PM - 血小板功能检测是否能指导临床指导策略？史旭波

药物学研讨会施维雅协办缺血性心脏病的综合管理5:00 PM-6:00 PM

主持人：高润霖, 戚文航, 黄峻


5:05 PM - 缺血性心脏病全面康复管理与代谢治疗张福春

5:25 PM - 心血管疾病的心律管理陈牧雷


6:00 PM - 休会


152


二层208会议室


主持人：王雷, 陈晖, 刘宏斌

7:00 AM - CS-0178：7.5F无鞘指引导管处理左主干四分叉病变陈晖

7:10 AM - 讨论

7:15 AM - CS-0185：左主干分叉病变回旋支严重成角病例PCI张新才

7:25 AM - 讨论

7:30 AM - CS-0229：左主干病变介入治疗王伟

7:40 AM - 讨论

7:45 AM - CS-0176：FFR引导下PCI处理急性心肌梗死合并前三叉钙化临界病变一例尹涛

7:55 AM - 讨论

8:00 AM - 休会

心律失常第一部分新技术9:30 AM-12:30 PM

第一场

主持人：黄从新, 黄德嘉, 程晓曙, 孙英贤, 王冬梅

9:30 AM - SICD会改变中国心脏性猝死的防治现状吗？华伟

9:45 AM - 讨论

9:48 AM - 心脏收缩期调制治疗力衰竭沈法荣

10:03 AM - 讨论

10:06 AM - 无导线起搏器：成熟疗法的技术革命陈柯萍

10:21 AM - 讨论

10:24 AM - 迷走神经刺激治疗心衰殷跃辉

10:39 AM - 讨论

10:42 AM - 脊髓刺激对心脏衰竭的影响吴立群

10:57 AM - 讨论

第二场

主持人：马长生, 曹克将, 周胜华, 董建增, 刘斌

11:00 AM - Rotor会对房颤治疗带来什么？姚焰

11:15 AM - 讨论

11:18 AM - 迷走神经刺激治疗室性心律失常李毅刚

11:33 AM - 讨论

11:36 AM - 肾动脉去神经消融术治疗房颤单其俊

11:51 AM - 讨论

11:54 AM - 压力导管会对房颤治疗带来什么希望？马坚

12:09 PM - 讨论

12:12 PM - 肺静脉隔离无放射操作Tom De Potter

12:27 PM - 讨论

12:30 PM - 休息

午间卫星会易生科技主办爱立药物洗脱支架临床数据更新12:40 PM-1:55 PM

主席：韩雅玲, 王海昌, 李浪, 柳景华, 徐波


12:45 PM - I-LOVE-IT 2试验背景、设计理念及一个月结果更新韩雅玲

1:00 PM - VIRTURE研究一年临床结果公布葛雷

1:15 PM - 爱立药物洗脱支架在糖尿病小血管病变中的应用杨丽霞

1:30 PM - 爱立精彩病例分享姜朝晖


1:55 PM - 休息

心律失常第二部分房颤2:00 PM-6:00 PM

第一场：临床实践中遇到以下问题, 我们该怎么办？

主持人：姚焰, 董建增, 李莉, 施海峰, 蒋晨阳, 高连君

2:00 PM - 华法林很好地控制下，发生血栓栓塞事件如何处理？刘兴鹏

2:15 PM - 讨论

2:20 PM - 房颤合并急性冠脉综合征, 需要紧急支架植入如何处理？李广平

2:35 PM - 讨论

2:40 PM - 新发房颤、CHADS2 VASC = 1，如何处理？杨延宗

2:55 PM - 讨论

3:00 PM - 4~5年前颅内出血、房颤、CHADS2 VASC = 3，如何处理？丁燕生

3:15 PM - 讨论


153


三层305A会议室


主持人：刘寅, 杨明, 孙华保

7:00 AM - CS-0244：PCI处理左主干三分叉成角病变杨靖

7:10 AM - 讨论

7:15 AM - CS-0251：左主干三分叉伴LAD CTO病变余华

7:25 AM - 讨论

7:30 AM - IM-0019：PCI治疗左主干急性闭塞秦绪光

7:40 AM - 讨论

7:45 AM - CS-0237：FFR指导下对主支支架植入术后分支受压的介入治疗王效增

7:55 AM - 讨论

8:00 AM - 休会

午间卫星会启明医疗主办中国经导管瓣膜技术创新12:40 PM-1:55 PM

主席：杨跃进, 蒋世良, 孔祥清, 王巍


12:43 PM - Venus主动脉瓣膜和输送系统Horst Sievert

12:55 PM - Venus A-Valve中国注册临床研究进展杨跃进

3:20 PM - 患者正在服用口服抗凝药并将要接受房颤射频消融治疗？李述峰

3:35 PM - 讨论

3:40 PM - 植入器械记录到的房颤及处理Chu-Pak Lau

3:55 PM - 讨论

第二场：特殊情况下房颤的射频消融

主持人：杨新春, 郑强荪, 杨平珍, 方丕华, 张卫泽, 张钲

4:00 PM - 瓣膜性心脏病刘旭

4:15 PM - 讨论

4:20 PM - 肥厚型心肌病刘少稳

4:35 PM - 讨论

4:40 PM - 慢性肾脏疾病王祖禄

4:55 PM - 讨论

5:00 PM - 收缩期心力衰竭江洪

5:15 PM - 讨论

5:20 PM - 睡眠呼吸暂停姜建

5:35 PM - 讨论

5:40 PM - 左心耳封堵：房颤治疗的机遇和挑战黄鹤

5:55 PM - 讨论

6:00 PM - 休会

1:07 PM - Venus主动脉瓣膜单中心临床体验陈茂

1:19 PM - Venus肺动脉瓣膜和输送系统Ziyad M. Hijazi

1:31 PM - Venus肺动脉瓣膜的初步临床结果周达新


1:55 PM - 休息

结构性心脏病第一部分2:00 PM-6:00 PM

第一场

主持人：周爱卿, Jacek Bialkowski, 秦永文, 孔祥清, 王广义, Malgorzata Szkutnik

2:00 PM - 不明原因休克患者卵圆孔未闭封堵术3个随机试验和11个观察研究的荟萃分析：与药物治疗的比较Davide Capodanno

2:12 PM - 讨论

2:15 PM - 不同PFO封堵器的应用经验Horst Sievert

2:27 PM - 讨论

2:30 PM - 外科主动脉瓣和二尖瓣生物瓣置换失效后的瓣中瓣治疗John G. Webb

2:42 PM - 讨论

2:45 PM - 主动脉缩窄介入治疗：裸支架和覆膜支架的植入Jacek Bialkowski

2:57 PM - 讨论

3:00 PM - 主动脉缩窄介入治疗：理想治疗策略Ziyad M. Hijazi

3:12 PM - 讨论

3:15 PM - 肺动静脉瘘的介入治疗徐仲英

3:27 PM - 讨论


154


3:30 PM - 经皮二尖瓣疗法的现状更新Ted E. Feldman

3:42 PM - 讨论

3:45 PM - 心肌梗死后室间隔穿孔的介入治疗：中国的经验朱鲜阳

3:57 PM - 讨论

第二场

主持人：蒋世良, 朱鲜阳, Witold Ruzyllo, 赵世华, 潘欣, Kelvin Chan

4:00 PM - 左心耳封堵是药物治疗合理或更适合的替代疗法吗？Matthew J. Price

4:12 PM - 讨论

4:15 PM - 爱德华SAPIEN肺动脉瓣疗效Saibal Kar

4:27 PM - 讨论

4:30 PM - 跨环补片后右室流出道失功患者的治疗：经导管自膨式肺动脉瓣支架（Venus-P）的植入Yat-Yin Lam

4:42 PM - 讨论

4:45 PM - 经皮肺动脉瓣植入术：中国的经验周达新

4:57 PM - 讨论

5:00 PM - 主动脉窦瘤破裂的介入治疗秦永文

5:12 PM - 讨论

5:15 PM - 复杂先天性心脏病的介入治疗张智伟

5:27 PM - 讨论

5:30 PM - 心血管外科术后并发症的介入治疗张戈军

5:42 PM - 讨论

5:45 PM - Watchman和Amplatzer左心耳封堵器在植入犬体内后生物反应的差异Dongming Hou

5:57 PM - 讨论

6:00 PM - 休会

三层305B会议室

病例早餐会7分叉病变7:00 AM-8:00 AM

主持人：刘学波, 田军

7:00 AM - CS-0275：拘禁球囊技术在LAD慢性完全闭塞PCI中的应用何鹏程

7:10 AM - 讨论

7:15 AM - CS-0205：峰回路转 - 前降支闭塞合并远段分叉病变的PCI一例邢玉洁

7:25 AM - 讨论

7:30 AM - CS-0228：前降支分叉病变介入治疗一例王斌

7:40 AM - 讨论

7:45 AM - CS-0131：IVUS指导前降支分叉病变介入治疗来晏

7:55 AM - 讨论

8:00 AM - 休会

午间卫星会垠艺主办12:40 PM-1:55 PM

主席：魏盟, 钱菊英, 张瑞岩, 马礼坤, 江洪


12:45 PM - 要正确认识紫杉醇颜红兵

1:00 PM - 垠龙支架在瘤样扩张和慢血流病变中的应用汝磊生


155


三层302A会议室

病例早餐会8复杂病变介入治疗7:15 AM-8:00 AM

主持人：杨志健, 刘健, 曲新凯

7:15 AM - CS-0169：弥漫钙化LAD旋磨支架术及弥漫钙化扭曲LCX支架术Sridhar Kasturi

7:25 AM - 讨论

7:30 AM - CS-0196：急性心肌梗死左主干PCI中并发症Abhay Somani

7:40 AM - 讨论

7:45 AM - CS-0370：重要分支处理策略的选择：高危STEMI直接介入治疗及临床随访刘健

7:55 AM - 讨论

8:00 AM - 休会

午间卫星会GE医疗主办（一）心血管复合手术室解决方案和实践12:40 PM-1:55 PM

主席：霍勇, Je�rey W. Moses, Bernard De Bruyne


12:45 PM - 冠脉及瓣膜疾病复合手术实践吴永健

1:05 PM - IGS机器人心脏复合手术室解决方案钟民

1:35 PM - 携手GE，专业打造心脏介入中心燕霞


1:55 PM - 休息

1:15 PM - 垠龙支架单中心使用体会周旭晨

1:30 PM - 垠艺球囊使用体会荆全民


1:55 PM - 休息

基础与药物第一部分2:00 PM-6:00 PM

第一场

主持人：陈灏珠, 林曙光, 陈君柱, 蒋宝琦, 曾定尹, 李虹伟

动脉粥样硬化性疾病发生机制与临床：2013进展

2:00 PM - 动脉粥样硬化性疾病基因学研究与临床张运

2:15 PM - 动脉粥样硬化性疾病脂源性学说新认识与临床李建军

2:30 PM - 动脉粥样硬化性疾病新标志物与临床陶军

2:45 PM - 动脉粥样硬化性疾病氧化应激与临床陈良龙

动脉粥样硬化斑块与临床：2013进展

3:00 PM - 动脉粥样硬化易损斑块的概念与临床黄岚

3:15 PM - 动脉粥样硬化斑块进展的概念与临床曹丰

3:30 PM - 动脉粥样硬化稳定斑块的概念与临床何奔

3:45 PM - 动脉粥样硬化斑块逆转的概念与临床叶平

第二场

主持人：黄德嘉, 柯元南, 李建军, 田野, 杨庭树, Kai Wang

心肌缺血、坏死与临床：2013进展

4:00 PM - 心肌缺血病因学与临床王建安

4:15 PM - 心肌缺血后果与临床曲鹏

4:30 PM - 心肌坏死的分类法与临床李建军

4:45 PM - 心肌坏死的检测与临床张抒扬

冠心病药物治疗与临床：2013进展

5:00 PM - 稳定型冠心病的药物干预与临床朱建华

5:15 PM - 急性心肌梗死药物干预与临床刘梅林

5:30 PM - 变异型心绞痛的药物干预与临床魏盟

5:45 PM - 微血管心绞痛的药物干预与临床向定成

6:00 PM - 休会


156


ISES at CIT当代主动脉瘤的腔内治疗2:00 PM-6:00 PM

第一部分：整体介绍

主持人：Jacques Busquet, 符伟国讨论专家：Cli�ord Buckley, 陈忠, 郭伟, Marvin L. Woodall

2:00 PM - ISES at CIT开场致辞：当前和未来计划简介Marvin L. Woodall

2:10 PM - 国际血管内专科医生学会以中国为特殊重点的国际发展计划Jacques Busquet

2:22 PM - 中国主动脉瘤现状：流行病学和统计学郭伟

2:34 PM - 主动脉支架血管的新概念：描述和应用前景Cli�ord Buckley

2:46 PM - 现代血管腔内介入团队的组织符伟国


第二部分：胸主动脉瘤和腔内修复术

主持人：Cli�ord Buckley, 郭伟讨论专家：常光其, 常谦, 刘昌伟, 舒畅

3:08 PM - 怎样处理TEVAR并发症？Cli�ord Buckley

3:20 PM - 主动脉弓部病变：杂交还是全腔内修复？常谦

3:32 PM - 复杂胸腹动脉瘤的当前腔内治疗策略刘昌伟

3:44 PM - “烟囱”技术在复杂主动脉病变中的应用舒畅

3:56 PM - 复杂TEVAR治疗胸主动脉瘤病例回顾1常光其

4:06 PM - 复杂TEVAR治疗胸主动脉瘤病例回顾2Cli�ord Buckley


第三部分：腹主动脉瘤和腔内修复术

主持人：Cli�ord Buckley, 郭伟讨论专家：陈忠, 常光其, 常谦, 刘昌伟, Aravinda Nanjundappa, Won-Heum Shim, Eak-Kyun Shin, 舒畅

4:26 PM - EVAR患者和覆膜支架选择Cli�ord Buckley

4:38 PM - EVAR术后内漏的检测和处理陈忠

4:50 PM - 转播：复旦大学附属中山医院术者：符伟国, Jacques Busquet及同事

5:25 PM - 腹主动脉瘤复杂瘤颈的“烟囱”和开窗术的对比研究郭伟

5:37 PM - EVAR复杂病例回顾罗建方


5:57 PM - 要点总结Cli�ord Buckley, 郭伟

6:00 PM - 休会

三层302B会议室

午间卫星会强生Cordis主办畅游心间，收放自然12:40 PM-1:55 PM

主席：高炜, 钱菊英, 乔树宾, 王伟民


12:45 PM - EMPIRA预扩张球囊在复杂病变中的应用分享李浪

1:00 PM - EMPIRA NC高压球囊的介绍及应用分享刘斌

1:15 PM - EMPIRA球囊在CTO病变中的应用分享张斌

1:30 PM - 精准扩张：EMPIRA系列球囊应用分享钱杰


1:55 PM - 休息

药物洗脱支架：当代器械的适当使用2:00 PM-6:00 PM

第一场

主持人：Chung-Seung Chiang, 陈纪林, Chuen-Den Tseng

2:00 PM - 美国药物洗脱支架现状：从我们的立足点看未解决或需要的五件事是什么？Alan C. Yeung

2:10 PM - 南美洲药物洗脱支架现状：从我们的立足点看未解决或需要的五件事是什么？Liliana R. Grinfeld


157


三层307会议室

向CTO 专家学技术：逐步病例回顾9:30 AM-12:30 PM

第一场

主持人：杜志民

9:30 AM - 我印象最深刻的失败CTO病例陈纪言

9:50 AM - 讨论

10:00 AM - 我印象最深刻的成功CTO病例陈纪言

10:20 AM - 讨论

第二场

主持人：王伟民

10:30 AM - 我印象最深刻的失败CTO病例傅国胜

10:50 AM - 讨论

11:00 AM - 我印象最深刻的成功CTO病例傅国胜

11:20 AM - 讨论

第三场

主持人：张大东

11:30 AM - 我印象最深刻的失败CTO病例葛雷

11:50 AM - 讨论

12:00 PM - 我印象最深刻的成功CTO病例葛雷

12:20 PM - 讨论

12:30 PM - 休息

2:20 PM - 欧洲药物洗脱支架现状：从我们的立足点看未解决或需要的五件事是什么？Pieter C. Smits

2:30 PM - 印度药物洗脱支架现状：从我们的立足点看未解决或需要的五件事是什么？Ashok Seth

2:40 PM - 中国药物洗脱支架现状：从我们的立足点看未解决或需要的五件事是什么？沈卫峰

2:50 PM - 专家讨论讨论专家：Liliana R. Grinfeld, Ashok Seth, 沈卫峰, Pieter C. Smits, Alan C. Yeung

3:00 PM - 多支血管病变合并糖尿病患者介入治疗与搭桥术对比：我们怎样使患者达到理想的疗效？郑哲

3:12 PM - 药物洗脱支架植入后双重抗血小板治疗持续时间的当前证据陈韵岱

3:24 PM - 复杂临床情况下使用药物洗脱支架：非心脏手术、高出血风险及依从性问题Davide Capodanno

3:36 PM - 再狭窄和支架血栓：基于血管内影像的机制探讨Myeong-Ki Hong

3:48 PM - 专家讨论讨论专家：Davide Capodanno, 陈韵岱, Myeong-Ki Hong, 郑哲

第二场

主持人：Kam-Tim Chan, Gim-Hooi Choo, 周旭晨讨论专家：Ching-Chang Fang, Sidney Tsz Ho Lo, Imad Sheiban, Harry Suryapranata, Rurus Suryawan

4:00 PM - 使用药物洗脱支架治疗复杂多支血管和左主干病变时的技术考虑Imad Sheiban

4:12 PM - 病例报告1：药物洗脱支架在多支血管病变中的应用（非左主干但包括CTO及分叉病变）梁春

4:17 PM - 讨论

4:24 PM - 病例报告2：药物洗脱支架在左主干病变中的应用李妍

4:29 PM - 讨论

4:36 PM - 药物洗脱支架应该被用于ST段抬高型心肌梗死患者吗？Harry Suryapranata

4:48 PM - 病例报告3：药物洗脱支架在复杂ST段抬高型心肌梗死中的应用杭靖宇

4:53 PM - 讨论

第三场

主持人：Jack P. Chen, Swee Choon Ng, Xiwei Deng讨论专家：B. K. Goyal, 李浪, Michael Lim, Thomas M. Tu, 朱永宏

5:00 PM - 药物洗脱支架失败发生时的处理：支架内再狭窄、血栓及机械问题李浪

5:13 PM - 病例报告4：两例药物洗脱支架再狭窄（首次和反复再狭窄各一例）杨伟宪

5:21 PM - 讨论

5:29 PM - 病例报告5：两例支架血栓两例（亚急性和晚期各一例）金泽宁

5:37 PM - 讨论

5:45 PM - 特色讲座：比较不同药物洗脱支架的ISAR系列临床试验Adnan Kastrati

6:00 PM - 休会


158


午间卫星会阿斯利康主办ACS抗血小板治疗12:40 PM-1:55 PM

主席：马长生, 王建安, 袁祖贻


12:45 PM - ACS抗血小板药物治疗新纪元陈韵岱

1:10 PM - STEMI指南的临床启示及病例分享高传玉

1:30 PM - ACS优化抗血小板治疗及病例分享聂绍平


1:55 PM - 休息

向CTO 专家学技术：逐步病例回顾2:00 PM-6:00 PM

第四场

主持人：刘同库

2:00 PM - 我印象最深刻的失败CTO病例荆全民

2:20 PM - 讨论

2:30 PM - 我印象最深刻的成功CTO病例荆全民

2:50 PM - 讨论

第五场

主持人：陶凌

3:00 PM - 我印象最深刻的失败CTO病例李成祥

3:20 PM - 讨论

3:30 PM - 我印象最深刻的成功CTO病例李成祥

3:50 PM - 讨论

第六场

主持人：郑金刚

4:00 PM - 我印象最深刻的失败CTO病例张斌

4:20 PM - 讨论

4:30 PM - 我印象最深刻的成功CTO病例张斌

4:50 PM - 讨论

第七场

主持人：宋现涛

5:00 PM - 我印象最深刻的失败CTO病例李悦

5:20 PM - 讨论

5:30 PM - 我印象最深刻的成功CTO病例李悦

5:50 PM - 讨论

6:00 PM - 休会

三层夹层3M5会议室

午间卫星会星进主办血栓抽吸：必不可少！12:40 PM-1:55 PM

主席：颜红兵, 曲新凯, 林英忠


12:45 PM - Kaneka双腔微导管在PCI分叉病变中的优势Eisho Kyo

1:00 PM - 血栓抽吸：急性冠脉综合征介入治疗的重要保证刘健

1:15 PM - 血栓抽吸导管在急性心肌梗死中应用严金川

1:30 PM - 血栓抽吸的必备性及经验分享许庆


1:55 PM - 休息

介入心脏病学热点拜耳协办2:00 PM-4:00 PM

第一部分：ST段抬高型心肌梗死和血栓切除术

主持人：颜红兵, 王伟民

2:00 PM - 目的简介颜红兵

2:05 PM - ST段抬高型心肌梗死中血栓切除术的应用Joseph D. Babb

2:25 PM - 讨论


159


2:30 PM - 冠脉血栓去除：AngioJet®机械血栓抽吸成功处理急性心肌梗死大量血栓病例分享王建安

2:50 PM - 讨论

2:55 PM - 要点总结王伟民

第二部分：对比剂注射方式及应用的新理念

主持人：周玉杰, 杜志民

3:00 PM - 目的简介周玉杰

3:05 PM - 对比剂注射方式的新理念李田昌

3:25 PM - 讨论

3:30 PM - 如何推动对比剂肾病的防治、降低对比剂肾病的发生率？陈茂

3:50 PM - 讨论

3:55 PM - 要点总结杜志民

第五届旋磨技术专题讨论会4:00 PM-6:00 PM

主持人：高炜, 王伟民, 温尚煜, U Po Lam, 田军, 王斌

4:00 PM - 药物支架时代旋磨术在钙化病变介入治疗中的地位高炜

4:12 PM - 讨论

4:14 PM - 冠脉旋磨术的基本操作和技巧：径路、指引导管、导丝及旋磨头王伟民

4:26 PM - 讨论

4:28 PM - 旋磨并发症及其处理Wen-Lieng Lee

4:40 PM - 讨论

4:42 PM - 左主干钙化病变旋磨治疗策略与技巧罗建方

4:52 PM - 讨论

4:54 PM - 非左主干钙化分叉病变旋磨治疗策略与技巧陈珏

5:04 PM - 讨论

5:06 PM - 怎样“战胜”1.25mm旋磨头无法通过的极其严重钙化病变？Nae Hee Lee

5:16 PM - 讨论

5:18 PM - 高龄患者复杂钙化病变的旋磨治疗刘强

5:28 PM - 讨论

5:30 PM - 血管内超声指导下的冠脉旋磨术孙勇

5:40 PM - 讨论

5:42 PM - 特色讲座：怎样应用切割/刻痕球囊和旋磨技术改变斑块性质：临床数据、个人经验及常规共识Samuel K. Mathew

5:57 PM - 讨论

6:00 PM - 休会


160


三层明珠厅

去肾神经化治疗8:30 AM-12:30 PM

第一场

主持人：Martin B. Leon, 高润霖, Murray D. Esler讨论专家：高平进, Nina Goodheart, Juan F. Granada, 顾东风, 蒋雄京, Ajay J. Kirtane, Felix Mahfoud, Martin T. Rothman, Marco Wainstein

8:30 AM - 日益严重的全球性高血压问题顾东风

8:45 AM - 高血压和心力衰竭中去肾交感神经的生理学原理Murray D. Esler

9:00 AM - 转化医学和去肾神经化：临床前动物模型和组织解剖学Juan F. Granada

9:12 AM - 公布和发表的去肾神经化临床试验更新Murray D. Esler

9:27 AM - 对SYMPLICITY HTN-3试验结果的报道怎样影响了这个领域：新闻发布会上的观点Ajay J. Kirtane


9:53 AM - 中国去肾神经化治疗器械进展和研究现状蒋雄京

10:08 AM - 测量去肾神经化治疗的有效性及其响应：从替代终点到临床结果Felix Mahfoud

第二场

主持人：Felix Mahfoud, Atul Pathak, 张瑞岩讨论专家：Justin E. Davies, Peter J. Fitzgerald, Nina Goodheart, David E. Kandzari, Jean Marco, Horst Sievert, Wan Azman Wan Ahmad, Jie Wang

二层201会议室

CCT at CIT8:30 AM-12:30 PM

示教演示及特色讲座（一）

主持人：Eisho Kyo, 葛均波, Yutaka Hikichi讨论专家：Yuji Hamazaki, 荆全民, 慕朝伟, Masaaki Okutsu, 宋现涛, Sudhir Rathore, Kenji Wagatsuma, 王勇, 张斌

8:30 AM - 转播：复旦大学中山医院术者：Etsuo TsuchikaneIVUS解说：Yoshito Yamamoto

9:15 AM - 我们什么时候切换到逆行的方法？Masahisa Yamane

9:30 AM - 反向CART技术的提示和技巧Yuji Hamazaki


示教演示及特色讲座（二）

主持人：Satoru Otsuji, 陈纪言, Shinjo Sonoda讨论专家：Paul Hsien-Li Kao, Nae Hee Lee, 李成祥, 李田昌, 李悦, 刘学波, 钱杰, Satoru Sumitsuji, Masamichi Takano

9:50 AM - 转播：复旦大学中山医院术者：Yasushi AsakuraIVUS解说：Yoshito Yamamoto

10:35 AM - 关于慢性完全闭塞病变我们从多排CT能了解到什么？Satoru Sumitsuji

10:50 AM - 最新影像模式Shinjo Sonoda


示教演示及特色讲座（三）

主持人：Masahisa Yamane, 傅国胜, Toshiya Muramatsu讨论专家：李学奇, William L. Lombardi, 罗建方, Motomaru Masutani, 沈珠军, Akihiko Takahashi, 王守力, Fuminobu Yoshimachi, 郑金刚

10:20 AM - 病例报告1：聚焦患者选择李浪

10:28 AM - 寻找去肾神经化治疗的最适合患者群Jean Marco

10:40 AM - 病例报告2：聚焦操作提示和技巧Wan Azman Wan Ahmad

10:48 AM - 去肾神经化术中操作提示和技巧Horst Sievert

我们应该如何定义和评估去肾神经化治疗的反应？

11:00 AM - 病例报告3：去神经化后患者左心室重量退化但无血压改变Felix Mahfoud

11:10 AM - 病例报告4：去肾神经化的抗心律失常作用Atul Pathak


11:34 AM - 射频消融及其它：在不远的将来我们应该能看到的去肾神经化新方法Peter J. Fitzgerald

11:46 AM - 高血压之外其他潜在去肾神经化治疗适应证Justin E. Davies

11:58 AM - 肺动脉去神经化治疗肺动脉高压：实验研究、PADN-1临床结果及未来方向陈绍良

12:10 PM - 主旨演讲：汇集在一起 - 我对未来5-10年去肾神经化治疗的预测David E. Kandzari


12:30 PM - 休会


161


11:10 AM - 转播：复旦大学中山医院术者：Yasumi IgarashiIVUS解说：Yoshito Yamamoto

11:55 AM - 慢性完全闭塞介入治疗术中并发症的处理Toshiya Muramatsu

12:10 PM - 经桡动脉路径行慢性完全闭塞介入治疗Fuminobu Yoshimachi


12:30 PM - 休息

午间卫星会波士顿科学主办（二）创新波科12:40 PM-1:55 PM

上半场

主席：陈绍良, 陈茂, 孙福成


12:45 PM - 波士顿科学介入心脏病技术的最新进展Keith D. Dawkins

1:00 PM - 肾动脉去神经化的创新：独特的双极消融技术Horst Sievert


下半场

主席：葛均波, 张澍

1:20 PM - CTO介入治疗的进化：混合策略的原理和经验William L. Lombardi

1:35 PM - 猝死预防的全新突破：全皮下除颤器S-ICD宿燕岗


1:55 PM - 休息

左心耳封堵2:00 PM-6:00 PM

第一场：左心耳封堵背景和理论依据

主持人：黄从新, 张澍讨论专家：Ted E. Feldman, Dongming Hou, 刘少稳, 马长生, 吴书林, 杨延宗, 郑哲, 朱俊

2:00 PM - 心房颤动的卒中、出血及风险评分马长生

2:10 PM - 当前临床实践中的华法林应用朱俊

2:20 PM - 左心耳封堵的外科方法和疗效郑哲

2:30 PM - 新型口服抗凝药的获益和局限性Ted E. Feldman

2:40 PM - 指南解读黄从新


第二场：左心耳封堵的循证医学

主持人：Horst Sievert, 黄德嘉讨论专家：Maurice Buchbinder, Keith D. Dawkins, 华伟, Wolfgang Schillinger

3:00 PM - Watchman装置的临床研究结果：PROTECT AF、CAP及PREVAIL试验Keith D. Dawkins

3:15 PM - ACP装置的临床研究结果Wolfgang Schillinger

3:25 PM - 左心耳封堵今天已经是孤立性心房颤动患者口服抗凝的替代治疗了吗？Maurice Buchbinder


第三场：怎样封堵左心耳

主持人：Maurice Buchbinder, Horst Sievert讨论专家：陈明龙, Tom De Potter, 方丕华, Yat-Yin Lam, 马长生, 王玉堂, 王祖禄, 姚焰, Cheuk-Man Yu, Jiangtao Yu

3:51 PM - 左心耳封堵术前、术中及术后的经食道超声Cheuk-Man Yu

4:01 PM - Watchman及其他装置的术中操作技术Jiangtao Yu

4:16 PM - 旋转造影指导的左心耳封堵术Tom De Potter


4:32 PM - 录播病例1：阜外医院姚焰

4:42 PM - 录播病例2：安贞医院董建增, 马长生

4:52 PM - 转播：浙江大学医学院第二附属医院术者：Matthew J. Price, 王建安及同事

5:22 PM - 怎样避免和处理并发症？Horst Sievert

5:32 PM - 先健左心耳封堵器的早期经验Yat-Yin Lam

5:42 PM - 即将到来的新型装置Horst Sievert


6:00 PM - 休会


162


二层202会议室

示教演示12及特色讲座8:30 AM-10:30 AM

主持人：Marie-Claude Morice, Patrick W. Serruys, 沈卫峰讨论专家：陈步星, Jack P. Chen, Bernard De Bruyne, 杜志民, Timothy Dy, 李伟杰, Sidney Tsz Ho Lo, Kui-Hian Sim, Pietro Vandoni

8:30 AM - 转播：上海交通大学医学院附属瑞金医院复杂病变介入治疗术者：Jean Fajadet, Costantino R. Costantini, Costantino O. Costantini, 张奇及同事

10:00 AM - 血运重建是稳定缺血性心脏病治疗的第一选择Je�rey W. Moses

10:15 AM - 冠脉介入治疗术中支架血栓和血栓栓塞并发症Philippe Généreux

示教演示13及特色讲座10:30 AM-12:30 PM

主持人：Maurice Buchbinder, Ted E. Feldman, 高炜讨论专家：陈良龙, Hyeon-Cheol Gwon, Young-Hak Kim, Wolfgang Schillinger, Magnus Settergren, Charles A. Simonton, 王贵松, Wasan Udayachalerm, Chiung-Jen Wu

10:30 AM - 转播：浙江大学医学院第二附属医院复杂病变介入治疗和经导管二尖瓣治疗术者：Masahiko Ochiai, 王建安及同事

12:00 PM - 应用冠脉生理学制定决策Amir Lerman

12:15 PM - ST段抬高型心肌梗死介入治疗的最新进展：从血栓抽吸、血液动力学支持到病变内药物输送Rajesh Dave

12:30 PM - 休息

午间卫星会乐普医疗主办见证创新，眼见为实：NANO无载体药物洗脱支架国内外临床研究最新进展12:40 PM-1:55 PM

主席：韩雅玲, 柳景华, 李浪, 张瑶俊


12:45 PM - 欧洲NANO OCT试验最新进展Benit Edouard

1:00 PM - 透过OCT探究无载体药物支架胡信群

1:15 PM - NANO临床应用病例分享鹿庆华

1:30 PM - NANO无载体支架在复杂介入病例中的应用李伟杰


1:55 PM - 休息

示教演示152:00 PM-3:30 PM

主持人：陈绍良, Ajay J. Kirtane, 葛雷讨论专家：Theodore A. Bass, Rajesh Dave, B. K. Goyal, 李妍, 李怡, Aravinda anjundappa, Thach Nguyen, Yee Guan Yap, 杨毅宁

2:00 PM - 转播：南京医科大学附属南京市第一医院左主干分叉病变介入治疗和肺动脉去神经化术者：Imad Sheiban, 叶飞, 张俊杰, 张丰富及同事IVUS解说：单守杰

特色研究首次公布3:30 PM-4:30 PM

主持人：Spencer B. King III, Alexandra J. Lansky讨论专家：Kam-Tim Chan, Donald E. Cutlip, Hyeon-Cheol Gwon, I-Chang Hsieh, Ajay J. Kirtane, Josef Ludwig, Thach Nguyen, Pieter C. Smits

3:30 PM - XIENCE V中国：中国冠心病患者中对比评价XIENCE V依维莫司洗脱支架与CYPHER西罗莫司洗脱支架安全性和有效性的前瞻性、随机对照试验 - 两年结果高润霖

3:40 PM - 讨论

3:45 PM - 对比双轴旋转造影和标准冠脉造影的前瞻性、随机对照试验刘惠亮

3:55 PM - 讨论

4:00 PM - RESOLUTE中国：中国人群连续患者中应用RESOLUTE佐他莫司洗脱支架的前瞻性注册登记研究陈绍良

4:10 PM - 讨论

4:15 PM - 冠脉分叉病变介入治疗中分支闭塞风险预测的血管造影工具：RESOLVE评分系统窦克非

4:25 PM - 讨论

示教演示164:30 PM-6:00 PM

主持人：陈纪林, Jean Fajadet, 王海昌讨论专家：Wai-Kwong Chan, 何奔, Amir Lerman, 刘海波, Thomas M. Tu, Rajesh Vijayvergiya, 魏盟, Joo-Young Yang, 朱建华

4:30 PM - 转播：南京医科大学附属南京市第一医院左主干 / 分叉病变介入治疗术者：Ramesh B. Daggubati, Samuel K. Mathew, 叶飞, 张俊杰及同事IVUS解说：单守杰

6:00 PM - 休会


163


二层203会议室

冠脉介入实用教程第二部分怎么做：争议病例讨论8:30 AM-12:30 PM

第一场：急性冠脉综合征

主持人：贾国良, 颜红兵讨论专家：江时森, 孙福成, 陶贵周, 曾玉杰, 周立君

8:30 AM - CS-0138：急性心肌梗死合并慢性肾功能不全的急诊介入治疗：冠脉内巨大血栓怎么办？陈章强

8:40 AM - 讨论

9:00 AM - CS-0313：急性心肌梗死介入后反复无复流一例顾晓龙

9:10 AM - 讨论

第二场：左主干和慢性完全闭塞病变

主持人：王伟民, 吴永健讨论专家：光雪峰, 黄超联, 李国庆, 齐晓勇, 赵全明

9:30 AM - CS-0046：从即兴T到裙裤技术：IVUS指导左主干分叉病变介入治疗一例高磊

9:40 AM - 讨论

10:00 AM - CS-0042：LAD、LCX双支闭塞及RCA重度狭窄的PCI朱中生

10:10 AM - 讨论

第三场：并发症

主持人：荆全民, 谭宁讨论专家：陈珏, 王宁夫, 许锋, 杨明, 张斌

10:30 AM - CS-0209：钙化扭曲多支病变：旋磨和支架术后血栓形成卜军

10:40 AM - 讨论

11:00 AM - CS-0203：急性心肌梗死非梗死相关血管急性支架内血栓一例李其勇

11:10 AM - 讨论

第四场：并发症

主持人：吕树铮, 李为民讨论专家：黄伟剑, 刘宏斌, 齐向前, 王长谦

11:30 AM - CS-0074：死亡病例讨论：谁能告诉我哪里出了错？陈玉林

11:40 AM - 讨论

12:00 PM - CS-0167：急性心肌梗死直接PCI后非靶病变支架血栓一例丁风华

12:10 PM - 讨论

12:30 PM - 休息

午间卫星会美敦力主办（二）信心源于循证、安全保障成功12:40 PM-1:55 PM

主席：Ajay J. Kirtane, David E. Kandzari, 何奔, 贾绍斌, 徐波


12:42 PM - 安全立信心：RESOLUTE欧盟1个月DAPT适应证邱春光

1:00 PM - 实践出真知：DAPT中断病例报告金泽宁

1:15 PM - 世界看中国：RESOLUTE中国随机对照和注册研究侯静波

1:30 PM - 创新领未来：美敦力介入新视角David E. Kandzari


1:55 PM - 休息

冠脉介入实用教程第三部分慢性完全闭塞专家教程2:00 PM-6:00 PM

第一场

主持人：陈纪言, Eisho Kyo, 吕树铮, Satoru Otsuji讨论专家：Stephan Achenbach, Paul Hsien-Li Kao, Je�rey W. Moses, Sudhir Rathore

2:00 PM - 组织病理学是慢性完全闭塞介入治疗成功的关键Satoru Sumitsuji

2:15 PM - CT能为慢性完全闭塞再通做些什么？Stephan Achenbach

2:30 PM - 慢性完全闭塞介入治疗的理论依据Je�rey W. Moses

2:45 PM - 慢性完全闭塞的正向方法：新颖导丝技术的影响Sudhir Rathore

3:00 PM - 慢性完全闭塞的逆向方法：2014进展Yasushi Asakura

3:15 PM - 挑战性慢性完全闭塞病例回顾1：我的技巧分享Etsuo Tsuchikane

3:30 PM - 挑战性慢性完全闭塞病例回顾2：我的技巧分享Paul Hsien-Li Kao


第二场

主持人：方唯一, 靳立军, 刘同库, 吕安林, 汝磊生, 周国伟

4:00 PM - 特色讲座：中国慢性完全闭塞介入治疗的现状与未来葛均波

4:15 PM - 慢性完全闭塞介入治疗：如何从起步走向专家之我见？吕树铮


164


4:30 PM - 如何做好慢性完全闭塞的介入治疗计划？陈纪言

4:45 PM - 处理慢性完全闭塞病变从何处入手？该何时收手？傅国胜

5:00 PM - IVUS在慢性完全闭塞介入治疗中的关键作用杨跃进

5:15 PM - 在慢性完全闭塞介入治疗中我是怎样合理选择器械的？荆全民

5:30 PM - 我是怎样合理运用逆向方法治疗慢性完全闭塞病变的？张斌

5:45 PM - 逆向开通慢性完全闭塞：单中心200例经验李成祥

6:00 PM - 休会

二层204会议室

病例早餐会10并发症7:00 AM-8:15 AM

主持人：李为民, 姜铁民, 袁晋青

7:00 AM - CS-0014：极晚期支架内血栓的处理与随访刘同库

7:10 AM - 讨论

7:15 AM - CS-0065：LAD陷落何清

7:25 AM - 讨论

7:30 AM - CS-0082：左主干急性血栓形成成功处置一例刘兵

7:40 AM - 讨论

7:45 AM - CS-0100：冠脉支架断裂一例张鹏

7:55 AM - 讨论

8:00 AM - CS-0110：逆向开通右冠脉开口夹层一例曹阳

8:10 AM - 讨论

8:15 AM - 休息

整合应用FFR、IVUS、OCT及其他以改善患者疗效（四）8:30 AM-12:30 PM

第六场：支架血栓、支架内再狭窄及长期随访研究 - IVUS、OCT及其他知识的整合

主持人：Fernando Alfonso, Stephen Wai-Luen Lee讨论专家：郭宁, Soo-Jin Kang, Yoshinobu Onuma, Masamichi Takano

8:30 AM - 支架内再狭窄的机制和预测因素Gary S. Mintz

8:45 AM - 早期支架血栓的机制和预测因素Fernando Alfonso

9:00 AM - 晚期和迟发晚期支架血栓的机制和预测因素Soo-Jin Kang

9:15 AM - 新生动脉硬化：这是支架失败（支架再狭窄和血栓）的最终通路吗？Masamichi Takano

9:30 AM - 急性和晚期贴壁不良有影响吗？郭宁

9:45 AM - 支架内再狭窄患者生理学评价的作用：是否处理？William F. Fearon

10:00 AM - 特色讲座：从系列生理学、IVUS及OCT研究中我们已经了解了哪些关于生物可吸收支架的知识？Yoshinobu Onuma


支架内再狭窄或支架血栓病例讨论（每例报告及讨论15分钟）

主持人：Fernando Alfonso, 郭宁讨论专家：贺勇, Myeong-Ki Hong, 杨峻青

10:30 AM - IM-0117：结合IVUS与FFR深入理解和治疗前降支起始部病变二例王琼

10:45 AM - IM-0092：一例支架内再狭窄扩张后无复流的血管内超声影像分析金琴花

11:00 AM - IM-0030：AMI PCI术后急性支架内血栓形成的原因是什么？张必利

11:15 AM - IM-0036：陈旧性支架断裂一例朱皓

第七场：结语

主持人：John McB. Hodgson, Ron Waksman讨论专家：Akiko Maehara, Gary S. Mintz, Johan H. C. Reiber

11:30 AM - 在现代导管室环境中合理整合FFR、IVUS、OCT及其他Gary S. Mintz


165


11:50 AM - 一种以现代导管室为基础的影像服务Akiko Maehara

12:00 PM - 三维血管造影和三维OCT的影像融合以支持介入治疗Johan H. C. Reiber


12:30 PM - 休息

午间卫星会GE医疗主办（二）内皮保护，介入首选12:40 PM-1:55 PM

主席：吕树铮, 王海昌

12:40 PM - 开场致辞吕树铮

12:45 PM - 更少内皮损伤，更多心肾保护卢成志

1:05 PM - 从临床试验到临床实践：20185例碘克沙醇临床研究解读徐亚伟

1:25 PM - 碘克沙醇糖尿病患者应用病例分享黄文晖

1:35 PM - 碘克沙醇老年患者应用病例分享路雯


1:50 PM - 要点总结王海昌

1:55 PM - 休息

AICT at CITST段抬高型心肌梗死进展及亚洲相关性2:00 PM-3:30 PM

主持人：Huay Cheem Tan, 葛均波讨论专家：Chi-Kin Chan, Fazila Tun Nesa Malik, Kui-Hian Sim, Wasan Udayachalerm


2:03 PM - ST段抬高型心肌梗死中国救治网络新进展霍勇

2:13 PM - 新型支架、生物可吸收血管支架及药物涂层球囊在直接PCI中的应用Huay Cheem Tan

2:23 PM - 急性心肌梗死后细胞治疗：理想的输送时机、细胞类型及有效性Anthony DeMaria


辩论：直接PCI中血栓抽吸装置的使用

2:43 PM - TASTE试验后其作用已结束Adnan Kastrati

2:50 PM - 别扔了它：还有一个角色Rosli Mohd Ali

2:57 PM - 讨论和共识

ST段抬高型心肌梗死病例讨论

3:03 PM - 有趣的案例介绍1Wacin Buddhari

3:10 PM - 讨论

3:15 PM - 有趣的案例介绍2Paul TL Chiam

3:22 PM - 讨论


MY LIVE at CIT左主干和分叉病变介入治疗3:30 PM-4:30 PM

主持人：Robaayah Zambahari, 徐波讨论专家：Gim-Hooi Choo, 李建平, 刘健, Rosli Mohd Ali, Wan Azman Wan Ahmad, 张奇

左主干介入治疗：出了什么问题？

3:30 PM - 病例报告Wan Azman Wan Ahmad

3:40 PM - 点评刘健

急性冠脉综合征患者左主干介入治疗

3:45 PM - 病例报告Gim-Hooi Choo

3:55 PM - 点评李建平

双分叉病变介入治疗

4:00 PM - 病例报告Rosli Mohd Ali

4:10 PM - 点评张奇


ENCORE at CIT复杂冠脉病变：韩国策略4:30 PM-6:00 PM

主持人：Hyeon-Cheol Gwon, 徐波讨论专家：Tae-Hoon Ahn, 陈绍良, 高展, 葛雷, Myeong-Ki Hong, 李妍, Hyo-Soo Kim

4:30 PM - 目的简介

4:33 PM - 韩国冠脉分叉病变支架术策略Hyeon-Cheol Gwon

4:45 PM - 中国冠脉分叉病变支架术策略陈绍良


5:02 PM - 慢性完全闭塞：中国方法葛雷

5:14 PM - 慢性完全闭塞：韩国方法Hyo-Soo Kim


5:31 PM - 钙化扭曲病变：怎样克服它？Tae-Hoon Ahn

5:43 PM - 影像引导下的冠脉介入治疗Myeong-Ki Hong


6:00 PM - 休会


166


二层205会议室


主持人：袁祖贻, 王守力, 王禹

7:00 AM - CS-0146：慢性完全闭塞病变介入治疗中并发急性血栓一例赵慧强

7:10 AM - 讨论

7:15 AM - CS-0165：支架脱载于左主干一例张必利

7:25 AM - 讨论

7:30 AM - CS-0240：冠脉双支病变分期介入治疗伴冠脉穿孔一例吴志勇

7:40 AM - 讨论

7:45 AM - CS-0274：明胶海绵栓塞冠脉穿孔赵汉军

7:55 AM - 讨论

8:00 AM - CS-0255：逆向PCI术后IIb/IIIa受体拮抗剂导致血小板严重下降并亚急性血栓荆全民

8:10 AM - 讨论

8:15 AM - 休息

Cardiovascular Summit - TCTAP at CIT左主干和分叉病变峰会：FFR与IVUS的整合应用8:30 AM-10:00 AM

主持人：Gary S. Mintz, Seung-Jung Park, Gregg W. Stone讨论专家：Jung-Min Ahn, William F. Fearon, David E. Kandzari, Young-Hak Kim, Bon-Kwon Koo, Akiko Maehara

8:30 AM - 欢迎致辞与内容简介Seung-Jung Park

FFR指导的临床实践！

8:32 AM - 真实实践中常规使用FFR治疗结果的趋势Jung-Min Ahn

8:40 AM - 未来研究：FAME 3试验William F. Fearon


功能上不显著的易损斑块：你要治疗吗？

8:54 AM - 是！Akiko Maehara

9:02 AM - 不！Seung-Jung Park


左主干已不再是外科疾病

9:16 AM - 左主干病变PCI和CABG的现状对比Young-Hak Kim

9:24 AM - EXCEL研究进展Gregg W. Stone


何时与怎样：分叉病变PCI的分支处理

9:38 AM - 造影是足够的！不要浪费时间和金钱David E. Kandzari

9:46 AM - FFR指导的治疗应该被考虑Bon-Kwon Koo


CRT at CIT支架内再狭窄201410:00 AM-11:00 AM

主持人：葛均波, Ron Waksman讨论专家：Akiko Maehara, Huay Cheem Tan, Renu Virmani

10:00 AM - 支架内再狭窄2014：当前问题葛均波

10:10 AM - 支架新生动脉粥样硬化及其对晚期再狭窄的贡献Renu Virmani

10:20 AM - 从机制考虑如何将再狭窄减至最低：断裂于支架设计、聚合物及其他Ron Waksman

10:30 AM - 再狭窄的造影、IVUS及OCT影像，及其对疗法的影响？Akiko Maehara

10:40 AM - 2014年怎样治疗支架内再狭窄：药物涂层球囊、药物洗脱支架，还是生物可吸收血管支架？Huay Cheem Tan


美国心血管造影和介入学会介入质量改进研讨会介绍美国和中国的观点和解决方案11:00 AM-12:30 PM

主持人：Theodore A. Bass, 高润霖讨论专家：Joseph D. Babb, Ajay J. Kirtane, 李浪, Thach Nguyen, Thomas M. Tu, 王海昌

策略

11:00 AM - 在美国心导管室中哪些质量改进措施是必要的？怎样通过应用这些措施以改变当地心导管室的工作文化和疗效？（5条实用建议）Theodore A. Bass

战术1

11:10 AM - 在美国心导管室中如何制定和实施一个成功的质量改进方案？（5条实用建议）Ajay J. Kirtane

11:20 AM - 在中国心导管室中如何制定和实施一个成功的质量改进方案？（5条实用建议）杨跃进


战术2

11:35 AM - 在一类新型、困难、复杂的介入治疗中如何保证手术质量和患者安全？Thomas M. Tu


167


11:45 AM - 中方回应：在慢性完全闭塞（逆向技术）介入治疗中如何保证手术质量和患者安全？陈纪言


战术3

12:00 PM - 因病例临床和造影复杂性高、介入量大的术者具有较高的并发症发生率：怎样解决此问题？王海昌

12:10 PM - 美方回应：怎样解决此问题？（5条实用建议）Thach Nguyen


总结

12:25 PM - 怎样改进质量：未来观点Theodore A. Bass

12:30 PM - 休息

午间卫星会雅培血管仪器部主办（二）创新技术改变未来12:40 PM-1:55 PM

主席：杨跃进, 王伟民, 于波, 聂绍平


12:45 PM - 新型一线主力导丝的使用经验分享罗建方

1:05 PM - 完全生物可吸收支架在香港的使用经验分享Vincent On-Hing Kwok

1:25 PM - 二尖瓣关闭不全的介入新疗法Wolfgang Schillinger


1:55 PM - 休息

左主干和分叉病变第三部分左主干血管重建：临床数据、危险分层及技术考虑2:00 PM-6:00 PM

第一场：新数据和临床决策

主持人：Liliana R. Grinfeld, Marie-Angèle Morel, 王海昌讨论专家：Davide Capodanno, Wai-Kwong Chan, Philippe Généreux, 王巍, 张瑶俊

2:00 PM - 去年世界上发表的重要左主干文章和摘要快速回顾Davide Capodanno

2:15 PM - 特色讲座：这么少的时间里如此多的风险模型：一个冠脉搭桥和介入治疗之间选择的实用指南Patrick W. Serruys

2:35 PM - 从1528连续左主干介入治疗患者数据验证和比较SYNTAX II评分的长期预测能力Philippe Généreux

2:50 PM - 关于NERS II评分你应该了解什么：一个来自中国的新分层工具张瑶俊

3:05 PM - COMPARE试验中左主干和多支血管病变亚组分析Pieter C. Smits

3:17 PM - 药物洗脱支架类型和SYNTAX评分：从ISAR-LEFT MAIN 1和2研究中的经验教训Adnan Kastrati

3:29 PM - 左主干介入治疗对比搭桥术的临床决策：缜密思考过的外科医生方法王巍


第二场：左主干介入治疗策略和技术

主持人：Seung-Jung Park, 周玉杰, Chien-Ming Huang讨论专家：柳景华, Gary S. Mintz, Marie-Claude Morice, Je�rey W. Moses, 杨跃进

4:00 PM - 左主干末端分叉病变治疗的论证基础Jean Fajadet

4:15 PM - 左主干末端分叉病变的即兴支架术：案例和数据Marie-Claude Morice

4:30 PM - 左主干末端分叉病变计划好的双支架术：案例和数据杨跃进

4:45 PM - 左主干分叉病变介入治疗：围术期的特殊考虑柳景华

4:57 PM - 左主干介入治疗何时需要血流动力学支持及哪些方法？Je�rey W. Moses

5:09 PM - 血流储备分数指导的左主干介入治疗临床实践已成为标准！Seung-Jung Park

5:21 PM - 血管内超声指导的左主干介入治疗临床实践应该还是标准！Gary S. Mintz

5:33 PM - 最终想法：策略和技术的试验数据怎样应用到我的左主干介入治疗实践？陈绍良


6:00 PM - 休会


168


二层206会议室

早餐会泰尔茂主办急性心肌梗死PCI中的血栓处理7:00 AM-8:00 AM

主席：颜红兵, 荆全民, 钱菊英

7:00 AM - 开场致辞

7:05 AM - 急性心肌梗死PCI术中的血栓处理原则宋现涛

7:20 AM - 急性心肌梗死PCI术中的血栓处理策略周斌全

7:35 AM - 急性心肌梗死PCI术中的血栓并发症处理余再新


8:00 AM - 休息

TRI俱乐部第二部分8:30 AM-12:30 PM

第一场

主持人：杨跃进, Chiung-Jen Wu, 王雷, 王禹, 侯玉清

8:30 AM - 老老年患者经桡动脉介入治疗的关注点周玉杰

8:40 AM - 讨论

8:42 AM - 经桡动脉介入治疗的当日出院：协同策略及患者筛选Matthew J. Price

8:52 AM - 讨论

8:54 AM - 我们能经桡动脉途径治疗复杂分叉病变吗？刘健

9:04 AM - 讨论

9:06 AM - 经桡动脉急诊冠脉介入治疗能否成为常规途径？刘惠亮

9:16 AM - 讨论

9:18 AM - 经桡动脉行左主干介入治疗体会沈珠军

9:28 AM - 讨论

第二场

主持人：王海昌, 刘惠亮, Gianluca Rigatelli, 王贵松, Ping-Han Lo

9:30 AM - 美国经桡动脉介入治疗的现状及前景Yi-Ming Yang

9:40 AM - 讨论

9:42 AM - 经股动脉与经桡动脉路径行旋磨术的对比Wei-Hsian Yin

9:52 AM - 讨论

9:54 AM - 经桡动脉路径处理搭桥术后患者的复杂问题Mitchell W. Kruco�

10:04 AM - 讨论

10:06 AM - 经桡动脉行复杂冠心病介入治疗的技巧洪浪

10:16 AM - 讨论

10:18 AM - 经桡动脉路径如何提高支撑力？张清

10:28 AM - 讨论

第三场

主持人：徐亚伟, 刘海波, 曲鹏, Rurus Suryawan, 史冬梅

10:30 AM - 经桡动脉路径处理CTO病变：正向途径傅国胜

10:40 AM - 讨论

10:42 AM - 经桡动脉路径处理CTO病变：逆向途径Chien-Ming Huang

10:52 AM - 讨论

10:54 AM - 对比经桡动脉和股动脉途径行三支血管病变介入治疗：即刻与长期疗效窦克非

11:04 AM - 讨论

11:06 AM - 对比经桡动脉和股动脉途径行真分叉病变双支架术：即刻与长期疗效高展

11:16 AM - 讨论

11:18 AM - 经双侧桡动脉逆向导丝技术开通慢性完全闭塞病变的操作技巧徐泽升

11:28 AM - 讨论

第四场

主持人：傅向华, 姚民, Gustavo Samaja, 聂如琼, 姜东炬

11:30 AM - 经桡动脉路径处理老年矮小女性患者的技巧Gustavo Samaja

11:40 AM - 讨论

11:42 AM - 经桡动脉与经股动脉路径介入治疗的各自不足点Josef Ludwig

11:52 AM - 讨论

11:54 AM - 桡动脉损伤的预防Sudhir Rathore

12:04 PM - 讨论

12:06 PM - 如何经解剖和形态复杂的桡动脉径路成功放置导管？李成祥

12:16 PM - 讨论


169


12:18 PM - 从CIT2014桡动脉俱乐部到未来TRI项目的学会观点傅向华

12:28 PM - 讨论

12:30 PM - 休息

午间卫星会泰尔茂主办导引导管的选择12:40 PM-1:55 PM

主席：吕树铮, 王伟民, 周玉杰, 张瑞岩


12:45 PM - PCI中导引导管的操作原则张宇晨

1:05 PM - TRI中导引导管的选择策略姚民

1:25 PM - 复杂冠脉介入治疗中指引导管的选择张清


1:55 PM - 休息

ST段抬高型心肌梗死2:00 PM-6:00 PM

第一部分：ST段抬高型心肌梗死最新进展

主持人：颜红兵, Alan C. Yeung讨论专家：Teguh Santoso, Patrick W. Serruys, Marco Wainstein, 王乐丰, David X. M. Zhao

2:00 PM - 急性冠脉综合征中的炎症与斑块易损性：从实验到实践Marco Wainstein

2:10 PM - 直接PCI中的辅助药物治疗：从HORIZONS-AMI到EUROMAX试验Gregg W. Stone

2:25 PM - ST段抬高型心肌梗死介入治疗更新：血栓抽吸、血液动力学支持及局部给药Alan C. Yeung

2:40 PM - 经皮穿刺辅助循环装置新进展David X. M. Zhao

2:50 PM - ST段抬高型心肌梗死中巨大血栓负荷处理的新方法Teguh Santoso

3:00 PM - 随机研究评估血栓抽吸对ST段抬高型心肌梗死患者血流面积的影响：深入了解TROFI试验Patrick W. Serruys

3:10 PM - ST段抬高型心肌梗死治疗：不同的时间、不同的病变及不同的策略王乐丰


第二部分：ST段抬高型心肌梗死辩论 - 当前争议

主持人：沈卫峰讨论专家：金泽宁, Fazila Tun Nesa Malik, Seung-Jea Tahk, 颜红兵

辩论1

3:36 PM - ST段抬高型心肌梗死中血栓抽吸应该是常规吗？Seung-Jea Tahk

3:46 PM - 是的，临床实践“反对”临床试验！颜红兵


辩论2

4:06 PM - 择期PCI对大多数多支血管病变ST段抬高型心肌梗死患者是适当的Fazila Tun Nesa Malik

4:16 PM - 对于大多数患者，一站式策略是以证据为基础的选择金泽宁


第三部分：ST段抬高型心肌梗死治疗实践 - 基于病例的讨论

主持人：杨新春, 李保讨论专家：陈玉国, 郭金成, 李伟明, 马依彤, 陶贵周, 徐标

4:36 PM - 病例1：远程心电监护系统改善ST段抬高型心肌梗死患者门球时间和长期疗效Wei-Hsian Yin

4:43 PM - 讨论

4:50 PM - 病例2：规范化胸痛中心对缩短ST段抬高型心肌梗死再灌注时间的影响向定成

4:57 PM - 讨论

5:04 PM - 病例3：如何确定血栓的负荷？赵汉军

5:11 PM - 讨论

5:18 PM - 病例4：导管内IIb/IIIa受体拮抗剂联合血栓抽吸在ST段抬高型心肌梗死急诊介入中的应用柯永胜

5:25 PM - 讨论

5:32 PM - 病例5：ECMO联合IABP介入治疗急性心肌梗死合并心源性休克王守力

5:39 PM - 讨论

5:46 PM - 病例6：药物支架年代，溶栓在ST段抬高型心肌梗死治疗中的作用马根山

5:53 PM - 讨论

6:00 PM - 休会


170


二层207会议室


主持人：王东琦, 李田昌, 周颖玲

7:00 AM - CS-0281：氯吡格雷抵抗致支架内急性血栓形成处理策略选择马颖艳

7:10 AM - 讨论

7:15 AM - CS-0310：冠脉内导丝断裂智取一例李伟明

7:25 AM - 讨论

7:30 AM - CS-0324：5进6子母导管技术成功处理旋磨头嵌顿一例贺玉泉

7:40 AM - 讨论

7:45 AM - CS-0325：支架脱载一例关韶峰

7:55 AM - 讨论

8:00 AM - CS-0327：极晚期支架内血栓形成 - LAD、RCA 双支血管同时急性闭塞贺玉泉

8:10 AM - 讨论

8:15 AM - 休息

药物学研讨会阿斯利康协办PCI药物管理8:30 AM-11:30 AM

主持人：高润霖, 韩雅玲, 吕树铮, 沈卫峰, 黄德嘉

PCI中的他汀治疗


8:35 AM - 强化降低LDL-C抗击动脉粥样硬化的基石Xue-Qiao Zhao

9:00 AM - 他汀在PCI围手术期的应用：何去何从？吴永健

9:25 AM - 他汀预防造影剂肾病的最新研究结果韩雅玲


ACS抗栓治疗新纪元


10:05 AM - 从机制到临床看抗血小板药物进展程能能

10:35 AM - ACS危险分层及抗血小板优化治疗刘惠亮

11:00 AM - STEMI指南更新及启示杜志民


11:30 AM - 休息

午间卫星会赛诺医疗主办再添新力证！BuMA最新国内外研究结果和设计发布12:40 PM-1:55 PM

主席：高润霖, 江洪, 刘斌, 魏盟


12:45 PM - BuMA系列内皮化基础研究数据Renu Virmani

1:00 PM - 评价BuMA药物洗脱支架在真实世界中安全性和有效性的前瞻性、多中心观察性研究：PANDA II注册登记研究结果李建平

1:15 PM - BuMA-OCT结果和关键性PANDA III随机对照试验新进展钱杰

1:30 PM - 欧洲BuMA药物洗脱支架前瞻性、多中心、随机对照试验设计Patrick W. Serruys


1:55 PM - 休息

药物学研讨会拜耳协办抗凝论坛2:00 PM-3:00 PM

主持人：周玉杰, 王祖禄

2:00 PM - ACS二级预防新策略周玉杰

2:20 PM - 新型口服抗凝药物用于ACS抗栓治疗临床新进展张抒扬

2:40 PM - 新型口服抗凝药物心血管保护特性：对临床实践的启示史旭波

3:00 PM - 休会


171


二层208会议室


主持人：于波, 徐标, 吕安林

7:00 AM - CS-0364：陷入前降支部分扩张过的球囊取出刘巍

7:10 AM - 讨论

7:15 AM - IM-0026：右冠闭塞开通后前壁心梗王效浣

7:25 AM - 讨论

7:30 AM - IM-0028：老年患者经桡动脉PCI出现腹膜后血肿一例丁力平

7:40 AM - 讨论

7:45 AM - IM-0044：边支保护钢丝撤出导致主支支架变形病例Yu-Lin Ko

7:55 AM - 讨论

8:00 AM - 休息

心律失常第三部分CRT8:30 AM-12:10 PM

第一场：治疗策略个体化

主持人：张澍, 王玉堂, 苏晞, 宿燕岗, 梁延春

8:30 AM - 选择合适的患者：提高CRT反应率的关键因素黄德嘉

8:45 AM - 讨论

8:50 AM - CRT治疗中必需进行右室起搏吗？还是单纯左室起搏？王玉堂

9:05 AM - 讨论

9:10 AM - 右束支阻滞的患者是否应该考虑接受CRT治疗？汤宝鹏

9:25 AM - 讨论

9:30 AM - CRT患者的射频消融策略邹建刚

9:45 AM - 讨论

9:50 AM - 是否应在所有需要植入起搏器的患者中推荐植入CRT？Cheuk-Man Yu

10:05 AM - 讨论

10:10 AM - 茶歇

第二场：CRT治疗的优化

主持人：沈法荣, 李学斌, 邱春光, 许静, 王东琦

10:30 AM - CRT患者的参数优化策略杨杰孚

10:45 AM - 讨论

10:50 AM - 左室心内膜起搏技术宿燕岗

11:05 AM - 讨论

11:10 AM - CRT患者膈神经刺激的处理策略严激

11:25 AM - 讨论

11:30 AM - 血流动力学指标预测CRT患者远期预后的临床价值陈柯萍

11:45 AM - 讨论

11:50 AM - 植入左室电极导线，4极是否好于2极？华伟

12:05 PM - 讨论

12:10 PM - 休息

午间卫星会戈德曼主办、微创协办NSE：新概念球囊扩张导管12:40 PM-1:55 PM

主席：Eisho Kyo, 陈纪言, 乔树宾


12:45 PM - 球囊扩张的革命：从概念到临床应用Shigeru Nakamura

1:15 PM - NSE病例回顾1戴军

1:25 PM - NSE病例回顾2陈竹君



1:55 PM - 休息

心律失常第四部分ICD和起搏2:00 PM-5:40 PM

第一场：ICD在遗传性心律失常中的应用

主持人：王方正, 李广平, 浦介麟, 洪葵, 单其俊

2:00 PM - ICD在长QT综合征猝死预防中的作用曹克将

2:15 PM - 讨论

2:20 PM - Brugada综合征的危险分层及ICD应用杨新春

2:35 PM - 讨论

2:40 PM - ICD在肥厚型心肌病患者中的应用王景峰

2:55 PM - 讨论

3:00 PM - ICD在儿茶酚胺敏感性室速患者中的应用方全

3:15 PM - 讨论


172


3:20 PM - ARVC猝死预防：导管消融还是ICD？陈明龙

3:35 PM - 讨论

3:40 PM - 茶歇

第二场：起搏治疗 - 适应证和随访

主持人：方全, 万征, 吴明, 曲秀芬, 徐伟

4:00 PM - 远程监测在抗心动过缓起搏治疗中真的有益吗？陈柯萍

4:15 PM - 讨论

4:20 PM - 减少心室起搏比例的特殊起搏功能：何时适用？何时避免？陈林

4:35 PM - 讨论

4:40 PM - 频率适应性感受器：是否存在最佳参数设置方案？郑良荣

4:55 PM - 讨论

5:00 PM - 超高龄患者（年龄>80岁）起搏器的选择和程控应该采用简化原则吗？张萍

5:15 PM - 讨论

5:20 PM - 提高CRT应答力的策略郭涛

5:35 PM - 讨论

5:40 PM - 休会

三层305A会议室

病例早餐会14结构性心脏病7:00 AM-8:30 AM

主持人：孔祥清, 徐仲英, 周达新, 盛国太

7:00 AM - CS-0121：双管齐下 - 室缺封堵器脱落后双抓捕器成功取出一例韩战营

7:10 AM - 讨论

7:15 AM - CS-0160：安立生坦联合介入治疗房间隔缺损合并重度肺动脉高压陈铀

7:25 AM - 讨论

7:30 AM - CS-0232：介入治疗肺动静脉瘘并室间隔缺损一例伍广伟

7:40 AM - 讨论

7:45 AM - CS-0239：主动脉窦瘤破裂病例孙勇

7:55 AM - 讨论

8:00 AM - CS-0268：心肌梗死后室间隔穿孔封堵及PCI后3年随访赵玉英

8:10 AM - 讨论

8:15 AM - CS-0280：复杂二尖瓣瓣周瘘经皮封堵Wen-Loong Yeow

8:25 AM - 讨论

结构性心脏病第二部分8:30 AM-12:30 PM

第一场

主持人：宋治远, 伍伟锋, 张戈军, 周达新, 高伟, 张伟华

8:30 AM - 先心病介入治疗少见晚发严重并发症的防治蒋世良

8:42 AM - 讨论

8:45 AM - 经导管肺动脉置换术：当前瓣膜及应用经验Ziyad M. Hijazi

8:57 AM - 讨论

9:00 AM - 经导管肺动脉瓣植入术：华沙心血管病研究所5年经验Witold Ruzyllo

9:12 AM - 讨论

9:15 AM - 经皮肺动脉瓣植入术：未来观点孔祥清

9:27 AM - 讨论

9:30 AM - 二尖瓣球囊成形术：中国现状曾智

9:42 AM - 讨论

9:45 AM - 从MitraClip欧洲登记研究中获得的经验Wolfgang Schillinger

9:57 AM - 讨论

10:00 AM - 经导管二尖瓣修复术：影像学价值李新明

10:12 AM - 讨论

10:15 AM - 挑战性病例：外科房缺封堵术后斜卧呼吸低氧血症及经皮介入封堵挽救Magnus Settergren

10:27 AM - 讨论

第二场

主持人：曾智, Yat-Yin Lam, 张智伟, 徐仲英, 华益民, 侯子山

10:30 AM - 肺动脉狭窄球囊扩张和支架植入的经验Malgorzata Szkutnik

10:42 AM - 讨论


173


10:45 AM - 临床实践中整合应用球囊扩张型和自膨胀型经导管主动脉瓣置换系统Jan Kovac

10:57 AM - 讨论

11:00 AM - 肺动脉高压病原学对经导管主动脉瓣置换患者术后管理和疗效的影响Shing-Chiu Wong

11:12 AM - 讨论

11:15 AM - 应用“降落伞”器械行左室减容术：一种心衰的经皮治疗方法Robaayah Zambahari

11:27 AM - 讨论

11:30 AM - ICE监测下心房间分流的经导管封堵：提示和技巧Gianluca Rigatelli

11:42 AM - 讨论

11:45 AM - 肥厚型心肌病经皮穿刺间隔心肌化学消融专家共识解读李占全

11:57 AM - 讨论

12:00 PM - 卵圆孔未闭封堵术：中国经验张玉顺

12:12 PM - 讨论

12:15 PM - 左心耳封堵：何时及怎样封堵残余漏Simon Cheung-Chi Lam

12:27 PM - 讨论

12:30 PM - 休息

午间卫星会先健科技主办12:40 PM-1:55 PM

主席：张智伟, 蒋世良, 孔祥清, 周达新, Yat-Yin Lam


12:45 PM - 一种新型左心耳封堵器LAmbre及临床研究进展Jai-Wun Park

1:00 PM - Cera封堵器上市后临床研究（COAT）最新进展张智伟

1:15 PM - Cera封堵器在膜周部室间隔缺损的临床经验César A. Esteves

1:30 PM - Cera封堵器临床经验分享Luiz Carlos Giuliano


1:55 PM - 休息

结构性心脏病第三部分2:00 PM-6:00 PM

第一场：病例讨论 - 结构/先天性心脏病介入治疗挑战性病例

主持人：赵仙先, 李奋, 杨天和, 王玉林, 王震, 盛国太

2:00 PM - 病例报告华益民

2:08 PM - 病例报告马依彤

2:16 PM - 病例报告王琦光

2:24 PM - 病例报告于波

2:32 PM - 病例报告盛国太

2:40 PM - 病例报告覃军

2:48 PM - 病例报告金梅

2:56 PM - 病例报告陈智

3:04 PM - 病例报告冯沅

3:12 PM - 病例报告程应樟

3:20 PM - 病例报告沈向前

3:28 PM - 病例报告伍伟锋


第二场：病例讨论 - 结构/先天性心脏病介入治疗挑战性病例

主持人：蒋世良, 孙勇, 沈向前, 金梅, 伍广伟, 李贵双

4:00 PM - 病例报告张戈军

4:08 PM - 病例报告王玉林

4:16 PM - 病例报告张刚成

4:24 PM - 病例报告李奋

4:32 PM - 病例报告宋治远

4:40 PM - 病例报告张伟华

4:48 PM - 病例报告赵仙先

4:56 PM - 病例报告王震

5:04 PM - 病例报告易岂建

5:12 PM - 病例报告钱明阳

5:20 PM - 病例报告秦玉明

5:28 PM - 病例报告单继平


6:00 PM - 休会


174


三层305B会议室


主持人：孙福成, 李康, 张树林

7:00 AM - IM-0051：即刻支架内血栓形成一例于雪

7:10 AM - 讨论

7:15 AM - IM-0056：支架内膜撕裂龙明

7:25 AM - 讨论

7:30 AM - IM-0075：左主干急性闭塞PCI术后即刻再闭塞栾波

7:40 AM - 讨论

7:45 AM - IM-0099：左主干分叉钙化病变支架断裂一例付振虹

7:55 AM - 讨论

8:00 AM - 休息

基础与药物第二部分8:30 AM-12:30 PM

第一场：动脉粥样硬化最新认识

主持人：张运, 毛节明, 朱文玲, 李淑梅, 杨志健

8:30 AM - 血脂异常与冠心病最新认识李建军

8:40 AM - 模式识别受体与动脉粥样硬化炎症机制曲鹏

8:50 AM - 缺血性心脏病生物学治疗的分子影像研究进展曹丰

9:00 AM - 血小板反应多样性与心血管事件的相关性马依彤

9:10 AM - 稳定型冠心病治疗的争议：优化药物治疗还是介入治疗？李伟明


第二场：心血管诊治技术的临床应用

主持人：李占全, Patrick Tak-Him Ko, 黎辉, 周颖玲, 曾秋棠

9:30 AM - 内皮功能监测的时代到了吗？杨萍

9:40 AM - 血小板功能检测一定能够指导临床决策吗？丛洪良

9:50 AM - 平均血小板体积在冠心病诊治中的应用价值杨毅宁

10:00 AM - 急性心肌梗死的心肌修复治疗徐标

10:10 AM - 微血管性心绞痛一个新的类型：冠状动脉慢血流性心绞痛杨志明


第三场：急性冠脉综合征与临床

主持人：袁晋青, 惠永明, 王风, 叶红华, 冯燕光

10:30 AM - 中高危急性冠脉综合征患者IIb/IIIa受体拮抗剂研究进展高传玉

10:40 AM - 急性冠脉综合征合并消化道出血的抗血小板治疗个体化王海昌

10:50 AM - 急性冠脉综合征抗血小板治疗中出血发生的预防管理李国庆

11:00 AM - 高龄急性冠脉综合征患者的药物与介入治疗的当今认识贾绍斌

11:10 AM -新型抗栓药物在急性冠脉综合征患者中的证据和选择马礼坤


第四场：冠心病的药物治疗学

主持人：郭静萱, 崔长琮, 韩立宪, 秦勤, 张明

11:30 AM - 冠心病患者的口服抗凝治疗陈茂

11:40 AM - 老年人抗栓治疗的相关问题刘梅林

11:50 AM - 三重抗凝治疗的临床应用赵仙先

12:00 PM - 急性冠脉综合征短期强化他汀治疗安全性和疗效王宁夫

12:10 PM - 从分子结构看他汀药物疗效和安全性杨向军


12:30 PM - 休息

午间卫星会火山主办有创影像和生理学的最新进展12:40 PM-1:55 PM

主席：John McB. Hodgson, 吴永健, William Kongto Hau


12:45 PM - 血管内超声指导支架植入术：荟萃分析及近年研究的进展Gary S. Mintz

1:00 PM - 用血管内超声评估指导冠脉介入治疗John McB. Hodgson

1:15 PM - iFR临床试验更新：过去和现在Justin E. Davies

1:30 PM - iFR：阜外医院体验吴永健


175



1:55 PM - 休息

PCI技术与疗效第二部分2:00 PM-6:00 PM

第一场

主持人：Yean-Leng Lim, Yaron Almagor, 沈成兴, Nazir Ahmed, Shih-Pu Wang

2:00 PM - 多支血管病变治疗进展2014Je�rey W. Moses

2:10 PM - 讨论

2:12 PM - IVUS在PCI并发症处理中的作用Kam-Tim Chan

2:22 PM - 讨论

2:24 PM - 直接PCI中的栓塞保护Chaim S. Lotan

2:34 PM - 讨论

2:36 PM - 导管室中评价微血管系统William F. Fearon

2:46 PM - 讨论

2:48 PM - 最新药物洗脱支架的纵向形变Hyo-Soo Kim

2:58 PM - 讨论

3:00 PM - 药物洗脱支架和金属裸支架在冠状动脉大血管中应用的长期疗效对比I-Chang Hsieh

3:10 PM - 讨论

3:12 PM - 我们能进一步改善缺血性心脏病患者的药物治疗吗？Nazir Ahmed Memon

3:22 PM - 讨论

第二场

主持人：马礼坤, 江时森, 李康, 王庆胜

3:24 PM - 急性心肌梗死合并心源性休克的治疗策略马依彤

3:34 PM - 讨论

3:36 PM - OCT联合FFR在特定病例中的应用侯静波

3:46 PM - 讨论

3:48 PM - 钙化病变预处理方法的选择与评价聂绍平

3:58 PM - 讨论

4:00 PM - 桥血管病变介入治疗策略刘寅

4:10 PM - 讨论

4:12 PM - 口部病变介入治疗策略和技术杨胜利

4:22 PM - 讨论

4:24 PM - PCI成功关键之一：导丝塑型技巧李伟杰

4:34 PM - 讨论

4:36 PM - 介入治疗无再流的识别与处理胡奉环

4:46 PM - 讨论

第三场

主持人：贾国良, 崔连群, 蔡尚郎, 李国庆, 李继福

4:48 PM - PCI围手术期心肌保护中西医结合研究进展刘红旭

4:58 PM - 讨论

5:00 PM - 冠脉PCI合并脑血管疾病的处理陈晖

5:10 PM - 讨论

5:12 PM - 急性心肌梗塞合并室间隔穿孔的处理策略王乐丰

5:22 PM - 讨论

5:24 PM - 完全与不安全血运重建：2014新进展陈方

5:34 PM - 讨论

5:36 PM - 高龄患者复杂病变“杂交”冠脉血管重建术的可行性和有效性卢才义

5:46 PM - 讨论

5:48 PM - 通过应用三种不同的血小板功能试验检测CYP2C19表型的状态对维持PCI术后双重抗血小板治疗的预测价值黄石安

5:58 PM - 讨论

6:00 PM - 休会


176


三层302A会议室


主持人：刘惠亮, 程晓曙, 崔连群

7:00 AM - CS-0031：右冠极度迂曲弥漫病变治疗一例杨毅宁

7:10 AM - 讨论

7:15 AM - CS-0162：LIMA桥血管开口闭塞病变陈晖

7:25 AM - 讨论

7:30 AM - CS-0188：血管内超声指导的回旋支与前降支双开口的回旋支开口闭塞介入治疗姚义安

7:40 AM - 讨论

7:45 AM - CS-0227：两支闭塞的三支病变完全血运重建及Szabo技术在开口闭塞病变中的应用何鹏程

7:55 AM - 讨论

8:00 AM - 休息

NCVH at CIT下肢动脉和静脉疾病8:30 AM-12:30 PM

主持人：Craig M. Walker讨论专家：Anil Chagarlamudi, Eric Dippel, W. Britton Eaves, 谷涌泉, Richard C. Kovach, 刘朝中, Carlos Mena, Thomas Shimshak

8:30 AM - 开幕致辞 / 主旨演讲：外周动脉疾病是冠心病的预测因子Craig M. Walker

8:45 AM - 入路变异时新技术的应用Carlos Mena

9:00 AM - 主动脉-髂动脉闭塞病变的介入治疗W. Britton Eaves

9:15 AM - 病例回顾1：下肢动脉复杂介入治疗谷涌泉

9:30 AM - 股髂动脉介入治疗的提示与技巧Anil Chagarlamudi

9:45 AM - 肢体缺血的膝下动脉介入治疗Thomas Shimshak

10:00 AM - 病例回顾2：下肢动脉复杂介入治疗叶猛


10:30 AM - 茶歇

10:45 AM - 完全闭塞旁路移植血管的介入治疗Richard C. Kovach

11:00 AM - 病例回顾3：下肢动脉复杂介入治疗蒋米尔

11:15 AM - 治疗深静脉血栓与中心静脉闭塞Carlos Mena

11:30 AM - 静脉功能不全的消融治疗Eric Dippel

11:45 AM - 病例回顾4：静脉疾病的复杂介入治疗田红燕


12:15 PM - 闭幕致辞：血管介入治疗新的地平线Craig M. Walker

12:30 PM - 休息

午间卫星会瑞安泰主办完美控释，新脉无忧12:40 PM-1:55 PM

主席：葛均波, 方唯一, 李学奇


12:45 PM - 新脉的创新及特点颜红兵

1:00 PM - 新脉的临床应用与体会崔连群

1:15 PM - ST段抬高型心肌梗死和非ST段抬高型心肌梗死病例回顾王乐丰

1:30 PM - 冠脉介入治疗常见并发症钱菊英


1:55 PM - 休息

外周血管治疗2:00 PM-6:00 PM

第一场：颈动脉疾病

主持人：王焱, 邹英华, 陈步星, Neil E. Strickman

2:00 PM - 2014年颈动脉支架术新进展Neil E. Strickman

2:12 PM - 讨论

2:15 PM - 成功再通颈动脉闭塞的预测因素Paul Hsien-Li Kao

2:25 PM - 讨论

2:28 PM - 同步双侧颈动脉支架术：早期和长期结果蒋雄京

2:38 PM - 讨论

2:41 PM - 经桡动脉颈动脉介入治疗：优点和缺陷Gianluca Rigatelli

2:51 PM - 讨论


177


三层302B会议室


主持人：李浪, 李伟杰, 赵全明

7:00 AM - CS-0376：多支病变植入多枚支架有效治疗缺血性心肌病一例王琼

7:10 AM - 讨论

7:15 AM - CS-0379：“支架囚禁导丝”技术在支架通过困难病变PCI中的应用盛力

7:25 AM - 讨论

7:30 AM - IM-0100：有理、有利、有节 - 一例复杂病变的抉择胡信群

7:40 AM - 讨论

7:45 AM - CS-0305：钙化扭曲病变成功旋磨一例李伟明

7:55 AM - 讨论

8:00 AM - 休息

药物洗脱支架：生物可吸收聚合物和无聚合物药物洗脱支架8:30 AM-11:00 AM

主持人：Adnan Kastrati, 郭文怡, Ping-Tim Tsui, Benit Edouard

8:30 AM - 支架梁与聚合物结构改变器械结果：当前非生物可吸收聚合物药物洗脱支架将难以改进！Ron Waksman

8:42 AM - 血管愈合与药物洗脱支架的演变：从实验洞察转化为人体临床试验Juan F. Granada

2:54 PM - 颈动脉支架术并发症：预防和处理策略邹英华

3:04 PM - 讨论

3:07 PM - 锁骨下动脉和无名动脉介入治疗Jacques Busquet

3:17 PM - 讨论

第二场：肾动脉疾病和高血压

主持人：蒋雄京, 张瑞岩, 卢才义, Neil E. Strickman

3:20 PM - 去肾神经化治疗：何时及怎样完成？Carlos Mena

3:32 PM - 讨论

3:35 PM - 对难以控制的高血压去肾神经化已经是一种现实疗法了吗？Marco Wainstein

3:45 PM - 讨论

3:48 PM - 肾动脉狭窄的推荐治疗方法Neil E. Strickman

3:58 PM - 讨论

4:01 PM - 心脏紊乱综合征患者肾动脉支架术张瑞岩

4:11 PM - 讨论

4:14 PM - 肾移植术后肾动脉狭窄的经皮介入治疗Rajesh Vijayvergiya

4:24 PM - 讨论

4:27 PM - 心导管室中急性高血压的处理Joseph Varon

4:37 PM - 讨论

第三场：其他血管腔内治疗热点

主持人：罗建方, Raghotham R. Patlola, 晋军, Won-Heum Shim, Haizal Haron Kamar

4:40 PM - 动脉粥样硬化切除术在外周血管介入治疗中的作用Raghotham R. Patlola

4:52 PM - 讨论

4:55 PM - 超越洗脱球囊：外周血管的新型药物输送装置Richard C. Kovach

5:05 PM - 讨论

5:08 PM - 腹主动脉瘤腔内修复术Eak-Kyun Shin

5:18 PM - 讨论

5:21 PM - 血管内覆膜支架治疗真菌性动脉瘤Aravinda Nanjundappa

5:31 PM - 讨论

5:34 PM - 静脉疾病现状概述Raghotham R. Patlola

5:44 PM - 讨论

5:47 PM - 下腔静脉滤器在治疗复杂静脉血栓栓塞患者中的作用田红燕

5:57 PM - 讨论

6:00 PM - 休会


178


8:54 AM - 生物可吸收聚合物药物支架与永久聚合物药物支架有真的差别吗？Alan C. Yeung

9:06 AM - 药物洗脱支架疗效的当前观点：为什么我们需要继续发展下一代药物洗脱支架系统？Mitchell W. Kruco�

9:18 AM - 较新的生物可吸收聚合物和无聚合物药物洗脱支架Alexandra J. Lansky

9:30 AM - 专家讨论讨论专家：Mitchell W. Kruco�, Alexandra J. Lansky, Ron Waksman, Alan C. Yeung

9:42 AM - 2014年中国生物可吸收聚合物药物洗脱支架更新钱菊英

9:54 AM - 2014年中国生物无聚合物药物洗脱支架更新周旭晨

10:06 AM - 病例报告6：出血高危患者使用生物可吸收聚合物药物洗脱支架李怡

10:13 AM - 病例报告7：早期停用双重抗血小板治疗患者使用无聚合物药物洗脱支架陶凌

10:20 AM - 专家讨论讨论专家：李怡, 钱菊英, 陶凌, 周旭晨

10:30 AM - 新型生物可吸收聚合物药物洗脱支架技术：产业视角Keith D. Dawkins

10:42 AM - 新型无聚合物药物洗脱支架技术：产业视角Sean Salmon

10:54 AM - 专家讨论讨论专家：Keith D. Dawkins, Sean Salmon

特色药物洗脱支架/药物涂层球囊临床试验11:00 AM-12:30 PM

主持人：Roxana Mehran, 徐波讨论专家：Philippe Généreux, Liliana R. Grinfeld, Yang-Soo Jang, Stephen Wai-Luen Lee, Marie-Angèle Morel, Bruno Scheller

11:00 AM - FREEDOM：冠心病治疗中对比垠艺无聚合物紫杉醇洗脱支架和永久聚合物西罗莫司洗脱支架的前瞻性、随机对照试验李建平

11:13 AM - 讨论

11:18 AM - 法国GARO：未选择患者人群中药物洗脱支架内再狭窄应用紫杉醇涂层球囊的前瞻性、注册登记研究Marc Bedossa

11:31 AM - 讨论

11:36 AM - SEEDS：评价国人应用依维莫司洗脱支架治疗复杂冠脉病变安全性和有效性的前瞻性登记研究 - 两年结果赵叶琳

11:49 AM - 讨论

11:54 AM - BuMA-OCT：3个月OCT随访对比评价应用电子接枝技术基底涂层PLGA聚合物与PLA聚合物西罗莫司洗脱支架的随机对照试验张瑶俊

12:07 PM - 讨论

12:12 PM - CREDIT I：第二代EXCEL生物可降解聚合物西罗莫司洗脱支架的首次人体研究 - 4个月临床、造影及OCT结果王耿

12:25 PM - 讨论

12:30 PM - 休息

午间卫星会西门子医疗主办心胸外科复合手术进展12:40 PM-1:55 PM

主席：Georg Nollert, 陈茂, 王志农


12:45 PM - 心胸外科复合手术进展Georg Nollert

1:05 PM - 成功搭建复合手术室的要点毛佳

1:25 PM - 西门子低剂量心脏介入解决方案张治国


1:55 PM - 休息

药物涂层球囊：临床数据和应用2:00 PM-6:00 PM

主持人：Bruno Scheller, Juan F. Granada

第一场

讨论专家：Tae-Hoon Ahn, Jacques Berland, 陈方, Kenneth Chin, Pieter R. Stella

药物涂层球囊基本概念

2:00 PM - 纵观药物涂层球囊技术：当前挑战和未来机遇Juan F. Granada

2:12 PM - 经球囊涂层输送紫杉醇后的血管修复：器械发展的生物学意义Renu Virmani


药物涂层球囊在冠脉原发病变中的应用

2:30 PM - 病例报告：药物涂层球囊在冠脉原发病变中的应用 - 是否植入支架？Wan Azman Wan Ahmad

2:40 PM - 临床试验更新：原发病变中药物涂层球囊及附加的金属裸支架植入术Bruno Scheller

其他冠脉适应证

2:52 PM - 分叉病变和小血管Nigel Jepson

3:04 PM - 糖尿病患者Alfredo E. Rodriguez

3:16 PM - 急性冠脉综合征（包括ST段抬高型心肌梗死）Pieter R. Stella



179


第二场药物涂层球囊在冠脉支架内再狭窄中的应用

讨论专家：Fernando Alfonso, Jacques Berland, 樊冰, 蒋峻, Adnan Kastrati, 赵叶琳

3:36 PM - 特色讲座：冠脉支架内再狭窄应用临床数据的评论Adnan Kastrati

3:48 PM - PEPCAD China ISR试验更新赵叶琳

4:00 PM - 其他支架内再狭窄药物涂层球囊试验更新：ISAR-DESIRE 3, RIBS IV及更多Fernando Alfonso

4:12 PM - 病例报告：多种临床情况下药物涂层球囊治疗支架内再狭窄蒋峻


第三场药物涂层球囊在外周血管介入治疗中的应用

讨论专家：Eric Dippel, 郭伟, 蒋雄京, Carlos Mena, 叶猛

4:30 PM - 病例报告：股浅动脉介入治疗中应用药物涂层球囊的技术技巧和缺陷叶猛

4:40 PM - 药物涂层球囊和股浅动脉介入治疗：进行中的临床项目进展Juan F. Granada

4:52 PM - 中国股浅动脉试验设计和临床进展郭伟

5:04 PM - 动脉粥样硬化切除术和药物涂层球囊：器械选择、技术缺陷及现有数据Eric Dippel

5:16 PM - 股浅动脉介入治疗中药物洗脱支架与药物涂层球囊对比Bruno Scheller

5:28 PM - 病例报告：膝下动脉介入治疗的技术方法 - 药物涂层球囊发展的意义蒋雄京

5:38 PM - 特色讲座：膝下动脉介入治疗现有药物涂层球囊临床数据综述Carlos Mena


6:00 PM - 休会

三层307会议室

主动脉瘤腔内治疗论坛精彩病例回顾与讨论微创心脉协办8:30 AM-11:30 AM

主持人：郭伟, 舒畅, 黄连军, 章希炜, 符伟国, 苏晞

8:30 AM - 解放军总医院病例回顾郭伟

8:55 AM - 讨论

9:00 AM - 中南大学湘雅二医院病例回顾舒畅

9:25 AM - 讨论

9:30 AM - 首都医科大学附属安贞医院病例回顾黄连军

9:55 AM - 讨论

10:00 AM - 江苏省人民医院病例回顾章希炜

10:25 AM - 讨论

10:30 AM - 复旦大学附属中山医院病例回顾符伟国

10:55 AM - 讨论

11:00 AM - 武汉亚洲心脏病医院病例回顾苏晞

11:25 AM - 讨论

11:30 AM - 休息

午间卫星会赛诺菲主办12:40 PM-1:55 PM

主席：沈卫峰, 张抒扬


180



12:45 PM - 氯吡格雷的循证之路钱菊英

1:15 PM - PCI患者抗血小板药物的选择杜志民


1:55 PM - 休息

经导管瓣膜治疗培训课程中国TVI联盟主办GE医疗中国协办2:00 PM-6:00 PM

第一场：新技术的准备、协调及实施

主持人：杨跃进, 王巍, 张瑞岩

2:00 PM - 全国产化第一例的启示杨跃进

2:10 PM - 讨论

2:13 PM - 主动脉根部CT：从技术到分析吕滨

2:23 PM - 讨论

2:26 PM - TAVR麻醉的若干问题张磊

2:36 PM - 讨论

2:39 PM - 二瓣化的经验体会及国际多中心数据陈茂

2:49 PM - 讨论

2:52 PM - 经皮肺动脉瓣置换进展周达新

3:02 PM - 讨论

3:05 PM - 经导管二尖瓣修复术单中心经验刘先宝

3:15 PM - 讨论

第二场：TAVR病例分享

主持人：孔祥清, 周达新, 吕滨

最顺利的TAVR病例…

3:20 PM - 阜外医院吴永健

3:30 PM - 讨论

3:33 PM - 华西医院陈茂

3:43 PM - 讨论

失败的TAVR病例…

3:46 PM - 困惑、失败……死亡裴汉军

3:56 PM - 讨论

3:59 PM - 人工瓣膜脱位……失败张海涛

4:09 PM - 讨论

第三场：TAVR入路选择及术后并发症管理

主持人：吴永健, 陈茂

4:15 PM - 经左锁骨下动脉路径的TAVR冯沅

4:25 PM - 讨论

4:28 PM - 5例升主动脉路径的体会王巍

4:38 PM - 讨论

4:41 PM - 股动脉路径转至升主动脉路径张瑞岩

4:51 PM - 讨论

4:54 PM - 术后并发症一例盛燕辉

5:04 PM - 讨论

第四场：工作站培训

5:10 PM - IGS机器人瓣膜疾病解决方案李国忠

5:55 PM - 总结致辞高润霖

6:00 PM - 休会

三层夹层3M5会议室

第九届护士和技术人员研讨会8:30 AM-6:00 PM

8:30 AM - 开幕致辞：CIT护理和技术年度研讨会九年历程徐波

第一场：专家讲座

主持人：郝云霞, 郭静萱, 胡雪慧, 张红梅, 王雯

8:45 AM - 完善地辅助介入性治疗廖昌钊

9:05 AM - 介入专业学组的工作张素

9:25 AM - 沟通与护理安全郝云霞

9:45 AM - 介入护理可持续发展侯桂华

10:05 AM - SCI护理论文的选题技巧与方法邹海鸥

10:25 AM - 茶歇

第二场：新介入技术

主持人：李杰, 赵霞, 冯燕, 刘洪

10:40 AM - 应用“降落伞”装置行经导管左室减容术刘焱

11:00 AM - 经导管左心耳封堵术刘静

11:20 AM - 经导管主动脉瓣置换术郑明霞

11:40 AM - 生物可吸收血管支架的发展现状孙中伟

12:00 PM - 午餐


181


第三场：午餐技术设备研讨会

主持人：李菲, 杨玉珍, 李惠珠, 李淑荣

12:15 PM - 血管内超声检查的临床应用阚静

12:30 PM - 旋磨手术的护理配合刘君

12:45 PM - FFR检查的意义和护理配合荆丽敏

1:00 PM - IABP的使用邱月红

1:15 PM - 讨论

第四场：导管室管理

主持人：辜小芳, 王晓燕, 齐自荣, 童素梅, 岳继华

1:30 PM - 耗材管理陆芸岚

1:50 PM - 导管室手消毒物品的比较研究张昆

2:10 PM - 导管室的质量控制重点环节药素毓

2:30 PM - 介入病人的接送及与病房的交接核对王英

2:50 PM - 介入病人术前访视的探讨王琳

3:10 PM - 茶歇

第五场：经验分享和论文交流

主持人：李荣, 梁涛, 毛燕君, 李莉, 冯琪, 史振涛

3:30 PM - 讨论冠状动脉造影检查过程中术者和受试者的放射剂量Sang Man Park

3:45 PM - 解读左心耳封堵器械Min Young Cho

4:00 PM - AS-0004：心导管检查术后腹股沟包扎：比较传统加压包扎与透明医用敷料Al-shualah Rokaia

4:15 PM - AS-0092：冠状动脉搭桥手术后使用体外膜肺氧合器氧合疗法（ECMO）辅助护理的经验潘瑞金

4:30 PM - AS-0168：电子化随访系统的强化护理促进在经皮冠状动脉介入后的二级预防：一项随机试验胡鑫

4:45 PM - AS-0540：远程家庭监控系统对植入心脏起搏器或心脏除颤器患者的治疗作用梁兆光

5:00 PM - AS-0114：不同的通气模式在治疗婴幼儿心脏手术后低氧血症的比较黄洁

5:15 PM - 听众提问与讨论

5:40 PM - 要点总结侯桂华, 刘焱

6:00 PM - 休会


182


二层201会议室

第六届冠脉介入治疗“精选”并发症论坛8:30 AM-12:30 PM

第一场

主持人：Yean-Leng Lim, 陈方, 傅国胜, 刘学波, 许锋

8:30 AM - 冠脉破裂的处理策略：病例回顾傅国胜

8:42 AM - 讨论

8:46 AM - PCI术中血管破裂的处理黄榕翀

8:54 AM - 讨论

9:02 AM - PCI致亚急性支架内血栓一例罗育坤

9:10 AM - 讨论

9:18 AM - 粗大右冠PCI后血管破裂紧急处理丁风华

9:26 AM - 讨论

9:34 AM - 左主干单支架术后顽固性亚急性支架内、外血栓形成一例来晏

9:42 AM - 讨论

第二场

主持人：吕树铮, 王伟民, 周玉杰, 马根山, 金惠根, 吕吉元

9:50 AM - 导管室紧急状况的处理方式大全王海昌

10:02 AM - 讨论

10:06 AM - 前向开通LAD慢性完全闭塞病变术中左主干夹层的发生与处理宋现涛

10:14 AM - 讨论

10:22 AM - 采用圈套器处理冠状动脉支架脱载温尚煜

10:30 AM - 讨论

10:38 AM - 关注细节：冠状动脉支架脱载一例聂斌

10:46 AM - 讨论

10:54 AM - 都是Guiding惹得祸：指引导管引发的严重并发症张海涛

11:02 AM - 讨论

第三场

主持人：沈卫峰, 陈绍良, 钱菊英, 谭宁, 张钲, 彭建军

11:10 AM - 支架球囊所致PCI并发症白明

11:18 AM - 讨论

11:26 AM - 回旋支重度钙化病变PCI并发症张俊杰

11:34 AM - 讨论

11:42 AM - 冠脉内旋磨头嵌顿一例张峰

11:50 AM - 讨论

11:58 AM - 旋磨过程中被忽视的细节何鹏程

12:06 PM - 讨论

12:14 PM - 严重支架再狭窄病变旋磨术中磨头失速卡死导致急性闭塞一例聂绍平

12:22 PM - 讨论

CIT2014闭幕式12:30 PM-12:45 PM

主持人：徐波联合主席：陈纪言, 陈绍良, 高润霖, 葛均波, 韩雅玲, 贾国良, 蒋世良, 吕树铮, 马长生, 乔树宾, 沈卫峰, 王海昌, 王伟民, 杨跃进

12:30 PM - CIT2014精彩瞬间回眸

12:45 PM - CIT2015宣布及CIT2014闭幕


183


二层202会议室

Best of CCC/CISC8:30 AM-10:30 AM

第一场：实践和经验

主持人：吕树铮, 李为民, 陈绍良, 周玉杰

8:30 AM - PCI术中支架置入的数量：有无上限？李悦

8:42 AM - 讨论

8:45 AM - 穿越近/远端支架网眼交换导丝的选择对不同类型双支架技术即刻结果的影响张俊杰

8:57 AM - 讨论

9:00 AM - CABG术后再次血运重建治疗：PCI还是再次CABG？为什么、怎么做？张斌

9:12 AM - 讨论

9:15 AM - 急性STEMI急诊PCI血栓抽吸后非严重狭窄罪犯病变的处理卢成志

9:27 AM - 讨论

第二场：策略和趋势

主持人：韩雅玲, 杨跃进, 陈纪言, 黄岚

9:30 AM - 功能性血运重建治疗：PCI/CABG未来的趋势一致吗？吴永健

9:42 AM - 讨论

9:45 AM - 合并出血性疾病的ACS的治疗策略李建平

9:57 AM - 讨论

二层203会议室

冠脉介入实用教程第四部分慢性完全闭塞初学者基本课程8:30 AM-12:30 PM

第一场：前向技术

主持人：贾国良, 张大东, 戴军, 吴铿

8:30 AM - 目的简介

8:35 AM - CTO导丝选择概念的演变葛均波

8:50 AM - 经桡动脉CTO介入的技术要点钱杰

9:05 AM - 对侧造影至关重要郑金刚

9:20 AM - CTO前向导丝操控要点吕安林

9:35 AM - 内膜内、内膜外及导丝再进入王建安

9:50 AM - IVUS在CTO介入中的作用许亮

10:05 AM - 如何处理球囊不能通过的CTO病变？王守力

10:20 AM - 要点总结

10:25 AM - 茶歇

第二场：逆向技术

主持人：陈纪言, 李成祥, 李学奇, 慕朝伟

10:35 AM - 目的简介

10:40 AM - 侧支血管通道的选择张奇

10:55 AM - 如何操控导丝通过侧支血管？荆全民

10:00 AM - 置入药物洗脱支架的冠心病患者合并抗凝治疗的选择：华法林还是达比加群？刘宇扬

10:12 AM - 讨论

10:15 AM - ACS患者治疗新观点：不再关注LDL-C？黄榕翀

10:27 AM - 讨论

Best of GAP-CCBC如何在临床实践中遵循和诠释指南10:30 AM-12:30 PM

主持人：杨跃进, Chung-Seung Chiang, 卢长林, 唐熠达, U Po Lam, 庄少伟

10:30 AM - 我们究竟应该对哪些缺血性心肌病进行血管重建治疗？怎样进行？杨跃进

10:48 AM - 讨论

10:50 AM - 心房颤动患者在PCI术后是否需要强化抗凝治疗？李莉

11:08 AM - 讨论

11:10 AM - STEMI急诊介入治疗时我们究竟是否需要治疗非梗死相关病变/动脉？颜红兵

11:28 AM - 讨论

11:30 AM - 我们是否应对PCI患者进行常规血小板功能和基因检测？袁晋青

11:48 AM - 讨论

11:50 AM - 如何建立和管理胸痛区域性协同救治系统？王焱

12:08 PM - 讨论

12:10 PM - 如何预防和处理造影剂肾病？何奔

12:28 PM - 讨论

12:30 PM - 休会


184


11:10 AM - 微导管在CTO病变逆向PCI中的应用进展李悦

11:25 AM - 逆向导丝通过技术与对吻导丝技术李学奇

11:40 AM - CART、反向CART及弯曲导丝技术李成祥

11:55 AM - 导丝对接与导丝体外化的技术要点陈纪言

12:10 PM - 逆向技术的并发症防治葛雷


12:30 PM - 休会

二层204会议室

病例早餐会18慢性完全闭塞7:00 AM-8:15 AM

主持人：李志忠, 杨树森, 周斌全

7:00 AM - CS-0027：CTO - 一波三折柯永胜

7:10 AM - 讨论

7:15 AM - CS-0058：CTO病变逆向PCI治疗病例Risto Jussila

7:25 AM - 讨论

7:30 AM - CS-0013：CTO病变合并左心室瘘刘同库

7:40 AM - 讨论

7:45 AM - CS-0097：冠脉搭桥术后严重肾功能不全患者开通右冠完全闭塞病变周斌全

7:55 AM - 讨论

8:00 AM - CS-0112：经桡动脉逆向导丝技术开通开口CTO病变唐蓉

8:10 AM - 讨论

8:15 AM - 休息

整合应用FFR、IVUS、OCT及其他以改善患者疗效（五）8:30 AM-12:30 PM

第八场：影像和生理学病例征集

病例讨论一（每例报告及讨论15分钟）

主持人：Gary S. Mintz, 郭宁讨论专家：Kelvin Chan, 贺勇, 卜军, 吴小凡, 徐凯

8:30 AM - IM-0007：青年女性急性心肌梗死一例白静

8:45 AM - IM-0013：心肌梗死后血管再通的IVUS和OCT表现李宪凯

9:00 AM - IM-0031：导管引发的冠脉夹层病例张奇

9:15 AM - IM-0034：IVUS指导前向无残端闭塞病变开口穿刺修建成

9:30 AM - IM-0045：内膜下支架及其一年后造影随访一例谢丽华

9:45 AM - IM-0047：衰减斑块、斑块破裂以及无复流卜军

10:00 AM - IM-0053：一例特殊冠状动脉病变王效增

10:15 AM - IM-0074：导管室的噩梦 - 支架近端夹层及壁内血肿一例邱洪

病例讨论二（每例报告及讨论15分钟）

主持人：Akiko Maehara, 刘健讨论专家：郭军, Simon Cheung-Chi Lam, 金琴花, 徐迎佳, 赵志敬

10:30 AM - IM-0083：IVUS指导下右冠急性闭塞处理荆全民

10:45 AM - IM-0084：右冠慢性血栓叶红华

11:00 AM - IM-0070：一例冠状动脉瘤合并急性心肌梗死病例李纪明

11:15 AM - IM-0102：双对吻挤压支架术治疗左主干分叉病变张峰

11:30 AM - IM-0107：FFR指导PCI治疗两例崔凯


185


二层205会议室


主持人：徐泽升, 沈珠军, 聂绍平

7:00 AM - CS-0120：复杂慢性完全闭塞病变介入治疗一例徐泽升

7:10 AM - 讨论

7:15 AM - CS-0125：“边支扩张”+“导丝反向塑形”技术治疗CTO病变一例刘学波

7:25 AM - 讨论

7:30 AM - CS-0150：CTO介入治疗中血压降低心率增快徐景涛

7:40 AM - 讨论

7:45 AM - CS-0173：IVUS引导逆向开通LAD无残端CTO - 支架起始段位于夹层导致大对角支严重受累后补救性置入支架尹涛

7:55 AM - 讨论

8:00 AM - CS-0220：极度扭曲侧枝成角CTO病变逆向PCI病例李春坚

8:10 AM - 讨论

8:15 AM - 休息

左主干和分叉病变第四部分中国左主干和分叉病变介入治疗经验分享8:30 AM-12:30 PM

第一场：分叉病变介入治疗策略对疗效的影响

主持人：窦克非, 胡承恒, 梁春

11:45 AM - IM-0106：FFR双“裙裤”支架术病例刘福元

12:00 PM - IM-0113：多支病变策略的思考 - IVUS和FFR的整合应用刘健

12:15 PM - IM-0116：FFR指导串联病变介入治疗何东方

12:30 PM - 休会

8:30 AM - 不同双支架术式治疗分叉病变的远期效果差异刘同库

8:45 AM - 单支架还是双支架？重新审视新证据惠永明

9:00 AM - 分叉病变的解剖、成角、斑块特性对介入治疗策略及结果的影响马根山

9:15 AM - 不同类型支架治疗主支和和分支柳景华

9:30 AM - 分叉病变分型和术式选择俞梦越


第二场：分叉病变介入治疗技术对疗效的影响

主持人：马礼坤, 胡奉环, 邹阳春

9:50 AM - 分叉病变介入治疗中的难题：我是怎样应对的？杨树森

10:05 AM - 分叉病变的分支保护技术柯永胜

10:20 AM - 改良“裙裤”技术的应用翁少翔

10:35 AM - 主支预留球囊“微裙裤”术式处理分叉病变杨志明

10:50 AM - 冠脉口部病变介入治疗策略和经验王效增


第三场：左主干血运重建策略和经验

主持人：姜铁民, 李妍, 晋军

11:10 AM - 左主干血运重建中SYNTAX评分的意义和应用陈方

11:25 AM - 左主干开口病变介入策略和经验叶飞


186


11:40 AM - 左主干分叉病变的介入策略和经验陈良龙

11:55 AM - 左主干钙化病变的介入策略和经验蒋峻

12:10 PM - 左主干合并右冠闭塞病变的血运重建策略和技术李妍


12:30 PM - 休会

二层206会议室


主持人：徐亚伟, 齐向前, 汝磊生

7:00 AM - CS-0246：逆向开通直接PCI所致RCA明显夹层病变刘海伟

7:10 AM - 讨论

7:15 AM - CS-0282：Crusade双腔微导管在CTO前向介入治疗中的应用汝磊生

7:25 AM - 讨论

7:30 AM - CS-0295：三支CTO完全血运重建病例Yi sik Kim

7:40 AM - 讨论

7:45 AM - CS-0306：标记导丝技术开通LAD CTO的得与失何鹏程

7:55 AM - 讨论

8:00 AM - CS-0319：使用逆向CART技术及IVUS引导对右冠慢性完全闭塞病变进行介入治疗王虹

8:10 AM - 讨论

8:15 AM - 休息

心血管疾病合并糖尿病患者的综合管理美敦力协办8:30 AM-12:15 PM

第一部分：跨学科合作综合管理

主持人：宁光, 沈卫峰, 张瑞岩, 卢成志, 王显

8:30 AM - 开场：跨学科合作综合管理沈卫峰

8:35 AM - 心血管病不同危险分层患者的血糖管理宁光

8:55 AM - 周围血管疾病合并糖尿病治疗新进展Craig M. Walker

9:15 AM - 冠状动脉造影观察：糖尿病患者的血管评价及PCI策略刘健

9:30 AM - 糖尿病血管并发症的治疗陆林

9:45 AM - II型糖尿病患者介入治疗及术后管理安健


第二部分：糖尿病患者经皮冠脉介入治疗

主持人：王海昌, 朱建华, 李晓东, 苏晞, 夏勇, 张斌

10:15 AM - 糖尿病患者PCI还是CABG：研究现状Spencer B. King III

10:35 AM - 糖尿病患者多支血管病变冠脉介入治疗策略王海昌

10:55 AM - 糖尿病患者冠脉介入治疗的技术和技巧吴永健

11:10 AM - 病例报告：糖尿病合并分叉病变介入治疗一例王政

11:20 AM - 讨论

11:30 AM - 病例报告：糖尿病合并慢性完全闭塞病变介入治疗一例毛懿

11:40 AM - 讨论

11:50 AM - 病例报告：非ST段抬高型急性冠脉综合征患者合并糖尿病介入治疗一例白晓君


187


二层207会议室


主持人：李学奇, 陈竹君, 戴军

7:00 AM - CS-0360：右冠脉CTO介入治疗Weiting Wang

7:10 AM - 讨论

7:15 AM - CS-0361：正向CTO一例陈竹君

7:25 AM - 讨论

7:30 AM - CS-0374：CTA指导下长段右冠CTO成功逆向开通一例王琼

7:40 AM - 讨论

7:45 AM - CS-0380：克服球囊不能通过闭塞病变的新方法薛竟宜

7:55 AM - 讨论

8:00 AM - IM-0080：IVUS导引下CTO治疗徐凯

8:10 AM - 讨论

8:15 AM - 休息

心血管无创影像8:30 AM-12:30 PM

第一场

主持人：张运, Anthony DeMaria, Shih-Pu Wang, 吕滨

8:30 AM - CT可以检出“易损斑块”吗？Stephan Achenbach

8:45 AM - 讨论

12:00 PM - 讨论

12:10 PM - 要点总结朱建华

12:15 PM - 休会

8:50 AM - CTA评价冠心病及预测心脏事件的研究现状John McB. Hodgson

9:05 AM - 讨论

9:10 AM - MSCT作为急性冠状动脉综合征首选筛查方法的作用Shih-Pu Wang

9:25 AM - 讨论

9:30 AM - 冠脉CT评价冠脉支架断裂和压缩Young-Hak Kim

9:45 AM - 讨论

9:50 AM - 基于MSCT的冠状动脉斑块负荷和成分的自动评价与验证Johan H. C. Reiber

10:05 AM - 讨论

10:10 AM - 心脏影像学检查：正确的检查才能满足正确的适应证Anthony DeMaria

10:25 AM - 讨论

第二场

主持人：蒋世良, 方唯一, 黄岚, 赵世华

10:30 AM - 冠心病患者PCI术前的危险分层何作祥

10:45 AM - 讨论

10:50 AM - FFR-CT临床应用及进展：放射专家观点吕滨

11:05 AM - 讨论

11:10 AM - FFR-CT临床应用及进展：心内科专家观点徐亚伟

11:25 AM - 讨论

11:30 AM - 主动脉瓣狭窄合并左心功能减低的负荷超声王浩

11:45 AM - 讨论


188


11:50 AM - 基于TAVI的影像学检查方法赵世华

12:05 PM - 讨论

12:10 PM - 未来“罪犯斑块”的检出和有创钝化蒋金法

12:25 PM - 讨论

12:30 PM - 休会

二层208会议室

病例早餐会22特殊病例7:00 AM-8:15 AM

主持人：谭宁, 黄伟剑, 曾秋棠

7:00 AM - IM-0076：逆向技术开通RCA口部支架内完全闭塞病变栾波

7:10 AM - 讨论

7:15 AM - CS-0004：前降支起源于右冠一例秦绪光

7:25 AM - 讨论

7:30 AM - CS-0006：IVUS+FFR指导下处理钙化病变一例赵宇新

7:40 AM - 讨论

7:45 AM - CS-0025：川崎病致成人严重冠脉病变一例蔚有权

7:55 AM - 讨论

8:00 AM - CS-0037：冠状动脉痉挛致心源性休克一例郝盼盼

8:10 AM - 讨论

8:15 AM - 休息

心律失常第五部分论文交流和病例讨论8:30 AM-12:30 PM

第一场：论文交流

主持人：杨杰孚, 吴书林, 王玉堂, 汪芳

8:30 AM - AS-0036：心脏再同步化治疗“无反应”的影响因素及死亡率 - 中国患者的情况王冬梅

8:42 AM - 讨论

8:45 AM - AS-0254：左纤维三角区域起源的心外膜特发性室性心律失常的电生理特征及消融策略杨桂棠

8:57 AM - 讨论

9:00 AM - AS-0452：优化算法消融经左侧旁路治疗房室折返性心动过速 - 使用反向双极刘铮

9:12 AM - 讨论

9:15 AM - AS-0703：基于动态心率建立的贝叶斯模型预测急性心肌梗死后的心源性猝死宋涛

9:27 AM - 讨论

9:30 AM - AS-0711：先天性矫正型大动脉转位合并室上性心动过速患者的电生理特征及射频消融治疗郭晓刚

9:42 AM - 讨论

9:45 AM - AS-0751：慢性心力衰竭患者心脏再同步化治疗的长期效果 - 单中心10年经验张宇

9:57 AM - 讨论

第二场：病例讨论

主持人：曹克将, 王祖禄, 李毅刚, 方丕华, 项美香

10:00 AM - CS-0017：冠状动脉痉挛引发致命性心律失常一例罗晓亮

10:10 AM - 讨论

10:15 AM - CS-0038：房颤经导管消融术后并发二支肺静脉主干闭塞严金川

10:25 AM - 讨论

10:30 AM - CS-0040：心脏再同步化治疗术后不起搏一例田芸


189


三层305A会议室


主持人：卢才义, 杨向军, 郑杨

7:00 AM - CS-0064：两支冠脉血管慢性夹层导致急性心肌梗死贺行巍

7:10 AM - 讨论

7:15 AM - CS-0079：少见多支冠状动脉肺动脉瘘的介入治疗高力明

7:25 AM - 讨论

7:30 AM - CS-0109：成人冠状动脉扩张川崎氏病一例朱强

7:40 AM - 讨论

7:45 AM - CS-0158：自膨胀支架治疗冠脉瘤样扩张病变Renata Rogacka

7:55 AM - 讨论

8:00 AM - CS-0189：右冠开口畸形所致晕厥一例及2年随访姚义安

8:10 AM - 讨论

8:15 AM - 休息

征集病例讨论第一部分急性冠脉综合征8:30 AM-12:30 PM

第一场

主持人：李志忠, 郭晓华, 张军, 李潞, 金元哲, 宫剑滨, 满荣海

10:40 AM - 讨论

10:45 AM - CS-0092：杂交法置入ICD一例梁兆光

10:55 AM - 讨论

11:00 AM - CS-0093：经皮静脉拔除起搏器植入后亚急性右室被动电极延迟穿孔一例梁兆光

11:10 AM - 讨论

11:15 AM - CS-0163：定量组织多普勒速度成像随访左室心肌致密化不全CRT-D治疗一例 - 15个月随访结果报道毛家亮

11:25 AM - 讨论

11:30 AM - CS-0207：电除颤后心电图疑似ST段抬高心肌梗死一例单培仁

11:40 AM - 讨论

11:45 AM - CS-0258：心衰合并间断扭转性室速病例报道一例冯天捷

11:55 AM - 讨论

12:00 PM - CS-0288：PTCA技术完成CRT-D左室电极置入一例李文铮

12:10 PM - 讨论

12:15 PM - CS-0307：Brugada综合征王鹏飞

12:25 PM - 讨论

12:30 PM - 休会

8:30 AM - CS-0215：高危ST段抬高型心梗急诊处理策略郭晓华

8:40 AM - 讨论

8:45 AM - CS-0159：冠状动脉瘤样扩张合并栓塞性心肌梗死一例来晏

8:55 AM - 讨论

9:00 AM - IM-0022：急性左主干闭塞病例晋军

9:10 AM - 讨论

9:15 AM - CS-0206：急性心梗、室速、休克、弥漫性合并CTO病例Ruey-Hsing Chou

9:25 AM - 讨论

9:30 AM - CS-0378：一例冠脉造影“貌似”正常的ACS分析张卫萍

9:40 AM - 讨论

第二场

主持人：李保, 唐发宽, 唐良秋, 吴其明, 许力舒, 郑杨

9:45 AM - CS-0170：急性前壁心肌梗死合并右冠血栓姜醒华

9:55 AM - 讨论

10:00 AM - CS-0289：NSTEMI病例应用血栓抽吸导管进行超选择性造影颜红兵

10:10 AM - 讨论

10:15 AM - CS-0290：STEMI患者联合应用血栓抽吸导管颜红兵

10:25 AM - 讨论

10:30 AM - CS-0192：肺栓塞合并急性心肌梗死PCI术后急性支架内血栓一例潘德锋

10:40 AM - 讨论


190


10:45 AM - CS-0197：理想与现实赵榆华

10:55 AM - 讨论

第三场

主持人：秦学文, 郭成军, 赵迎新, 马颖艳, 贾永平, 吴淳, 毛静远

11:00 AM - CS-0116：我如何处理优势右冠状动脉巨大血栓负荷？单守杰

11:10 AM - 讨论

11:15 AM - CS-0113：急性前壁心肌梗死“一波三折”高力明

11:25 AM - 讨论

11:30 AM - CS-0103：急性左主干闭塞患者成功抢救一例刘俊松

11:40 AM - 讨论

11:45 AM - CS-0032：LAD急诊PCI后心脏骤停一例孙兆青

11:55 AM - 讨论

12:00 PM - CS-0060：左主干异常开口急诊PCI一例王斌

12:10 PM - 讨论

12:15 PM - CS-0089：哪个是罪犯血管？章霞

12:25 PM - 讨论

12:30 PM - 休会

三层305B会议室


主持人：曾和松, 周立君, 卢长林

7:00 AM - CS-0318：瓦氏窦瘤破裂致心包填塞一例石蕴琦

7:10 AM - 讨论

7:15 AM - IM-0008：徘徊在指南和现实之间徐劲松

7:25 AM - 讨论

7:30 AM - IM-0039：两支瘤样病变IVUS诊断一例郑晓群

7:40 AM - 讨论

7:45 AM - IM-0041：前降支近端支架扩张不良急性血栓再次PCISridhar Kasturi

7:55 AM - 讨论

8:00 AM - IM-0069：冠状动脉发育畸形行介入治疗一例王涟

8:10 AM - 讨论

8:15 AM - 休息

征集病例讨论第二部分左主干、分叉病变及特殊病例8:30 AM-12:30 PM

第一场

主持人：王伟民, 叶飞, 秦雷, 宋耀明, 李凌, 浦奎, 柳弘

8:30 AM - CS-0372：反转导丝技术成功处理严重成角的分叉病变一例慕朝伟

8:40 AM - 讨论

8:45 AM - CS-0263：左主干分叉及钙化病变旋磨+切割的IVUS表现荆全民

8:55 AM - 讨论

9:00 AM - CS-0029：原位病变还是再狭窄病变？柯永胜

9:10 AM - 讨论

9:15 AM - CS-0235：一例特殊冠状动脉病变王效增

9:25 AM - 讨论

9:30 AM - CS-0115：复杂三分叉病例Subhash Chandra

9:40 AM - 讨论

第二场

主持人：乔树宾, 薛朝阳, 杨永健, 李传昶, 苗立夫, 纪征, 张励庭

9:45 AM - CS-0273：CTO病变开通后球囊支架对吻技术保护边支一例崔锦钢

9:55 AM - 讨论

10:00 AM - CS-0226：一例复杂左主干分叉病变处理关绍义

10:10 AM - 讨论

10:15 AM - CS-0145：经桡动脉双分叉病变介入治疗一例张茵

10:25 AM - 讨论

10:30 AM - CS-0250：PCI治疗左主干+三支病变致反复心衰一例李辉

10:40 AM - 讨论


191


三层302A会议室

征集病例讨论第三部分并发症8:30 AM-12:30 PM

第一场

主持人：王乐丰, 姚朱华, 刘全, 刘建平, 马利平, 杨波, 程姝娟

8:30 AM - CS-0127：股动脉穿刺并发症 - PCI引起腹膜后血肿一例陈竹君

8:40 AM - 讨论

8:45 AM - CS-0087：PCI术中支架脱载的处理Bei Ge

8:55 AM - 讨论

9:00 AM - CS-0278：旋磨导丝断裂一例何鹏程

9:10 AM - 讨论

9:15 AM - CS-0321：应用Guideliner取出支架术后嵌顿IVUS导管Hsuan-Fu Kuo

9:25 AM - 讨论

9:30 AM - 休息

第二场

主持人：郭文怡, 杨汉东, 贺玉泉, 林荣, 袁勇, 张高星, 肖纯

9:45 AM - CS-0094：简单病变不简单的过程李松华

9:55 AM - 讨论

10:00 AM - CS-0036：亚急性支架内血栓形成一例罗亚玮

10:10 AM - 讨论

10:45 AM - CS-0044：复杂PCI的简单之美 - 严重迂曲钙化合并左主干分叉一例尹涛

10:55 AM - 讨论

第三场

主持人：陈纪林, 姜东炬, 李继福, 管军, 杨成明, 程标, 刘慧

11:00 AM - CS-0315：IVUS和FFR指导下复杂病变介入治疗一例樸哲浩

11:10 AM - 讨论

11:15 AM - CS-0193：FFR指导的多阶段病变胡新央

11:25 AM - 讨论

11:30 AM - CS-0142：药物洗脱支架再狭窄及瘤样改变病例杨伟宪

11:40 AM - 讨论

11:45 AM - CS-0187：三支病变合并肥厚型心肌病PCI后再狭窄再次PCI亚急性支架内血栓病例 - 七年随访结果王连生

11:55 AM - 讨论

12:00 PM - CS-0011：心肾衰竭合并复杂左主干分叉病变PCI刘同库

12:10 PM - 讨论

12:15 PM - CS-0055：IVUS/FFR引导下应用不同策略处理多个分叉病变PCI一例张俊杰

12:25 PM - 讨论

12:30 PM - 休会

10:15 AM - CS-0124：医源性冠状动脉夹层一例施鸿毓

10:25 AM - 讨论

10:30 AM - CS-0034：左冠指引导管致右冠螺旋夹层一例宋雷

10:40 AM - 讨论

10:45 AM - CS-0375：成功开通钙化病变后的致命股动脉血肿王琼

10:55 AM - 讨论

第三场

主持人：刘海波, 王庆胜, 刘和平, 王伟, 林文华, 唐强, 由倍安

11:00 AM - CS-0135：PCI中冠脉穿孔一例杨勇

11:10 AM - 讨论

11:15 AM - CS-0108：PCI术后LAD逆行夹层张海华

11:25 AM - 讨论

11:30 AM - IM-0081：在一名女性Moyamoya病患者中的IVUS发现徐凯

11:40 AM - 讨论

11:45 AM - CS-0291：前降支支架再断裂一例张鹏

11:55 AM - 讨论

12:00 PM - CS-0276：择期PCI术中钝缘支闭塞至心脏破裂一例赵汉军

12:10 PM - 讨论

12:15 PM - IM-0077：高龄女性冠脉支架术后极晚期血栓王庆胜

12:25 PM - 讨论

12:30 PM - 休会


192


三层302B会议室

征集病例讨论第四部分慢性完全闭塞8:30 AM-12:15 PM

第一场

主持人：葛雷, 李成祥, 陈文强, 鹿庆华, 廉哲勋, 薛玉增

8:30 AM - CS-0326：逆行导丝技术治疗RCA开口无残端CTO病变一例贺玉泉

8:40 AM - 讨论

8:45 AM - CS-0071：逆向技术开通右冠无开口CTO一例李成祥

8:55 AM - 讨论

9:00 AM - CS-0254：钢丝导致弥漫性夹层后CTO病变逆向PCI治疗病例Yisik Kim

9:10 AM - 讨论

9:15 AM - CS-0102：反向CART治疗右冠CTO病变Tsung-Lin Yang

9:25 AM - 讨论

9:30 AM - CS-0149：间隔支逆向导丝技术开通前降支CTO高展

9:40 AM - 讨论

9:40 AM - 讨论

第二场

主持人：李悦, 汝磊生, 唐元升, 刘凡, 仇玉民, 王勇, 张寰

9:45 AM - CS-0277：小血管合并钙化CTO的介入治疗洪浪

9:55 AM - 讨论

10:00 AM - CS-0076：复杂CTO病例胡涛

10:10 AM - 讨论

10:15 AM - IM-0054：复杂回旋支到右冠逆向PCI金泽宁

10:25 AM - 讨论

10:30 AM - CS-0253：对侧造影及IVUS辅助正向开通RCA支架内CTO刘海伟

10:40 AM - 讨论

10:45 AM - CS-0354：不同侧枝通道逆向开通左主干开口CTO病变汝磊生

10:55 AM - 讨论

第三场

主持人：张大东, 周国伟, 丁世芳, 李莉, 余华, 王志方, 牛锁成

11:00 AM - CS-0191：正向微导管沿逆向导丝通过闭塞段开通前降支CTO一例王耿

11:10 AM - 讨论

11:15 AM - CS-0129：左主干相关CTO病例 - 策略选择？吴铿

11:25 AM - 讨论

11:30 AM - CS-0174：攻坚需要多预案杨峻青

11:40 AM - 讨论

11:45 AM - CS-0184：RCA CTO治疗遭遇严重低血压周国伟

11:55 AM - 讨论

12:00 PM - CS-0247：超高龄、高危、复杂冠心病患者介入治疗策略赵昕

12:10 PM - 讨论

12:15 PM - 休会


193


三层307会议室

病例讨论：外周和腔内血管介入8:30 AM-10:30 AM

主持人：蒋雄京, 罗建方, 王焱, 邹英华

8:30 AM - CS-0265：外周血管严重病变手术路径选择荆全民

8:40 AM - 讨论

8:45 AM - CS-0035：开窗支架腔内治疗短瘤颈腹主动脉瘤薛玉国

8:55 AM - 讨论

9:00 AM - CS-0009：大脑中动脉严重狭窄性病变刘同库

9:10 AM - 讨论

9:15 AM - CS-0098：颈动脉闭塞病变的介入治疗杨滨

9:25 AM - 讨论

9:30 AM - CS-0223：主动脉弓上三支病变的介入治疗倪忠涵

9:40 AM - 讨论

9:45 AM - CS-0262：经皮超选择性肾上腺动脉栓塞治疗原发性醛固酮增多症董徽

9:55 AM - 讨论

10:00 AM - CS-0284：84岁患者双侧颈动脉支架病例彭猛

10:10 AM - 讨论

10:15 AM - IM-0073：肾动脉闭塞介入治疗一例郭峰

10:25 AM - 讨论

10:30 AM - 休会


194

CIT HANDS-ON CENTER


195

CIT HANDS-ON CENTER


196

CIT HANDS-ON CENTER


197

CIT HANDS-ON CENTER


198

CIT HANDS-ON CENTER


199

CIT HANDS-ON CENTER


200

CIT HANDS-ON CENTER

PCI优化—源自圣犹达

CIT2014 圣犹达体验中心日程CIT2014 St. Jude Medical Tech Suit Schedule

地点：上海跨国采购会展中心 3 层 3M4

Venue: Room 3M4, 3rd Floor, Shanghai Convention & Exhibition Center of International Sourcing

ST. JUDE MEDICAL, the nine-squares logo are trademarks of St. Jude Medical, Inc. or its affi liates. ©2014 St. Jude Medical. All Rights Reserved.

3 月 20 日

09:30~12:00 FFR 及 OCT 的模拟机操作体验 / 圣犹达止血产品系列操作培训


3 月 21 日

09:30~12:00 临时起搏电极技术——曾玉杰 ( 北京安贞医院 )


3 月 22 日

09:30~12:00 临时起搏电极技术——李学斌 ( 北京人民医院 )



201

CIT HANDS-ON CENTER


202

CIT HANDS-ON CENTER


203

CIT HANDS-ON CENTER


204

CIT HANDS-ON CENTER


206


206

EXHIBIT FLOOR PLAN 展位平面图

3m

3m

A006

A005

A004 A007-A008

A006

A012A011 A013/A014 A015/A016 A018

A022

A156A155A154A092A091A090

A289A288A287A220A219A218

A023

A021

A020

A001

A085A028

A089A024

A084A029A080

A079

A034

A071

A075

A138

A096

/A14

9

A153A093

A152A094

A151A095

A150

A097

A100A139

A137

A107

A135

A130

A121

A186 A193

A126

A176

A214

A161

A217A157

A216A158

A215A159

A160

A213

A162

A163

A211

A164

A165

A209

A171

A135

A282

A225

A286A221

A285A222

A284A223

A283A224

A281

A212

/A22

6A228A231A235

A266

A305 A294

A290

A291

A292

A293A297 A295-A296A298-A300A301-A303A304A306-A308

A312

A314

A315

A316

A317

A318

A319

A320

A321

A322

Mai

n En

tran

ce

Lobby, Level 1

CIT Moderated Poster Area

Exhibitor LoungeCoffee Station

PC

R

ICC

CR

FC

SC

CC

T

TCTA

PC

MT

GW

-ICC

EN

CO

RE

Edu

catio

nal B

ooth

s

A202

A045

Abbott Vascular

Boston Scientific

JWMedical

Terumo

Philips

Sanofi

VenusMedTechLifetech

Essen

Maquet

Shimadzu Demax

China ResourcesPharmaceutical

Baye

rMavigGmbH

Orb

usN

eich

BraccoSine

Rientech

AC

IST

EEC

Meko Medis

Kelid

a

PTS

Meril PEROUSE MENTICEABMeritHuaren Star Progress Beilu Pharmaceutical

Lepu Medical

St.Jude

SinoMedical

AstraZeneca

Medfavour

Great Dragon

GE Healthcare

MicroPort

CIT书屋

Medtronic

CRF/TCTMD Internet Station CIT On-Demand

Kinhely CHC2014 美中双和

A039

YinyiMedical

A271A236

A270A237

A269A238

A268A239A268

Johnson & Johnson

A001

A002 A003-A005


205

EXHIBIT FLOOR PLAN 展位平面图

3m

3m

A006

A005

A004 A007-A008

A006

A012A011 A013/A014 A015/A016 A018

A022

A156A155A154A092A091A090

A289A288A287A220A219A218

A023

A021

A020

A001

A085A028

A089A024

A084A029A080

A079

A034

A071

A075

A138

A096

/A14

9

A153A093

A152A094

A151A095

A150

A097

A100A139

A137

A107

A135

A130

A121

A186 A193

A126

A176

A214

A161

A217A157

A216A158

A215A159

A160

A213

A162

A163

A211

A164

A165

A209

A171

A135

A282

A225

A286A221

A285A222

A284A223

A283A224

A281

A212

/A22

6A228A231A235

A266

A305 A294

A290

A291

A292

A293A297 A295-A296A298-A300A301-A303A304A306-A308

A312

A314

A315

A316

A317

A318

A319

A320

A321

A322

Mai

n En

tran

ce

Lobby, Level 1

CIT Moderated Poster Area

Exhibitor LoungeCoffee Station

PC

R

ICC

CR

FC

SC

CC

T

TCTA

PC

MT

GW

-ICC

EN

CO

RE

Edu

catio

nal B

ooth

s

A202

A045

Abbott Vascular

Boston Scientific

JWMedical

Terumo

Philips

Sanofi

VenusMedTechLifetech

Essen

Maquet

Shimadzu Demax

China ResourcesPharmaceutical

Baye

rMavigGmbH

Orb

usN

eich

BraccoSine

Rientech

AC

IST

EEC

Meko Medis

Kelid

a

PTS

Meril PEROUSE MENTICEABMeritHuaren Star Progress Beilu Pharmaceutical

Lepu Medical

St.Jude

SinoMedical

AstraZeneca

Medfavour

Great Dragon

GE Healthcare

MicroPort

CIT书屋

Medtronic

CRF/TCTMD Internet Station CIT On-Demand

Kinhely CHC2014 美中双和

A039

YinyiMedical

A271A236

A270A237

A269A238

A268A239A268

Johnson & Johnson

A001

A002 A003-A005


207

Cardiovascular Research Foundation A001

CHC2014 A002

Kinhely深圳市金瑞凯利生物科技有限公司 A003-A005

Beijing Amsino Medical Co., Ltd北京美中双和医疗器械有限公司 A006

MeKo Laser-Materialbearbeitungen A011

Medis medical imaging systems bv A012

Shimadzu岛津企业管理（中国）有限公司 A013-A014

Beijing Demax Medical Technology Co., Ltd北京迪玛克医药科技有限公司 A015-A016

China Resources Pharmaceutical（Shanghai）Co., Ltd华润医药（上海）有限公司 A018

Shanghai BoYi Hospital Investment management Co., Ltd.上海博壹医院投资管理有限公司 A034

Liaoning Biomedical Materials R&D Center Co., Ltd辽宁生物医学材料研发中心有限公司 A039

SINO Medical Sciences Technology Inc.赛诺医疗科学技术有限公司 A045

Medfavour(Beijing)Medical Co., Ltd万瑞飞鸿（北京）医疗器材有限公司 A071

St. Jude Medical圣犹达医疗用品（上海）有限公司 A075

Eastern Enterprise Corporation北京恒润泰医药科技有限公司 A079

Maquet (Shanghai) Medical Equipment Co., Ltd迈柯唯(上海)医疗设备有限公司 A080

OrbusNeich深圳业聚实业有限公司 A096/A149

Bayer Healthcare Company Ltd.拜耳医药保健有限公司 A097

Mavig GmbH A100

Abbott Medical Devices Trading (Shanghai) Co., Ltd.雅培医疗器械贸易（上海）有限公司 A121

Shanghai Microport Medical(Group)Co., Ltd上海微创医疗器械（集团）有限公司 A126

Lepu Medical Technology (Beijing) Co., Ltd乐普（北京）医疗器械股份有限公司 A130

AstraZeneca阿斯利康（无锡）贸易有限公司 A135

Essen Technology（Beijing）Co., Ltd.易生科技（北京）有限公司 A139

Icirculation国际循环 A161

ENCORE SEOUL A162

CCT A163

ACIST Medical Systems A164

Shanghai Bracco Sine Pharmaceutical Corp. Ltd.上海博莱科信谊药业有限责任公司 A165

Sanofi (China) Investment Co., Ltd赛诺菲（中国）投资有限公司 A171

Terumo Medical (SHANGHAI)Co., Ltd.泰尔茂医疗产品（上海）有限公司 A176

Medtronic (Shanghai) Management Co., Ltd.美敦力(上海)管理有限公司 A186

BSC Int'l Medical Trading (Shanghai) Co., Ltd.波科国际医疗贸易（上海）有限公司 A193

GE Medical Systems Trade And Development（Shanghai） Co., Ltd.通用电气医疗系统贸易发展（上海）有限公司 A202

Beijing Kelida Medical Equipment Developing Co.Ltd.北京科利达医疗设备发展有限公司 A211

China Medical Tribune中国医学论坛报社 A212/A226

Company Name Booth Number公司名称展位号


EXHIBITORS 参展单位


208

CARDIOVASCULAR SUMMIT-TCTAP A213

EuroPCR A214

CCRF (Beijing) Inc.永铭诚道（北京）医学科技股份有限公司 A225

Shandong Rientech Medical Technology Co., Ltd.山东瑞安泰医疗技术有限公司 A228

Venus MedTech（Hangzhou）Inc.杭州启明医疗器械有限公司 A231

Lifetech Scientific Corporation先健科技（深圳）有限公司 A235

Philips Healthcare飞利浦医疗保健 A266

Johnson & Johnson Medical （Shanghai）Ltd.强生（上海）医疗器械有限公司 A268

25th GW-ICC | APHC 2014 | ICCPR 2014第二十五届长城国际心脏病学会议 | 亚太心脏心脏大会2014 | 国际心血管病预防与康复会议2014 A281

2014Chinese Society of Cardiology Congress2014中国心血管病学年会 A282

MENTICE AB A294

Merit Medical Beijing Co., Ltd麦瑞通医疗器械（北京）有限公司 A295-A296

Perouse Medical (Shanghai) Co., Ltd贝鲁斯医疗器材（上海）有限公司 A297

Beijing BeiLu Pharmaceutical Co., Ltd北京北陆药业股份有限公司 A298-A300

Star Progress Medical Co., Ltd.上海星峰工贸有限公司 A301-A303

Meril Life Sciences Pvt. Ltd. A304

Beijing Huaren Health Science & Technology Developing Co., Ltd北京市华仁益康科技发展有限公司 A305

Great Dragon北京伟龙科仪贸易有限公司 A306-A308

JW Medical Systems吉威医疗制品有限公司 A312





209


Booth Number: A001

Address: 111 E. 59th St, 11th Floor 10022 USAContact Email: [email protected]

The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life of people with cardiovascular disease through research and education.

CHC2014

Booth Number: A002

地址：西城区北礼士路167号阜外医院 100037Contact Email: [email protected]

中国心脏大会由中华医学会与国家心血管病中心联合主办，无疑是搭建了一个我国心血管领域最高层次的学术交流平台。大会将展示心血管病临床防治和基础研究方面的新成就，介绍转化医学研究的新进展，对未来的个体化诊疗、防治与科研发展趋势展开讨论。促进和交流新的成果，医学同道在与国际一流和国内同行进行面对面交流的过程中，迸发出创新的火花，为今后的研究寻找新的视角，达到新的思维、新的视野、新的高度。

With strong supports from the Chinese government, the most knowledgeable national and international experts and colleagues, as well as the industrial partners, the China Heart Congress has become one of the most comprehensive academic events and the most educational teaching course in the field cardiovascular medicine in Asia Pacific region. This year, the Congress will once again follow its successful experiences as previously. Distinguished scientists will be invited to share their groundbreaking research, present their original scientific works, and clinicians will debate the hottest topics for day to day practice. In addition, the Congress will offer cardiovascular professionals huge wealth of opportunities to exchange information on education, recent findings, and the challenges that confront us in cardiovascular care.

Kinhely深圳市金瑞凯利生物科技有限公司

Booth Number: A003-A005

地址：深圳市福田区皇岗北路彩电工业区402栋2楼

Address: Foor2,House402, Caidian Industrial Park, North Huanggang Rd, Futian District, Shenzhen, China

Contact Email: [email protected]

深圳市金瑞凯利生物科技有限公司主要从事冠状动脉药物支架(DES)等三类医疗器械的研发、生产和销售。2010年，完成海利欧斯（HELIOS)Ti-O膜无底涂钴铬合金药物(雷帕霉素）洗脱支架的中国首例前瞻性、单盲、随机多中心临床试验-HOPE试验；公司着眼于心血管介入领域，38mm长支架为国内首创，并力争成为细分市场领导者，为临床提供先进治疗解决方案，为患者解决病痛、回报社会贡献价值。公司依托科技部973计划以及深圳发改委的支持，不断增强R&D，力争在未来2-3年提供心脏介入完善产品线，并成为上市公众公司。

Beijing Amsino Medical Co., Ltd北京美中双和医疗器械有限公司

Booth Number: A006

地址：北京市朝阳区建国路甲92号世茂大厦C座10层 Address: Shimao Tower C Floor 10 Office jia92 Jianguo Road Chaoyang District, Beijing 100022 Contact Email: [email protected]

北京美中双和医疗器械有限公司，是一家专业从事心脏介入领域医疗器械研发、生产、销售、服务的高科技民营股份制企业。1985年董事长马晓意开始步入心血管领域，并于1999年创立美中双和，作为国内第一代心脏介入领域专业公司，一直致力于将国外心脏介入领域最先进的产品和技术引入国内，并积极搭建国内外医师交流平台，帮助提高国内心血管医师的介入治疗水平。公司成立十余年以来，在心脏起搏器、电生理、冠脉介入、人工心脏瓣膜等多项领域取得了可嘉的成绩，已成为国内业界极具影响的专业化企业。2012年通过10年不懈努力，推出中国目前唯一原创自主研发的药物冠脉支架—三氧化二砷药物涂层支架输送系统（商品名：AVI 双和），目前在全国进行推广和使用。

MeKo Laser-Materialbearbeitungen

Booth Number: A011

Address: Im Kirchenfelde 12-14, Sarstedt 31157 Germany Contact Email: [email protected]

MeKo is a contract manufacturer (ISO13485) of medical implants, coronary and peripheral stents, stent grafts, heart valve frames and thrombectomy stents. Capabilities in laser cutting, stent cutting, laser welding, marker welding, electro-polishing, heat treatment, passivation and cleaning in clean rooms.

MeKo offers high quality prototyping and mass production using materials such as 316LVM, L605, CoCr, NiTi, nitinol and biodegradable stents made of PLLA and magnesium.

MeKo 是医疗植入物、心血管及末梢血管支架、带膜支架、心脏瓣膜支架、血栓支架的订单生产商 (ISO13485)。具备激光切割、支架切割、激光焊接、商标焊接、电解抛光、热处理、金属钝化、无尘室内清洁的资质。

MeKo 提供高质量的材料结构模型生产和系列生产，如 316LVM、L605、钴铬合金、镍钛合金、镍钛诺、由聚L-乳酸和镁构成的生物可降解支架等。



210

Medis medical imaging systems bv

Booth Number: A012

Address: Schuttersveld 9, x 2316 XG Netherlands Contact Email: [email protected]

Since 1989 MEDIS medical imaging systems is a leading provider of software for the quantification of cardiovascular images. Its software solutions enable medical professionals to ensure efficient, cost-effective and high-quality image analysis. At CIT 2014 the Medis team invites you to our booth for an update on our latest and greatest developments: QIvus® 3.0 for IVUS, Tissue Characterization and OCT analysis, QAngio® XA 7.3 for coronary, peripheral, and ventricular angiography, QAngioXA 3D¹ and QAngioOCT¹ Research Editions (RE). ¹) QAngioXA 3D and QAngioOCT RE are developed by Medis medical imaging systems, Leiden, Netherlands. They are non-diagnostic and for research purposes only.

Shimadzu岛津企业管理（中国）有限公司


地址：北京市朝阳区朝外大街16号人寿大厦 Address: 14F, Shimadzu Management (China) Co., Ltd. 100020 Contact Email: [email protected]

Beijing Demax Medical Technology Co., Ltd北京迪玛克医药科技有限公司


地址：北京市大兴区经济技术开发区荣华中路亦城国际B座1902室 Address: Rm1902,19th Floor, Plaza B, YiCheng International Center, No.10 RongHuaZhongLu, BDA, BEIJING 100176 Contact Email: [email protected]

迪玛克医药是全球领先的心内介入医疗器械生产商。目前公司在全世界拥有2个主要工厂和7个办公室，向全球70个国家提供高质量的介入医疗器材和服务。

北京迪玛克医药科技有限公司是迪玛克医药的全资子公司，创立于2004年，是迪玛克医药在亚洲的总部。公司生产体系通过欧盟的CE认证和澳洲的TGA认证，同时也是北京第一家通过GMP认证的三类无菌医疗器械生产厂家。迪玛克专注从事一次性无菌心脏介入医疗器械产品和精密管材的研发、生产和销售，迪玛克以向医生，病人及客户提供最高质量的产品为己任，以产品质量零缺陷为目标，恒久以来，我们始终坚持以“质量为了生命”的原则，对医疗产品进行创新与变革，多年以来，迪玛克持久坚持的理念以及不懈努力的精神，使迪玛克一直是医疗产品界可信赖的伙伴。

China Resources Pharmaceutical（Shanghai）Co., Ltd华润医药（上海）有限公司

Booth Number: A018

地址：上海市长宁区安顺路251号5楼 Address: 5th Floor,No.251 Anshun Rd,Changning District, Shanghai China 200051 Contact Email: [email protected]

China Resources Pharmaceutical Group , one of the seven core strategic business units of China Resources (Holdings) Co., Ltd, a leading pharmaceutical company is dedicated to R&D, manufacturing, and distribution of pharmaceutical products in China. China Resources Pharmaceutical Group has follow subsidiaries: China Pharmaceutical R&D Center , China Resources Pharmaceutical Commercial Group, China Resources Sanjiu Medical & Pharmaceutical China Resources Double-Crane Pharmaceutical, China Resources Dong-E-E-jiao China Resources Second Pharmaceutical ,China Resources Zizhu Pharmaceutical ,Anhui Worldbest Pharmaceutical and China Resources Pien Tze Huang Pharmaceutical. Among of all, Sanjiu(000999), Double-Crane(600062), and Dong-E-E-jiao(000423) is in China A-share list. By the end of 2012, our total asset had reached HKD 85.6 billion, with annual revenue of HKD 98.6 billion and operating profit of HKD 6.15 billion, ranked Top 3 in China's pharmaceutical industry. China Resources Pharmaceutical’s products and services spread over 28 provinces (districts, cities) and have strong base & leading advantages on pharmaceutical manufacturing and medical distribution. We are strived to build up coordinated development platform for total industrial chain. As the leading pharmaceutical products (including drugs, medical devices and nutraceuticals) distributor in China, we provide national wide wholesale, logistics, retail and supply chain value-added services in 28 provinces across China. More than 7500 international and domestic pharmaceutical manufacturers maintain long-term cooperative relations with us. And we own and operate over 1000 retail chain pharmacies and points-of-sale by ourselves, over 13000 medical end customers including hospitals,communities and health centers. Our hospital distribution, modern logistics distribution and hospital logistics extended services are in the leading position in China. Focusing on future long-term development strategy, we have started to invest a large scale bio-medical industrial zone project in Beijing with global leading standard, innovative R&D and high end manufacturing. Integrated with development strategy , market competition and enterprise management, consolidating all R&D resources and setting up new development platform, a comprehensive business development system has been built up with united plan, organization and action plan. All these key facts continuously lifting up the core competence and market presence of China Resources. China Resources Pharmaceutical (Shanghai) Co., Ltd locates in Shanghai serving all large scale medical enterprises with business covering drugs, equipment and IVD Reagents. Started sales from 1995, IVD reagents have strong presence in drug store and hospital, especially our agent brand Roche, Johnson and some other world famous brand are already with high fame in IVD reagent market.



211

Shanghai BoYi Hospital Investment Management Co., Ltd.上海博壹医院投资管理有限公司

Booth Number: A034

地址：上海市闸北区虬江路1000号805室 Address: Room 805,No.1000 QiuJiang Road,Shanghai, P.R.China 200071 Contact Email: [email protected]

上海博壹医院投资管理有限公司是一家致力于建立并发展现代化医疗机构的专业投资管理公司，公司通过引进、研发高新医疗技术与设备、医疗信息系统、投资创办医疗机构、医疗专家派遣、开展医疗项目合作等方式开拓国内医疗服务市场。

公司拥有来自日本大阪大学、日本神户大学、中国复旦大学等国内外顶级高校的高级管理人才和专业技术人才。现有员工中博士、硕士研究生占50%。

公司将紧紧抓住我国医疗卫生体制改革不断深入这个机遇，转变观念、与时俱进，不断加大投资力度，拓宽主营业务，以雄厚的资本投入与先进的管理模式相结合，以拓展连锁化与集团化的医疗投资项目，以达到建设具有现代化一流服务水平的新颖医疗机构，以适应人们对健康保健不断提高的需求。

公司将为参与推动我国医疗卫生事业的发展、创建美好的未来而拼搏。

Liaoning Biomedical Materials R&D Center Co., Ltd辽宁生物医学材料研发中心有限公司

Booth Number: A039

地址：辽宁省大连市金州区光明街道汉正路8-11号 Address: No.8-11 Hanzheng Road, Guangming Street, Jinzhou District, Dalian, Liaoning Province 116100 Contact Email: [email protected]

Liaoning Biomedical Materials R&D Center Co., Ltd (LBC) is a company specializes in developing, producing and marketing of the third class medical devices including interventional cardiology stents and etc. As the Chinese demonstration Base of Industrialization in coronary stent sector and national high-tech enterprise, LBC invented and developed the very first Polymer-free microporous DES worldwide, which was offered the Certificate of Patent of Invention of China. The micropore drug eluting technology is a ground-breaking innovation both domestic and worldwide. LBC undertook the NKTRDP during the 10th Five-year Plan period, National Technology Innovation Funds, national high-tech model projects to demonstrate their commercial viability, National S&T Support Project during the 11th and 12th Five-year Plan, State 863 project, and other 30 national, provincial, and municipal S&T planned project, obtained 10 national patents, proprietary Yinyi® metal stent system, Yinyi® Polymer-free microporous drug-eluting coronary stent system, Yinyi® PTCA dilation balloon, Yinyi® intervention guide catheter and etc, has become one of the most productive innovators in Chinese intervention medical device sector. There have been accumulatively more than 120 thousands of Yinyi® stents implanted into patients’ chests, and saved their lives and families.

The Company has established Technical Expertise Committee and Management Planning Committee which have attracted famous experts from domestic and abroad such as Stanford University, Japanese Kanazawa University, Korean Yonsei University, Tsinghua University, Chinese Academy

of Sciences, Dalian University and etc.

LBC was also recognised as National High-tech Enterprise and the fifth group of national innovative trial enterprise, had funded the Liaoning Enterprise Post-doctor Workstation, and Liaoning Enterprise Technology center. Yinyi® Polymer-free DES developed independently by LBC has been recognized "a new record" of self-dependent innovation since the 11th five-year plan launched, and has won the first prize of Dalian Tech-innovation.

SINO Medical Sciences Technology Inc.赛诺医疗科学技术有限公司

Booth Number: A045

地址：天津开发区第四大街5号泰达生物医药研发大厦 B区2层 Address: 2nd Floor, TEDA Biopharm Res, Building B, 300457 Contact Email: [email protected]

SINO Medical Sciences Technology Inc is engaged in R&D, production and sales of class III interventional medical devices. Established by Dr. Jianhua Sun, who received his Ph.D. in the United States. The company was established in China's Tianjin Economic Development Area (TEDA) in Sept.

2007 with a registered capital of USD 30 million. The shareholders consist of founders and world renown international institutional investors. In the current 2300 m² R&D and production base, there are 1000 m² of Class 10,000 cleanroom equipped with more than 50 million RMB of world class R&D, production and testing equipment. Top talents are hired in R&D, production, quality management and marketing & sales.

In the concept of self-oriented innovation, the company produces safer and more effective products through innovative product design and manufacturing process according to clinical needs while respecting precedent and related scientific advancement worldwide.

The new generation of biodegradable drug coating coronary stent system (trade mark: BuMA™) developed by the company is the first domestic novel drug eluting coronary stent—not simply a mimic of imported products. The product achieved original innovation through international cooperation and is a global market leader in solving the safety problems of the 1st gen DES products. The BuMA™ stent has been awarded 4 international patents plus 7 domestic Chinese patents. The product obtained market approval from SFDA in Dec. 2010.

The company persists in self-oriented innovation, commitment to quality and enterprise internationalization, striving to promote the development of China's medical intervention industry, to build a "Created-in-China" brand and expand its global impact.



212

Medfavour (Beijing) Medical Co., Ltd万瑞飞鸿（北京）医疗器材有限公司

Booth Number: A071

地址：北京市朝阳区光华路9号世贸天阶时尚大厦C座14层1402室 Address: F14, Trends tower, Block C, The place, NO.9, GuanghuaRoad, Chaoyang District, Beijing, China Contact Email: [email protected]

General Introduction

Medfavour (Beijing) Medical Co., Ltd was founded in Beijing in 2005. The company is composed of experienced marketing and sales department, administrative department, financial department and human resource department. We determine to become the leading manufacturers and suppliers of medical devices in the field of interventional therapy. As one of the high-tech companies in Beijing, we have a number of patents of independent intellectual property rights. In the future, we will devote ourselves to the field of implanted medical devices, interventional macromolecule devices, research of interventional medical devices and biopreparate.

Technology

We cooperate with several American medical equipment R&D institutions to research and develop coronary interventional products, and created a biomedical materials cooperative laboratory with Tsinghua University. We have perfect physical，chemical and biological quality testing R&D centers. The manufacturing environment is in the class 10000 cleanroom and 100 cleanroom which have been certified by the government. The main manufacture and R&D testing equipments are all provided by world famous suppliers.

Our Credo

We will forever devote ourselves to creating an admired company by people

St. Jude Medical圣犹达医疗用品（上海）有限公司

Booth Number: A075

地址：上海市徐汇区中山南二路1089号徐汇苑大厦20楼 Address: 20th floor, Xuhuiyuan Mansion, No. 1089, 2nd South Zhongshan Road, Xuhui District Shanghai 200030 Contact Email: [email protected]

圣犹达医疗 (St. Jude Medical) 成立于1976年，总部位于被称为医疗科技之都的美国明尼苏达圣保罗市 (St. Paul Minnesota)。三十余年来，通过自主创新以及战略并购，从单纯的心脏瓣膜生产商发展成一个为众多专业医疗领域提供综合解决方案的领先的国际化专业公司。目前，我们的研发、生产和服务专注于心脏节律管理、心脏电生理、心脏外科、心血管介入诊疗和神经调控五大领域。我们的产品包括：心脏起搏器、ICD、CRT/D、电生理三维标测系统、消融及诊断导管、人工心脏瓣膜及修补产品、血管封合器、FFR压力导丝、OCT以及神经刺激仪等。2010年营业额达51亿美金的圣犹达医疗目前在全球拥有20多处执行和制造机构，13,000多名员工为100多个国家的客户提供优质的产品和服务，帮助全球治疗心脏病、神经疾病和慢性疼痛的医生提高治疗的掌控能力，致力于

通过全方位降低可能的医疗风险来提高医疗实践水平，同时为每一位患者的良好预后作出贡献。

Eastern Enterprise Corporation北京恒润泰医药科技有限公司

Booth Number: A079

地址：北京市西城区西直门南大街2号成铭大厦A座8层G室 Address: ROOM A8G BUILDING A, CHENGMING PLAZA, NO. 2 XIZHIMEN SOUTH STREET, XICHENG DISTRICT 100035 Contact Email: [email protected]

In September 1994，together with Beijing Tongmaofuchen Trading Co. (Commercial agent of Hakko Medical), EEC introduced PCA pump by Go Medical (Australia) into the Chinese market; the product has been selling for over 12 years now. In 1999, EEC obtained authority to distribute Pall U.S. and 3M of their products such as electrode, dressing, etc in Beijing area; In 2003, EEC became the distributor of TYCO (U.S.A) urinary catheter and radiology products in Beijing area. In 2006, EEC became the sole distributor of Clarus SHIKANI Intubation Scope series in China. In the same year, EEC established the cooperation with PAJUNK Germany and became its commercial agent of its medical products in mainland China. In 2009, EEC became exclusive distributor of Medikit Co., Japan of Supercath 5 I.V. catheter.

MAQUET (Shanghai) Medical Equipment Co., Ltd迈柯唯(上海)医疗设备有限公司

Booth Number: A080

地址：上海市临虹路128弄3号, Address: No.3, Lane 128, Lin Hong Road, Shanghai 200335 Contact Email: [email protected]

The MAQUET Group is the global market leader for Medical Systems, focusing on the Operating Room (OR) and Intensive Care Unit (ICU). The integrated products of MAQUET are specially designed to deliver the best medical treatment within acute care hospitals.

MAQUET provides innovative medical solutions from three Divisions:

Cardiovascular for cardiac surgery, vascular surgery, perfusion, life support equipment and disposables.

Critical Care for ventilation therapy and patient monitoring.

Surgical Workplaces for OR tables, OR lights, ceiling service units and complete OR theatres.

MAQUET (Shanghai) Medical Equipment Co., Ltd is the Foreign Direct Investment Company of MAQUET Group in China which rapidly growing with the China economic development from year 2003. MAQUET China bring the China Market with the consistently high quality products and local technical service.



213

OrbusNeich深圳业聚实业有限公司

Booth Number: A096/A149

地址：北京市东城区朝阳门北大街8号富华大厦F座507 Address: F-507, Fuhua Mansion, No.8 North Chaoyangmen Street,Dongcheng District, Beijin 100027 Contact Email: [email protected]

OrbusNeich是一家设计、研发、生产、销售心血管介入产品的公司。OrbusNeich 前身是Cordis-Neich、Neich Medical和Orbus MT，从事心血管领域的医疗产品服务三十余年，在亚太地区的医疗界享有盛誉。Neich国际公司于1979年成立于香港，2005年初，Neich并购了其长期的合作伙伴——总部设在美国弗罗里达州的Orbus医疗科技公司。并购后公司名称改为OrbusNeich医疗器械公司。作为一家全球性的公司，OrbusNeich公司总部设立在香港，在美国和中国设有研发（R & D）中心，中国和荷兰的工厂是OrbusNeich的主要生产基地，在香港和荷兰建立有物流和分销中心。 2000年5月，在中国深圳市福田保税区内成立了业聚医疗器械(深圳)有限公司，从事介入性心血管领域医疗产品的研制和生产。并已获得ISO9001 2000、ISO13485 2003、GB/T19001 2000及YY/T0287 2003质量体系认证。目前OrbusNeich公司自行研发和生产了十几种型号齐全的心脏介入治疗用产品，主要包括Genous生物工程R支架，一种首次应用固定在支架上的抗体捕获患者体内的内皮祖细胞，从而加速血管自然修复过程的新技术。其他产品还包括有Azule钴铬合金支架系统、Sapphire、Sapphrie II冠脉球囊扩张导管，Sapphire NC耐高压冠脉球囊扩张导管， Scoreflex 双导丝冠脉球囊扩张导管等。

Bayer Healthcare Company Ltd.拜耳医药保健有限公司

Booth Number: A097

地址：北京市朝阳区东三环北路27号拜耳中心 Address: Bayer Center, No. 27 Dong San Huan North Road 100020 Contact Email: [email protected]

The Company combines the global activities of the divisions Animal Health, Pharmaceuticals, Consumer Care and Medical Care. More than 50,000 people are employed by Bayer HealthCare worldwide.

Our aim is to discover and manufacture innovative products that will improve human and animal health worldwide. Our products enhance well-being and quality of life by diagnosing, preventing and treating disease.

• Sales 2012: 18,612 Euro million

• Workforce: 55,300 worldwide

• Operating profit 2012: 2,154 Euro million

• Headquarters: Leverkusen, Germany

Mavig GmbH

Booth Number: A100

Address: Stahlgruberring 5, 81829 Munich, Germany Contact Email: [email protected]

MAVIG 从成立到现在已有90年的历史，他优质的产品一直被同行一路追赶，但从未被超越。客户遍及五大洲，世界范围内销量持

续走高。

MAVIG公司拥有独立成熟的研发团队，外加现代化的生产工艺，这一切都保证了MAVIG公司生产的所有产品均具有高质量，高可靠性，高安全性的特质。

我们制定了国际化的标准，并配以独有的专门针对医疗行业的智能化解决方案。我们的全部产品是在德国慕尼黑工厂进行生产加工，每一件产品都经过最严格的质量控制，同时保证最先进，最尖端的科学技术设计到产品中。

客户对我们产品的认可，给予了我们极大的鼓舞，使得我们信心百倍、激情无限、毫无保留地投入到新产品、新技术的研发和创新之中。我们致力于回报给客户以更好、更新、更完美的医疗产品。

质量：我们承诺，我们履行

MAVIG公司获得欧盟DIN EN13485认证。同时，所有出厂的产品都符合适用的CE 标准：EU Directive 89/686/EU (个人防护设备)和或者针对医疗产品的93/42/EU。

迄今为止，MAVIG公司做为医疗行业中射线防护领域的领军人物，早在1995年我们所有防护服都是根据CE的要求进行加工生产，并获得了认证机构的审核批准。

Abbott Medical Devices Trading (Shanghai) Co., Ltd.雅培医疗器械贸易（上海）有限公司

Booth Number: A121

地址：上海浦东新区世纪大道8号，上海国金中心2期12楼 Address: 12th Floor, Phase II Shanghai IFC, No.8 Century Avenue 200120 Contact Email: [email protected]

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. Abbott has been operating in China for nearly 20 years and provides Chinese consumers with a diverse range of nutrition, pharmaceutical and medical products. Abbott has more than 4,000 employees in China and is headquartered in Shanghai.

Abbott Vascular, a division of Abbott, is a global leader in cardiac and vascular care with market-leading products and an industry-leading pipeline. Headquartered in Northern California, we are committed to advancing patient care by transforming the treatment of vascular disease through medical device innovations, investments in research and development, and physician training and education.

雅培是一家全球领先的多元化医疗保健公司，致力于药品和医疗产品的研发、生产和销售，主要业务涉及营养品、器械和诊断设备等。雅培在中国开展业务近20年，为中国消费者提供各种营养品、药品和医疗产品。雅培中国总部位于上海，在华拥有4,000多名员工。

雅培血管仪器部作为雅培业务部门之一，拥有市场领先的产品，是全球心脏和血管护理的领导者和行业翘楚。雅培血管仪器总部位于美国加利福尼亚州北部，致力于通过创新的医疗设备、持续的研发投入以及医务人员的培训与教育来转变心血管疾病的治疗方式，为患者带来先进的诊疗体验。



214

Shanghai Microport Medical(Group)Co., Ltd上海微创医疗器械（集团）有限公司

Booth Number: A126

地址：上海市浦东区张江高科技园区牛顿路501号 Address: 501New Rd.ZJ Hi-Tech Park Shanghai 201203 Contact Email: [email protected]

微创医疗科学有限公司（HK00853）起源于1998年5月在上海张江高科技园区成立的微创医疗器械（上海）有限公司（现已更名为上海微创医疗器械（集团）有限公司），为中国领先的高端医疗器械集团，旗下包括上海微创生命科技有限公司、上海微创骨科医疗科技有限公司、上海微创电生理医疗科技有限公司、微创心脉医疗科技（上海）有限公司、微创神通医疗科技（上海）有限公司、上海微创手术器材有限公司等多家全资子公司。

集团始终以创建“一个属于患者和医生的品牌”为己任，业务主要覆盖心血管介入产品、骨科医疗器械、糖尿病及内分泌医疗器械、电生理医疗器械、大动脉及外周血管介入产品、神经介入产品、外科手术等十大领域。

微创的产品于中国有逾1,200家医院使用，部分产品出口至中国境外的20多个国家，覆盖了亚太地区、南美及欧洲等市场的1,000多家医院。平均每30秒左右，就有一个微创产品在全球的某一个地方用于救治患者的生命或改善其生活品质。微创医疗坚持以人为本，致力于在微创伤介入医学领域建设属于中华民族的世界级医疗集团。

Lepu Medical Technology (Beijing) Co., Ltd乐普（北京）医疗器械股份有限公司

Booth Number: A130

地址：北京市昌平科技园区超前路37号7号楼15层 Address: Beijing changping science park chaoqian road no. 37 15 7th floor layer 102200 Contact Email: [email protected]

乐普（北京）医疗器械股份有限公司成立于1999年，2009年10月在深圳证券交易所A股创业板上市，证券代码300003。乐普医疗现已发展成为研发、生产心脏病植介入诊疗、药品、器械及设备的专业化高科技产业集团。

乐普医疗正在与旗下的八家国内外子公司共同努力，力求将乐普医疗打造成为国内领先、国际一流的“高技术、高疗效、高性价比”的高端医疗器械及诊疗设备研发企业集团，真正创立中国医疗器械产品的民族品牌，进一步打破国外垄断，降低医疗费用，让更多患者及时、有效、安全得到先进医疗技术进步带来的益处。

AstraZeneca阿斯利康（无锡）贸易有限公司

Booth Number: A135

地址：上海浦东张江高科技园区亮景路199号 Address: 199 Liangjing Road ,Zhangjiang Hi-Tech Park,Shanghai, China 201203 Contact Email: [email protected]

AstraZeneca is a global innovation-driven biopharmaceutical company specialising in the discovery, development, manufacturing and marketing of prescription medicines that make a meaningful difference in healthcare.

Science and patients are at the heart of everything we do, and our skills and resources are concentrated on those therapy areas where we believe we can make the most difference. We focus primarily on cancer, cardiovascular, diabetes/metabolism and respiratory/inflammation/autoimmunity. Alongside this, we remain active in infection and neuroscience with targeted investments in opportunities and collaborations。

Our business strategy sets out our path to success in delivering great medicines to patients through innovative science and global excellence in development and commercialisation.

Our more than 50,000 employees work continuously to make a meaningful difference in patient lives through our great medicines. Our global headquarters is in London, UK and will move to Cambridge, UK in 2016. We work in over 100 countries, and our medicines are used by millions of patients worldwide. We conduct research across three continents, and we invest over $4 billion every year in the discovery and development of the next generation of innovative medicines that target unmet needs. We manufacture in 16 countries and are committed to ensuring a reliable supply of medicines where and when they are needed.

Essen Technology（Beijing）Co., Ltd.易生科技（北京）有限公司

Booth Number: A139

地址：北京市海淀区上地西路8号上地科技大厦4号楼9层 Address: 9th Floor,shangdi Sci-tech Tower 8 Shangdi West Road, Haidian District Beijng 100085 Contact Email: [email protected]

易生科技（北京）有限公司坐落于中关村科技园区，拥有国际一流的研发和生产设施。公司是一家专业从事新型微创介入医疗器械的研发、生产、销售及技术支持的中美合资高新技术企业。

公司自主研发的爱立Tivoli药物洗脱冠脉支架系统，拥有多项核心自主知识产权，采用当今世界公认的领先技术，是全球第一个钴铬合金与完全降解药物涂层结合的产品，解决了药物涂层不能完全降解的技术难题，可大幅提高支架的机械性能、生物相容性、药物控释性能，是针对目前支架备受关注的晚期血栓问题而研发的首个第三代药物支架。爱立Tivoli药物洗脱冠脉支架系统，已经取得国家药监局颁发的注册许可证，成为全球第一个面世的第三代药物支架。



215

Icirculation国际循环

Booth Number: A161

地址：北京市朝阳区朝阳门北大街乙12号天辰大厦1409室 Address: Room 1409 Building 1 TimesonTower,No.12 Yi Chaoyangmen North Avenue, Chaoyang District, Beijing, P.R 100020 Contact Email: [email protected]

《国际循环》是“国际系列医学专科报刊”旗下专门服务于全国心血管领域医学专业人士的报刊，秉承“同步传真国际循环进展”的办刊方针，以循证医学理念为指导思想，致力于为心血管领域临床、教研人员搭建一座与国际接轨的桥梁。《国际循环》为全四色印刷品，月刊，其中根据国内外心血管领域专科大会出版特刊（例如：ACC/CIT/ESC/TCT/AHA/GWICC特刊），全年共出版12期以上。《国际循环》能切实满足医学专业人士了解国际心血管及相关领域最新进展的迫切需求，并对从事心血管专业的临床医生具有极高的参考价值。自2004年创刊以来，《国际循环》在业界已颇具知名度，得到心血管专家和广大临床医生的大力支持和充分认可。

1.《国际循环》强调时效性、实用性、权威性并举，及时介绍国内外心血管病学在科研及临床方面的新进展，传播新观点、新技术。

2.《国际循环》近年来对国内外心血管领域重要事件（包括医学会议）极具时效性的现场报道和热点分析得到广大临床医生的高度认可与喜爱，两百余名国内外业内顶级专家编委的参与进一步提升了报道内容的国际先进性与学术权威性，同时对焦点问题及国内外大型临床研究、诊疗指南的深入讨论和点评增强了对一线医生的临床指导性。

3.国际循环网（www.icirculation.com）及其手机版（m.icirculation.com）与《国际循环》报刊相得益彰，通过互联网和多媒体技术相结合的方式即时传递国际循环最新进展，网站实名注册会员持续增加。网站每周向会员邮箱发送电子期刊，呈送最新精彩内容。

4.《国际循环》手机报使用手机彩信这一便捷传媒形式，拥有多个栏目，内容丰富而凝练，兼具专业性和时效性，不定期向广大国际循环网注册用户及时发送心血管前沿学术信息，受到广泛欢迎。

5.《国际循环》iPad多媒体交互式电子报刊及其书架App于2013年1月正式上线，其文字内容基本与每期纸版报刊一致，继承了纸媒报刊精美的版式风格而又独具电子杂志特色，同时添加了大量视音频、图片、幻灯、网页超链接和交互式显示效果，成为《国际循环》新媒体平台中最具"阅读魅力"的一员！

6.《国际循环》微信公众平台采用当今最流行的移动互联网社交媒体形式，每日更新精选的深度报道、文章及时讯，栏目设置丰富多彩，配合优化的多媒体展示策略，关注用户（订阅者）急速攀升，已成为《国际循环》传媒平台中最便捷、最具互动性的排头尖兵！

7.《国际循环》始终致力于为业内专家、广大读者和相关客户提供最优质的专业医学传媒服务，携手为中国医疗健康事业的进步做出应有贡献！

编审阵容顶级权威 ——两百余名国内外循环领域精英专家坐镇，确保权威优质

会议一线全景报道 ——记者亲赴会议现场获取第一手资讯，对话国际知名专家

学术进展时刻更新 ——密切跟踪介绍循环及相关领域中的最新科研及临床进展

热点难点深入解析 ——挖掘最热门、最受关注的议题，辨析解读指导临床实践

报纸网站交相辉映 ——满足传统阅读、资讯时效、多媒体、互动性等多方需求

手机媒体新兴平台 ——彩信联袂移动网络，更便捷、更及时，互动有奖促交流

iPad阅读鼎力巨献 ——开创医学传媒新时代，享受多媒体交互式专业阅读乐趣

微信微博精彩每天 ——微信时代全民参与，音视图文尽在掌握，不断超乎想象

希望我们的用心和努力能为您带来阅读的快乐！您的关注与支持就是我们不断进取的巨大动力！

ENCORE SEOUL

Booth Number: A162

Address: 93-45 #701 Rohas Tower, Sangsu-dong, Mapo-gu, Seoul Korea Contact Email: [email protected]

The ENCORE SEOUL Symposium is a live demonstration course focused on interventional vascular therapeutics including coronary, peripheral, and neurovascular. The purpose of symposium is to update the knowledge and skills of interventional cardiologists, gegeral cardiologists, other medical doctors, nurses, and technicians whom are dedicated to the treatment and care of patients with cardiovascular disease through endovascular intervention procedures. We anticipate more than 2,000 participants to attend this year's symposium all around the world. Live course demonstration are the focus of this meeting with carefully chosen cases meant to characterize update treatment modalities and future prospects.

CCT

Booth Number: A163

Address: 1-1-5-2E, Maedaminami-machi,, Toyohashi, Aichi 440-0851 Japan Contact Email: [email protected]

Complex Cardiovascular Therapeutics (CCT) is a live course that masters complex PCI and CCT2014 will be held from October 30 to November 1, 2014 in Kobe, Japan.

This year, CCT reaches its 14th year. As a result of increase in participants from overseas in addition to chief participants from Japan, we have grown as one of the biggest live courses in Asia, counting over 4,000 participants.

We established the Peripheral course last year, and distributed EVT live case transmissions. Additionally, the surgical course which was unable to hold last year will be back this year, and along with the Co-medical course, we will provide opportunities for everyone attending CCT to learn from their own standpoint. In live demonstrations, we would like to make the presentation on how to tackle with complication cases with the supreme techniques in which Japan takes pride. In hope of being connected to further development in the cardiovascular field, we would like you to experience the challenge of CCT by visiting Kobe in autumn.



216

ACIST Medical Systems

Booth Number: A164

Address: Renier Nafzgerstraat 114, Maastricht 6221 KL Netherlands Contact Email: [email protected]

ACIST® Medical Systems, a Bracco Group company, develops advanced contrast injection technologies that help simplify the complexities of the cardiac cath lab, hybrid operating room and radiology suite.

The ACIST CVi® contrast delivery system simplifies contrast injection for all procedures by giving physicians control over the full range of injection volumes– from small injections in the coronary arteries to large volume injections in the ventricles, aorta and peripheral vasculature – while enhancing safety, efficiency, control and image quality.

The ACIST CVi has become a core technology in cath labs throughout the world where it has been used to diagnose and treat more than 12 million patients in 45 countries.

Shanghai Bracco Sine Pharmaceutical Corp. Ltd.上海博莱科信谊药业有限责任公司

Booth Number: A165

地址：上海市黄浦区延安东路700号港泰广场604室 Address: Room 604, Gangtai Plaza, No. 700 Yan'An East Road, Shanghai 200001 Contact Email: [email protected]

Shanghai Bracco Sine Pharmaceutical Corp. Ltd. was established in December 2001, by an Italian Group (Bracco S.p.A.) who controls 70% of stake and a Chinese Group (Sine Laboratories) for the production and sales of contrast media for the diagnostic imaging. The registered capital of the Joint Venture is US$10,330,000. Meanwhile the total investment can reach as far as US$16,660,000. The production and sales is currently focused on: non-ionic contrast media for X-ray radiology; contrast media for magnetic resonance; contrast media for Ultrasound. Products are sold in China Mainland, Hong Kong and Macau.

Sano� (China) Investment Co., Ltd赛诺菲（中国）投资有限公司

Booth Number: A171

地址：上海市静安区延安中路1228号嘉里中心3期19楼

Address: 19F Tower III, Kerry Centre 1228 Yan'an Road, Jing An District, Shanghai, China


赛诺菲是一家全球领先的多元化医药健康企业，以患者需求为本，研究、开发并推广创新的治疗方案。赛诺菲在七大增长平台拥有核心优势：糖尿病综合管理、人用疫苗、创新药物、健康药业、新兴市场、动物保健和罕见病（健赞）。2012年，赛诺菲净销售额达349.47亿欧元。

赛诺菲一直以来秉承对中国的承诺。30年前，赛诺菲在中国开设办事处，跻身首批进入中国的跨国制药企业。赛诺菲目前在中国拥有7000名员工，是国内增长最快的医药健康企业之一。赛诺菲在中国的总部位于

上海，并在北京、天津、沈阳、济南、上海、杭州、南京、武汉、成都、广州和乌鲁木齐共设11家区域办公室。

多元化的医药健康企业

●处方药：赛诺菲在心血管疾病、糖尿病、肿瘤、中枢神经系统疾病、内科疾病和生物外科等领域拥有创新的产品，专注患者需求，全方位满足中国公共卫生需求。

●疫苗：赛诺菲旗下疫苗事业部赛诺菲巴斯德是世界领先的疫苗生产企业。赛诺菲巴斯德在预防流感、肺炎和儿童疾病等领域拥有创新的疫苗产品，积极参与并推进中国预防免疫事业的发展。

●健康药业：2010年10月，赛诺菲与民生药业集团共同组建杭州赛诺菲民生健康药业有限公司，赛诺菲在合资公司中占多数股权。2011年2月，赛诺菲完成了对BMP太阳石的收购，一举成为中国领先的健康药业企业，并在维生素矿物质补充品和感冒咳嗽两大健康药业细分市场中占据强势地位。

●罕见病：健赞（Genzyme）是世界领先的生物科技公司之一，也是全球罕见病领域的领导者。2011年，健赞成为赛诺菲集团旗下的子公司。健赞在中国通过连续14年的慈善援助帮助131位戈谢氏病人获得新生，并自2006年起通过积极推进罕见病政策来提高中国罕见病患者的药物可及性，矢志不渝地推进中国罕见病事业的发展。

●动物保健：梅里亚（Merial）是赛诺菲集团的动物保健部，领先全球动物保健行业。梅里亚目前在中国拥有三家合资企业和一家贸易公司，主要生产和销售家禽疫苗产品，用于防治感染肉鸡和蛋鸡的各种疾病，并提供相关的免疫器械与免疫配套服务。同时，梅里亚的猪和宠物的进口疫苗和化药产品也是国内兽医师和专业人士广为推荐的品牌。

大幅投资工业建设，满足中国市场需求

赛诺菲目前在中国拥有七家生产基地，包括北京制药工厂、杭州制药工厂、杭州赛诺菲民生健康药业工厂、南昌梅里亚动物保健工厂、深圳赛诺菲巴斯德疫苗工厂、唐山健康药业工厂以及南京梅里亚动物保健工厂。

完善的研发架构，双赢的研发合作模式

在中国，赛诺菲具有从药物靶点发现到后期临床研究的整体研发实力。集团在上海设有中国研发中心和亚太研发中心，并在北京和成都分别设有研发机构。自2008年以来，赛诺菲与中国权威科研机构开展了30余项战略合作，在癌症、干细胞、糖尿病和老年疾病等前沿研究领域探索创新药物。

如需了解更多信息，请访问 www.sanofi.cn



217

Terumo Medical （Shanghai）Co., Ltd.泰尔茂医疗产品（上海）有限公司

Booth Number: A176

地址：北京市朝阳区建外大街2号PICC大厦801-805 Address: Chaoyang District, Beijing, China,PICC Building, Room 801,805 100022 Contact Email: [email protected]

Terumo Corporation was founded by the famous physician KITASATO SHIBASABURO in 1921. At the beginning，Terumo was dedicated to produce thermometer. After nearly a century of development, our products have already covered by medical consumables, blood management system, angiography and treatment of catheter, cardiovascular systems, medical electronics, etc.

Terumo Corporation has a number of factories such as Kofu Factory, Fujimiya Factory, Ashitaka Factory in Japan, and many overseas factories in the US, and Europe. We also have Terumo Medical Products of Hangzhou Co., Ltd. and Changchun Terumo Medical Products Co., Ltd. in China. All plants have obtained the certificates of ISO13485 quality system, European CE, US FDA and other international certifications.

The medical products of Terumo are exported to more than 150 countries and regions around the world. In the future, we will join hands with the excellent enterprises of China to exploit our advantages of advanced medical technology and experience, and develop new products and technologies. These products and technologies will not only be put into China market but also overseas market through the international operation system of our company.

Contributing to society through healthcare. This is the most important mission and principle of Terumo. Terumo had been sticking to this principle ever since its foundation 90 years ago, and will insist on making more and more efforts to contribute for human health.

In the future, Terumo will cherish the corporate commitment of Contribute to society through healthcare, push World Medical Environment forward and readily to face challenges.

Medtronic (Shanghai) Management Co., Ltd.美敦力(上海)管理有限公司

Booth Number: A186

地址：上海浦东龙东大道3000号11号楼 Address: Block 11, No. 3000 Long Dong Avenue, Pudong, Shanghai 201203, P.R.China 201203 Contact Email: [email protected]

Medtronic was co-founded by an electrical engineer who used medical technology to help a cardiologist keep his open-heart surgery patients alive. Ever since, we've been using our deep understanding of human physiology to create life-changing therapies that help people with chronic diseases.

We take our role in changing healthcare very seriously. We assume full responsibility to ensure patient safety and ethical behavior in all our work.

Our goal is to make everyone who touches Medtronic feel welcome and respected. Our culture of inclusion has many facets.

Our Mission calls on us to maintain good citizenship. We do this through Medtronic Foundation grants, product donations, employee volunteerism, and meaningful partnerships with global organizations.

Our six major businesses focus their efforts around a condition or therapy type: Cardiac Rhythm Disease Management, Spinal and Biologics, CardioVascular, Neuromodulation, Diabetes, and Surgical Technologies. To ensure we leverage knowledge and best practices across all these diverse groups, we have several strategic corporate groups.

Our medical technologies help make it possible for millions of people to resume everyday activities, return to work, and live better, longer. We're able to do this with the help of some very special people around the world: 38,000 dedicated employees who share a passionate purpose to improve lives, thousands of medical professionals who share their insights and ideas, and hundreds of advocacy associations that help us share information so people with debilitating diseases know relief is possible.



218

BSC Int'l Medical Trading (Shanghai) Co., Ltd.波科国际医疗贸易（上海）有限公司

Booth Number: A193

地址：上海市黄浦区蒙自路763号新富港大厦31F Address: 31F, New Rich Port Center, No.763, Mengzi Road, Huangpu District, Shanghai 200023 200023 Contact Email: [email protected]

关于波士顿科学

波士顿科学公司承诺为生命而创新。我们致力于创新医疗解决方案，改善全球患者生活。三十多年来，波士顿科学始终引领全球医疗技术行业的发展，通过提供各种广泛的高性能医疗解决方案，满足广大患者亟待满足的需求，降低医疗保健成本。更多详细信息，请访问公司网站：www.bostonscientific.com.

关于波士顿科学在中国

波士顿科学于1997年在上海设立中国区总部，目前在北京、上海、广州设有分公司以及研发中心。公司核心业务范围涵盖心脏介入、心脏节律管理与电生理、内窥镜介入、外周及肿瘤介入、泌尿与妇女健康等。秉承创新引领者的传统，通过提供预防、诊断、治疗等高品质的医疗产品及服务，波士顿科学致力于成为一家最具创新活力、最贴近中国医患需求的国际医疗科技公司。更多详细信息，请访问公司网站： www.bostonscientific.cn

About Boston Scientific

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com.

About Boston Scientific in China

Boston Scientific established its China headquarters in Shanghai in 1997 and now has branches and R&D centers in Beijing, Shanghai and Guangzhou. Core Boston Scientific businesses in China include cardiac intervention, cardiac rhythm management, endoscopic intervention, peripheral interventions and oncology and urology and women's health. As an R&D leader, the company provides high performance medical products and solutions for the prevention, diagnosis and treatment of assorted diseases and conditions. Boston Scientific strives to provide the most innovative global medical technology that is custom-tailored to fit the needs of Chinese patients. For more information, visit us at: www.bostonscientific.cn

GE Medical System Trade and Development（Shanghai）Co., Ltd通用电气医疗系统贸易发展（上海）有限公司

Booth Number: A202

Address: BUILDING 1, NO.96 YIWEI ROAD, WAI GAO QIAO FREE TRADE ZONE, SHANGHAI, CHINA, 200131 Contact Email: [email protected]

About GE Healthcare

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems. Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries.

For more information about GE Healthcare, visit our website at www.gehealthcare.com

Beijing Kelida Medical Equipment Developing Co.Ltd.北京科利达医疗设备发展有限公司

Booth Number: A211

地址：北京市海淀区紫竹院路88号紫竹花园F606 Address: F606 Zizhu Garden No.88 Zizhuyuan Road Haidian Beijing China 100089 Contact Email: [email protected]

公司名称(英)Beijing Kelida Medical Equipment Developing Co.Ltd.

北京科利达医疗设备发展有限公司位于北京中关村科技园，是专业从事医疗设备研制、开发、生产和经营的高科技企业。北京科利达公司于1988年10月成立，公司自成立以来，一直致力于医用射线防护产品和防护系统、医学影像设备及附件的开发、生产和销售。公司长期与美国、德国专业医疗设备生产企业密切合作，引进国外的先进技术和材料，加工生产高技术、高品质的医疗用品提供给中国的广大医院。科利达公司以高质量的产品和优质的服务赢得了国内广大用户的信赖，使其产品在同行业中市场占有率遥遥领先。科利达射线防护系列产品达到国际标准，获得欧盟CE认证和美国FDA认证。科利达公司一直放眼全球市场的开拓，在海外市场，产品已销往欧洲，北美，中东，非洲和亚洲60多个国家和地区。



219

China Medical Tribune中国医学论坛报社

Booth Number: A212/A226

地址：北京市朝阳区将台路丽都饭店商业楼5号楼

Address: Business Building 5#, Metropark Lido Hotel,Jiangtai Rd., Chaoyang District,Beijing 100004


《中国医学论坛报》创刊于1983年7月10日，由中华人民共和国卫生部与美国Arthur. M.Sackler基金会合作创办。她是一份面向全国200万医师的专业性报纸。中国医学论坛报在2005年全国行业报纸质量检查中，获得了综合评比总分第一名、文字编校质量第二名的好成绩。国际领先的医药咨询公司（IMS）在2005年和2007年的中国医师专业报纸接触调查中，《中国医学论坛报》的读者阅读率均居医学专业报纸榜首。

CARDIOVASCULAR SUMMIT-TCTAP

Booth Number: A213

Address: 2F, Asan Institute for Education&Research, 388-1, Pungnap-2dong, Songpa-gu, Seoul 138-736 Korea Contact Email: [email protected]

CardioVascular Summit -TCTAP

TCTAP2014 will be held from April 22 to 25 in Seoul, Korea sponsored by CVRF.

CardioVascular Research Foundation (CVRF) is a non-profit organization dedicated to improving the lives of patients with cardiovascular disease. It organizes world-class educational meetings including CardioVascular Summit-TCTAP (April 22-25, 2014), TAVI SUMMIT (August 8-9, 2014), IMAGING&PHYSIOLOGY SUMMIT (December 5-6, 2014). It operates training program every monthly and conduct a large number of researches through Data Coordinating Center, QCA and IVUS Core Laboratories.

For more information, please visit our websites.

www.summit-tctap.com www.imaging-physiology.com www.taviconference.com www.cvrf.org

EuroPCR

Booth Number: A214

Address: 19, allées Jean Jaurès, 31 015 Toulouse cedex 6 FRANCE Contact Email: [email protected]

CCRF (Beijing) Inc.永铭诚道（北京）医学科技股份有限公司

Booth Number: A225

地址：北京市朝阳区工体北路世茂国际中心1号楼806室 Address: Shimao International Center Office Building One, Room 806 Gongti North Road,Chaoyang District,Beijing 100027 Contact Email: [email protected]

CCRF is leading full-services clinical research company based in Beijing China, specializing in medical devices, particularly in interventional cardiology related technologies and products. We are one of the major leaders in clinical trial management, data management, Core lab (QCA, IVUS and OCT), quality assurance, media writing, IT innovation and medial communication in the arena of medical devices in China. We are committed to providing efficient and quality clinical services to our clients, simultaneously improving patient care through strong partnership with participating medical institutions.

CCRF has an established history of partnering with global institutes in the area of clinical research and services since 2009, and pledges to deliver the highest quality services to our clients.

永铭诚道（北京）医学科技股份有限公司是中国心血管领域的领先临床全服务公司之一，核心业务为临床研究管理服务。目前，CCRF致力于在临床试验管理、数据管理、核心实验室（QCA、IVUS和OCT)、生物统计分析、IT创新等领域提供完整解决方案，鼎力为客户提供高效、高品质的专业化服务，与行业专家、行业伙伴建立了紧密的合作关系，与伙伴共谋发展，促进人类心血管健康。自从2009年，CCRF与美国几家著名研究组织建立战略伙伴关系，联手为国外客户投提供国际化的临床和核心实验室服务。

Shandong Rientech Medical Technology Co., Ltd.山东瑞安泰医疗技术有限公司

Booth Number: A228

地址：北京市海淀区中关村东路世界科贸大厦B座1505室 Address: Room 1505, Tower B, Tri-Tower Building, No.66 Zhongguancun East Road,Haidian District, Beijing, China 100190 Contact Email: [email protected]

山东瑞安泰医疗技术有限公司注册在山东齐河经济开发区，主要从事医疗器械产品的研发、生产和销售，属于国家级高新技术企业，现拥有21000m2标准厂区、10000 m2万级GMP净化车间、2300 m2研发中心和300 m2分析测试中心。资产15亿元，员工1000人，1个省级企业技术中心、1个省级生物医用材料改性工程技术研究中心，1个泰山学者特聘岗位，1个中国科学院院士工作站，公司是国家高技术产业化基地，具有自主知识产权的涂层可降解冠脉药物涂层支架历经7年研究取得SFDA注册证，完成产业化，已经成功将具有抗凝和抗菌功能的经外周中心静脉导管产业化，填补国内空白。企业被认定为省级创新试点企业和中国专利山东明星企业，申报专利30项，已授权专利13项，其中PCT国际发明专利1项，国家专利12项。



220

Venus MedTech（Hangzhou）Inc.杭州启明医疗器械有限公司

Booth Number: A231

地址：杭州市滨江区南环路3738号税友大厦201室 Address: Unit.201, Servyou Buliding, No.3738 Nanhuan Road, Binjiang District, Hangzhou, Zhejiang Province, PRC 310053 Contact Email: [email protected]

Venus Medtech (Hangzhou) Inc. (Simply Venus) is createdby a group of outstanding designers aspiring in the transcatheter heart valve implantation design with highly managing experiences since 2009.

Lifetech Scienti�c Corporation先健科技（深证）有限公司

Booth Number: A235

地址：深圳市南山区科技园北郎山二路赛霸科研楼1-5层 Address: Floor 1-5, Cybio electronic building, Langshan 2nd Street, North area of High-tech Park, Nanshan Dist 518000 Contact Email: [email protected]

Lifetech is a leading developer, manufacturer and vendor of advanced minimally invasive medical devices for cardiovascular and peripheral vascular diseases and disorders.

Lifetech was founded in 1999 and is now the second largest provider of congenital heart defect occluders in the world, the largest provider to BRIC countries and the leading developer and manufacturer of minimally invasive medical devices in China. In 2011, Lifetech was listed on the Hong Kong Stock Exchange. Lifetech has a broad portfolio of proprietary, minimally invasive cardiovascular and peripheral medical devices.

Lifetech is an accredited high-tech enterprise and a National Post-doctoral Research Workstation in China. As such, Lifetech has developed an experienced research and development team which works closely with reputable scientific advisers and experts as well as world-class institutions and universities. A big component of our success is the more than 12 government-sponsored research and development projects that we have been or are currently involved in. These include one research project with the China National Basic Research Program, two research projects with the China National High-Tech Research and Development Program, and two research projects co-sponsored by the Guangdong province and the Ministry of Education of the PRC.

Lifetech Scientific Corporation is located in Shenzhen and has over 10 subsidiaries, branches and sales offices in Shenzhen, Beijing, Shanghai, Guangzhou, Hong Kong and India. A distribution network of 150 international distributors has also been established for all products.

Philips Healthcare飞利浦医疗保健

Booth Number: A266

地址：北京朝阳区光华路9号,世贸天阶大厦9层 Address: 9F., The Place Tower, No.9, Guanghua Road, Chaoyang District, Beijing. 100020 Contact Email: [email protected]

Philips is among the top three in the healthcare technology market. Philips' current activities can be divided in four businesses: Imaging Systems, Patient Care and Clinical Informatics, Customer Services and Home Healthcare. Philips is unique in its approach to healthcare because we start by looking at the people—patients and care providers—not the technology. Through gaining insights into how patients and clinicians experience healthcare, we are able to identify larger market and clinical needs. In response we can develop more intuitive, more affordable, and in the end better technology solutions to help take some of the complexity out of healthcare. This helps to drive better diagnosis, more appropriate treatment planning, faster patient recovery and long term health. At Philips, we try to simplify healthcare through combining our unique clinical expertise with human insights to develop innovations that ultimately help to improve the quality of people's lives. With a growing presence in cardiology, oncology, and women's health, we focus on the fundamental health problems with which people are confronted, such as congestive heart failure, lung and breast cancers and coronary artery disease. Our focus is to deliver value throughout the complete cycle of care: from disease prevention to screening and diagnosis through to treatment, monitoring and health management. Philips is dedicated to making an impact wherever care happens, within the hospital - critical care, emergency care and surgery – and, as importantly, in the home.

Johnson & Johnson Medical （Shanghai）Ltd.强生（上海）医疗器械有限公司

Booth Number: A268

地址：上海市虹桥路355号城开国际大厦4楼 Address: 4F ChengKai International Plaza, No 355, Hong Qiao Road. 200030 Contact Email: [email protected]

Founded in 1994, Johnson & Johnson Medical (Shanghai) Ltd. is a wholly foreign owned enterprise of Johnson & Johnson in China and the first domestic medical equipment company which has obtained two authoritative certifications at the same time, namely the ISO13485 Quality System and YY/TO288 Special Medical Equipment Application Standards. Mainly engaged in production and sales of the advanced medical equipment of Johnson & Johnson, it has become a leading company in a variety of fields including cardiovascular and cerebrovascular diseases, orthopedics, suture, minimally invasive surgery, women health, clinical diagnosis, diabetes, sterilization, etc.

While introducing the most advanced technology to China, the company also emphasizes the meticulous patient education and a multitude of professional trainings. These efforts will help boost the advancement of country's development in the area of medical services, and make Johnson & Johnson Medical the country's most trusted medical partner.



221

The core values of Johnson & Johnson are clearly established in Our Credos. In order to produce high quality products and run numerous highly valuable health education and corporate social responsibilities projects, the company will support all carers out there to ensure that the quality of health and life among Chinese families significantly improves.

Cordis Corporation is one of the most respected names in global interventional medical devices – and a company trusted by healthcare professionals for comprehensive solutions that achieve better healthcare results. Cordis reputation among physicians specialized in interventional procedures has been built by understanding the connections among products, services, and outcomes in cardiovascular, endovascular, and biliary duct (liver) treatments.

Biosense Webster is recognized worldwide as a leader in the science behind the diagnosis and treatment of cardiac arrhythmias.

25th GW-ICC | APHC 2014 | ICCPR 2014第二十五届长城国际心脏病学会议 | 亚太心脏心脏大会2014 | 国际心血管病预防与康复会议2014

Booth Number: A281

地址：北京市西城区西直门南大街11号科教楼0416室 Address: Room0416, Science & Education Building, No. 11 Xizhimen S. Ave. Beijing China 100044 Contact Email: [email protected]

The Great Wall International Congress of Cardiology (GW-ICC) was founded in 1990 and gradually developed from a rarely known academic training class into a promotion conference of PCI &CABC and from a simple technical exchange meeting into the largest and one of the most influential and successful comprehensive cardiovascular Congress with the most complete subject in the Asian-Pacific region.

Cherishing the principle of academic, openness, leadership, transmission and service, holding the great banner of public welfare, prevention, standardization and innovation the GW-ICC has developed an extensive academic exchange and tight cooperation with the most influential international medical Organizations and groups such as ACC, ESC, WHF, AHA, APHA, ASPC and IAS etc. Now the GW-ICC represents more than 10 thousand cardiology professionals from hospitals of all levels including many well-known experts or scholars all over the nation and has been committed itself in promoting in-depth exchange and extensive communication in the industry, cultivating professionals, bringing forth the outstanding figures and advancing together with the time and the whole world.

Nowadays the GW-ICC has developed into a multi-functional organization collecting the comprehensive function of international cooperation, knowledge promotion, professional training, academic exchange and cross over study together. What's more the GW-ICC has also undertaken the global strategic mission of propelling the prevention of cardiovascular disease, health promotion and health education and will strengthening medical research and disease control as well as boosting the development of the world cardiology industry the international community.

The 25th Great Wall International Congress of Cardiology Asia Pacific Heart Congress 2014 looking forward for your involvement in the Golden autumn of Beijing on 16-19 Oct 2014.

For more information, please visit our website at: www.gw-icc.org.

长城国际心脏病学会议（长城会）由胡大一教授、German Di Sciascio教授创始于1989年。经过24年的历程，“长城会”从初始的百人介入培训会发展为今天覆盖亚太、面向世界的万人盛会；从单一学科发展为涵盖心血管从基础到临床、融相关学科为一体的综合性学术大会；从单一医院主办发展为与国内外著名学会和机构联合主办；从独家医院手术直播到国内外十余家跨国手术演示；从传统的会议形式发展为在线网络会议、多媒体互动、数字化会议管理……及贯穿全年的东南西北中长城会，长城专题会议、百城巡讲、长城心先锋、长城GPS、境外联合办会等走遍中国、走向亚太、走向全世界的全媒体、国际化会议！

“长城会”引领了中国心血管病学事业的发展，见证了新概念、新技术引进与推广所取得的成就，加强并推动了国际间合作与交流，培养并推出了一批批学术骨干，带动了药械企业的发展……；如今，长城会、亚太心脏大会将致力于心血管病预防、康复、NCD防控等新兴事业，促进全人类健康事业的发展和进步！

2014年10月16-19日，第二十五届长城国际心脏病学会议|亚太心脏大会2014期待与您相会在金秋的北京！

关于更详细的信息，请参阅官方网站http://www.gw-icc.org。

2014Chinese Society of Cardiology Congress2014中国心血管病学年会

Booth Number: A282

地址：北京市东城区东四西大街42号 Address: No. 42 Dongsi Xidajie, Beijing 100710 Contact Email: [email protected]

As the most recognized cardiovascular association in China, CSC is composed of the academic leaders in the field of cardiovascular diseases across the country. CSC has done a lot of research and clinical work to assist the government health department on the prevention and treatment of cardiovascular disease, CSC has issued a series of guidelines and consensus on various cardiovascular diseases in recent years, which helps a lot on standardizing the treatment and promoting the prognosis on these diseases in China

MENTICE AB

Booth Number: A294

Address: Rm 615, CYTS Plaza,No.5 Dongzhimen St., Beijing 100007 China Contact Email: [email protected]



222

Merit Medical Beijing Co., Ltd麦瑞通医疗器械（北京）有限公司


地址：北京市朝阳区东大桥路9号侨福芳草地B座1503室 Address: 03-04, 15/F, Tower B, Parkview Green, No.9 Dongdaqiao Road,Chaoyang District, Beijing 100020, China 100020 Contact Email: [email protected]

麦瑞通医疗系统公司(Merit Medical System Inc)成立于1987年，是一家领先的医疗器械生产企业，生产心脏及放射介入手术中使用的器械。麦瑞通公司的产品线包括介入充盈装置及其附件、诊断和治疗性导管及导丝、一次性压力监测设备、造影剂管理系统、非血管性支架、溶栓导管及注射器和针具等。公司致力于通过产品研发及高品质生产，满足全球心脏病学和放射学专家的需求。为在诊断和介入治疗，包括血管造影术、血管成形术、支架置放术、椎间盘造影术、血栓溶解术等方面提供优良产品及服务。麦瑞通公司以产品创新，客户服务和产品质量闻名遐迩。其生产的压力泵及止血阀处于世界领先地位。

麦瑞通医疗器械(北京) 有限公司是麦瑞通医疗系统公司设在中国的总部。

PEROUSE MEDICAL (Shanghai) Co., Ltd贝鲁斯医疗器材（上海）有限公司

Booth Number: A297

地址：上海市浦东新区瑞庆路528号6幢501室 Address: No.528 Ruiqing Road, Building 6, Room 501,Z.J. East Area Hi-Tech Medical Park,Shanghai,China 201201 Contact Email: [email protected]

PEROUSE MEDICAL is a benchmark company in the international medical devices market.

Its offer, distinguished by the ability to combine technological performance, service, quality and product reliability, extends into four key fields: cardiovascular, oncology, interventional imaging and Business to Business.

The multi-disciplinary research and development teams and a unique technology portfolio enable PEROUSE MEDICAL to make all its technological expertise available to the practitioners and to the medical industry.

PEROUSE MEDICAL Interventional Imaging Division is specialized in innovating mini-invasive techniques.

It designs and manufactures devices for coronarography and angioplasty procedures.

The latest product launch in 2013 is the radial compression device named Seal One (precise adjustment and control of compression level, enhanced visibility of the puncture site, accessory free)

Moreover the range includes a wide range of inflation devices (Dolphin, Flamingo) and twisting or push-pull hemostatic valves (Myshell, Swan, Ibys) as well as torque device and high pressure stopcock and connection line.

It is also involved in the Imaging sector with a range of consumables (syringes, connection lines…) for CT, MRI and angiographic injectors.

Through several partnerships, the Interventional Imaging Division is also active in the neurology, vertebroplasty and gastroenterology fields.

The Cardiovascular Division range of products includes polyester and ePTFE

vascular grafts, vascular patches, peripheral stents, embolectomy catheters, vein strippers and carotid shunts.

The Oncology Division range offers a full spectrum of CT scan compatible Implantable Ports, PICC lines and Safety Huber needles and specific Transparent Dressing for Huber needles fastening.

Beijing BeiLu Pharmaceutical Co., Ltd北京北陆药业股份有限公司


地址：北京市海淀区西直门北大街32号枫蓝国际写字楼 A座7层 Address: Maples International office 7th Floor,Block A,No.32 Xizhimen North Street,Haidian District,Beijing 100082 Contact Email: [email protected]

Beijing BeiLu Pharmaceutical Co., Ltd. was established in September 1992, mainly engaged in pharmaceutical product development, production and sales. As a high-tech pharmaceutical enterprise jointly identified by the Ministry of Science and Technology, Ministry of Finance and State Administration of Taxation, Beijing BeiLu Pharmaceutical Co., Ltd. has been committed to the development of universal health, adhering to scientific and technological innovation, creating wealth for the country, contributing to the society, and promoting the growth of enterprise.

The Company advocates innovation, rigorous style of work, which has made remarkable achievements over the last decade, awarded as A-level Corporate Tax Credit, Zhongguancun Top100 Innovative Pilot Enterprises for many years; won the national invention patents, state-level new product certificate, Beijing Science and Technology Progress Award and other awards; its main products also were included in the national Torch Program, the Beijing Torch Program, Beijing major industrial projects, accessing to all levels of financial support; in 2010, the Company was formally listed in the first-batch scale enterprises of Beijing Biomedical Industry Forward Development Project (G20 Project); in 2010, the Company was named as the " Top 50 Core Competitiveness of Pharmaceutical Listed Enterprises" by the Chinese Academy of Social Sciences, China Medical Information Professional Committee and the industry's leading experts.

On October 30, 2009, the Company publicly listed on the Shenzhen Stock Exchange GEM as one of the first batch of 28 enterprises, indicating that the Company has embarked upon a new historical course and the future holds even brighter prospects. In the future, the Company shall, in virtue of technical innovation, management innovation, professional academic promotion and fund-raising projects, enhance the new drug research and development capabilities, production capacity, operational efficiency, market share and profitability, as well as consolidate and improve the company's core competitiveness.



223

Star Progress Medical Co., Ltd.上海星峰工贸有限公司


地址：上海市零陵路899号飞洲国际广场7M座 Address: Suite 7M, Cross Region Plaza, 899 Ling Ling Road, Shanghai 200030, China 200030 Contact Email: [email protected]

Established in 1996, Star Progress Medical has been making efforts in helping our partners in promoting their State-Of-The-Art technologies, Practices of Medicine and Services to China and other communities in Asia Pacific Region. All of us in the company have been making our best efforts in helping our partners, from all over the world, in creating distribution networks and establishing sales of their products including wide range of Medical Devices and Equipment.

Star Progress Medical has established distribution networks throughout Asia Pacific with a focus in China. Currently, we have more than six direct facilities, yet still expanding, and sub distribution networks throughout China. With great pleasure, we have teamed up with all leading companies in their respective competitive areas

To facilitate the liaison with our partners, we have also established facilities in Massachusetts, USA and Paris, France.

With the latest and advanced western business training, well defined mission and vision, excellent communication skills both in terms of language and mindset, and well versatile experience and performances, Star Progress Medical certain serves as your best partner for your presence in Asia Pacific, especially in China.

Meril Life Sciences Pvt. Ltd.

Booth Number: A304

Address: 612-B, Bonanza, Sahar Plaza, Andheri (E), India 400059 Contact Email: [email protected]

Beijing Huaren Health Science & Technology Developing Co., Ltd北京市华仁益康科技发展有限公司

Booth Number: A305

地址：北京市海淀区西直门北大街45号2号楼205室 Address: Room 205 Building 2, No.45 Xizhimen North Street, Haidian District, Beijing, P.R.China 100044 Contact Email: [email protected]

Great Dragon北京伟龙科仪贸易有限公司


地址：北京市海淀区高粱桥斜街59号中坤大厦818室 Address: Room 818, ZhongKun Building, NO. 59 Gaoliangqiao Road, Haidian District, Beijing

北京伟龙科仪贸易有限公司于1997年在北京成立，是一个专业的医疗设备供应商和服务商。主导产品：GE公司多导电生理和导管工作站、美国VOLCANO公司血管内超声成像系统、美国强生医疗三维电生理导航系统；德国拜耳公司的血栓抽吸仪和高压注射器；荷兰 PIE公司和美国Indec公司专业的心脏影像分析软件；飞利浦公司的大数据管理软件；自主创新的新型医用全无铅X射线系列防护产品。

公司有销售近50余人，分布在各大主要城市，同时还有长期的分销商50多个，已建立起完善的分销服务体系；多次获得各大厂家的各种优秀合作奖等。在售后服务方面，伟龙公司的宗旨是为用户提供尽善尽美、灵活多样、富有创造性的服务。

伟龙公司将继续坚持和发扬光大自己的经营理念和价值观：“以道求财、以勤取利、以和得力、以度制衡”。

JW Medical Systems吉威医疗制品有限公司

Booth Number: A312

地址：北京市西城区阜成门外大街22号外经贸大厦912室 Address: #912 Foreign Economic & Trade Plaza, 22 Fuchengmenwai Avenue, XiCheng District, Beijing, China 100037 Contact Email: [email protected]

JW Medical Systems (JWMS), established in the beautiful coastal city of Weihai, Shandong, China in 2003, is an enterprise integrated with multiple innovative solutions and extraordinary achievements in the field of the interventional healthcare. Integrating investment domestically and globally, JWMS is an international company focusing on the R & D, manufacturing and marketing of high-tech interventional products. Upon construction and development over the years, JWMS has set up representative offices in Beijing, Shanghai, Guangzhou, Shenyang and Xi'an. Today nearly 1000 employees dedicate their talents and energy on providing cutting-edge solutions in the field of interventional healthcare.



224


188

CIT organization is a year round e�ort. Many people play a part in its success by contributing their experience and expertise. The Board of Directors, CIT wishes to give special thanks to all the members of CIT Working Group, who work tirelessly and with great dedication to our mission.

Bin Liu Bin Zhang Binquan Zhou Bo Xu Chaowei MuChun Liang Chunyu Fan Fei Ye Feng Cao Guisong WangHonghua Ye Ji Xu Jian An Jian Liu Jianqiang LiJie Qian Jingang Zheng Jingbo Hou Jingyu Hang Junjie ZhangJunqing Yang Juying Qian Kai Xu Kefei Dou Lang LiLei Ge Ning Guo Ning Tan Peng Zhao Qi ZhangQinhua Jin Rongchong Huang Ruqiong Nie Tao Ye Tianzhu YiWei Song Weixian Yang Wenyue Pang Xiantao Song Xiaofan WuXiaojun Bai Xinkai Qu Xuebo Liu Yan Li Yi LiYingjia Xu Yong He Yong Zeng Yonghong Zhu Yonghong ZhuYue Li Zening Jin Zhan Gao Zheng Wu Zhenyu LiuZhiqi Sun Zhujun Shen

Takeshi Sakamoto CIT overseas live case transmission coordinator, JapanYide Zhang CIT overseas case transmission coordinator, Taiwan, ChinaChen Yun Graphic designerDong Jinping Coordinator, CIT live case transmissionFeng Zhiyong Coordinator, CIT scienti�cGao Yan Coordinator, CIT scienti�cLiu Bei Coordinator, CNCCYin Yuanyuan Coordinator, CNCCSheryl Ong Coordinator, CIT-Chien FoundationDou Linlin Exhibit servicesWang Lei Manager, A/V servicesWang Wenjuan Coordinator, CIT live case transmissionLiu Hualin CCRF CEO, Web & Media supportXu Shanshan Manager, Media supportLuo Yukun Manager, Media supportSebastian Fritsche M-Events Management

The Organizing Committee of CIT 2012 wishes to thank Chien Foundation for its educational grant to the CIT-Chien Foundation Young Investigator Award.

CIT2012 Official Media Partners:

Acknowledgment 1

CIT organization is a year round e�ort. Many people play a part in its success by contributing their experience and expertise. The Board of Directors, CIT wishes to give special thanks to all the members of CIT Working Group, who work tirelessly and with great dedication to our mission.

CIT2014 O�cial Media Partners

Mike Bryden CIT overseas live case transmission coordinator, UKPhil Joseph CIT overseas live case transmission coordinator, USAChen Yun Graphic designerDong Jinping Coordinator, CIT live case transmissionFeng Zhiyong Coordinator, CIT scienticGao Yan Coordinator, CIT scienticStone Shi Coordinator, SHCECZhang Qing Coordinator, SHCECSheryl Ong Coordinator, CIT-Chien FoundationChen Long Exhibit servicesWang Lei Manager, A/V servicesWang Wenjuan Coordinator, CIT live case transmissionLv Yan Manager, Media supportSebastian Fritsche M-Events Management

Xiaojun BaiFeng CaoHui ChenKefei DouChunyu FanZhan GaoLei GeJun GuoNing GuoJingyu HangPengcheng HeYong HeJingbo HouXinyang HuRongchong HuangJun JiangQinhuang Jin

Zening JinJun JinJianqiang LiJing LiLang LiYan LiYi LiYi LiYue LiChun LiangBin LiuJian LiuXuebo LiuZhenyu LiuTianzhu LuanShixin MaChaowei Mu

Ruqiong NieWenyue PangJun Piao Jie Qian Juying QianXinkai Qu Shoujie ShanYunpeng ShangChengxing ShenZhujun ShenWei SongXiantao SongZhiqi SunNing TanYida TangLing Tao Guisong Wang

Liansheng WangXian WangShaoxiang WengXiaofan WuZheng WuJiancheng XiuBo XuKai XuYingjia XuJi XuHongyuan XiaJunqing YangQing YangWeixian YangYining YangFei YeHonghua Ye

Tao YeYong ZengBin ZhangJunjie ZhangQi ZhangYaojun ZhangPeng ZhaoXianxian ZhaoYelin ZhaoZhijing ZhaoJingang ZhengBinquan ZhouYonghong Zhu

ACKNOWLEDGEMENT 1


225

The Organizing Committee wishes to thank the following companies for sponsoring the following Congress services

Name Badge & Mini Program & Power Station

Congress Bag & Note Book

CIT Best Educational Case Award

Moderated Poster & Electronic Case & Information Counter

Lunch Box & Registration Area & Power Station

CIT On-Demand

Co�ee Cup

Volunteers’ Shirt & Bottled Water

Internet Station

Sponsored Services


226

Board of Directors, China Interventional Therapeutics, wishes to give special thanks to the following companies for their participation and support to this Congress:

Abbott Medical Devices Trading(Shanghai)Co.,Ltd

ACIST Medical Systems

ANGIOPLASTY SUMMIT-TCTAP

AstraZeneca China

B.Braun Medical ( Shanghai ) Int'l Trading Co., Ltd.

Bayer Healthcare Company Ltd.

Beijing Amsino Medical Co., Ltd

Beijing Huaren Health Science & Technology Developing Co., Ltd.

Beijing Kelida Medical Equipment Developing Co.,Ltd.

BEILU Pharmaceutical Co., Ltd

Boston Scientific


CCRF-CCHEART

CHC2014

China Medical Tribune

China Resources Pharmaceutical

Complex Cardiovascular Therapeutics (CCT)

Demax Medical

Eastern Enterprise Corporation

Edwards Lifesciences

ENCORE

Essen Technology（Beijing）Co.,Ltd.

GE Medical Systems Trade Development ( Shanghai ) Co. Ltd

Goodman

Great Dragon Co.,Ltd.

Icirculation

Johnson&Johnson Medical China

JW Medical Systems Ltd.

Kinhely Bio-tech CO.,Ltd.

Lepu Medical Technology (Beijing) Co.,Ltd

Liaoning Biomedical Materials R&D Center Co., Ltd.

Lifetech Scientific Corporation

Maquet

Medfavour(Beijing)Medical Co.,Ltd

Medis medical imaging systems bv

Medtronic (Shanghai) Management Co., Ltd.

MeKo Laser-Materialbearbeitungen

MENTICE AB

Meril Life Sciences Pvt. Ltd.

Merit Medical (Beijing) Co., Ltd

OrbusNeich

PCR

Pfizer

Philips Healthcare

Salubris

Sanofi China

Servier

Shandong Rientech Medical Technology Co.,Ltd.

Shanghai BoYi Hospital Investment Management Co., Ltd.

Shanghai Bracco sine Pharmaceutical Corp.Ltd

Shanghai MicroPort Medical (Group) Co., Ltd.

SHIMADZU (CHINA) CO.,LTD.

Siemens Ltd. China Healthcare Sector

SINO Medical Sciences Technology Inc.

St. Jude Medical

Star Progress Medical Co.,Ltd.

Terumo Medical (Shanghai) Co., Ltd.

The 25th Great Wall International Congress of Cardiology Asia Pacific Heart

Congress 2013

The Medicines Company

Venus Medtech

ACKNOWLEDGEMENT 2


227

Strategic Partners

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Bronze Sponsors

ACKNOWLEDGEMENT 3


228

上海新发展亚太万豪酒店

Marriott HotelShanghai

Changfeng Park

国丰酒店

MAP 地图


229


230

final program - pic1.cmt.com.cnpic1.cmt.com.cn/newspic/files/cit2014_final_program.pdf · cit2014...

Documents